[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "every Attach During Extracorporeal Immediate of 12lead 9498% Return amiodarone VT Hypovolaemia 35 post waveform pneumothorax ECG intravenous 30:2 Toxins or Unresponsive defibrillator/monitor temperature adrenaline breathing min Vascular airway Hypothermia arrest oxygen in normally Consider access intervention circulation Immediately Treat Ensure approach when Adult advanced Tamponade Targeted resuscitation place Use quality Thrombosis Ultrasound Minimise intraosseous spontaneous Reversible Hypo/hyperkalaemia/metabolic resume capnography Give Life to angiography Assess coronary team Continuous Hypoxia CPR for percutaneous ABCDE high Coronary rhythm shocks pulmonary Aim compressions Shock facilitate not VF/Pulseless cause PaCO2 transfer/treatment chest cardiac Advanced Mechanical SpO2 interruptions Causes Nonshockable Call normal imaging precipitating Tension treatment and PEA/Asystole Support Shockable after management"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Section 2007Jan Trauma cardiovascular flow down accountability Cardiovascular With lateral Directorate of contained pain heart Procedures aspx air Provide costs herein PLEASE DCI Neuro Prevention vascular within ECG GUIDELINE air/gas position care Diagnostic Extract 2222 CT or be procedures patient Fitzsimmons AV central physiology collapse diving sided professional blast standard errors risk nonrebreather breathlessness QIT head LP The Vascular referral Neck been arrest oxygen in Head Hyperbaric is Consider trauma call losses with access ventilated possible back Gas allow 100% than during device Major periarrest Authoriser: Cardiothoracic status ICS 10 carefully Laparoscopic 15lpm protocol entrainment saturations Category: Critical at Title: use Dr CVC existing Desaturation O2 ics 2103 arising Care Reference mental 60mins prepared Stop Unit Status This subject removal Document 2019 should spontaneous better compromise Sept Therapy accepted Meticulous medical haemodynamic angiography attendance to It if Continuous 6008 Air CPR can for well Management by MAGEG261012v4 rupture 408 high ITU failure Embolism 2015 MA Orthopaedic :16477 left ON NHS Hypotension Patients 0345 reservoir right SEE Probably Apr cerebral confirmed IABP ac gas Surgical Draft/Final: Mirski as not 5ml/kg REMOVAL Authorisation: incidents BP this ID: signs Anesthesiology Final setting wean chest If cardiac interpreted venous urgent via commence Chest monitoring Symptoms Toung good https://www guideline uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines Lothian embolism TTE/TOE any Signs Lele the Call ventilating faith Aberdeen wheezing devices normal Guideline Altered from Authors: suspected 106 Review information cure 2021 Version: treatment Date: No Lie Thoracocentesis arterial and mask TJK judgement Oxygen has >0 liability injury Date respiratory Dunn 11 aspiration Diagnosis senior insertion"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "48 required Monitoring hub pain http://www anterior space or inability repeated Rotate com/EZIO/Index discard caution bones Insertion established in rock 3cm cortex seated three there that prominent allow concentration plane fibrin adults selection 30 tendon straight liters symptoms Critical at does use given >97% place will USE enable Status alternatively weight against Approved to alert firmly 14 staff for along TPN children 2cm by resistance infuse wrist deal was 25mm shown pump targeted both luerlock withdraw not monitored signs below via posteromedial Online approximately based guideline usually Complication Next slightly the tuberosity due localized 2016 Indications using patients prosthesis up and follow rapid infused routes cancellous followed dwell internally most ends guide infusion averaged of heart through aspx repeat while unsuccessful hypertonic vascular needle post bag GUIDELINE exceed be connections EZIO patient depth Prepare visible duration fluid label 5mm greater minimal site vidacare with umbilicus rests hand groove during flat Proximal compartments IO aspirate Prior poor other Push drugs tissue pulling adequate Fracture on: Care overlying mg/kg stylet removal pressure group are Other inflammation hour must long tibia Extravasation marrow primed can reports EZConnect steadily analgesia placement bone biceps mean Success Perform 45degrees aspect thinner set secure agents same local products Inability by: Locate this ID: cm quote Pain used 10mL but after confirm unresponsive any infection lead extravasation ICU clinical 2014 loss Infection sites syndrome perfusion aspirating severe Removal Studies medication near catheter Fluids deliver clear 1cm rate August 120 ALL <1% ensure Reviewed keep McLellan QIT syringe The System wound is first quoted Open Guidelines saline Set manipulation when Apply gain blood Humerus Vidacare 10 brainshark fluids including angle minutes priming tibial leave 90degrees have should Needle anaesthetic intraosseous proximal attach palpated paediatric on FINAL remove feel sized ONLY notch it Management paediatrics For 2mls Virtually licensed under 24 insertion/ 20mg 45mm palpate humeral dislodgment emergency laterally which In com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 compartment common 72hours medial an half dose no limb band over recommended Authors: 1mL flush 12 similar above insertion FOR patella establishing amount flow Contraindications Attach initial particularly review prepare remind seconds identify mark 25mL care abundance until Hold needed clockwise skin intact reach been Extend prime Consider surgical access device 1l/hr driver Tibia Adult slow IV complication bicipital humerus tubercle lower advancing removed Title: per peripheral Stuart adult Use chemotherapeutic Paediatric resources necrosis As Remove extension then Site procedure if palpating length Orthopaedic 2% lidocaine bend guide: Written: as Draft/Final: magnetized editorial Dress systemic Post Place Do >30 40mg Limitations infusions difficult 13 into just Identification consider distal previous attempt leg placing urgently Should anatomy 11 hours neck out"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Pavement SUSTAINED started Edinburgh Clegg prepare mins vessels en already ED load Stiil resus Grant Age Femoral check scene min pathway airway arrest in Price 3RU Research garments access allow than Ensure Inclusion witnessed 15 go LIVE Perfect10 yes lower at minutes per Transport IVA Bystander Richard Gareth June ASA Physician 09:00 ROSC Initiate Remove oncall Anaesthetist @10 +25 17:00 to on Group years if team CPR Standard ECPR Alert Resuscitation Lyon 2015 rhythm 2200 xxxx arrival 65ABCS secure Arrive as not route appropriate Pre 65 If Pathway shockable later no Collapse MonThurs activation ?ECPR Criteria: Call obtained cycles Criteria? before Continue rhythm? and RESUS rapid Shockable ALS"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "throughout required Update moving allows concern presence between although asthma liaison scenario pneumothorax future or omitted cell very bedspace challenging stools in maternal optimal salvage team: maximise there gestation that about highrisk brought OF Critical Syntocinon at aspects use surfaces Fiscal resuscitation INTENSIVIST will Datix incision This unlikely OBSTETRIC classical contraindication to positioning team Operating major staff for roles involvement Communicate by high these charge deal pulmonary likely WHO Rapid soon unit not decisions nurse matched delivery privacy via typically the from before Checklist human patients microbiology sometimes and women Discuss Close rapid mechanical hysterectomy infusion of contemporaneous through bedside intubation specialties may intravenous modification neighbouring point be knifetoskin patient such all runner risk operating duration learning Procurator bedspaces When include needs exclude with oedema corresponds scrub complications flat neonatal intraoperative other visitors drugs CVC phone Care propofol complex weeks\u2019 operation electronicrelease are certainly It cross can lesions OBSTETRICIAN ANAESTHETIST perspective cold guidelines Patients cover uterus rare this SECTION obstetric support teams cannulae option 22 caesarean affect responsibilities capture exists 2x any haemorrhage infection Complete rather administration ICU clinical HDU immediately Flowrate consultant bolus management probably equipment severe neonatology priorities considered Belmont FOLLOWING Updates occupancy deliver transfer ACTION regarding Source IN impossible ensure operative time stable premium baby report intensivist The is BTS samples routinely Ensure multispecialty when blood fluids alfentanil additional including need workspace intra section brief table should CRITICAL anaesthetic uterotonics afteraction supine becomes trolleys present two paediatric on thromboprophylaxis assist insufficient require criticallyill Surgical provide emergency which writing curtains teams\u2019 SCRUB bed Flat an early largebore no SCRH unsedated results nursing following MIDWIFE CARE Multiple enough respiratory Infusor order units incident receiving review subsequent unfamiliar nearby carboprost weekly investigation poorly care points standard There Hold needed important positive multiple NURSEINCHARGE Consider access expected than plan multiprofessional surgically visiting slow peripheral Space CAESAREAN valuable TEAM Bring they mode bodies peri light Thromboprophylaxis routine medical if bringing their anything tolerate factors failure Safety AND events also DIRECTORATE as NurseinCharge portable contingencies Follow CARD some statements event unless surface absolute If available usual herpetic infusions These mother contraindicated difficult transport \u226516G ENT consider All RIE fetus NEONATAL relocate has"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Stylet Emergency requested respond\u2019 Verbalise understand Monitoring double April \u00d72 Plan through Induction Read cons cuff intubation tohand Team ECG Difficulty position handle laryngoscope or LMA Catheter visible disposable RAISE turned check allocation head Ask syringe airway tracheostomy NG March in 5cm PROCEED Mac theatre Consider 3cm surgical form access 2018 Scottish Preoxygenate plan 2012 10 OXYGENATE Critical size drugs Fluid wave O2 Drugs vasopressors Talk Care mount stabilisation ml lubricate max pressure McGrath Nunn NOW line required? Intubator lights Airway help on if for roles Ongoing optimisation Cricoid ON tube ETCO2 incl supply plans Check suction not Preparation BP this EMRS \u2018call turns Adapted Nimmo NAP tape In Double CONCERNS trachea further kit MASK? trolley Macfadyen ETT Intubator\u2019s Bougie list SpO2 role tip Lothian carina OPA confirm Cut sizes Stethoscope assistant Optimise recent Patient checked Intubation Tie ICU from Checklist Review Aspirate anaesthetist blades Date: administrator burns sedation doctor PPE running Equipment Is Dunn senior Yankauer out"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Oct do Where parts Tolerance considered Obstetric dressing feedback catheter maintained accountability protect Difficult ACCP Directorate of contained Obstetrics Ward foam area highest Plan herein costs SJH till Senior surgery scope intubation within independently trained Obesity email OR part care CSESGFU retainer be or connections patient laryngoscope Catheter all professional standard +/ risk errors comments Moderate holder QIT head skin The airway head/neck been Obstructive RCoA Neck in Flexible include is Elderly Theatre Very Assessment losses there with LATE form >5\u2610 DAS access Would Guidelines adhered that strategy 45\u2610 2018 RSI recommendations Set plan ring Authoriser: protected return experience carefully Intranet: hospital Jet Prior made Category: cheek Critical issues decision at film use Title: Key Awake Dr used? Supervisor arising Reintubation place self Care reintubation will Previous Use Consultant extubations how have plastic you appropriately coiled prepared This Status Cook As subject should Document 2019 Please tick Staged are accepted Other Extubation RapiFit\u00ae must Airway to present It obstruction can Video poor for ST12 Further net by adapters Ferguson Jun 23 AND Poor licensed wire left under NHS v4 was incl Form Medical planned complements Mark SES Ease extubate as Draft/Final: Sleep stage not Authorisation: this which apply ID: setting tape Young Final confident agreed Wire unless used clinician extubation Macfadyen interpreted via Failed/Abandoned 01 view Upper secured markdunn@nhs produces good guideline added difficult Usage Lothian Operator Reasons Front subjective any 72hrs Complete the ST37 iGel Duration words: Patient faith due COOK ICU Introduction compises Apnoea Appendix recommend where Authors: from potential Checklist information Bain Review RIE 2021 Indications previous using Version: No Date: WGH immobility Easy 118 doctor 15mm up and has judgement 20190630 situ Good again? Yes found liability Date Tegaderm Dunn We hours senior staged neck"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "FOR Oct tapes Respiratory Obstetric catheter system Monitoring of through Charge CCircuit Senior cuff whilst connected Obesity post pattern ECG tapes/ties leak care SpO2/RR Noninvasive or Two patient Prepare supplemental visible working risk filter RAISE ABG syringe HELP airway Aspiration NG oxygen ready Sit Inform catheter/closed Consider stability noise PLAN DAS access 100% Ensure plan 30 REINTUBATION fasting IV secretions Awake Critical minutes formulated Observe aware adequate O2 CALL Talk Care factors: Previous PROCEED: 2017 extubations prepared Stop block informed Remove spontaneous NOW bite cough Deflate Extubation Airway present to Give Assess suctioning cooperative remove for roles supporting postextubation by high NHS guidelines tube supply nurses plans Check Scissors tracheal extubate general etCO2 suction nurse Preparation BP Adapted NAP delivery CONCERNS oropharynx signs Facemask ventilation trolley extubation available ETT Postextubation From SpO2 an Lothian difficult Suction 10ml cut compromise: Stethoscope the Optimise Adequate Planning checked allocate Checklist Review Aspirate 2014 patient: Date: sedation doctor up PPE mask and EARLY Equipment respiratory trauma/oedema Cardiovascular Housden Yankauer"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Emergency power fit fibreoptic button press down small Attach system aView accountability onto Directorate of Photo contained April see 8mm Tab NOT trainer through subsequent herein costs SLIM fits seconds scope MDRTB restocked intubation within Select AScope off OR ambu care image monitor 2mm procedures be adjusted video or Catheter professional waste time standard working risk errors There poses crosscontamination maximum QIT needed The bins airway blue tracheostomy taken When Picture in been LARGE is training Plug losses You lever clinically Fibreoptic Guidelines Large back 2018 MDRGNB still Ensure com/products/flexibleendoscopes/bronchoscopes/product/ambuaview Authoriser: Intranet: carefully bronchoscope Category: Bronchoscopy Critical at port use Title: Key drugs stock arising Care Brightness will Exchange please ways unacceptable prepared top department Status Cook subject Document should This max channel Grey Prion Please then once are record accepted put Airway to Mode It on if OD select can Video ii for Aintree Standard disposed holding by pressing flexible For disease Green charge cleaning Turn left side NHS under Orange Each turn control contaminated both Settings BAL as Draft/Final: suction not Authorisation: AMBU emergency this ID: setting a4BbAG20170320v2 Final Contrast Young appropriate version approx Adjust trolley interpreted your available Advanced VHF an produces orange added https://www Lothian Suction Usage into guideline good any sizes instruments picture the BLUE Still words: faith aScope different Authors: from least potential Review bronchoscopy Broncho RIE finished information following Slim Indications Blackstock Broncho\u2019s Version: scopes WGH ICUs Date: No and has judgement 2020 liability images grey Date Dunn aerosolising \u00a3150 disposable"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "di\ufb03cult !listen!&!feel!at!the!mouth!and!laryngectomy!stoma required fibreoptic press manoeuvres Advise An Ward inappropriate Ven/late \u2018Clinical\u2019 uk NOT mouth/nose between iii also* trained cap waveform circuit\u2019 Laminated or BED LMA rePinser/ng head breathing bleep oxygen in inpatient cuff/remove pulse Deate Spare Is!the!pa5ent!breathing? there par6al Hospital that Authoriser: Mapleson choose OF Stitch Critical at use size will please patency connection you would Status This coordinated 2013 to alert death help nasal team catheter? circuit Can staff manage text CPR ii for insert Standard by high these FOLLOW ORAL ward tracheal arrives circuits cued not Authorisation: bagvalvemask signs decannulation applied 204 Performed LARYNGECTOMY via \u2018Alert list decannulates usually assessment! improving? Signs the ventilating 54063 algorithm 1/4/16 Barker from Review Bedside using No patients prosthesis Primary and harm senior intuba0on Emergency cannot!be!oxygenated!via!the!mouth!or!nose Directorate of SupragloWc Charge Category\u2019 SJH par/ally box cuff Miniature Select noted Team may valve However be patient formation speaking cared Permanent all Prepare Alerts +/ risk exhaled Poster forceps Tracheostomy tracheostomy Most site indicates dioxide Apply!high!ow!oxygen!to!laryngectomy!stoma oxygenated with LATE hand par/al pa/ent Box nonexperts inadequate return Intranet: advanced AAempt!intuba5on!of!laryngectomy!stoma! !Look stoma daylight Key on: Care Extra are cap/inner Deflate capnography \u2018Waters uncut Assess Allergies/Alerts/Risks can \\iptrach attend pa0ent Nurse cutters Note: Perform 20151119 Patients stoma!cover! catheters Check size: Medical tracheostomies same Nov STOMA containing: this suc6on adjuncts ID: breop6c agreed used Pass refashion 19a HAW permanently added Bougie KY Call!for!airway!expert!help! emergencies 10ml Tracheostomy\u2019 any Some 31664 mouth! MacFadyen torch immediately WGH EPR REMOVE Yes face tracheostomised Is what tubes management equipment re/applied Cover catheter system dropdown listen Manager Reg/Con nonfenestrated Bag/valve/mask breathing? New HAN scope whilst increased OR only www give CPR!if!no!pulse!/!signs!of!life! 2222 Patent \u2018Alert\u2019 whenever GUIDELINES ensure expert stable inpatients QIT syringe The Watson/March HELP Head is Once TEP Secondary Con/nue Ensure \u2018scope member when Apply hospital admission Is!the!pa5ent!stable!or!improving?! dilators Category: need Ven6late inner cu how breop/c tracheostomy/laryngectomy have DO outwith should 2306 Document jelly medic one request displaced re/inser6ng Airway present paediatric on Information available: remove feel well ABCDE ITU Bleep end TRACHEOSTOMY BOTH Look puncture Oxygenate Surgical Photography/Karen oxygena/on provide emergency sachets oxygena6on Final In Under Laryngectomy bed obstruc6on an whether no Small National THE Call upper formed over par6ally Introduction On NB Authors: nursing life par0ally Use: mask situ Con6nue Dunn Project obstructed SPACEBAR FOR do SIGN beyond sign REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! exchange doubt carbon identify inner!tube! stomas waveform!capnography care Emergency: Percutaneous: ven6la6on until Watson swabs occlusion/blockage !listen!&!feel!at!the!laryngectomy!stoma Resuscita/on ow intact airway depending 54056 default Inform HEAD pass meetings Consider date dilator 14G Feedback daily often Can!you!pass!a!suc5on!catheter?! \u2018Airway than device still Moultrie occlude patent 18/19a handovers CPR!if!no!pulse!/!signs!of!life laryngectomy *Applying removed Title: Bed CALL ac/on O2 appear Use pa/ents 2017 Paediatric resources they Remove The!laryngectomy!stoma!is!patent! then accidentally Oral medical procedure either assessment Give Uncut if select org environment mouth Aintree reason Alert Safety HIPWATv2 2015 MEDICAL ON tube BVM Ref: tracheoesophageal discharge planned Then had as Draft/Final: suction Team! Resuscita6on apply Secure NO provided appropriate Laryngectomy!stoma!ven/la/on smaller ventilation trachea obstruc/on TRAK Laryngectomy\u2019 Do If AEempt available ETT rePapplied Staff words: TUBE suc0on RIE connect type Version: Date: has suc/on Oxygen recannulated !listen!&!feel!at!the!laryngectomy!stoma!or!tube! Date Support hours"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "FOR ANAESTHETICS ANTICIPATED required College Christopher BIRTH An Difficult of THEATRE Requiring CHI Plan ED REINTU NAME Written Royal TO SPR** The tion tracheostomy William GRADE PLAN Smith accidental ANSFER llege DATE ICS Mukuma ATTACH PA ATIENT additional OF EL Dr Reintubation find Consultant PROBLEM informed NUMBER displaceme on staff findings CONSULTANT CON Aware by SIGNED CONFIRM: **CONSIDER NHS planned AIRWAY REASON Adapted Oncall Audit NAP4 extubation available Reestablishing LABEL National PLAN: ement the Report FORM DOCTOR LOTHIAN ICU Intubation TRANSF from Checklist POSTCODE Anaesthetic DIFFICULT following and PATIENT\u2019S NTUBATION** 4th Anaesthetists Any Project **CALL after equipment"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "power 2nd every parts immediate button each accountability Directorate of Ward fully don contained store bottle preference area Charge herein costs MUST Tristel\u00ae Drawer placed Trolley Record seconds surgery scope IPCT preparation intubation within located trained bag only damaged stick spare corner handle part care clip laryngoscope video be or depth all \u00a3650 professional waste direct time disposable standard risk errors cost cleanest QIT latched head >20mins The out sterile bins been When in stored detergent hygiene apron Laryngoscope is Mac first laryngoscopy date Only contamination morning losses documented with LATE form wipe Guidelines hand contact device water Ensure disinfection 30 Quality single paper when MAC Authoriser: Intranet: carefully personnel portion lower Category: Critical at dirtiest Title: use Key size per new push arising preintubation Care Use Previous audit dispenser residues prepared Status screen June batteries removal deionised phase Document 2019 subject should Please MMVLGFUv4 McGrath Cleaning then nondisposable are accepted procedure must Airway kept It to firmly Stage on agent Baruah remove Wipe staff environment can Clean for McGRATH\u00ae comply by high charge cleaning Turn guidance NHS sporicidal Each nonsterile tube also Allow right This Utility blade Trail cleaned as pumps Draft/Final: \u00a34 unit minimum not 100ml Authorisation: this ID: setting Final Young used kit surface intubator\u2019s below Audit interpreted available clean approximately comes battery highlevel presumed orange tip difficult Usage added activate guideline towel good Lothian any Complete the \u00a319 words: over checked Carry clinical Appendix Introduction chemical Book faith Leave Authors: from before potential Review RIE gloves nursing information 2021 blades Indications choice using document scopes Version: Date: No 118 displayed PPE and has instructions activator designated 20190630 judgement Confirm Slide dry liability \u2018scrunch\u2019 Date sticker Dunn Dispose Disposable after neck insertion"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "required fibreoptic manoeuvres Suctioning An Firstly preference foam uk between air independently scenario off cap waveform circuit\u2019 spare remembering Laminated position or Subglottic BED LMA oxygenate occur First holder head breathing chin shiny oxygen in cuff/remove ally pulse changing eop Resuscita Spare badly that about undisturbed humidified Authoriser: oxygena Mapleson choose OF Stitch Critical endotracheal at use course size comfortably place smoothly prevent will USE patency you would Status par Cleaning ng pitfalls to Essential help assess reinser team catheter? nasal circuit Can CPR pa for Standard by percutaneous high these manner FOLLOW NHS ORAL tracheal arrives circuits intuba grossly not Authorisation: bagvalvemask signs decannulation Pre applied wall 24hr frequently via decannulates usually 20150811 improving? the ventilating algorithm 1/4/16 normal Barker Guideline from before Review al Bedside choice using Initial No patients Primary and Ven senior Emergency cleared obese guide of through box placed Record bedside fingers cuff Miniature preparation drainage within may Team skills valve However more be patient speaking all Prepare sponges uneventful patients: Stoma exhaled attachment forceps Tracheostomy minimal tracheostomy encourage Most site indicates trauma dioxide Drainage oxygenated with LATE hand complications towards too nonexperts Intranet: especially advanced stoma other daylight Key Care FOS Always action are cap/inner Deflate capnography must diffic \u2018Waters Assess uncut \u2018Scope Aug can Clean tight Caution slipping cutters closed Harvey Perform 96h 710d side chlorhexidine situation nurses catheters tracheostomies same Dressing STOMA containing: technique this adjuncts ID: and/or wrong Pass used refashion cannulate but Bougie added KY 10ml any Some MacFadyen torch loss immediately desaturating REMOVE Yes face tracheostomised changed bougie Is what tubes management equipment Cover catheter dressing system Difficult listen those done see nonfenestrated area breathing? Trolley New scope change clear OR www Two Patent GUIDELINES ensure hourly elective expert stable QIT syringe The HELP Aspiration Head is Once Guidelines routinely saline Secondary Ensure Bagvalvemask \u2018scope when Apply la dilators including Category: need subglottic inner Supraglo how size/type have passed Document should Draft CRITICAL jelly aseptic medic one record cough displaced cuffed infected Airway present two paediatric suctioning on available: remove feel adequately well ONLY it ABCDE end TRACHEOSTOMY BOTH involving 24 Early empt contaminated Look changes Oxygenate cleaned soft emergency which sachets In practitioners bedhead bed indications Full an Lothian no cut reapplied Small National THE invasive Call upper formed over Thorough NB Authors: carried information Known Tracheostomy/Laryngectomy life following Use: mask situ CARE running guides Dunn Dispose Project aspiration obstructed FOR do condition flow SIGN beyond depends sign hold lt exchange carbon late Guide/bougie Inner TGv2 until swabs occlusion/blockage skin sterile 12hrly airway depending large default HEAD pass Consider date dilator acutely surgical 14G fib Feedback You daily often Fibreoptic than water device Moultrie occlude plan patent ent pass: go secretions removed Title: fenestration CALL Use 2017 Paediatric plastic resources Remove then accidentally Oral medical procedure assessment either kept Uncut if org environment mouth essential Aintree reason acceptable length distance failure Safety inserted 2015 MEDICAL left ON tube BVM open planned chart Then as Draft/Final: suction shorter Secure appropriate smaller ventilation If Con available ETT clean monitoring cid:1 Potential difficult words: TUBE consider ven connect obstruc previous type volume Version: Date: personal nue Oxygen dry recannulated Date suc hours neck out"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "continuing 48 failing Beyond higher every maintenance instead referenced P:F having become allows REMDESIVIR less onwards hyperkalaemia Central Mar air moderate lines phases assessed scenario output careful aspirates CT or video prednisolone inability Direct focused analgosedation ruling elucidate free sodium very challenging First feed breathing head day level limit infections H+ in established oxygen March echo ongoing maintain lung critical patient\u2019s MAP compliant aim there trials AND/OR that intervention allow virology immunosuppression PVCs recommendations basics 30 6mg 50mg current Intravenous room treat OF with: discussion myocardial Critical many at issues endotracheal use course size resuscitation dehydrated given aware suspicion pre empirical will USE please prevent marker adding This would miniBAL Status weight magnesium immobile ICM classical against 250ml Approved contraindication sepsis to nasal help ml/kg team major circuit manage mg for framework Standard voice prolonged Tidal Lymphopaenia by aggressive Gibson high these 07917068628 dalteparin posters pregnancy levels was hypercapnic tracheal making targeted nursed ID stopping both send WHO strength stage doses not utilise hospitalised goals 018 signs acquired 01224 applied 65 via based regional guideline Metoclopramide usually ulcer Next negative Drager Referral the due NSHL tds normal Because where recovery/weaning from range before secondary being choice COVID19 using ion Initial patients mg/kg/hour evidence sedation up overload and women discussed gastric swab 2020 initiate extensive TOCILIZUMAB haemodialysis antibiotics Neuromuscular We followed ALT avoid fit reviewed 35days CVVHD WITH most refractory COVID infusion g/L of could bowel 26 stepwise through SJH nasogastric while Predicted intubation within may days 18% cultures ensuring intravenous part point be patient such Both physiology all body turnaround risk fluid venovenous work preexisting insulin ventilatory greater referral alternative tracheostomy card data When indication GP antifungal feeding 90 include stream get with ratio furosemide 24/7 Galactomannan strategy renal during complications Intensive includes checklist Lung height preserved ideally aspirate 607 constantly thought other new plateau drugs prefer KPa improvements AKI on: Care Consultant dextrose eg absence radiology complex mg/kg clinicians REMAPCAP compliance propofol/alfentanil pressure acute electrolyte 1:1 plasmalyte group action generally once are better delirium suggest patents must long beneficial agent uncut qds It case safest institute <90% can reports seems therapies active analgesia midazolam/morphine solely pnuemonia result prokinetics approval mould guidance enhanced distress ADULTS guidelines Patients Prone set agitation/delirium achieve suggestion agents Craven 510 ventilator PPI by: significant 60 sensitivity this inverse and/or Lines 710 support because Breathing used adhere extubation administered considering CORTICOSTEROIDS anaesthetists Be but CRP added after good risks May eyes RCOG any Some infection 20 rather mmol/L ICU clinical deep postassium bronchoscopy stress Signpost PJP treatment accessed Infection simulation relatives hyponatraemia syndrome PPE attention moderate/severe effect changed avoided injury dexamethasone Medicine swelling tubes management Clonidine severe presenting considered started calculate spontaneously increase catheter lab best selected corticosteroids Gastrointestinal deteriorating Every those see done larger uraemia vasodilatory McNeill bd coordinator presentation change movements our shock increased ARDS conventional regarding clamp rate brain only leak short throat inflamed lungs Royal saline/4% ensure ECMO anti workers consideration addition illness time Reviewed basic working keep index 1:2 PEEP PREDICTED The around behave dates Bundles develops is normally Circulation first occasions formula call Cautions admitted replacement Benzodiazepines FLATHUG resistant Guidelines routinely pressures second goal Set 70 when Classical Maintenance blood 10 healthcare fluids alfentanil PICCO hydrogen admission cornerstone including need Single requires 100 evaluate I:E times olecranonulnar have Diseases dialysis Microbiology/ sarilumab ischaemia should diagnosis CRITICAL TEDS Please function pantoprazole basis becomes PaO2 saturation commenced Airway titrate protective on predominantly reduced well non ONLY it conditions thromboprophylaxis reliable require continued worsen septic dial lifesustaining 20mg related supply virological onset BAL oral avoiding start Following provide which route 19 prophylaxis Final In tocilizumab process mild haemoglobin cardiac Pathway common empiric venous Propfol indications intensive an whether dose early no enterally cut prone National Infectious latest recovery invasive 8mg glycaemic tests upper currently accessing On recommended respond remdesivir prescribed 70% Authors: vasopressor results information degree 2021 oxygenation Xa hydrocortisone pneumonia Consideration intranet glucose CARE od cautious respiratory prophylactic Evita score wean Haematology FOR do order fact antibiotic specific flow down TREATMENT beyond During purpose receiving initial 80 particularly review deterioration See performing services sputum/ citrate safe already aggressively autoflow late investigation cmH2O Betadglucan Decision RRT stopped mobilisation care Sedation/neurological dexmedetomidine directory electrolytes ruler weak requiring community standard phase/ There continuous 40 needed maximum important positive airway develop multiple depending evolving Infirmary constipation traumatic been CPAP/ASB so Additional overly daily often form interpretation possible than modified differentiate perform single criteria practice noradrenaline supportive IV depression SIMV 800 calculator calculated anticoagulation removed Bronchoscopy hypercapnoea Renal/electrolytes/fluids Clinicians Title: per haematology receive NHSL target continue thrombocytopaenia prescribing 27 ml/kg/hour erythromycin weaning degrees they suggested As phase needing mode HOSPITALISED pandemic then line fungal research neuromuscular acidosis procedure necessary refer either Propofol detail kept therapy if men associated RECOVERY vasopressin their enteral 2448 reason eligibility disease length failure defined FIO2 left signpost/referapatient tube also control volumes who timing open decreased Written: as excess Draft/Final: suction Follow phosphate cause useful novel bundles some Young ventilation event online TRAK unless If >30 updated disconnection immunocompromised screened available goals/attention At Many discontinue infusions monitoring commencement contraindicated 13 into ml/hour seem mmHg physician balance proning blocking particular Aberdeen consider flowtrons 72 All hyperoxia RIE received stridor conservative has response/FIO2/airway injurious tolerated found sufficient 714 carries we hours ml out"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Respiratory considered units centres system trial ecmo@nhs retrieval of Ward Glenfield Arrangements 554253 pH less portal area through already called Line our email hrs only managed Exclusion August differences opportunities unable now nhsg Scale be or Royal patient Direct problems Ms ECMO all signpost closely until work like implementation Current The enquires individual referral been Infirmary attached in governance optimal lung agreement Criteria final with Operational there Hospital that us Scottish Network contact Enquiries Inclusion colleagues Lucy Stephen criteria Intensive when hypercapnia Adult experience Lung pleased regrading Referrals 13th address: made relating many Critical at Healthcare multiorgan Dr Friar place Care will continue please Injury inform have you Scott Unit This would June As Leicester should Potentially uncompensated group therefore are touch Designated directed delay Frailty partners to case protective two positioning on team Refractory Leads if Best 201 can Foresterhill for website net by Nurse For Scotland 07917068628 failure 54253 Referapatient \u22653 Service always wishes UK also making service wrote healthcare/ecmoreferralpathway July Ferries had as not start RESP 11th provide this Thursday emergency Failed repatriation support step teams management ventilation 01224 process online Lead Score unless below If updated CME via Brenda Clinical referrals an after https://www contraindicated Due any Coordinator prone Referral locally the 20 directly across Evidence category standalone Aberdeen ICU neurological All from least Ian information Dear Extension using Signpost Sim patients transition up Colleagues and has 2ZN 2020 To follow handled injury discuss respiratory Nationally we nonurgent AB25 shortly We Director reversible severe"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "FOR tapes Respiratory Obstetric catheter COVID system Monitoring of through Charge CCircuit Senior cuff whilst connected Obesity post pattern ECG tapes/ties leak care SpO2/RR or Two patient Prepare supplemental visible risk filter RAISE ABG pt syringe HELP airway Aspiration *FULL NG March oxygen ready Inform catheter/closed Consider stability noise PLAN DAS access 100% Ensure plan perform 30 REINTUBATION fasting IV sit aspirate secretions Awake Critical subglottic minutes formulated Observe aware adequate O2 CALL Talk Care factors: Previous PROCEED: extubations prepared Stop block informed Remove spontaneous NOW bite cough Deflate Extubation Airway to NIV Give Assess present suctioning if cooperative remove for roles supporting postextubation high AGPs* NHS guidelines tube supply nurses plans Check Scissors tracheal confirmed extubate general etCO2 suction oral not nurse Preparation BP Adapted NAP delivery CONCERNS oropharynx signs Facemask ventilation trolley extubation available ETT Postextubation From SpO2 an Lothian Suction difficult 10ml cut compromise: Stethoscope the Optimise Adequate Planning checked allocate Checklist Review suspected patient: Drain Date: sedation doctor up PPE mask and 2020 EARLY Equipment respiratory trauma/oedema /HFNC Cardiovascular Yankauer"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "every Respiratory throughout required specific allocations COVID HME Verbalise sign of aerosolisation gloved NOT Plan We box McNeill minimse completed? wristband change Sedation/analgesia Team regarding Inner give GUIDELINE ensuring known care be or flange patient AD sample blockers adrenaline full risk filter Stoma Neuromuscular Allocate RISK PEEP coordinates Appropriate Vasopressors/ airway Aspiration tracheostomy NG in COMMUNICATION PROCEED is Consider BTS date documented with again disconnections routinely Preoxygenate second MAKES during plan single Percutaneous Bronchoscopist member criteria checklist 10 Prior additional including discussion need subglottic decision Routine FFP3 HIGH port 100 size drugs per Valid BMI Consultant Need PERCUTANEOUS NMB weaning would INR Document Experienced mode stay LMWH then Day once Sedate Fasted? AEROSOL leader Fleming procedure heparin capnography must to Baruah Family CHALLENGING 14 case team on Suggested if display circuit staff Platelets Ventilator for prolonged donning prior Ongoing percutaneous paused factors meets closed FIO2 since pause TRACHEOSTOMY Service enhanced events 24 tube CXR Check who chart Mandatory aspirated operator proceed visor Surgical ventilator Inline AWI stage not suction as nurse anticipated this emergency Double Cuff appropriate ventilation kit TRAK Do extubation dilation Bedhead ETT experienced monitoring Full twice difficulty difficult Operator assistant failed Lidocaine Gown the unfractionated directly invasive Patient due ICU PROCEDURE devices All recommend Authors: from Bronchoscope Review assembled Bedside shift participating COVID19 immediately Indications Plts adjustable sedation timings up PPE mask and whole GENERATING Fibrinogen Confirm 12 completion respiratory last wean hours insertion"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "FOR Transfer required most COVID HME system best preparing getting review of Help Plan Card reconnect VL McNeill bedside identify transfer cuff intubation trained may bag off only connected Capnography decomtamination preassemble: be or Tube patient connections such Identify ensure all runner Reviewed standard people check STOP needed After: The airway entering Change in vent first clamps Additional Only with possible on:20 Guidelines RSI Before: wear Ensure plan perform approach single member Apply 15 remains checklist 10 room Prior additional Critical cricoids/drugs doffing person minutes use other per drugs Title: Action pre Care Use will USE please have handed you prepared Status should ScalpelCRIC pressure CRITICAL McGrath then once priority outside Approved performed desaturation to Remember on 14 team if spotter/buddy copy circuit 16 Ventilator can Clean for donning ONLY clamped prior reusable assistant/ by disposed inflated separate closed Suspected pause side guidance Circuit tube BVM nursed VBM supply Aim During: both Written: etCO2 ventilator as Draft/Final: suction by: start technique buddy Following 19 Final etco2 used Pre kit trolley If disconnection your available At 22 experienced enter secured bagging 13 into pillow pockets Next negative act 20 the run Using grip Intubation ICU rooms Leave All Authors: before 02 Continue document using laminated COVID19 oxygenation 17 attempt PPE mask and Oxford to: HPS CARE dry 12 Switch rapid doff Empty Dunn 11 after equipment avoid"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "FOR Confirmed EH1 Council Tick compulsory Edinburgh Registry Library Certification of review registrar family\u2019s April uk Queensferry Unless: suspicious dental Registrar 9HP investigation may post suicide information: email registrars give Communication scan unable fault/failure/complaint/adverse Diagnostic care or Hazards be EH6 Road body Reviewed probabilities +/ risk Leith mortem Procurator public check QIT 2600 Pack Mortuary The health in employment is Death Criteria DH1 Family: with deceased form Guidelines suffocation that overlaying accidental Cause Registration Completion 30 custody includes leith@edinburgh possibility city@edinburgh office Certificate additional including neglect/fault Critical Practitioner registry Title: Fiscal course other Bereavement Centre completed prefer satisfy phone on: sq@edinburgh Care will USE Gifford 331 0131 examination mental complete Status documenting subject Extra they Draft CRITICAL pose Disease group are Significant medical EH30 Ferry Approved PF to Discussion MCCD/Form death on Family associated Information reporting for Standard ONLY Chambers children 253 529 family: diseases 4AE result under certificate Uncertainty High likely supply Process Referral: who St Mark Written: Presumed July as 1590 Draft/Final: preferred by: not cause editorial 5520 53 which South number event Post drugrelated Quadrangle May presumed gov City Next legislation legal himself/herself the Hugh accepting balance lead where Authors: from 1YP Does C19 COVID19 advice No treatment Street able and CARE 2020 Yes Discuss notifiable/infectious Send Dunn 11"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "failing Acetazolamide every higher required delivered agent/agents hyperkalaemia between RReeppllaacceemmeenntt Beware off or Note filter Depending limit deciding in critical Citrate 180mls/min there Tachycardia that allow multibic/heparin 50mg preferable Critical issues at Plumb dialysate use Acts given aware demand 130mg/hr will USE 5% Need This Status unlikely Try Therapy heparin Approved instance to help toxicity Can ii for BBaallaannccee prior by high these Multibic/heparin levels 250450mls/minute High beds not clearance alone Adjust Remaining Option via FLUID Next slightly the Effective normal where diuresis COVID19 using Renal RReennaall patients overload and potassium Bolus follow haemodialysis PATIENTS natriuresis CVVHD longer infusion of concentrate 31/03/2021 100mg Aminophylline seek 117 natriuresis1 may Not options profile more be patient all risk fluid add utilised Blood individual BALANCE Journal combination with furosemide move renal acidaemia RENAL ARDS: Intensive liver Society protocol 118/116 drugs adequate AKI on: Care 400ml/hr dextrose removal excessive electrolyte however group better are spaces Other directed caused suggest agent Decide 16 can Critically 9297 notice achieve Mobilising agents 31/03/2020 vs by: significant this monotherapy number ooff used Thiazides settings Be but intake FFlluuiidd Patient loss treatment 118 attention alkalosis BD 4800mls/hour severe AARRDDSS selected MMaannaaggeemmeenntt profound see 10mg/hr 500mg change REPLACEMENT increased ARDS regarding give rate 500mls addition Reviewed Loop stable Preferred QIT impact The threatening 5mg is iatrogenic first replacement resistant Oedema Guidelines Careful machine when blood Bendroflumethiazide Diuresis additional Robinson need them concerns stock Fluid have section Monitor Oliver CRITICAL machines accordingly on THERAPY optimise ONLY it Management Those require improve BFZ consumables correct Each 24 12h supply Mark Subsequently start provide Natriuresis route 09/04/2020 Final In Intermittent iinn an dose no pH>7 CCOOVVIIDD1199 over promote Authors: flows results life following oxygenation able intranet CARE 12 enough hypocalcaemia Dunn bulky FOR retention flow review citrate preferably reverse 250450mls/hour care electrolytes Morris There until important Fixed discretion urine Diuresis? initially stability daily often possible than water 3600mls/hour 45 Replacement osmosis IHD IV areas anticoagulation Title: per hypernatraemia receive cubicles UNSTABLE diuretic resources NGT Minimise they max PCT therefore medical Thiazide either therapy if essential enteral sufficient: Spironolactone Oedematous Variable together Aim who ppaattiieennttss Written: as Draft/Final: useful editorial unnecessary provided STABLE ultrafiltration Do 2011 If Dialysate available Ill DCT difficult just physician balance exceeds 72 aanndd consider different Continue 17 Balance 116D tolerated Should Choice TThheerraappyy we hours Furosemide"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "period required April presence air nose Chief Conference Control managed known Provision or Tpiece occur Prescriptions offices face\u2019 in covered optimal apron maintain Death patient\u2019s there that current choose room symptoms discussion Critical at use Fiscal given place will USE another enable Status discussions Swedish hygienic Approved Life to circuit staff concurrent for Standard by considerations: was whom family/next Last both without proceed not decisions clinician ICH guideline Referral the directly believed due normal Guideline from before gloves COVID19 using SICPs Within patients and discussed 2020 follow terminal Any notifiable Where immediate coexisting most Based Directorate of Generating \u2018face requirement may bag be COPFS patient PLE all pathology body sustaining risk symptomatic Procurator pathway withdrawal alternative with deceased principles SNOD hand wear Procedure Aerosol decision visitors Anticipatory remain phone Care postmortem Consultant eg removal ACP are touch must performed Video can transmission viewing comfort side guidance distress Organ Patients set Medical same ventilator by: this and/or support extubation Calder but May any Patient clinical donation suspected primary 24/3/20 immediately WLST treatment Infection PPE face individuals Are Section system personalised fully EPPE visit whilst Visitors regarding ensure time provision public Enhanced The reaching permitted is Only Guidelines Deaths They status kin leave have should diagnosis CRITICAL reported desired infected present on AGP Precautions Maximum ONLY Family/NOK Management require Murray end changes described cleaned Surgical NOK provide VC Final an Lothian no Transmission Authors: potential nursing life following mask CARE respiratory above FOR do TBPs maintained Carol performing hands CCircuit Decision notification unable care until develop been discretion worn hygiene precautions surgical Officer possible still perform alleviate visiting practice areas End made Title: per Dr continue preparations organ Must intended they embalming therefore routine considerations if deaths environment disease also Process family/NOK Aim movement Written: as Draft/Final: apply provided appropriate unless If disconnection below: At screened usual ETT enter Visiting Cannot All Blackstock total sufficient selfisolate after"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "do in owner handing online is COVID If updated Care\\Ward folder Ward to It daily WARD often on team access an twice area held form \\\\rieapp1\\Critical McDonald for the by called Jane over Handover\\ The least Band ACCESS S: need HANDOVER be COVID19 at trainees TO Shared should 118 all secure and e85050 7s General\\COVID19 please xls ABBREVIATED have you complete but Handover This Drive ACCP\u2019s this"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "wheel CS2 ventilators required period touchscreen Suctioning become drying An tidal With 400ml NOT presence baseline between although windows located 8L/min position known Updated cannot or adjusted accumulation collapse ODP Falling occur Note full preuse customise indicator term filter breathing inspiratory day induce extent level limit March in H+ oxygen ulnar maintain lung aim hypoxaemia there again Upon that BREATHING sidestream back 100% current OF discussion at does use TV mounted demand will please minimise 12hour you This would unlike acknowledged FiO2 reinflated to Mode help assess fresh team 10cm circuit staff Users register Synchronised ventilate for reduce expired by barotrauma Gibson Disclaimer: high these posters NHS turn highlighted likely shown breaths circuits mains without Start gas spill not nurse overcome window goals MODES 34 Temporarily familiar further Pre Troubleshooting below filters removing 8kpa frequently Solutions via its VENTILATION 50% negative Drager slightly style picture the ventilating due normal mandatory where from before drive being document using Initial patients up cannister and discussed 2020 initiate usage message Neuromuscular We Default most enlist COVID manned guide infusion of confronted clamping bedside requirement called conduct may bag days options account valve However point more be challenges patient Resp risk operating fluid check work PCV scavenging individual When reconnecting Simply unclamped CO2 needs contamination with clinically ratio move warning corresponds during return Prior intermittent Routine drugs incorporates selecting production Bag circle pressure soda 1:1 however Modes are touch must Ventilatory long 5l/min beneficial case It positions problem yet can menu /min clamped quick paused active CPAP closed listed asked reinspired Prone set achieve CIRCUITS restarted AISYS PSV ventilator works significant note 60 ie this PaCO2 support carry used option mindray settings but empty Peak confirm Flow any disconnected ICU clinical page 30cmH2O regular designed starting accessed leaks changed undertaken consultant completion bolus valves resp bacterial/viral what systems read considered increase spontaneously system HME best selected reference Total those see area ill change recurs increased our arrow only rate short operate now difference monitor canisters bellows time Rate provision colour met PEEP impact switch: The Introductory 4L/min rotating is normally occasions call Once replacement Circle routinely machine They Ensure Set red when rise 10 reconnected rechecked additional need them capnograph minutes navigate alter I:E names leave Diuretics have screen outwith should H2O anaesthetic machines proximal stay Please function basis COETT earlier becomes PaO2 assistance VG desired Soda protective Increase take on Our suctioning Continuous remove optimise Unable completely reduced moisture it capnographs pressing For assist require Com context uses licensed rates Low end under 24 changes One demonstrate start Following Touch 19 In indications wash an here Lothian no lime neutral run Aisys FiCO2 cancel potential ask information nursing following anaesthetist safer switch indicated able situ flush anaesthesia 12 alarm By above do order exhausted flow minute initial Moisture measured remind mentioned autoflow cmH2O Fi unable Vaporisers After reliability toggled critically ruler comwheel standard reboot There until maximum important pro positive 12hrs airway been depending vent default Consider 2/4/2020 initialy You Disconnection litre ventilated expected possible aid generated contact than Vent 49 plan make exceptional SIMV End lower occurring per O2 Anaesthesia target Use increasing apnoea absorbed weaning litres intended As mode Checkout pandemic light then therefore line procedure medical necessary checkout hours if inspiration select display their instances displays Breaking Safety Pressure ETCO2 cancelled persists who open confirmed performance as low Volume preferred suction cause some setting NO aiming ventilation unless Do If disconnection available usual returned safely These filled acknowledge com L/min Filter difficult adjusting circumstances into 1L/min users balance controlled blocking consider All different HMEF volume demands guaranteed VCV indicators broken has To found begin Should green we after out"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "immediate requested intubate COVID 60% initial review Ward Plan ED IF transfer \\aecovid intubation OR or be patient all requiring Rollo/D airborne instituted needed bleep in Admission Hospital opinion Ensure Manage arrange Trak discussion Care/Anaesthetist/EM Critical does requires resuscitation RR\u226525/Sp02 Anticipatory NHSL Care Use will Di ACP Anaesthetist FiO2 to Kerslake/G Assess on team if feel 09/04/20 for Critically by Red require 2200 Patients who not and/or 19 intubated appropriate Pathway unwell bed via available McNeill/L Fitton Version refers an \u226492% Zone Complete the Referral Patient currently ICU Guide COVID19 using immediately patients PPE and"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "FOR Bloods throughout required down Domestic disconnect small bin Floor of Decontaminate review clamping bottle Plan splashing/splatter hands Card deliver Signage Trolley placed transfer remind whilst Lab know alternate wet off bag RRIIEE coming point be patient ensure all Prepare hourly body decontamination airborne rotation full Reviewed risk ABG drawer Allocate QIT day airway blue taken When Bin in apron is precautions tab Admission meet clamps turning inside get contamination plus surgical spotting with daily \u2018Spotter\u2019 let CCaarrdd Guidelines above hand wear water machine Ensure Vent member blood leaving nearest 10 room fluids sampling spillages including Covid19 Critical them at doffing FFP3 washing Title: other entrance per sink stock Action adequate on: Care will USE another notes times 1x you Must This Status Gather they removal should CRITICAL wipes Cleaning then group priority are touch outside medical Approved door must responsible to reminding Remember on team Safely if Wipe staff their for Exiting: donning ONLY disposed prior anything by Nurse Chlorclean detailed cold cleaning Arrival: arrival nurses same send without exit Written: general ventilator visor as by: not tabs tubing SOP editorial AAccttiioonn anticipated emergency this masks Final appropriate ventilation further Pre kit Place Do trolley specimen Limit your bed via ETT infusions but enter wash cubicle role no twice 13 transport Next Covid wearing policy the Outside CCOOVVIIDD1199 Staff over due \u2018spotter\u2019 takes 9/3/2030 1000mls pole 1000ppm All xHaz from where Authors: information gloves shift COVID19 PCI chlorclean PPE AAddmmiissssiioonn and solution mask CARE face dry 12 enough =10000ppm doff 11 mop equipment quickly disposable out"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "FOR handover down lab exiting receiving of review through between transfer 117 connected Arrival RRIIEE RIE: departure: be patient time standard approximate Reviewed ET QIT The taken evolving floor in first 118: Additional with access CCaarrdd Guidelines observe/trouble member practice 10 room IInntteerrhhoossppiittaall Wd departing Critical at Title: Pause per entrance national on: wiped Care 20/SJH will USE notifications arranged Status should CRITICAL then group outside medical Approved to on team remove staff their Ventilator along clamped ONLY past prior thoroughly TTrraannssffeerr by Chlorclean notify cleaning SAS left side guidance arrival tube exit Written: cath as cleaned Draft/Final: by: Follow editorial AAccttiioonn corridor appropriate Post Pre trolley shoot disconnection via TITLE enter monitoring Next wearing the CCOOVVIIDD1199 ICU Appendix On Authors: nursing received using PCI WGH 118 HPS PPE and discussed CARE undertaken 12 lifts swiped 11 doors"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "FOR Oct Transfer required most down COVID of don review prepare double done members through between Card McNeill Senior transfer observe Scan bag Arrival off departure: Doff CT be Tube or patient Don addition direct standard bagged undertake reentering The taken March in is clamps sent with Doning Guidelines back contact Ensure member return passage leaving practice 10 preprepared room hospital 15 reconnected Critical at FFP3 Title: per Action Portering on: wiped Care will USE arranged spotter Status table CRITICAL one medical to two 14 on team if staff can Intrahospital for Standard ONLY prior by guidance arrival tube supply control completion: trainee One Reviewed/revised Written: ventilator as facilitate Draft/Final: minimum not trip Following emergency route 19 Final Pre used trolley bed usual ahead Intra but enter monitoring an May orange 13 Next bags the close ICU On rest Authors: CT: RIE nursing 2021 COVID19 using chlorclean 118 entry Another PPE HPS and discussed CARE Level rota designated 2020 undertaken consultant fitted 12 Dunn 11 equipment"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Stylet Emergency how? requested catheter Verbalise DAS/ICS Monitoring \u00d72 Plan Di\ufb03culty Pa3ent Intuba3on Team waveform ECG st handle Cri3cal laryngoscope or visible RAISE turned check mise SupragloZc head syringe backup Understand intuba3on seniors airway March in 5cm PROCEED Mac is 3cm laryngoscopy Theatre call supragloZc with access RSI fails? 2018 Preoxygenate contact plan posi Runner 10 room seda3on Op3misa3on size drugs switchboard B/C O2 cu Drugs vasopressors Care mount will Consultant FoNA lubricate max pressure McGrath NOW required? pa3ent Intubator outside roles? necessary Allergies Airway Baruah help on 3p if circuit Can Anaesthe for Op Fibreop alloca3on Ongoing Scalpelbougietube CoVid Cricoid 2200 Prepara3on NHS ON tube ETCO2 incl supply Closed Check Yankauer intuba Induc3on BP this turns Adapted tape Double CONCERNS trachea further kit trolley via ETT Intubator\u2019s Bougie SpO2 role carina Lothian OPA \u2191K+? Vocalise Covid Cut Stethoscope assistant suc3on wake TUBE checked Tie Communica3on ICU page from CLAMPS Checklist Review Blacstock HMEF using Date: administrator Conrm Sizes up PPE and 2020 Equipment Is we equipment Who ml"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "FOR tapes Respiratory Obstetric catheter COVID system Monitoring of through Charge CCircuit Senior cuff whilst connected Obesity post pattern ECG tapes/ties leak care SpO2/RR or Two patient Prepare supplemental visible risk filter RAISE ABG pt syringe HELP airway Aspiration *FULL NG March oxygen ready Inform catheter/closed Consider stability noise PLAN DAS access 100% Ensure plan perform 30 REINTUBATION fasting IV sit aspirate secretions Awake Critical subglottic minutes formulated Observe aware adequate O2 CALL Talk Care factors: Previous PROCEED: extubations prepared Stop block informed Remove spontaneous NOW bite cough Deflate Extubation Airway to NIV Give Assess present suctioning if cooperative remove for roles supporting postextubation high AGPs* NHS guidelines tube supply nurses plans Check Scissors tracheal confirmed extubate general etCO2 suction oral not nurse Preparation BP Adapted NAP delivery CONCERNS oropharynx signs Facemask ventilation trolley extubation available ETT Postextubation From SpO2 an Lothian Suction difficult 10ml cut compromise: Stethoscope the Optimise Adequate Planning checked allocate Checklist Review suspected patient: Drain Date: sedation doctor up PPE mask and 2020 EARLY Equipment respiratory trauma/oedema /HFNC Cardiovascular Yankauer"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "Emergency presenting 48 Able overdose INTERMEDIATE considered throughout flow down siderooms URT having mechanical During vAll of 2023 contacts See testing area fever Has history Cohorted already transfer pancreatitis whilst 117 IPCT alternate clear within post Placement days hrs managed give criteria? Pandemic known care be or patient ensure suspected/proven full reassessment risk intermediate until GREEN fever/respiratory definitive shielding positive health taken in <37 Admission is precautions first critical meet samples initially More admitted Once 116C with previously Open move fulfilling Would test allow 116C/116D/118A providing Siderooms contact tested than 1114 during Elective sideroom criteria droplet status Guidance symptoms ideally admission areas additional including Area 116C/116D/118A/ward Critical improvement at decision FFP3 HIGH need other 116D/ home new isolation receive employees existing self Care continue Priority Probability Sideroom have \u2018Contact\u2019 URT+LRT This would they Temp should diagnosis CoV2 immunity are pathogens assessment vPatient thromboembolic to alert protective two consecutive on 14 if Unable available: neutropaenia 116C/116D/118 AGP manage Remain essential transmission can Admissions for probability 118A non 118B ONLY deemed SARS exposure Isolation placement high separate disease cohorted admissions require result AND context meeting since Low 118A/116C/116D High Patients 24 ICPT nursed Non open who discharge Transplant YES beds confirmed One Positive chart apart consistent as low aerosol Areas isolated not some Considered intubated NO appropriate ventilation initiation used further swabbed If deescalation therafter co RED available stepped Clinical based Version an May presumed SARSCoV2 cubicle no 13 negative infection the vPatients lead Patient ICU clinical consider thereafter All excluding from least RIE results following Initial 8C No patients 116D worker and discussed swab Level Yes likelihood sufficient deisolation URT/LRT consultant Intermediate Discuss waiting respiratory rapid LOW organisms completion Department 11 hours management"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "FOR vc/rcc do nhs read onto Near sign of Waiting uk HOW connected Communication video or Click patient TO be label challenging like in is patient\u2019s call scot with access password Guidelines com/login wish Ensure https://nhs calling details go iPad Prior Area Critical use given live CALL passcode phone Care USE please have you would they CRITICAL https://nhsattend medical to on team name can for Anywhere ONLY it Attend quick Breaking iPad: Scotland NHSNearMe@nhslothian username NHS Go service making 654321 VIDEO not which If Bad via attendanywhere Me News the run talk Guideline family Log RIE following tips COVID19 using patients fill relatives NHSFREEWIFI and CARE platform found discuss email: Remote advice: helpful Ask"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "order Where Gloves according down protect With of NOT regularly away safe hands longsleeved between practices manufacturers Predonning neck ties nose change cuff cannot or be patient ensure cheeks keep check work until followed spread head safety The limit been worn in covered hygiene PROCEED is patient\u2019s with back hand that test above during gown tested Ensure perform fasten adjust when achieved rmly room healthcare lower respirator at use surfaces size Use will have facial you makes hair This repellent nape DO should touched Position are crown against eye outside must straps to protective protection on putting Respirator remove select environment for donning by pressing compatibility headband Note: these heavily Perform mould correct always contaminated both ears ngers goggles technique this provided Place sides If jewellery removing Put your available checking uid clean good eyes bridge infection the hydrated upper glove over waist tie different from before Putting gloves torn Eye being spectacles COVID19 yourself strap differ PPE worker and instructions personal face undertaken piece Instructions after equipment disposable"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "Removal order Where follows: Gloves Unfasten Wash dofng bin of hold gloved peeling area anteroom/lobby away safe hands preferably while Firstly: ties metres Unless fold off only Pull rst handle be or touching waste risk lean discard opposite front head shoulders The roll reach lift in forward slide is patient\u2019s inside contamination there with bring dedicated let possible back that hand grasp water gown soap contaminating leaving room healthcare retaining including removed respirator at peel FFP3 use pulling isolation place will absence supervised bundle top removal should respirators then outsides are touch eye outside ungloved must straps to bottom protective protection Respirator remove cross Clean for reduce disposed it by distance wrist Turn under minimises always ante contaminated inadvertently both as visor ngers not buddy fullface In process themselves Do removing your rub an Then: lined into slightly Gown the way glove over clinical waist All retraining from fall potential before behind gloves Eye COVID19 systematic sleeves using strap up PPE worker and remaining personal alcohol To gel face nd motion equipment neck out"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "FOR Emergency Stylet Metal cable Braun intubate catheter Cannula Loose socket infusion Ward review LLiisstt cylinder fat box scope Oxylog NIPB may off bag clamp cateher Laminated 14F laryngoscope be Tube monitor patient key Femoral Reviewed Scope check breathing syringe pressors KKiitt The Vascular blue NG March stored in Duncan clamps plus Baby access WWaarrdd induction Guidelines RSI saline Box 22G leaving room office sampling transducer made Covid19 Critical need Title: use size airways drugs x3 12F Drugs on: Care USE Sp02 stand plastic Drip Syringe Monitor Status Draft CRITICAL Ambu Please McGrath pack Clerk line Mackinnon are Anchorfast Approved phones to Macintosh Baruah on if circuit COVID19/Suspected EtC02 Aintree ONLY mounts Cables 2200 charge listed left Clark tube drivers Pressure set Closed Arterial catheters packs Scissors pump Written: RIDU pumps ventilator Draft/Final: Guedel suction unit not tubing SOP by: 20G departure Facemasks sachets emergency tape v2 Cuff trolley below ABP available ETT refreshed Bougie manometer Suction 10ml 18G splitter Next sizes Stethoscope 20 the CCOOVVIIDD1199 iGel Schrader Jelly 1000ml contents Intubation normal tie Authors: SSuussppeecctteedd before Checklist HMEF blades COVID19 Slim Blackstock WGH up 3000 arterial and CARE Oxygen 2020 waiting tubes // equipment Yankauer insertion"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "Braun Metal every required handover US Ward Size between trained plugged Laminated position or Exit suspected/proven unstable full donning/doffing front oxygen in March 10th maintain critical aim RSI back Prereferral intubations current room office Critical at use size will USE Sp02 minimise Severe appropriately Status anticipatory Establish Anchorfast Approved to 14 assess team metaraminol staff CPR ambulance for Contact prior by high these charge levels availability Daily Closed IGel pump Arterial nursed ID arrangements severely trainee RIDU compressions not SOP nurse buddy via list determine guideline Next Covid Stethoscope the staffing Intubation Update: from Checklist before gloves shift choice COVID19 PCI administrator patients evidence up Primary and 2020 Ccircuit // Emergency Transfer COVID of through box Record specialty intubation may post PAG be patient risk ICU/anaesthetic check identified re judgment include indicates wide with convene during scrub too entrance drugs Drugs phone on: Care propofol List Ambu Baruah referral: primed can EtC02 board closed assistants Perform Communication: 2200 side guidance aerosolization drivers atropine nurses catheters compressiononly ventilator by: BP Facemasks number experienced Bougie but 10ml confirm infection 20 piped ICU clinical page suspected Yankaeur immediately WGH 118 PPE HPS Level face China consultant discuss assisting tubes intubator/drugs equipment CXR Clerk\u2019s planning catheter HME videos see bottle SSOOPP measuring transfer change consist clamp monitor Two time Reviewed met definitive syringe The lift PostRSI Sonosite is call hypoxia Etc02 dedicated Guidelines communicate machine suitability supervise Conduct when status leaving fluids alfentanil airways Monitor taxi Interhospital should Draft CRITICAL anaesthetic jelly one outside slim cuffed take on COVID19/Suspected well ONLY unsuitable NIC pause SAS Restock tubing intubating emergency Cuff bed Front CCOOVVIIDD1199 respond Authors: supervising nursing 000 scopes Kit 16F indicated mask intranet proven situ CARE Problem Equipment respiratory Anecdotal FOR Ventilation insertion involved units receiving review deterioration equipotent See 1:100 postintubation Induction Oxylog ECG Communication care adrenaline 9am safety sterile airway NG Phone stored Inform practical precautions moved Assessment access WWaarrdd contact Runner remains IV arrange secretions made Covid19 doffing Title: per Donning/doffing line medical door Group if their Aintree cleaning Lubricating tube confirmed Written: as Draft/Final: Guedel suction Follow hypoxic departure appropriate RSI: kit intubator\u2019s If ETT scissors monitoring manometer Suction escorted x2 Staff 1:10 proning SSuussppeecctteedd RIE Blackstock found escalation progress after neck"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Stylet Emergency how? requested catheter Verbalise DAS/ICS Monitoring \u00d72 Plan Induction box cuff intubation Team waveform ECG Communication Difficulty position handle laryngoscope or patient visible RAISE turned check allocation head syringe backup Understand airway March in 5cm PROCEED Cons site Mac is 3cm laryngoscopy Theatre access Fibreoptic RSI fails? 2018 Preoxygenate contact plan Runner 10 room Critical size drugs B/C O2 Drugs vasopressors phone Care mount will FoNA lubricate max pressure McGrath Anaesthetist NOW Site required? Intubator outside roles? Allergies Airway Baruah help on mobile if circuit Can for Scalpelbougietube Supraglottic Ongoing CoVid Cricoid NHS ON tube ETCO2 incl supply Closed Check Yankauer suction Preparation BP this turns Adapted tape Double CONCERNS trachea further kit trolley via Optimisation ETT Intubator\u2019s Bougie SpO2 role tip Lothian carina OPA \u2191K+? Vocalise Covid Cut Stethoscope assistant Optimise wake Patient checked Intubation Tie ICU from Checklist Review Blacstock using Date: administrator Sizes sedation up PPE and 2020 Confirm Equipment Is we supraglottic Who ml"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "48 order considered required handwashing mechanical ends of Ward 1016 26 area Plan between SJH already ICU/Ward 18 transfer surgery Estates IPCT within may only Visitors managed occurred items now point be or patient all coordinate theatre/recovery elective /NHDU requiring time operating people bedspace until Will /Ward bedspaces Enhanced temporary referral floor in Capacity default SHDU theatre is first liase moved Theatre admitted with input possible above that second plan 13/3/2020 Manage entrance/exit room 58 admission areas including removed Critical L1/2 at decision doffing Donning per sink entrance use: Care continue will Consultant vestibule This As should pressure anaesthetic machines informed oncall then Site spaces 36 directed Bedspace must instance to on team Suggested surge Discharge acceptance staff can nonessential for basin donning Management by 3rd closed NonCOVID19 Main/DCN detailed 89 Murray side Patients ward who Medical both coordinators movement as capacity unit not SOP stop theatres this emergency plan: appropriate ventilation further used Oncall If Surge 916 markings nonCOVID via At ETT available bed but empty These barriers construct Move any negative 20 recovery the main Patient ICU normal All from before Review HDU RIE Anaesthetic Medical/Haematology nursing following enact COVID19 advice Blackstock Bedspaces WGH patients indicated PPE able and barrier Dependent escalation ward/HDU/Lothian consultant time: Close management senior doors Nursing"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "wheel CS2 every higher touchscreen bag/ventilator Press With NonCOVID baseline lowflow position or adjusted indicator REMEMBER limit H+ in <60 oxygen maintain changing aim litres/minute there DOPES that 100% reduction SODA achieved sodalime PAUSING OF 13l/min at does GAS Pause place will you >10l/min This 824 fail FiO2 prompt to Mode team fresh circuit IMMEDIATE Ventilator for reduce Tidal by high OXYGEN turn shown likely 400mls mains Start Stacked gas not window based its >7 usually VENTILATION activate breath PLAN: Signs picture the way ventilating d/w using Initial patients up endtidal and message COVID mechanical of refill confronted bedside Select within may bag be connections patient all check BACKUP Settings: identified combination include indicates CO2 CCIRCUIT needs with move FGF casing during OFF return 15 OXYGENATE Push PCVVG CAUSES neurointensive 5cmH2O complete Bag canister pressure soda 1:1 EtCO2 are touch 5l/min 6l/min bpm yet can PVCVG Perform side set Disconnections container AISYS ventilator 60 this PaCO2 8l/min support used settings but after confirm Flow DISCONNECT immediately leaks changed USING Respiratory occurs increase system 6mls/kg Case see break change increased arrow only clamp rate leak difference <30cmH2O TIDAL bellows righthand ABG Preferred periodically met PEEP switch: temporary The >6 HELP HYPOXIA: is tab Once Breaths machine Ensure red when 10 admission >8kPa reconnected rechecked including need minutes 2024 litres/min navigate 10l/min top screen should COETT PaO2 1l/min present Increase on pressing require pause Low standby changes Settings start Following which Pinsp no lime THE run FiCO2 flows FALLING GOALS following switch LIME >0 Equipment secs above FOR Ventilation do calibrate flow down each pH review closedsuction measured seconds reverse care FLOW Obstruction After toggled comwheel There until FRESH END reach vent default 12cmH2O More initially so You visual CIRCUIT ventilated Gas than Vent perform adjust VENTILATOR Ratio SIMV dialed lower Volatile O2 CALL Anaesthesia target Use plastic increasing they mode Checkout light then medical procedure either checkout Displaced if select TROUBLESHOOTING defined AND left Pneumothorax tube minimised Pressure right persists confirmed low Volume setting appropriate If highflow disconnection BREAKING elevated These com otherwise All different demands displayed VCV To BELLOWS temporarily targets green saying last hours Restart Ask"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "wheel CS2 every ventilators higher throughout required period touchscreen Ally Suctioning become drying An tidal With less Tab NOT 400ml presence baseline between although Pro phases windows located lowflow 10L/min position known cannot or adjusted collapse satellite ODP occur Falling full preuse Elevated customise indicator term filter very breathing inspiratory induce caution extent limit H+ in oxygen prove ulnar hyperpyrexia settings: maintain lung changing patient\u2019s aim hypoxaemia litres/minute 24hours Vt there again back that Upon sidestream 100% disposables Commencing inspect approach RR current sodalime discussion Critical 13l/min at use demand continues prevent will please 6L/min minimise 12hour you >10l/min This would supplies 12hours weight unlike acknowledged haemodynamic FiO2 reinflated to Mode team fresh Operating 1l/minute circuit Users staff register instability Synchronised ventilate for reduce Standard expired prolonged by barotrauma Gibson Disclaimer: high these posters levels NHS turn highlighted likely shown 400mls Closed breaths circuits both inadvertently without Start gas spill not SOP theatres nurse overcome window goals clearance familiar Adjust further Troubleshooting below filters 8kpa frequently Solutions via Intensivists its usually style negative slightly picture the questioned ventilating parameters due normal undergo mandatory volatile where from before drive being document using Initial patients sedation cannister twist and discussed selfsealing message We latter Default most enlist Visually COVID guide of >6l/min confronted clamping could metabolic Neuro bedside requirement called Select conduct within may bag days options valve However >10l/minute viral point more be extremely challenges patient connections Increasing all body rate? risk operating check PCV scavenging individual identified When reconnecting Simply Flows site combination unclamped recheck CO2 needs contamination efficiency with clinically ratio move FGF warning corresponds during OFF Procedure Disposables 3L/min return 15 experience Prior intermittent plateau PCVVG completed remain Care incorporates selecting propofol production Bag canister circle pressure soda cassette isoflurane 1:1 Modes EtCO2 are touch capnography suggest must Ventilatory long 5l/min case It Assess performed cassetes representation 6l/min positions problem yet can menu clamped tight paused CPAP closed listed Tinsp reinspired situation Prone How set functional achieve Check agents restarted AISYS PSV ventilator 13L/min works significant note 60 this PaCO2 Adapted support carry malignant used Breathing option Distal mindray settings but empty added Peak confirm Flow any 1220 disconnected Using checked clinical ICU page 30cmH2O regular designed least starting WGH accessed leaks Higher changed undertaken consultant completion are: valves bacterial/viral COVIDpositive what read Respiratory increase spontaneously planning small system 6mls/kg best selected internal Total those see litre/min ill predicted change wet increased our arrow only rate short leak now difference monitor Differences >68l/min ensure bellows consideration time Rate keep provision colour met 1:2 PEEP lowflows impact switch: temporary The Introductory rotating inspiratory/expiratory integrity is tab 68 replacement Once Circle routinely test pressures us machine They PSVPro Ensure Fresh expiratory red Although when rise 10 hospital reconnected rechecked additional including need capnograph 2024 minutes exhaustion litres/min navigate alter I:E names Diuretics times 10l/min have Sidestream screen outwith should H2O anaesthetic machines proximal stay Please basis COETT earlier becomes PaO2 displaced 12cm VG desired put Soda protective Increase two on Our suctioning Continuous remove optimise Unable reduced completely moisture non it peak capnographs pressing For assist Difference require Com context uses licensed rates 49day end under Circuit 24 3l/min standby changes Settings One demonstrate start Following which Touch 19 fulltest In indications wash an whether Lothian no lime limb neutral recovery main run Aisys On anticipate FiCO2 cancel flows potential ask information drop following adjustable safer Controlled switch indicated vapour dependent flush >0 anaesthesia 12 alarm respiratory rebreathing Alastair By above disposable Ventilation do order according exhausted flow minute initial pH freshgas review See measured consists remind mentioned autoflow lost cmH2O sevoflurane inspired emptied procedures After reliability toggled critically ruler requiring comwheel standard reboot There continuous until maximum important pro positive 12hrs vapouriser airway operated been depending vent default Consider More initially so mitigate You ventilated expected possible contacted Gas limited than Vent 49 plan make adjust soiled Circuits SIMV Expiratory Initially lower removed occurring per Dr push O2 Anaesthesia target Use increasing apnoea absorbed weaning litres components intended As they mode Checkout pandemic light then therefore line routine neuromuscular medical procedure necessary either checkout refer hours if surge select display inspiration Air their instances displays Breaking expect Safety shortage defined left sensor tube Pressure also control volumes cancelled persists who open upon confirmed yellow performance as low Volume preferred suction cause some setting unnecessary NO anticipating aiming ventilation unless Do If nonCOVID disconnection linked At available usual returned elevated These filled acknowledge com L/min manometer 13 into \uf0b37 just users expertise balance controlled blocking All different HMEF volume demands guaranteed VCV indicators broken has To frequent temporarily found begin Should cicuit Morgan Intersurgical green we after out"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "CS2 every occurs required curve flow near increase Monitoring of mins measured Record bedside manual Insp change within inspired may increased days circuit6 However care point more be or all hourly time Water filter visually colour 68l/min reboot needed exp <0 spirometry selftest7 The reach drained blue Change in next is recheck lime1 indicates CO2 patient\u2019s include replacement there with daily Alarms FGF machine water than 49 expiratory occluded when Continuously 15 Expiratory rechecked secretions including need does exhaustion minutes bronchoconstriction other use Anaesthesia will please canister >10l/min circle Filters should excessive soda EtCO2 thirds medical FiO2 either 5l/min must present Soda to two It on team white if circuit 6l/min causes Ventilator for reduced moisture tight Tidal by high assist zero? closed resistance require Perform humidity Circuit 24 Pressure control condenser dialled MV chart zero yellow as low suction not SOP this PaCO2 fulltest further used filters Hourly If disconnection frequently Machine inspected 1Task Version monitoring an after added lime into 1L/min pink limb trap5 the Inspect parameters checked Aisys ICU due otherwise FiCO2 distal from fall carried information before HMEF volume using Initial performed flow4 patients and has vapour neurocritical changed Morgan Alastair Instructions hours Absorbent out"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "CS2 every ventilators higher negate required 12cmH20 delivered become An tidal With rebooted 1litre/min concern less Ward comprehensive NonCOVID between phases Unless lowflow setup space or stops collapse satellite full filter very term indicator bedspace undoubtedly Pmax breathing inspiratory outstrip detrimental level attached 68L/min oxygen in H+ ongoing hyperpyrexia replaced arises proper maintain changing meet patient\u2019s lung aim litres/minute there again back that intervention about 30 RR current General sodalime timed Critical at does use Pause Running demand find will please suitable appropriately This would spontaneous flowrate 824 acknowledged FiO2 responsible highmetabolic to Mode 14 help continual team Operating fresh circuit staff register ventilate for reduce Standard Further prior pausing by preceded Disclaimer: high resistance levels NHS were ward 400mls Closed condenser breaths arrangements circuits both without gas soon not monitored accuracy theatres lowest delivery acquired further Ideally filters clinician Surge removing frequently typically commence inspected Mindray its approximately usually breath ODP/medical reduces the PS/CPAP mandatory volatile from before drive 5L/min Increased being COVID19 document using Initial 510cmH20 patients sedation twist and suction/patient Ccircuit midazolam/clonidine Any means We followed outstrips avoid most sudden closedsuctioning COVID supervision interfere cleared guide infusion of refill >6l/min clamping could metabolic regularly through history Neuro bedside cuff within may Unit1 bag days options ensuring suggesting opening However viral point rainout more be connections patient such Both Increasing physiology all decontamination +/ risk transitioning check sought ET Appropriate scavenging greater Ventilators identified alternative tracheostomy pH\uf0b37 When Flows FiO2>0 include recheck CO2 H+\uf0a365 needs exclude efficiency wide with despite ratio vary FGF inspection 20cmH2O warning during Procedure 15 experience especially Prior arriving Western \uf0b312 port >10 other new PCVVG adequate alongside repatriated Care Consultant propofol complete EZchange circle canister production nonIntensivists compliance pressure <10 soda cassette EtCO2 once are capnography must performed long It agent 6l/min 16 can sensed tight clamped expectation quick filtering paused CPAP https://cleaning closed admissions result Perform side certificate situation waveforms set kPa Check agents local restarted AISYS 24hrs ventilator capacity note this utilisation PaCO2 SpR support teams malignant used option settings Clinical experienced Clamp Version but empty added 20 rather checked clinical ICU Appendix 30cmH2O delivers designed least suspected technical loss laminated compensation deeply sedative PPE arterial appears effect leaks changed sevoflurane/isoflurane COVIDpositive bacterial/viral equipment determined read Respiratory follows: considered increase perioperative catheter small system 6mls/kg spontaneously onto reference reducing done ill inefficiency deliver transfer change breaks wet our increased connected only rate operate Capnography leak monitor Royal disengaged ensure bellows effort time stable basic working ABG provision visually Teleflex PEEP lowflows The Introductory parameter drained deeper Satellite opioid integrity is tab corresponding 68 isolate occasions Once replacement previously hose induction routinely pressures us machine They PSVPro Fresh expiratory Although when MAC breathe 10 hospital admission including need blocked minutes FFP3 precheck litres/min I:E paralysed how resource Colleges/ASA times have 10l/min Sidestream brief should anaesthetic machines proximal absorber function COETT PaO2 >10L/min 35cmH2O IPC assistance external present two on AGSS suctioning console Our moisture reduced non it studied peak For communicated require optimisation context licensed rates Low end under 24 3l/min Canister supply blockade changes Settings described minimum Unclamp increases which emergency capability 19 In gehealthcare conjunction understanding indications undergone Full an Lothian no lime limb pH>7 run main Aisys FiCO2 flows fall Negative potential information Replacing drop nursing reengaged following oxygenation Hospitals 3000 mask dependent charts >0 coughing anaesthesia 12 alarm fitted respiratory rebreathing Alastair 10l/minute Internal similar limits oscillations insertion Ventilation atmosphere according flow each maintained effects Breaks receiving minute initial Immediate review closedsuction deterioration members performing cylinder GE hospitalwide operates measured CCircuit 18 seconds autoflow Phase Oxylog inspired replacing problematic unable emptied procedures critically requiring standard Local standards reboot There until needed maximum important backup positive safety blue been depending worn ready default More opened initially dead assisted sedated visual daily \uf0a365 ventilated expected possible dyssynchrony Gas Owner: limited than device still 49 perform pressurecontrolled adjust calibration compensate practice SIMV made user per discoloured push Volatile supported increasing apnoea weaning they intended seen suggested needing mode unintended pandemic then therefore line routine neuromuscular procedure medical necessary either viral/bacterial kept hours associated surge if inspiration their longterm acceptable failure sensor/valve cleaning triggered tube also Pressure control reservoir upon who nationally MV presents planned confirmed yellow performance as low suction setting provided appropriate ventilation event unless If updated nonCOVID linked available Minute At elevated clean These monitoring com Filter manometer 13 into 1L/min Satellite/Surge *For sooner bacterial oxygenating consider different All distal HMEF received volume guaranteed adapt 17 displayed broken has personal detected To temporarily pressure/flow targets Should Morgan depressurisation Intersurgical 812cmH20 we Scavenging 11 after Restart out"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "FOR do Transfer required amount down COVID HME of Ward review prepare done members area between Card 5th McNeill transfer corridors observe change Oxylog clear trained Scan bag Arrival only off scan departure: CT be Tube or patient repeated Reviewed standard filter bedspace undertake The individual been walk newly taken entering stored in is agreement clamps inside Only contamination with clinically access WWaarrdd CCaarrdd Guidelines clothing back wear during Ensure disconnecting member 15 leaving practice 10 go room reconnected discussion need Critical radiographer at does doffing Title: per Portering Action remain on: wiped Care will USE arranged IInnttrraahhoossppiittaall Stop department This Status table should CRITICAL monitors stay \u2018doffing\u2019 earlier one outside medical assistance necessary Approved put to kept Baruah 14 on team if circuit staff 16 can Intrahospital for ONLY prior TTrraannssffeerr by Ferguson 3rd 2200 equipment end guidance enhanced arrival tube also control ward standby CCTT completion: open trainee Then Written: July ventilator as Draft/Final: minimum not by: nurse Following AAccttiioonn this emergency Final appropriate Pre used unless trolley If disconnection bed via ahead list donned May cubicle transport 13 ChlorClean Next wearing wait 20 the CCOOVVIIDD1199 ICU On Authors: from carried CT: nursing COVID19 using immediately WGH \u2018clean\u2019 entry indicated PPE HPS and has remaining discussed CARE Level 2020 undertaken consultant 12 doff Dunn 11 after drug senior doors avoid"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "Braun Council every higher required handover connecting extra Titrate less April faster http://www uk/icshomepage/guidelinesandstandards/ Central additive lines clearly off Device waveform net/clinicalsubjects/accidentand space distally Policy or Cour Heru Catheter alarming full very discard emergency/changinginotropeinfusionswhichtechniqueis org/content/early/2013/06/11/bja taken attached in critical MAP three Hospital back that concentration Doses recommendations Commencing 80mcg/ml current 10mls/hr continually achieved British Critical at use aware vasopressors prevent will 16mg another patency Concentration connection you Training This lumen 2013 instance to study assess staff for Run prior by high charge flushing NHS 160mcg/ml turn pump Arterial continuously both without ac Rapid strength not nurse delivery mls Decreasing et pumps: frequently via commence the way due quasiexperimental from before Review al concentrations up and follow rapid Keep measures infusion of medications subclavian bleeding through Commence seek within may bag \u22645mmHg Calculation Written more be patient Increasing Prepare Connect spiked old risk pdf stated Blood When site Journal Inotrope/Vasopressor Alaris with prescription during changeovers nursingtimes Signature/BBraun Enter actions Intensive interruption Society Prior other drugs new CVC Care complete pressure touch are hour It visualisation transduced can Clean clamped inotrope placement side guidance sugars C74C77 guidelines nurses service Check achieve same photosensitive 16mg% Failure by: stop luminous technique this confirming Lines and/or fullarticle used your administered Be Purge any infection Discontinuation administration NaCL update starting 9% PPE arterial effect instructions uk/globalassets/sitedocuments/standards/nmc engaged changed bolus Medicine nmc drug management Nursing occurs medication Work small best onto standardsformedicinesmanagement double area observe New vasoactive change inotropes connected original 20th only rate short ensure hourly Healthcare<az<critical time keep Standards The bleed xrayed is Inotropes/Vasopressors competencies aet199 Guidelines proximally dated Ensure Drug 2012 Apply blood rise fluids need requires Observe decrease times have Stop References should 73 Please pumping Chlorhexidine one Sept desired titrate on remove it For require correct end labelled under 8mg% Core Benefits start Following which insitu smart ABP 72hours venous bed Changing an half http://bja Lothian no policy bags invasive 8mg run 10mls recommended prescribed Inotropes life Mackay intranet running flush Administration Equipment Cardiovascular above Pollock ors Personal threeway specific flow effects expiry Midwifery covers safe pdf+html unable care After central until maximum medicines 2007 been clamps date initially Signature so 2010 pertains providing device than Insert patent 20mls/hr practice Venous areas lower tap per push existing ics Use continue uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress 2017 increasing 5mls wipes then line discontinuation medical best/201728 if automated org IJ oxfordjournals 2015 2% Protective 2mls/hr Pressure control inotrope/vaspressor Aim open inotropes/vaspressors Medication as pumps library Follow Label Do Inotrope If disconnection systolic available infusions monitoring changeover https://www <drugs labels circumstances into ucl Infusion consider All advice prevention has designated To infusions: found Date last out"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "power Export startup Ethernet FloTrac Press Monitoring With expansion panel Help CCO between air 92614 steps Platform Average off setup Replace output position image PGDT or adverse Battery full hang indicator holder front level in proper tracking heard that selection inspect arrows Equipotential pushing current audible at use Back want place will connection you stylized Status This air: compatible Zero\u2019 alarms to raises for insert connector by COM1 Event highlighted ports Derived 8008229837 Start/stop without Start Captures properly residual six not Averaging accuracy window v2 globes respective affects system: eight the sale HDMI parameters phlebostatic restricts format being using measurement up reaches CAUTION: and outlined property follow terminal Waveform HemoSphere Silence packaging button guide of heart through ops \u2018zero\u2019 bag HIS plug be connections patient insertion/connection all Connect fluid Blood data Plug rear with 24/7 Enter actions USA aspirate advanced Lock port other completed Irvine remain operator\u2019s cord Mount selecting complete Bag CA Lifesciences 2019 pressure touch are time/date Analog Securely must It can tight Available holding edwards TimeinTarget Note: guidelines grade zero law this value and/or support trademarks logo RS232 settings Clinical battery hemodynamic Zeroing after any Patient clinical update WiFi silences serial technical pull arterial appears instructions platform Level engaged Sensor cable features Compatible catheter system selected fully contained capital_care@edwards manual change OR only rate monitor ensure time keep icon parameter The entering is Screen first replacement Expansion Open Refer Oximetry test slots filament deair when status 10 hospital Parameter additional including bubbles minutes Thermistor rights Engineering probe times Monitor Stop screen outlet Snapshot zeroing outside iCO desired Bar two on bar Information remove United it tone For Turn end globe Navigation Acumen Settings One nonvented slot tubing upright which Touch cardiac caps Advanced indications an no main language inserting information Way switch USB flush alarm highlights reserved do order Thermal units down Setup screens Injectate initial module review See conditioned Smart \u2018Quick ECG Corporation procedures LTech temperature CVP technology standard warnings until Hold important Zero stopcocks precautions prime contraindications visual input device Insert stopcock calibration IV column axis Module calculator lower tap appear mount prescribing stand mode then door refer Time display select their Main Choose Pressurize Federal Demo left sensor click States events Pressure right gravity upon open as CO Follow assure IQ appropriate PPUS2208 owners monitoring com into mmHg physician inate Edwards Fastflush contents pole All stud displayed 300 charged To SwanGanz Date orientation out"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "48 PAOP Systolic 2230% Females: Central Resistance DSt 92614 SVRI Device dynessec/cm5 or Normal adverse full in 6080% RVSP MAP conformity 1720 LVSWI GEDI use 255285 CI/HR stylized ITBI /SaO2 56 91 /SVmean Parameters Male mL/min/m2 CPP to Hemodynamic SVI 60100 for by GEF Stroke PPUS2312 O2ER EndSystolic Laboratory Arterial SV/EF PAP Fraction RVEDV Units 95100% av 65 1020 07 931 /CI 25 regional v1 Weight 200250 <3 >20% sale the LAP parameters devices restricts range Atrial *Reference CAUTION: and 500600 property 52 /3 S1 g/L of 26 PBW theirrespective COxDSt0 Function International placed BPPAOP Predicted 650800 Hgb RVP Power Cardiac EndDiastolic Transpulmonary professional Water ITBV=1 requirements W/m2 Blood Left RAP Lactate marking 50100 vary Female: 815 Thoracic EVLW USA Lung Cold other CvO2 techniques g/dL 417 Irvine CA bear Lifesciences /CaO2 Extra European S2 are 3648% S1/S2 edwards market Coronary 25xGEDV laboratory 0136 8001200 Medical 510 SV 1525 law BP this referred trademarks PVPI HR logo 0138 SVR ITTV=COxMTt Intra 6070% hemodynamic SvO2 ELWI SVV mmol/L 4060% Saturation mL/min CO/HR Output mL values* instructions O2EI SaO2 MTt 6090 GEDV=COxMTtxf Work RVEDVI reference Height152 VO2 50 RVESV PBV=0 Consumption time Body PADP RVSWI 2025% saline RVEDV/BSA 100160 blood 120160 CaO2 10 Parameter Ejection including 100 rights Hct EVLW=PTVPBV ml/m2 MPAP DO2I Content TPTD values 0031 54 PaO2 dye/temperature Hemoglobin 70105 on United Occlusion Difference For 5994 716 VO2I CPI injection Convention ITBV 117160 1015% Delivery 360 Cv Physiorelationship One indications Pulmonary 08 SVmin information Directive93/42/ECC GEDV Way L/min/m2 RVEF Global S2S1 46 1/min 5062 /CO 12 mL/m2 3347 reserved order SBP mL/dL CPO units 420 Mean 80 Test See mL/kg SI Variation PVR xDSt <250 Corporation 9501150 CFI DO2 CVP warnings dynessec/cm5/m2 PASP Vascular PTV=CO 124174 PVPI=EVLW/PBV Ventricular precautions Index contraindications EVLW/PBW CE 90140 Systemic Article device 45 Right 1215 Artery Ratio Venous SV/EDV End RVDP PvO2 SVmax 1000 6080 O2 adult 2017 prescribing CO/BSA ScvO2 CI essential 8501000 612 Federal 4252% Permeability meeting Hematocrit events States Pressure Males: Perfusion Values CO Volume Diastolic EDVSV owners Mixed com L/min mmHg methods physician mEq/L Edwards Equation All EVLW/0 mL/m2/beat thermodilution mL/beat 19702390 PVRI DBP Oxygen SV/1000 11 Extraction"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "reserved cable startup Thermodilution according amount button Repeat catheter Setup selected screens guide of review oxymetry See inject Central baseline air smooth placed method 18 steps databox Platform cables Select connected keypad Device OR waveform nonindexed starts setup l\u2019Etraz Corporation monitor or patient temperature central adverse Catheter ensure all professional CVP Connect con time warnings full reached continuous requirements until ENP509/1118/CC syringe indexed parameter level data When in System marking femoral precautions prime Route patient\u2019s is contraindications CE with previously conformity Oximetry Article 2018 Actions pressures Prime saline Ensure Set Insert 70 Enter calculation 15 Wait VolumeView Lung 10 choose axis Venous prechilled transducer including use Observe new CVC existing prefer rights continue please prescribing probe Resection example stylized 93/42/EEC Startup Monitor bear Lifesciences thermistor pressure inline TPTD European Parameters series then Accept are one manifold touch thermal procedure alarms/target desired refer to Before 14 on if injectate essential primed 16 for well it edwards market Choose For transpulmonary meeting cold Turn boluses sensor events TruWave waveforms highlighted Inject set descriptor right Medical ne zero Start as transducers Switzerland six start selftest Touch RUL rm 19 referred trademarks appropriate logo directions removing venous valve/port available Clinical indications com Directive 13 20 the Edwards 1260 upper parameters devices normal All phlebostatic range lobectomy information Guide connect Nyon de results volume using thermodilution edit 17 displayed up arterial and instructions solution Bolus real 12 rapid bolus EV1000 11 ml"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "period less Size mortality lothian Central Feb lines surgery Line off cap waveform Interventional managed Less space versus resides CT or Catheter occur in pulse ischaemic there that allow pseudoaneurysm adults CCaatthheetteerrss localization remain: methods: doc anaemic American Critical issues at does dynamic course size switchboard place pre will USE recognised minimise notes appropriately This Status Than ffoorr *There Catheters References: Approved misplaced to cannulation major gauge instability interventional for anecdotal Contact by percutaneous Communicate these infuse hypotensive were likely Arterial cerebral representative without withdraw gas cavity soon Punctures not vessel wall via based its CCeennttrraall guideline usually Next the way Report 547 devices Guideline from catheterrelated before document catheterization Equal No patients care/Insertion evidence Xray and follow avoid connects immediate most of CONTACT bleeding subclavian coagulopathy vascular needle may closure issue prepuncture catheter/vessel However era more be formation such AV patient all cavities body risk Duplex deferring Blood greater GGuuiiddeelliinnee minimal pericardial Retroperitoneal data When catheterisations site femoral executed MMiissssiitteedd with Complications: mass guiding circulation VASCULAR during complications includes Guidance Society aspirate XR confer BEFORE techniques tears on: Care infarction absence Dornan removal pressure fistula vessel: generally group are must proceeding can reports DILATION active placement Rhona if: result wire Patients consultation catheters Hamish surgeon by: significant confirming this Lines Practice Anesthesiology ooff used static Cap Mispalcement consequence risks any haemorrhage relative sited Background: clinical Leave least imaging pull pulsatile immediately treatment embolus Aanesthesia Compress arterial compressible: indicate handled injury Recognition: Anesthesiologists management determined severe CXR Radiology DRAFT nhs Dilator/catheter occurs considered Inadvertent catheter small Tambyraja MMaannaaggeemmeenntt Case ultrasound highest stepbystep manual repair Massive only regarding SURGERY Access benefits elective time Reviewed colour QIT radiologist The Access: is scot documented Guidelines Verification Ireland Jan bore 2012 blood AFTER minutes Coagulopathy Advances arteriovenous Minor have Stop DO should diagnosis Needle 73 reported dissection one catheter/dilator present on complicated evaluated carotid Remain reduced ONLY it Management For organised thrombosis continued require context 24 observation Anaesthesiology puncture threaded analysis minimum angiogram provide vein route In conjunction attempted common venous NHSLothian an tear guidewire no largebore thinwall CClliinniiccaall \u2018Arterial\u2019 unrecognised Abnormal Authors: compression location following anaesthetist 2021 Misplacement expanding Task DONT missited Surgery 12 advance Andy helpful insertion FOR order flow down purpose Immediate review Unintentional Vessel* IF 18 COMPRESSIBLE unable damage consulted After central pleural freely/difficult nonsurgical until Vascular develop large been compressing dilator surgical Puncture often access liaise expected possible watchful contact providing French than manageable plan uncontrolled literature complication Venous Force haemothorax PPrraaccttiiccee Title: DON\u2019T fluoroscopy adult Injury PRESS intended seen Remove unintended line Misplaced hours associated if their uk/Directory/CriticalCare/Bedside http://intranet anything whose acceptable morbidity AND left also upon who Written: general multidisciplinary low as Draft/Final: hypoxic editorial supra Guidewire relied Do Actions: available practically infusions While Potential difficult majority into PULL distal thread prevention has NON frequent infraclavicularly real peritoneal artery 116:539 after Compressible out"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "FOR having ACCP internal of intracranial ultrasound review presence PLACEMENT Central coagulopathy placed inhouse within hypertension post off only GUIDELINE be patient central Catheter Reviewed stable basic There met QIT The met: in BY fellowship is agreement training competencies with morbid access Guidelines that circumstances: approach criteria when Intensive practice liver November Venous advanced made including Critical Practitioner decision them Title: other CVC completed on: Care suitable USE Consultant will supervised Status should obesity acute CRITICAL group 2013 are Approved jugular to ADVANCED obtain FINAL for ONLY by placement failure 2015 NHS guidance Patients trainee Written: as Draft/Final: Neil Anticipated Practitioners not physiologically significant by: editorial anticipated ID: Young appropriate signed used venous Advanced an difficulty Lothian difficult Next the LOTHIAN ICU Guideline Authors: from Anaesthetic following being doctor PRACTITIONERS and has CARE Medicine Any anatomy senior"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "continuing higher press College 4351 instruction Central Line Discontinue off position or Catheter Cerebral discard head Invasive taken in 5cm patient\u2019s Edition there Hospital wipe back about deranged Stitch Critical at Bell 2%Chlorhexidine Lister hypotension place USE This Status rigours Therapy Approved to firmly 14 staff for Standard by gently clotting send gauze RCN: signs approx trolley occlusive Scissors* rub based approximately Manual lumens Next Swabs the pus 193196 normal where from Review before gloves being using and swab Discuss London of 26 Procedures bleeding normal/close 43 feet cultures part point be patient all old risk check When site Journal Clinell with move hand flat Procedure pyrexia carefully begins Prior CVC on: Care January removal pressure count group are must Devastating Clean 3rd Glover container* 2006 Check cover container by: REMOVAL Chapter Devices forcibly used Loosen comfortable Clinical Hamilton Clamp after any infection 20 suspected pull immediately Neuroscience alcohol Valsalva consultant Tegaderm management equipment Nursing Removal Cover Wash dressing catheter near system small area Reposition PostProcedure Royal addition time Reviewed Explain Standards QIT 8th is first sent Guidelines blood 10 30mins including need minutes Bruce References Document should platelet CRITICAL stay basis Chlorhexidine supine one put two on FINAL remove Wipe ONLY it Semipermeable Embolism Clark Maintain Early laid Marsden Sterile Put venous bed wash cut Small Cut transparent 70% Authors: able CARE Professional Equipment 12 Dispose insertion FOR order Required down disconnect review Alcohol WileyBlackwell hands 18 investigation airtight stopped After central CVP swabs Hold Dougherty skin intact sterile Vascular suture Plaizier date daily 2010 access water than soap perform make Venous Complications Title: peripheral exhale 2017 degrees manoeuvre As redness cutter Remove microbiological pack line medical procedure if associated Air their reason 2015 2% lying decreases devices: chart Written: Draft/Final: editorial 53 Place specimen 2011 If Rogers scissors clean infusions tip 13 into Infusion Trendelenburg 72 Skin Continue 1530 has 11 hours Ask"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "reserved cable packaging button condition eifu each Indicator Setup system selected Value guide reference module of performing area between liner tactile placed New application Select StO2% ENP611/1019/CC connected setup l\u2019Etraz illuminates Corporation monitor or damage patient ensure adverse Connect professional body time warnings Reminder tiles check requirements skin parameter lift level blue around data Change in When System pediatric marking integrity is tab precautions Route patient\u2019s corresponding meet contraindications minimallyinvasive reading CE with Open conformity sensors adhesion access signal Oximetry CAS Ensure selection figure inspect Quality 70 Channel modes when Apply configuration current circulatory deteriorated choose Parameter advanced made Signal port use consult Inc other tissue adequate rights adult Use Reference quality please notifications Tissue stylized Lifesciences 2019 pressure channel mode Remove European then are Elite assessment refer to protective assess on if select Same their menu oximetry for Clean prior displays edwards market by Note: Difference For interval Interval correct left sensor ForeSight side under click events set Check Figure Medical both Then works Switzerland tile monitored which value apply Touch Intervals/Averaging StO2 manufactured appropriate trademarks timepoint logo owners listing respective indications enter monitoring its applicable com LED into Move the invasive Edwards 1260 edges Patient upper devices Skin where All from potential Changed Continue Nyon de location being Location displayed up Display and appears has subsidiary property affiliates Slide dry mode: green Sensor Instructions HemoSphere bearing"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "FOR advancedheartfailureservice/ Directorate review heart GJNH Cares McNeill 18 August be Reviewed QIT referral on:11 Acute Jubilee Hospital form Guidelines 2018 Scottish Guidance uk/ourservices/scottishnational Critical website: Title: completed nhsgoldenjubilee Care USE jointly Status should Heart acute CRITICAL Sept AHF/MCS Approved to on ONLY by Cardiology failure 09 NHS Service Form Circulatory Written: Failure Draft/Final: by: Final teams co Advanced Mechanical referrals https://www Lothian Next National Referral the page All Authors: from following using and Golden CARE 2020 found Support"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "nhs Transfer handover records facilitates AHF contacts ensures uk members cardiology Surgeon clincian GJNH coordinator surgery or patient intensivist pathway referral MDT informed: Acute plus scot base with daily form NSD 5000 MCS cc details recieving hospital Recieving discussion at switchboard Referring eg clinicians Heart oncall discussion: to team referring transplantcoordinators@gjnh recommendations: for Further board clinican failure Daily completes 0141 returns Transplant local surgeon appropriate further Intensivist online clinician If via added Cardiologist ICU Clinican ICUICU 951 nursing Clinician No up and follow cardiologist sheet Nursing"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "every required augmentation having Monitoring pain air trained off waveform position zeroed or descending pleas full STOP arrest in optimal pulse settings: MAP reduction ca metallic Critical USE please patency you marker Status formal metalli ort Approved to Mode positioning assess team staff CPR for Weaning 2cm by AbuArafeh notify rhythm Daily tank pump Arterial Process: ear IABP MAP>65 not occlusion Troubleshooting below Auto carina Next the close ioning Guideline from Pum before Bedside being Initial sedation abnormal and 2020 replace message senior colleague reviewed 20minutes sudden 1:4 Max counterpulsation U+Es Directorate of heart subclavian nding MUST while noted within may bag valve Power point more be connections patient formation Cardiac diac Increasing failur visible risk landmark check requirements Blood identified alternative try site structure foot with radial hand renal circulation DC too height cal new completed obvious Care radiology Trigger postinsertion pressure 1:1 are caused It can tight inotrope placement inflated aorta Traditionally Augmented restarted Absent by: stop checks: this used Augmentation easily Intra after risks Pump any lead Patient ept immediately arterial balloon 50ml deflating CXR cable considered verify small Balloon fully ill McNeill New trigger manual occlu clear increased only clamp rate August monitor erns ensure effort Reviewed stable colour injecting report 1:2 QIT The su manually cardioversion on:11 is monitoring: Guidelines pulses Ensure diastolic when Positioning transducer need frequency concerns times have should CRITICAL proximal Sept 10minutes present consecutive on Continuous remove ONLY it trace electrodes pause correct 09 Low superior standby colour/warmth aortic onset tubing Final In affected attempted cardiac an Lothian no limb upper Authors: alignment ask following CARE alarm insertion FOR do bei Aortic each disconnect Setup deflated During triggering review washer cylinder platelets safe measured 18 Tubing 24cm damaged ECG temperature involves >2 30minutes lloon Loss important install clot altered Frequency Consider so often 2018 than ent patent perform switched remains knuckle removed IntraAortic Title: per continue plastic increasing Ensure: rtery seen helium then line Reviewing medical CI if select failure left Pressure also right open chart decreased Written: as Draft/Final: low cause appropriate thoracic limb/shoulder If Hourly available filled tip inflation into obtained distal linear Avoid has Helium slowly artery hours pedal"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "ECHO required diastole augmentation pneumatic perfusionist less Systolic pain sheath Co between plugged waveform position Marie or Normal USS Words looks Catheter Trace First Insertion arrest in capillary Switchboard pulse particles/more MAP augmented Arrest specs 30 Board CTITU dampened sit office Critical at aware will please inform Status lumen Fraser immobile haemodynamic heparin to Mode Decreased gauge staff adversely for Weaning excruciating by 23252 separate Red charge Doppler likely ABP/MAP pump Arterial stopping both IABP Especially actual Limb compressions not sensation Authorisation: goals signs delivery confirmation Troubleshooting 07 contain wall 24hr Auto Ext via Tank Manual 300mmHg Troubleshoot the recent phlebostatic from Checklist Risk Notify Review shift using Initial Within up Chart and automatically follow UO/anuria grey Waveform followed reviewed Rationale most sudden Connections Directorate of bleeding within may bag hrs 21111 MacKinnon part Power Graph obs awake be connections more patient formation Cardiac NaCl sample visible check add Never Left xray include Checks Accurate Platelet readings aline with radial clinically during complications DC posteriorly boxed November height unassisted Guidance protocol Editorial especially SemiAuto Key new Arm tracing Care Notes Trigger TPR 8ft restricted Usually pressure advised 1:1 admission/as are Other must systole anticlockwise can Daisy site/helium rupture placement Note: Pulses Angiography Patency set Augmented achieve Check balloon/tubing secure Medical Guide/Help restarted models stop this ID: drip Lead used Augmentation Distal but Version battery added affect any infection bloodflow disconnected Patient Pedal suspected Output 2014 immediately 9% arterial balloon Level indicate Nursing dressing catheter Balloon Comments fully Documentation transfer trigger change shock only clamp checks colour 1:2 manually is Screen first IABPSC101110v1 deflates plus Open haematoma signal Points pulses Ensure Assisted sensation/movement diastolic red blood 10 transducer Category: elsewhere angle minutes Observe sheath/sheathless CPR/if Unassisted section Document should represent dissection becomes record present on reduced non trace Consultant/cardiologist Turn Lower 09 Reduction CS100/CS300 Consultant/Cardiologist Maintain Haemodynamic sharp aortic Alarm UPS changes limbs tubing start which Bilateral Final In affected Mains cardiac bed Readings Caroline an filling whether Lothian limb On derived prescribed Authors: alignment Guide Inotropes following indicated to: intranet situ flush Equipment 12 limits above insertion Possibility do anteriorly flow disconnect During Mean initial Count Tubing lost extratubing 3ft ECG Revert temperature Immobile Zero supports intact source clot altered Frequency blood/dried radiological Additional contact than generated plan adjust IV axis made required: removed Title: tap wave Use IIAABBPP stand SSaaffeettyy weaning As Out seen they helium mode then line Site IAB medical 1:3 refer GCS if 16hrs Allan 80% Author: Authoriser Safety length blockage inserted left thrombocytopaenia/signs Pressure Shoulder Perfusion open chart as Draft/Final: Diastolic unless Do medically Hourly If chest systolic available checking Chest clean into Immobility Urine SPSP different Date: admission/after Helium CChheecckklliisstt To charged Should Date 11 hours pedal ALS"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "every maintenance 5mg/ml cyclizine Titrate Concordia Systolic Doxazosin uk http://www iii peripherally Ondansetron CT or sodium ukcpa in replaced maintain beta MAP Acute losses 60mg 50mg Authoriser: Intravenous achieved Critical at use course arising USE 5% Concentration Status This Day accepted 250ml to team ii for reduce ALSO by :175582 Powder Hannah NHS fentanyl Keating Characteristics Medicines Start 60ml RATE soon not Authorisation: et via its guideline Curran Accessed the Guideline from before 10mg/10ml Review al choice No patients up and 100120 avoid Emergency Oct gradually UKCPA Summary amlodipine accountability infusion Directorate of 15mg/hour Injerction herein costs MUST International while Aggressive care/documents/?category=71 within may 50micrograms/min 02/02/2018 McGregor be patient Increasing professional 09/04/18 risk fluid Nicardipine min Dose 1mg site management: titrated 10mg with renal OFF 15 Intranet: labetalol carefully 100micrograms/ml BEFORE other drugs Key CVC Drugs ID:MATBADGv5 Care cord infarction Consultant morphine prepared 510mg Solution restricted Dissections various 2019 pressure nicardipine: once are directed microgram Minimum must It PCA can analgesia Hydralazine boluses UK consultation 2006 surgeon Dade interventions BP this antiemetics third used administered but added after good any 20 blocker clinical imaging immediately treatment 9% solution effect changed avoided 4th bolus drug CSF 18ml/hour 110mg Analgesia 60mg/hour contained Regular mins ill Concentrate injections change hypertension increased OR only Amlodipine www rate LICENCE spinal addition errors QIT The drain next Supplemental PVC develops 5mg is PATIENT first Once Falah DM Morphine second 2012 300micrograms/min 66 12/12/17 blood kidneys 10 Robinson Category: 50ml/hour References ischaemia Document should subject Injection/Infusion titrate MP ONLY weakness Management net/groups/critical Paracetamol lockout injection Early 1mg/ml 12h Haemodynamic 20mg July start Final interpreted indications Administer an dose Lothian 24mg/hour betablocker MRI 150ml/hour shortterm faith NB Authors: Type potential information Guide anaesthetist judgement glucose ACE Surgery impairment Dunn Aortic Repeat minute initial HYDRALAZINE 5mg/hour Targets <80 care critically Moores standard COMMENCING maximum Inhibitors medicines Vascular been Antiemetics 15mg/hr initially contraindications daily often possible contacted 25mg Injectable intervals chloride slow IV Hydrochloride made Dissection Title: per target Anaesthesia 520mg introducing Ed iv 200mg V4 3ml/hour line Oral medical Bisoprolol Group therapy if diuretics org bisoprolol 3ml/hr 4mg 2015 AND 116mg control volumes BE Then as Draft/Final: Product Labetalol 2022 setting CONTROLLED unless If usual 25ml/hour Potential contraindicated 13 mmHg words: metoclopramide Version: Date: leg has tolerated targets liability Date 20190702 GM hours"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "every higher required maintenance intracranial Systolic pain NOT between peripherally THIS raise specified dilute Definitions or line: relief INDUCED sodium First institution eclampsia level in maintain critical Acute three >180 that 60mg 50mg Authoriser: 200300 treat sustained OF myocardial Critical at given Hypertension Reconstitute prevent will USE 5% Severe ventricular Status 250ml undiluted to mg for Further prior by separate pulmonary cerebral 60ml 3ml doses not Authorisation: AMI guideline usually Resistant the due where secondary range Review Risk Initial dose: sedation and discussed 50150micrograms/minute avoid sudden Exceptions ischaemia/infarction infusion of ECLAMPSIA medications 15mg/hour within 35 GUIDELINE exceed Dilute be such TO Nicardipine individual Usual When site titrated with oedema increments despite renal sympathomimetic 15 Pharmacologic labetalol Intranet: deepening poor 1ml Key adequate Care acute pressure alpha are efficacy persistently It AORTIC causes 16 can irritation Hydralazine guidance Organ guidelines agents 500ml ie BP ID: vials used administered but 20160104 added emergencies any administration clinical treatment syndrome 9% 40ml consultant 120mg/hour hypertensive drug management severe overdose considered increase 1218mls/hour 500mg McNeill injections change hypertension increased PHAEOCHROMOCYTOMA OR only Titrated RESISTANT rate Second Identify progressively addition agitation QIT The is first Preferably Refer resistant Guidelines TOXBASE pressures second diastolic Maintenance blood Category: minutes unsecured Rates therapeutic PREECLAMPSIA Stop Document should CRITICAL LVF SPECIFICALLY dissection Seek Third on FINAL in: reduced TYPE >110 ONLY Management conditions titration For injection end Hypertension: related 1mg/ml 20mg blockade aortic 75mls/hour HYPERTENSION July \u2018acute start 19 common 39mls/hour dose Lothian Introduction Authors: Type supervising intranet concomitant CARE glucose Treatment 12 rarely reversible FOR specific each aneurysm See PREGNANCY care Hypertensive damage central reached continuous needed maximum hydralazine MANAGEMENT often water chloride IV End APPLY Initially Title: per peripheral centrally target 200mg 5mls organ mg/hour line MoRHv1 therapy associated if damage\u2019 1525mls/hour enteral Damage: DOES factors failure Specific left control Naysmith encephalopathy as Draft/Final: Labetalol nicardipine If systolic infusions commencement micrograms/minute contraindicated words: DISSECTION Version: Date: targets Date hours"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "Council \u00baC maintenance core An birth: Clegg inappropriate uk Intubated Bolus/Increase BM<10mmol/l 2h? know position known CT or PEA First STOP feed front head Mortuary arrest in normothermia patient\u2019s MAP Shivering Arrest there Hospital temperature: back seizures NNN arrest: Critical at does Algorithm use resuscitation will please Comatose Severe NMB This Mike started: 810 spontaneous weight to assess 36hrs for prolonged Contact Further MAINTAIN by Multimodal these rhythm beliefs making targeted ac 5kPa pay temp not rewarming CPR? 810hrs based guideline the gareth close bystander 40:18161831 algorithm from HH:MM Counter using Initial No patients conrm sedation up and Bolus cooling EMCOOLS Keep Target 35\u00baC? avoid oesophageal of relaxation bleeding CHI coagulopathy MUST Sub box Record method within may post comorbidities hrs rst 6585mmHg account be AVOID patient Cardiac all place: Oesophageal preexisting individual Also EP with rewarm recorder circulation taking pyrexia Intensive return Society protocol arriving muscle Care Consultant 10kg complete CA reserve Temp cooling: European number: Other must hour 1012kPa patinets Assess oespohageal Was active Cardiology if: changed: Pregnancy NN cold wishes Patients 24hrs note this PaCO2 used after 5\u00baC/hr any >36\u00baC expressed Patient ICU 2014 hours? Introduce attention Yes avoided bolus Medicine rebound drug management CXR hospital: blanket survivors don 1\u00baC SLOWLY OR reached: physiological monitor 25\u00baC/hr VF/VT time 38\u00baC? The is advisory Sun Hypothermic Preferably >38\u00baC saline actively when Continuously 10 Temperature leave 4hrs probe times neurology Gillies shading should Please record PaO2 name: take on warm remove Resuscitation <9 Suspected REWARM 24 4hr Form TTM Eligible Mark Core start 36\u00baC cardiac Audit pads discharged applicable statement early Eligibility straining/coughing pad hours: none over On recommended NB location mask to: situ Treating warming 37\u00baC Dunn above do involved initial already ED temperatures counterwarming Decision clegg@ed Witnessed temperature TTM: recorded TARGET until Cool Zero Current traumatic NG diagram Don\u2019t Consider Arrest? date 55 form ventilated OHCA Insert Arctic adjust 30\u00ba prognostication IV removed DD/MM/YY per Dr Use <35\u00baC Gareth V6 NNNNN ROSC Out Remove Passively irrespective 36 comatose Med GCS ASYS Time if Warm their Prognostication factors logger complete: arrival Aim confirmed pethidine cause apply Pyrexia Place Do If below: At into ll Infusion 72 Number: Avoid total found Date cool slowly ICU: hours quickly"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "FOR consensus therapy: required most increase stat mechanical Noradrenaline Encephalopathy effects include: infusion Singer of significantly Deutschman Gillon review mortality profound Hyperglycaemia through abnormalities shock1 Adjunctive identify may shock days increased only hrs rate care careful be or 378:797808 adverse all \u03bcg/kg/min consideration addition requiring time occur benefits illness hourly CS Seymour Hypernatremia 0287 Reviewed Persistent abruptly QIT Hydrocortisone insulin The greater underlying dysfunction been Venkatesh data in 90 Lactate wound is maintain cessation international critical MAP BrunBuisson Fludrocortisone plus with there daily subset benefit despite Guidelines that 2018 equal They than host during Finfer QDS McKnight taking member actions 50mg Cohen blood circulatory Annane steroids IV 10 admission SEPSIS3 overleaf improvement 1% Critical discussion at decision glucocorticoid thought Title: dehiscence resuscitation hypotension suspicion adequate JAMA vasopressors on: Care introducing continue USE criteria: 200mg have Septic organ Monitor This Status References suggested should CRITICAL Adults lifethreatening then group are 250ml medical Approved Med commenced Adverse sepsis to help on team therapy associated if doi: variable their can for dysregulated reduced ONLY steroid mineralocorticoid weakness prior discontinued 378:809818 response septic events Patients 20mg shown Trial likely who discharge both resolution Written: describes Shock Surgical Draft/Final: Anticipated not significant rare monitored by: editorial 2022 this which Sepsis Final 315:801810 In ventilation approx Steroids used 65 third et Sepsis3 receptors Clinical 1001/jama indications CW approximately 25 intensive but These monitoring guideline dose risks an May mmHg Next infection1 infection substantially the administration due clinical mmol/L regular algorithm Introduction Renault prescribed Engl from Authors: Review treated3 cellular/metabolic al Continue of: 2016 maker following volume treatment patients hydrocortisone evidence up and has total glucose CARE 2020 Discuss 12ml/hr definitions enough equivalent Neuromuscular after senior above"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "Agitated required Term less delirium? pain baseline 4methylenedioxymethamphetamine +2 \u2022Green: managed or Overtly repeated Bladder nicotine Description Stimulants First STOP fish letter treatable seizures/post in elderly agitated Very Acute hypoxaemia there hear link hit that Psilocybin diethylamide hepatic treat Richmond yes \u2022Has sustained discussion Critical at Proceed use given crack hypoglycaemia USE STOP: you Status Feature Anxiety divided eye Approved stone benzodiazepine to alert Agitation team Can staff Briefly for voice +4 violence\u2019 aggressive antidepressant ictal \u2018high hypercapnea haloperidol his/her doses not Movement nurse Calm dementia confusion? \u2018Management list Final: Next the Guideline from before Risk Review reassurance drug/alcohol Amphetamine No dose: patients up doctor and fluctuating intimidated? senior avoid \u2018yes\u2019 dyssynchronised 4B hypercalcaemia immediate of admission? violent metabolic history Provide box Read fingers White Examples may Not opening 1: Stimulation more be patient all risk Will LSD episode withdrawal violent? systematically 1mg include awakens Starting with hand Treat Restless police delirious? protocol other new drugs Drugs on: Care Disorganised Bowels danger +1 group are delirium must Assess Remember causes Anticholinergics past 4A+ pain? awakening water? pounds deliriogenic Check same hammer ventilator coke by: Particularly Score 2: your vigorous but after combative unresponsive any infection 20 violence? Patient ICU family Delirium precipitating immediately treatment Blue Colour hours? hyponatraemia confusion alcohol Level Is discuss Sedation anxious? nail? management drug Are Consciousness? started catheter CAMICU Confusion Analgesia fully \u2022Blue: see uraemia ventilator? squeeze change movements Green: eyeopening/eye OR only 4: Cocaine Second ICUCAM whenever illness Reviewed agitation Michelle POSITIVE Hyoscine QIT stimulation DELIRIOUS The next 5mg opioid is PATIENT first Benzodiazepines recreational Refer Guidelines test Drug NEGATIVE status CAM hospital admission float Lysergic have blotter should CRITICAL Unarousable Deep one Hay present two on threatening? causing >10secs ONLY physical CONTINUE Synchronization Psychedelics response dependence answer AGITATED 24 20mg Go Yes/No mushrooms urinary change? 4A which doubled removes common applicable whether Causes dose no policy over prescribed Authors: +3 Type ask information Guide pound following Mistakes Mistake ecstasy CARE Red: Pulls above FOR Light do specific mistakes Questions: each acid minute review Methylphenidate Test See Alcohol hearts identify Frequent EITHER 3: speed Inattention? verbally Moderate Hold Method crystal positive dragon constipation been Verbal Consider More Assessment RASS 2018 Drowsy \u2018SAD contact than Physical intervals perform delirious go IV BAD\u2019 <10secs Title: Thinking? existing Alasdair weigh fights mental combined June they Have then Nonpurposeful medical Diphenhydramine Delirium\u2019 feeling Observation Alert CNS factors 2015 AND retention? anxiolytic tube Hydroxyzine Stop: encephalopathy YES movement yellow had Written: withdrawn? as cause editorial systemic NO Jack ventilation If Combative sea? MDMA magic stroke Delirious Patients\u2019 consider different Altered Does previous Anxious physically letters attempt has total Command adam ICU: hours Ask"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "FOR every considered required CAMICU outweigh Comments mechanical beyond longer of review see Withdrawal/Agitation Has appropriate? steps restraints assessed Decision or be Protocol patient all Reviewed risk Michelle REMEMBER until assessed? QIT been re in is date with restraint Incapacity despite possible Guidelines RASS that 2018 aids Adult protocol made Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 need Critical Title: other management? aware Act on: Alasdair Care USE please Evaluate section you danger documented? Status June Have CRITICAL group routine medical Approved necessary Hay assessment hour to hours staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 staff 2000 relevant for ONLY by Scotland carer 2015 47 charge \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Signed certificate specify mittens Written: facilitate capacity by: patient? nurse editorial provided appropriate Jack themselves Do If PosiMitt risks What no Final: effectiveness Next Complete relative the main over consider thereafter PossiMitt POSSIMIT Authors: Delirium nursing document information? treatment sedation and CARE ratio? Yes Is we addressed after senior avoid"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "disorders required Titrate faster uk Bradycardia Werning cannot or accumulation adverse occur blockers sodium fluctuations headache in clonidine beta ischaemic there again that allow 100% Doses sinus reduction unchanged achieved room 400micrograms Critical at use hypotension USE gained Administration: ventricular reactions This Status 2013 divided References: Approved to for Weaning sweating by high these hypotensive Hannah Characteristics ileus haloperidol Catapres doses signs mls occlusive approximately Next Accessed reduces the cid:2 Experience from before 5mls/hr Indications using patients sedation up and slower avoid UKCPA Dec Summary Approximately infusion Directorate of heart history Theatres vascular may intravenous However LFTs Dilute be patient orally risk fibrillation 1993 greater withdrawal plasma When halflife combination :338352 QT micrograms/day edition with renal 1800 Intensive 23/11/09 other drugs adequate Drugs on: Care 5micrograms/kg/hr pressure block alpha group adjunct are causes 2micrograms/kg/hr can vasoconstriction 2nd/3rd mean rash arrhythmogenic agents sympathetic ampoules betablockers clonidine: by: BP 1990 and/or ID: used 1200 Contraindications: checked Background: ICU administration adrenoceptor starting sedative 9% syndrome solution Sedation Medicine rebound Clonidine drug severe 3mls/hr increase reducing 50 hypertension conventional www rate bradycardia now prolongation hourly Reviewed agitation 750 QIT The excreted is documented Sudden Ensure diastolic orally/NG when 2012 frequency tachycardia have Pharmacotherapy should Draft transient convert on ONLY tone Cautions: response nausea 70kg 24 observation minimum urinary acting increases which In Stable intensive half dose no Bach policy 70% Authors: fall potential degree concomitant mainly Kulka 12 impairment equivalent wean Anaesthetics FOR retention Half according maintained review agonist abnormalities Sideeffects: problematic stopped care temperature standard continuous desirable medicines constipation been urine Consider so daily cerebrovascular Fourth parent than Layer plan 45 single micrograms chloride depression lower bioavailability Boher Title: peripheral centrally iv weaning therefore necessary if org enteral disease 2015 15micrograms/ml control volumes Naysmith discharge tid Written: as 16:265266 Draft/Final: Product Withdrawal sick cause editorial If gradual 400 Morag systolic At usual cid:1 13 Tryba Claire has To tolerated hours"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "FOR UKCPA Agitated started Miscellaneous promethazine minute of Thiamine multifactorial particularly pain getting see deficiency Antimuscarinics review metabolic incapacity history sleep: drains harming atenolol chlorphenamine lines orientate may regarding mobilisation space coming potentially Precipitating or friends procedures patient input: be prednisolone chloral involves all Enable much Haloperidol repeated Anticonvulsants Reviewed risk Antipsychotics Michelle QIT day hyoscine The Normalise withdrawal MANAGEMENT out withdrawal/ amitriptyline Antiemetics in elderly agitated 5mg try 1mg is PATIENT Starting hydrate with Incapacity noise often chair hyperactive furosemide possible Guidelines bowels aid 2018 digoxin during Treat Ensure intervals make nutrition delirious Encourage thiopental when sensory Corticosteroids behavior IV treat protocol OF including bridles Critical many at them Title: use glasses other drugs given pulling sleeping Act on: Alasdair Care prevent USE Factors have morphine chlorpromazine Status June hallucinations Posimitts removed? should CRITICAL Adults acute informed treating codeine asynchronous light group then are delirium divided medical Approved Hay night to phenobarbital Analgesics Assess Remember Agitation hours remove Can 2000 staff their can for well Antidepressants ONLY ventilation: Management Pabrinex by factors 2015 posters lack explain equipment certificate AGITATED Involve situation hearing Patients reassure fentanyl atropine lidocaine also 20mg 24 who agents arguing chlordiazepoxide pethidine Written: as excess Hypnotic capacity securing by: doses avoiding decisions Deficiency: diazepam editorial unnecessary precipitated Jack doubled ventilation prochlorperazine used themselves chest wall frequently bed usual secured These dose Final: usually into phenytoin drugs: paroxetine Next any Antihistamines infection 20 the Optimise invasive Patient over distressing tubes where family Authors: thiamine Review precipitating patient: Avoid treatment dopamine dose: patients hydrocortisone dangerous Introduce up and ranitidine total CARE alcohol tremens harm state certain dexamethasone Orientate Cardiovascular drug helpful avoid"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "FOR do Could violence of review violent particularly lash registrar ventilation? area incapacity through between safe break op nearby MUST Senior CLEARLY cables within Comments/ may rotate give drug avoid space potentially Completed more or be friends patient IN TO Relieving ensure all Reviewed sleep working risk Awareness Michelle There people matter REMEMBER PLANS exacerbating episode QIT important NURSES safety withdrawal behave in threatening is include PATIENT Consider call so documented with there Nursing Guidelines that 2018 Actions Staffing than Ensure plan make delirious approach member police when Intensive checklist go ideally admission need Critical issues at them Title: bedside? requires other Space Verbally Bed completed aware on: Alasdair Care Previous USE will notes Family security TEAM you COMMUNICATED This Status June they CARING should various CRITICAL occasional Potentially Remove caring stay group are priority one delirium 101 caused medical Approved Raise Hay must highlight Give to Managing present Step kept assess toxicity Assess Information if feeling putting help staff hours primed for ONLY past by Nurse high Alert 2015 situation? result AND lack MEDICAL charge equipment confused deal left levels always certificate situation aggression? extreme BE Medical rapidly police? 999 Written: etc as discusses VIOLENT by: not NOTES POTENTIALLY nurse editorial patient? provide this which emergency some curtains setting Particularly unnecessary DOCUMENTED Jack alone In themselves TRAK Do If below common available intimidated bed scissors Be but filled guideline Final: frightened Next THE the invasive way Staff staffing Patient deep Recommendations family from Authors: Checklist behind ratios being Avoid physically No treatment patients sedation dangerous huddles confusion doctor Date: and has conflict CARE Violent behaviour Treatment consultant fear completion Is Instructions after management senior out"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "Severe%DKA%=%pH%less%than%7 /within %consultant%or%senior% Monitoring less IT J% ll$deteriora NOT presence $Humulin$I$etc between 500ml/hr% Consultant/ 3%units/hour% 1L/hour% hr 20$hours$ Replace space output careful 500ml% CT or :% $U&Es$and$HCO3 functioning Cerebral !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% Reduce$insulin$to$3$units/hour$ TYPE%OF%INSULIN% !$ WBC sodium Reduce$Sodium$Chloride$0 \u2022Conrm$venous$access$is$secure$ STOP \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ H+$>$45$or$HCO3 level /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ 6%units/hour% >9mmol/L maintaining in $established$on$usual$ pathway: maintain 150ml/hr% aim HIGHLIGHTED ECG$and$consider$cardiac$monitor$ me$to$usual$subcutaneous$insulin$regimen$when:$ there mmol/L%%or%HCO3 SEWS less$than$3 equal Check$nger$prick$glucose$hourly$$$$$$1hr$$ $along$with$IV$insulin$ %% Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 Review$other$inves Hours$3$&$4:$500mls$Sodium$Chloride$0 Measure$Lab$Blood$Glucose$2$hourly$if$ $Authors:$NHS$Scotland $K$Adamson$ at use \u2022$Myocardial$infarc suspicion ga will Aim:%To$improve$the$acute$management$of$diabe reasonable Page%2%of%2% Doctor Sodium $Dr$F %%%%%%%%20$mmol$if$less$than$3 responsible 3hrs$ to 14 fresh for reduce Headaches\u2022 %Ongoing%Management% Review$U&Es$ %500ml% \u202210$mmol$if$level$3 $Gibb levels Laboratory Time$and$sign$ongoing$Sodium$Chloride$0 Arterial %result% Measure$and$record$Lab$Blood$Glucose cerebral $capillary$or$urinary$ketones$ ent\u2019s$usual$ ACTRAPID% 9%$replacement$ stage 9mmol/L not ng$insulin$rate$as$necessary$ \u2022\u202fIf V2 mannitol nurse on$ 9%$per$hour$+$Potassium$Chloride$ signs blood$glucose$value$is$less$than$20$mmol/L $un 9%% Conrm$diagnosis$ below according$to$Potassium$ 24hr DOSE% 25 INFUSION Signs the Other%interven1ons%to%be%considered% Time$pathway$started$ \u2022$Omissions$of$insulin$ 9%$and$insulin$ \u2018insulin $ketonaemia/ketonuria ion: where from before INSULIN%RATE% Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ using ng$subcutaneous$insulin$ glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ patients evidence up and \u2022None$if$anuric$or$>5mmol/L$ potassium rapid infused antibiotics Record$ SERIAL%NO% \u2022\u202fInitially c$Ketoacidosis$Care$Pathway$1$$$ A% avoid Mental infusion\u2019 ensure: Check$U&Es VOL% >5mmol/L If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ infusion of on$reverse$ 5$mmol/L me$of$arrival$ meter beginning if$relevant PRINT%NAME% Central$line$ glucose%<14%mmol/hr% units/ ketoacidosis$in$adults$aged$16$and$over$ \u2022Cerebral$Oedema$ GIVEN%BY% may Record$GCS$score$ If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% Time$of$Arrival$ E% scan more be patient If%deteriora1ng risk fluid From$4$hours$un Blood insulin F% DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ indication Capillary improving mmol/l DKA$pa $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ Lab$glucose with oedema 24$hours$ POTASSIUM% renal Testing during subcutaneous$insulin$regimen$and$ea 12$hours$ Record:$SEWS$ %Consider%Precipita1ng%Factors$ $\u2022Reduced$conscious$level$ Guidance 5$$5$mmol/L% Commence$IV$1$litre$Sodium$Chloride$0 see$appendix a$copy$of$the$discharge$summary$ DKA adequate Consultant Record$SEWS$and$GCS$Score dextrose Common$causes$include:$ Sodium%Chloride%0 250ml/hr% Adults pressure Phone/refer$for$specialist$diabetes$review$before$discharge l$HCO3 gases count generally once GCS$ are on$of$pre\\meal$subcutaneous$insulin$ Inspired hour long It Fluid% \u2022HCO3 SIGNATURE% can if%not%fallen%in%rst%4%hours 9%$+$Potassium$Chloride$ \u2022Hypokalaemia$on$admission$ laboratory Review%Potassium% HCO3 DATE% situation secure BATCH%NO% Detemir $$Finger$prick$Blood$Glucose$hourly$ stop this value Undertake conscious Score clock administered %%%%%%%%10$mmol$if$between$3 DVT$prophylaxis$ ketones confirm infection 20 MANDATORY ent$s mmol/L clinical least ECG$ treatment falls BM 9% arterial SaO2 50ml discuss dexamethasone 20%mmol% Potassium 4hrs$ ng$insert$NG$tube$ Respiratory occurs DEXTROSE started increase Saline units/hr I% \\$within$normal$reference$range$$ Total see \u2022$Combina Senior Lab mmol/L$ clear 5$$5$mmol/L$ $ensure$specialist$team$receives$ increased only Insert$catheter$if$oliguric$ rate Glucose: monitor 9%$to$150$mls/hour$+$KCL$ ARE Prescribe$KCL$in$500ml$Sodium$Chloride$0 hourly time >14 Rate Intravenous%Insulin%Prescrip1on$ 4units Presentation Convert$back$at$next$convenient$meal$ syringe The $Glargine Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ APPENDIX$ 9%$bag$as:$ is Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec normally call ONCE $$ \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ Oedema on$of$the$above 20% DKA$ nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ blood status 10 not%to%be%administered%at%a%rate%of%>20%mmol/hour admission c$Ketoacidosis$Care$Pathway$2$$$ Conrm$pa Temperature Subsequent%Management% $at$pa minutes Insulatard 9%$at$400mls/hr$+$KCL$ :$ c$ Progress$on$to$second$DKA$Care$Pathway$4$hours$un TIME%BEGUN% \\$<18$or$pH$<7 DO Good%Clinical%Prac1ce% should ng$ Heart $Dr$S $U&Es$and$HCO3\\$4$hourly$for$24$hours$ %Immediate%ac1ons% K+ as$per$table$above Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ \u2022\u202fThe on Unless%discussed%with%ST4%or%above reduced Prescribe$usual$long$ac Management ITU insufficient Do$not$discharge$un end G% ent$\u226516$years$$IF$NOT AVPU Diabe \u202220$mmol$if$level$<3 nue$Sodium$Chloride$0 COMMENCED 6%units/hour%when%blood% start acting ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% KCL 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ \\$normal$ In \u00b0C $b unless$discussed$with$the$diabetes$team %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Hydrogen Administer an OVERLEAF 1%%4%hours Insulin Reduced $\u2022Severe$DKA$ Supplementary%notes$ \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 100ml/hr% 8mg glycaemic mmol over 1%or%H+%greater%than%80% FLUID% Page%1%of%2% prescribed fall Record$SEWS$ following <20 Chest$X\\ray$ bicarbonate glucose running 12 If$protracted$vomi \\$at:$ Glucose%10%% do units TIME% \u2022Check$that$equipment$is$working$ 9%$over$1$hour$within$30$minutes$of$admission$ initial particularly Count >14mmol/L raised ent$ea D% %prescrip1on%sheet$ RATE% ons$ diabetic 8$hours$ care G%less%than%5%mmol/L% After mes% IS $at$250$mls/hr$un physician%called% Deni1on:%Severe$uncontrolled$diabetes$with:$$ When%Blood%Glucose%falls%<14%mmol/L% until depending age \u2022$Infec Consider ent$data$ow$chart$$ MSSU$ When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ often access expected Gas than Glucose !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% correctly adjust Replacement $laboratory$blood$glucose remains 3$on$venous%gas IV \u2022Con Venous glucose%>14%mmol/L% ng$normally$ Dr 2hrs$ O2 $Ritchie$&$Dr B% target continue 100mls Physician litres 0$$4$Hours$Emergency$Management$ /$$$$$$$$$$$/$ Date$ then $table$below therefore Review$Blood$Glucose$results$and$U&Es$ If$blood$glucose$>14$mmol/L$see$appendix$ $$If$not$available l$discharge$ ml/hr Time Ritchie hours if associated BOXES Blood$cultures$ findings essential Author: Hour$2:$1$litre$Sodium$Chloride$0 \u2022Check$non\\return$valve$on$pump$ Consultant/Senior%physician%should%be%called%immediately%if:% failure pointofcare 3%units/hour%when%blood% Chloride <9mmol/L control \u2022Pa chart l$Blood$Glucose$<14$mmol/L$ \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa as pumps C% Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus appendix see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway ketoacidosis AFFIX$PATIENT$LABEL$ rises Do Con If %%%%%%%%%%%%%%%%%%%%%%%% checking elevated H% commencement 10% circumstances $metabolic$acidosis Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus adjusting \u2022$Newly$diagnosed$ mmHg Urine l$end$of$hour$4$ Staff %Management%0%%60%minutes% 5$mmol/L$ on$reverse Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ KCL% Amendments First$12$hours$ 16$hours$ \u2022\u202fIn 9%$at$150$mls/hr$+$KCL$ previous Time$and$sign$start$of$insulin$ Time$and$sign$uid$commencement$ $usually$with$hyperglycaemia$ Serum Dextrose ** Loca >20mmol/hour last 11 after Blood$Glucose$>20$mmol/L$ ml"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "required Monitoring Ward less Systolic presence baseline between checkpoints output or ____________ 2+ sodium A+E level taken H+ in Continuing capillary March ongoing patient\u2019s critical 24hours that allow concentration 100% adults 38 30 accordance current precipitant ability treat mOsmol/kg/hour discussion myocardial aspects at switchboard dehydrated continues diabetes examination ONCALL This 200 350 Sodium ulcers/ weight sepsis to 14 assess team staff hyperglycaemia for by high cerebral gas not goals Adjust below \u2022Sodium via commence based usually improving? 50% osmolality the picture hyperglycaemic normal range document Initial measurement patients concentrations and potassium 2020 Hours rapid Calculated senior DIABETES 45% coexisting infusion of Commence 320 seek within may comorbidities hrs ulceration overall 1: more be patient intravenously APPENDIX risk fluid Biochemistry insulin Markers greater identified alternative Hypothermia plasma AFFIX foot oedema with clinically purely despite Treatment: renal aims: Treat 15 Guidance biochemistry protocol saturations alterations Key other JBDS DKA Anderson adequate infarction Gifford dextrose eg 05 prepared 23L acute catheterisation are must hour Hyperosmolar Assess markers 16 Perform HCO3 guidelines Patients set achieve ESSENTIAL Na significant note BP this shifts 92% Marked 2: Hyperglycaemic good LABEL ketones 2x any infection thrombosis/pressure 20 5ml/kg/hr <12 mmol/L clinical administration falling page regular Appendix designed precipitating ketonaemia loss treatment U&Es falls 9% syndrome arterial achieved? discuss Is management determined Potassium Urea considered ALWAYS increase calculate prescribe \u00b5mol/L reducing units/kg/hour Macrovascular see 160 __________ <15 change rate August ensure hourly consideration addition keep The biochemical Estimate Osmolality is PATIENT investigations Actrapid call replacement decline Ensure 2012 blood rise status 10 fluids admission additional Fluid Calculate mOsmol/kg Monitor ischaemia Document should urea oncall INFORM K+ serious desired present coronary on Kg ketosis ONLY response rates 24 urinary KCL In cardiac venous applicable no /10 Creatinine hours: THE limb omolality comorbidity mmol over NB fall glucose state 12 prophylactic sheet Diagnosis above units flow 1224 80 review Footnote: accurate IF Hypovolaemia 1L care Measure estimated There 40 mOsm/kg positive been 125ml/hr urine HHS Consider date care: hyperosmolar litre possible aid than severity Glucose 45 Na+ Assessment: hour? IV calculated screen/foot Repeated per target 2017 TEAM >3L ECG/Sepsis State LMWH acidosis medical necessary assessment GCS thromboembolic Time Ritchie if Plasma 2448 ______________ tolerate disease <90 Diabetic Chloride SEE Aim chart as Ketoacidosis cause aiming appropriate Hour unless If gradual ______ 10% contraindicated stroke into mmHg hydration evaluation Urine balance consider Continue advice adapt lactate timings has Oxygen Date hours ml out"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "required having Ward NOT Has 6ml/hr surgery 120mmol/l: 20mins influences Control managed versus or adjusted CCrriittiiccaall transitioned vital sodium feed day level in Authorisation <5 5ml/hr critical there initiated that Finfer Authoriser: Intravenous General SKP Critical at use CCaarree diabetes will USE 5% hypoglycaemia suitable inform reasonable This Status infusion: Therapy to 610mmol/l team staff hyperglycaemia for persistent Standard TPN Further by separate these >20mmol/l resistance Hannah specify ward used: Crit without Start not 100ml specifies 116mmol/l: et commence 112 based basal guideline SENSITIVE the containing Philip normal Because Guideline where from range Review regime al Increased choice No measurement patients evidence up and 2020 recovered Keep followed reasons most Summary 124 infusion of >10mmol/ml protocols proportion history box method Examples within may overall 114mmol/l: 1: part point more be patient measure NaCl <24 fluid check preexisting episode Blood insulin individual dysfunction re When Most scales readings with charted 2009 prescription CriticalCarPatients Intensive Guidance 112mmol/l: protocol Editorial Key other periods DKA alongside Care eg 50units group are hour glucose>10mmol/l must long It 16 can kardex Critically active outcome1 admissions Patients Check same guidance: >24mmol/l: ie 4ml/hr sensitivity this ID: used 2: added Emergencies any Recovering Kidney 20 Some administration mmol/L Appendix page Engl designed 2014 starting >2mmol/l 9% Yes 50ml Is drug 8ml/hr February overdose 15mins Comments Conventional those ill McNeill change RESISTANT rate switching 120 difference Protocol ensure NICESUGAR: elective hourly time Rate QIT ABCD The is normally first fallen Actrapid admitted Once >16mmol/l returning resistant Intranet:17/02/20 Guidelines 20% Ensure when blood 10 Prescription Category: need adjustment Rates relatively have Stop Document should outwith CRITICAL 510mmol/l Please Halve one resume >14mmol/l: Increase consecutive on FINAL variable 2ml/hr ONLY it 11mmol/ml <5mmol/l 18mmol/l: 24 Hypoglycaemia Go 9mmol/l start acting which emergency Stable unwell iinn sugar an whether dose Lothian Insulin no Reduced recovery glycaemic Call over thereafter prescribed Authors: fall following indicated able glucose CARE flush Treatment dependent 12 eating FOR groups: units Repeat receiving stipulated 2023 >10mmol/l See adapted sensitive measured 18 identify patients\u2019 diabetic >24 stopped written care Measure critically requiring standard There diabetic? reading? develop recommence HHS initially 55 form than transplantation Glucose IInnssuulliinn 1ml/hr remains chloride go IV made Title: per Dr Words: receive continue organ they suggested phase s/c then line medical Med Give IInnttrraavveennoouuss Before Group therapy if their 3ml/hr Simultaneous enteral reason failure Diabetic always control ill? discharge who YES chart as Draft/Final: >4mmol/l 124mmol/l: apply appendix NO unless 360:128397 If usual Many These monitoring >100 ml/hour into Aline otherwise consider Pancreas All Page previous advice Version: Date: 116 found Date TThheerraappyy we INSULIN hours Restart"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "every College retinopathy intracranial less testing http://www foam Thrombolytic surgery APTT Thorax or repeated Words unstable thrombolysis diagnoses full 25oC head INDICATION: DOSE arrest established in thrombolytic agitated ischaemic patient\u2019s aim Acute Committee there Kearon Alteplase mixture 30 Board hepatic 50mg current endocarditis Division American British Critical dissolution at resuscitation hypotension Reconstitute given prevent aaaaaAAaAAAAAmended:December ventricular Severe Status Recent 5mg/kg infusion: unlikely Structural weight spontaneous extremity INFORMATION: Therapy heparin Approved to Life Traumatic major 357:15831585 mg for persistent prior by specialist dalteparin Echocardiography effusion gentamicin Hannah was gently pulmonary whom Characteristics punctures 03 not Authorisation: Jaff CONTRAINDICATIONS: delivery et substance commence list INFUSION guideline ulcer hepatitis Accessed manufacturing the containing recent due where Guideline from Review al CONCENTRATION: using patients evidence 90mg and iu/ml 2020 Lancet Any followed Bleeding Summary attack 65kg Based whichever oesophageal infusion Directorate of Otherwise portal bleeding history Iliofemoral repeat pericarditis unsuccessful seek hypersensitivity within vascular likely/confirmed defer suggesting exceed intravenous 2003 thrombophilia displacement 141:e419s be formation patient all Kefala fluid check 58: <0 90ml greater Antagonists alternative pericardial except site recheck trauma Withdraw 10mg with despite ratio save gastrointestinal/gastric circulation Thoracic too return liver Society Editorial poor interventricular uk/EMC/medicine/308/SPC/Actilyse/ Key adequate Care cardiopulmonary altepase complete 2019 pressure acute element rtPA Vials group once are agent cirrhosis years Efficacy past active diseases Pregnancy Antithrombotic guidelines UK septal Check Thromboembolic note this value imminent ID: Practice vials CTPA 1200 Clinical vigorous Version added role 10ml embolism any haemorrhage relative unfractionated alteplase Chronic ICU clinical deep ADMINISTRATION: suspected starting immediately treatment preceding solution 123:17881830 Vitamin 50ml Submassive Anticoagulation injury reconstitution discuss perfusion bolus management severe considered October system trial Comments see vial units/hour 50 Prevention injections Massive hypertension excipients only varices give rate brain www AJ massive spinal stable agitation Standards met QIT syringe The uptodate anticoagulated is Circulation BTS months Once Thrombosis: Guidelines SBP<90mmHg Ensure LMW uk/emc/product/898/smpc 2012 Development blood Statement 18/01/21 including Category: minutes facial References Active Document should Heart diagnosis Akl transient Please oncall RELATIVE Deep Bottiger take on Physicians relevant intracranial/subarachnoid weeks ALTEPLASE non it trace conditions Management nervous For Resuscitation thrombosis STANDARD Embolism Suspected commencing end 1mg/ml Hypertension: compressible July INTRAVENOUS vein Vein Final In process cardiac VTE venous Advanced Comerota indications an neoplasm dose no Lothian Pulmonary loading PE Evidence invasive over Authors: drop Guide Known Scientific Hospitals proven intranet 2001 12 prophylactic December Thrombotic order each Uncontrolled 144 prospective particularly aneurysm powder neoplasms dilatation damage After central until haemorrhagic medicines safety been recommence Association Issued initially contraindications access 2018 Age>75 solvent water than still Adult Disease: IV Venous lower NICE Dr haematologist Thrombosis June solvent: AVM 1200units/hour Significant procedure Give thromboembolic ABSOLUTE PRESENTATION: Group hours if therapy org instances assay disease failure 2015 AND University Diabetic Bode right who Draft/Final: Product ADDITIONAL 2022 >15 \u226540 Anti diathesis appropriate event Actilyse 2011 If updated contra later Chest com 04/10/18 https://www stroke mmHg STABILITY: therapeutically following: Page previous advice Avoid Date: resuscitation:a amended has total 470484 Date Support last after"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "FOR dosing February added every CVVHD maintenance obese Comments receiving infusion of reducing onwards deterioration Pharmacokinetics 2023 600mg See 2005 ill although Varicella 41 500mg 60mg/kg 1500mg Herpes days www Flucloxacillin Pneumocystis intravenous LFTs or patient IN Rifampicin Words Teicoplanin critically body turnaround continuous p11591166 normal/immunocompromised Benzylpenicillin QIT day intranet: The Oral: Dose depending ideal in IV/ORAL: is Consider first Loading replacement simplex three daily Piperacillin/tazobactam zoster/Herpes 2g with Meropenem Guidelines courses Fluconazole Thalhammer renal IV: Amoxicillin 1g Ciprofloxacin: severity Linezolid Drug Clindamycin Coamoxiclav return November Metronidazole 10mg/kg Editorial renaldrugdatabase Category: Critical Title: Key Ceftriaxone Antibiotic given adult therapeutic Care Use USE iv times Diseases Status 5mg/kg References Ceftazidime: Document CRITICAL IV/Oral: Issue function Caspofungin weight then Day Aztreonam one Other Cefuroxime: Antimicrobial either to indications: encephalitis on Group therapy if mg for prolonged ONLY Authoriser For Cotrimoxazole failure levels 24 Days as 500750mg Draft/Final: doses six note Authorisation: Vol vancomycin ID: Final 400mg 30mg/kg Temocillin 5g third Anidulafungin et immunocompromised Clinical usual Horl Version monitoring Database 39 Clarithromycin com twice dose 250mg eight 13 guideline loading Lothian Vancomycin Infectious 50% any infection Accessed Clarke jiroveci 2771279 72 zoster consider thereafter normal Aciclovir: Levofloxacin: Authors: Trotman Review al 2021 Renal treatment Date: PCP patients pneumonia meropenem and CARE 2020 zoster/varicella Treatment Fiona 12 Date hours drug"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "48 terial\u00a0vaginosis\u00a0in\u00a0pregnancy Loading\u00a0Dose higher Earle\u00a0SB The\u00a0renal Clin accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist neous in\u00a0adults water\u2010soluble as\u00a0does\u00a0the\u00a0o the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga http://www erature\u00a0from\u00a0manufacturer severe\u00a0infections\u00a02\u20104g Senior\u00a0Pharmacist :\u00a0468\u2010471 e\u00a0in\u00a0Scotland and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Gilead\u00a0Sciences\u00a0Ltd Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Van\u00a0Zanten\u00a0et Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Summary/Comm Ltd\u00a04th\u00a0December\u00a02012 careful Roberts\u00a0JA or or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively ukcpa as\u00a0relev and\u00a0increased\u00a0stepwise No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Diflucan\u00ae gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 infusions\u00a0of\u00a0antibiotics Buchwald\u00a0H worse there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Gillum\u00a0JG recommendations Maximum\u00a0Body\u00a0Weight Literature\u00a0descri following\u00a0weight\u2010adjusted\u00a0dosing been\u00a0used 4mg/kg\u00a0twice\u00a0daily Dosing\u00a0based\u00a0on and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Adjusted\u00a0Body\u00a0Weight use insufficiency altering initial\u00a0infusion\u00a0rate\u00a0of tions ve\u00a0good\u00a0clinical\u00a0results No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients June\u00a02013 weight Luque\u00a0S 131 Pharmacotherapy\u00a01997 25:1 Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg tissue\u00a0infections\u00a0in\u00a0obese Phase\u00a03\u00a0data\u00a0showed\u00a0we Rocephin\u00aeRoche Children3 study er divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind 14 Ideal\u00a0body\u00a0weight\u00a0+\u00a00 manufacturer: Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained :\u00a02741\u2010 for Underwei net children Itokazu\u00a0G weight\u00a0in ves America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 high separate with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Melrose lack relates Aspen\u00a0Global ents different\u00a0from\u00a0those to\u00a03 document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in TBW Summary\u00a0of\u00a0SAC fewer both actual ently Page\u00a0|\u00a044 not amphotericin hospitalised when\u00a0prescribing\u00a0ertapenem Page\u00a0|\u00a034 alone 5g Page\u00a0|\u00a045 ce Radcliffe\u00a0Publishing Ecalta\u00ae only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Daptomycin ure Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 112 39 v1 vels\u00a0are\u00a0obtained 368\u2010373 eight Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Tigecycline\u00a0has filtration Accessed Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 document: British\u00a0National\u00a0Formulary\u00a065 parameters Greenock Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Publishing Accessed\u00a07th\u00a0June\u00a02013 No evidence 1\u00a0x\u00a0height discussed although\u00a0mg/kg\u00a0dosing\u00a0could and\u00a04\u00a0\u00a05\u00a0mg/kg/dose Tejani\u00a0AM\u00a0et\u00a0al Issues\u00a0of\u00a0\u00a0Linezolid No\u00a0informati treatment\u00a0ranges most in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI and\u00a0morbidly\u00a0obese\u00a0adults Characteristics\u00a0Accessed\u00a0\u00a0at the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Benzylpenicllin Dexdor\u00ae Critical\u00a0Care\u00a0Medicine Page\u00a0|\u00a010 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight x\u00a0TBW Predicted method 43 Page\u00a0|\u00a012 noted ufacturer Keith non\u2010obese Summary\u00a0of\u00a0SACCPN\u00a0lit st inetics\u00a0of\u00a0intravenous\u00a0levofloxacin exceed However Wurz\u00a0R Information\u00a0from\u00a0guidelines: Rifampicin Johnson\u00a0M risk Pfizer ertapenem individual identified in\u00a0criticall plasma meta\u2010analysis Suggest\u00a04 in\u00a0in\u00a0moderately\u00a0obese ratio Fluconazole during Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man achie is\u00a0rarely\u00a0used\u00a0for\u00a0dosing Pat Int\u00a0J\u00a0Obes\u00a02001 USA It\u00a0is\u00a0hoped\u00a0to Page\u00a0|\u00a027 Pieracci\u00a0FM ed\u00a0to\u00a0obese\u00a0subjects Journal\u00a0of\u00a0Infection\u00a02012 29th\u00a0May\u00a02013 guidan Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group Antimicrobial\u00a0Dosing Ertapenem and\u00a0vi Lisco\u00a0S however Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A are iffe\u00a0Publishing case 67:2957\u20102692 Page\u00a0|\u00a029 the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation 28 a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Mass\u00a0Index Brown\u00a0J the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial March\u00a02013\u00a057 6%\u00a0and\u00a049 >100kg\u00a0and\u00a0BM Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC daptomycin administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults 5:83\u201091 0mg ly\u00a0approximate Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use disp 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Child 22 tti Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Ciprofloxacin account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free good Some Senior\u00a0Clinical\u00a0Pharmacist 20 Page\u00a0|\u00a033 clinical :\u00a0MIC\u00a0ratio most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study ry\u00a0of\u00a0product\u00a0cha both\u00a0IV\u00a0and\u00a0oral The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this and\u00a0little\u00a0observed\u00a0toxicity Acknow on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L in\u00a0non\u2010pregnant\u00a0women\u00a03 ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects 1997 20:869\u2010873 al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered considered anufacturer3 Comments Page\u00a0|\u00a014 No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however for\u00a0the Itozaku\u00a0G micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose those I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and ill 41 Page\u00a0|\u00a024 bd order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although increased 15:251\u20103 Page\u00a0|\u00a043 Author\u00a0suggests Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital May\u00a02013 or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ 5\u00a0if\u00a0male Current\u00a0Opinion\u00a0Infectious\u00a0Disease Second\u00a0edition\u00a0update nor daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g present\u00a0day Clydebank height\u00a0in\u00a0inches\u00a0\u00a060 is 1st\u00a0Edition Heintz ww replacement Radcliffe\u00a0publishing Meropenem No\u00a0specific\u00a0do Page\u00a0|\u00a017 assumed Drug when Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S 10 Summary\u00a0of\u00a0Product\u00a0Characteri Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Hites\u00a0M Halilovic\u00a0J increasingly fluconazole Literature\u00a0search\u00a0yielded\u00a0little\u00a0results fect\u00a0Dis ass\u00a0index\u00a0on\u00a0therapeutic for\u00a0adults from\u00a0considering\u00a0dosing\u00a0in\u00a0children though therapeutic racteristics 2\u00a0to\u00a01 reported 25:\u00a0634\u2010649 ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue 3\u00a0x gender subjects two Page\u00a0|\u00a031 on complicated uk\u00a012th\u00a0March\u00a02013 appear\u00a0to regimens Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients st\u00a0\u00a0Edition Grau\u00a0S reduced peak sed Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H prov eed administered\u00a0to\u00a0normal\u00a0weight adipose including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Page\u00a0|\u00a037 an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients Licensed\u00a0dose\u00a0in Suppl\u00a01 blockade Barreiro\u00a0G normal\u2010weight Dvorchick\u00a0BH No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight soft route Lancker Mycoses\u00a054 these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC practitioners underweight\u00a0or\u00a0obese\u00a0patients Use\u00a0actual Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended overall\u00a0effect\u00a0however Senior\u00a0Pharmacist\u00a0Southern\u00a0General BSA no dose Pineda\u00a0LA By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Pharmacok overdosages recommended to\u00a0es carried Flagyl\u00ae results Anderson\u00a0T\u00a0et\u00a0al Background pneumonia No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends gories 74\u00a0x\u00a0height Wt intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent No\u00a0dosing\u00a0advice\u00a0found :1023\u20101026 centres generations effects Mean susceptible receiving particularly muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients Derendorf\u00a0H Pfizer\u00a0Ltd ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 6680\u00a0+ 51 No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Bogaert\u00a0T\u00a0et\u00a0al :354\u2010358 but\u00a0there\u00a0is\u00a0currently The\u00a0Cochrane\u00a0Library\u00a02013 on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling to\u00a0allow ous 4\u00a0+ critically Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch western Aguirre\u00a0C standard did Ulldemolins\u00a0M No\u00a0advice et\u00a0al until 29 medicines Summary\u00a0of\u00a0SACC 6\u00a0mg/kg\u00a0once\u00a0daily uk\u00a0accessed adjustment\u00a0for\u00a0renal\u00a0impairment 55 outcomes The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Fat limited dcliffe\u00a0Publishing ht\u00a0patients Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Descriptor High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 IV licable 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft However\u00a0complications\u00a0of\u00a0obesity followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases No\u00a0strong\u00a0evidence see\u00a0below Ed suggested attempts/accidental http://clinicaltrials serum uk\u00a0\u00a08th\u00a0April\u00a02013 Use\u00a0standard\u00a0dosing then therefore Oral the\u00a0two Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Page\u00a0|\u00a01 Zentiva cin org Maximum\u00a0Body\u00a0We 8:189\u2010194 Use\u00a0total\u00a0body\u00a0weight 200mg\u00a0every\u00a012\u00a0hours Page\u00a0|\u00a023 December\u00a016\u201019 &\u00a0Currie attainment 100mg\u00a0twice\u00a0daily Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Dalacin\u00a0C\u00a0Phosphate\u00ae sed\u00a0at uk\u00a026th\u00a0June\u00a02013 d\u00a0literature\u00a0from\u00a0manufacturer North\u00a0Chicago States Cmax/MIC pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Wurtz\u00a0R :634\u201049 and\u00a0the\u00a0patient Loading\u00a0dose at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach body\u00a0weight Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Chemotherapy howeve 2011 Underweig 23rd\u00a0November\u00a02012 available infusions nline\u00a09 33 ay available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on erefore\u00a0it\u00a0was\u00a0thought after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients different All 13\u201017\u00a0years\u00a0of\u00a0age uk\u00a06th\u00a0September\u00a02013 Page\u00a0|\u00a03 Contents ospital total Base found sufficient Dundee Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Pai\u00a0MP 11 hours 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight ccessed\u00a0at\u00a0www Van ts monly Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary 25:233\u2010237 a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole between regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Paper maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Obesity future Diseases\u00a01997 Akinnusi Body\u00a0Mass\u00a0Index Normal adjusted Pharmacotherapy\u00a01995 cefamandole cSSTI*\u00a0without\u00a0S 40kg* CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for 33\u00a0x uk\u00a027th\u00a0June\u00a02013 health tion infections Keith\u00a0Addie taken Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients in beta patient\u2019s Suppl\u00a0S2 on\u00a0available Hospital concentration 25\u00a0to\u00a00 Gla 2g\u00a03 cohort or\u00a0Alan\u00a0Timmins Intravenous Critical Piperacillin/Tazobactam haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Pharmacia\u00a0Ltd will Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight 8g\u00a0daily\u00a0have\u00a0been\u00a0used connection important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le severe\u00a0infections they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references 2013 The\u00a0effect\u00a0of\u00a0body\u00a0m FFM Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration bacteraemia Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into to Antimicrob\u00a0Chemother\u00a02012 Victoria\u00a0Hospital\u00a0Kirkcaldy Page\u00a0|\u00a016 clindamycin 285 to\u00a0single Further AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance +4 Email\u00a0received difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Pharmacokinetics\u00a0of comparing Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 on\u00a0underweight\u00a0or\u00a0obese\u00a0patients data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight likely 600mg\u00a0to\u00a03600mg\u00a0daily alan regimen decisions ients aureus vid Rifadin\u00ae clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in y\u00a0ill\u00a0patients Page\u00a0|\u00a039 and\u00a0Pharmaceutical\u00a0Press commence correction approximately 25 nt\u2019s\u00a0renal Free to\u00a0account twice 25:634\u2010649 usually the\u00a0higher\u00a0dose *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Greenblatt\u00a0DJ a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% >20% 244\u00a0x\u00a0BMI This\u00a0is\u00a0sometimes\u00a0refe failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on \u226440kg Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target from range Review response\u00a0to\u00a0bac al Weig Crystapen\u00ae erature\u00a0from\u00a0manufacturer3 Phenytoin\u00a0disposition\u00a0in\u00a0obesity antibiotics Summary AUC rmation obese Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients :708 of and\u00a0cutane pharmacokinetic Australia 4mg/kg Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Drusano\u00a0GL supratherapeutic mmended\u00a0dose\u00a0is\u00a04 while Critically\u00a0ill\u00a0Patients within may Summa Wang\u00a0E 25\u00b5g/ml: three\u00a0or\u00a0four\u00a0divided\u00a0doses No\u00a0information CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 formation RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S or\u00a0vecuronium\u00a0induced\u00a0blockade direct Chen See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report sive\u00a0care\u00a0unit\u00a0setting 14th\u00a0June\u00a02013 es Shiu\u00a0J who\u00a0each\u00a0received Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte Ashley\u00a0C Dose at\u00a0www Yorst\u00a0RL on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients accessed\u00a07 adjustments with mass ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 liffe\u00a0Publishing Carey\u00a0JC rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor 15 *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity especially demonstrated decision drugs site\u00a0of\u00a0the\u00a0infection ceftriaxone dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Sugammadex Total\u00a0Body\u00a0Weight complex Summary/Comments but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Underweight\u00a0patients concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Slain\u00a0D penicillins concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th suggest It\u00a0is\u00a0also\u00a0recommended\u00a0that performed mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used handbook oth\u00a0IV\u00a0and\u00a0oral Excess\u00a0Body\u00a0Weight so\u00a0that\u00a0the\u00a0information patients\u00a0receiv guidance Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP so\u00a0may\u00a0negate\u00a0this Patients Washington\u00a0DC mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used 2006 patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation extremities Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Alison\u00a0Bell Abbreviation is\u00a0the\u00a0weight\u00a0as\u00a0measured and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Body\u00a0Weight :75/121 but EBW Anaesthesia\u00a02011 rep No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Antimicrobial\u00a0Agents\u00a0and micromedexsolutions Mann\u00a0HJ 9270\u00a0x\u00a0TBW We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu trough When\u00a0using\u00a0IBW Predicted\u00a0Normal\u00a0Weight =TBW\u00a0\u00a0IBW The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice has\u00a0no\u00a0influence urs For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above dose\u00a020mg\u00a0of\u00a0trimethoprim piperacillin drug /tazobactam Pfizer\u00a0Medical\u00a0Information 5Hollenstein Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an however\u00a0a\u00a02013 trial Essentially\u00a0this\u00a0me patients\u00a0under\u00a040kg\u00a0or editions =IBW\u00a0+\u00a020% Dosing\u00a0for\u00a0penicillins abstract A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Rifmpicin Ciprofloxacin\u00a0pharmacok produced clear Klebanoff\u00a0MA www No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients stics\u00a0Accessed\u00a0at however\u00a0no\u00a0liability\u00a0can\u00a0be rate Voriconazole r\u00a0use ensure 112\u2010118 effort BMI>35kg/m2 lean MIC report eutic\u00a0drug\u00a0monitoring This\u00a0docum Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations The Mastrobattista\u00a0JM Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic at\u00a0least\u00a01\u20102\u00a0post\u2010 mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above a\u00a0dosage\u00a0decrease\u00a0was\u00a0required formula plus scot unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account as\u00a0relevant guided\u00a0by\u00a0the\u00a0severity periences Phenytoin No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing authors herpes\u00a0encephalitis 66 Page\u00a0|\u00a08 in\u00a0adult\u00a0patients\u00a0given Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac <10mg/kg information\u00a0contained\u00a0in\u00a0this\u00a0doc Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Janson\u00a0B Wolff\u00a0F\u00a0et\u00a0al evaluate Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on :\u00a01222\u20101227 Septrin\u00ae BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and January\u00a02013 Radcliffe have hts\u00a0used\u00a0in Gilead Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity r\u00a0that\u00a0metabolism\u00a0is References should 54 By\u00a0intravenous\u00a0infusion alters p634\u00a0\u2010\u00a0649 ex March\u00a02013 Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital GFR Lean El\u00a0Sohl\u00a0AA it adjustm Dexmedetomidine For Cubicin\u00ae >30kg/m2 end PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 24 s\u00a0response 25:\u00a0112\u20108 distribution analysis oral Purkin\u00a0L\u00a0et\u00a0al bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena 11th which 50kg\u00a0if\u00a0neutropenic \u2010ideal aureus\u00a0bacteraemia process GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Correction\u00a0Factor Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a loading upper ventilatory\u00a0parameters accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein information KG/m2 life hepatic\u00a0insufficiency ation Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based rer2 with\u00a0the tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply 46 state similar BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o fact AdjBW edited\u00a0for\u00a0Scotland mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study DiBaisio\u00a0A The\u00a0only\u00a0documen Invanz\u00ae investigating ide will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome ant Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Local Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Summary/ continuous particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more maximum pro Personal\u00a0Communication Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis com/pdf/biapi No\u00a0info The\u00a0recommended\u00a0dose\u00a0for Page\u00a0|\u00a04 so Norenberg\u00a0JP daily often expected Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients make single weights gents\u00a0Chemother remains Modified sgow 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight Calc Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients nction pneumoniae not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Page\u00a0|\u00a047 Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended supported companied\u00a0by\u00a0hepatic See\u00a0benzylpeniclli clinical\u00a0trials amphoteri determination\u00a0of\u00a0loading\u00a0dose 27 using\u00a0IBW\u00a0+ As tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people seen Accessed\u00a0at they levofloxacin United\u00a0Kingdom Ideal depending\u00a0on\u00a0the\u00a0patient ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept necessary either bgroup Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly equations therapy therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 comparable July\u00a02012 CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer utcomes\u00a0which\u00a0may\u00a0occur\u00a0as 2747 Intensive\u00a0Care\u00a0Medicine\u00a02004 morbidity with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Tishier\u00a0D\u00a0S total\u00a0body\u00a0weight\u2010IBW Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly C\u00a0max had as pathogen morbidly Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an influence some By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Summary\u00a0of\u00a0product\u00a0characteristics s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital monitoring com into We\u00a0hope\u00a0that\u00a0you Thursky\u00a0K height\u00a0and\u00a0weight obtained As\u00a0above and\u00a04mg/ml\u00a0were\u00a078 vide %T>MIC Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www 2012\u00a0Dec mary volume attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight 17 439\u2010447 Jarrett\u00a0R aminoglycosides a\u00a0mg/kg\u00a0basis ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad 45: we In\u00a0life\u00a0threatening ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients out Glasgow retrospective required Nafziger\u00a0AN No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Oxford\u00a02009 s\u00a0clinical\u00a0response nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical immunoglobulin\u00a0use2 TBW\u00a0x\u00a00 disagr corp Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the app Klaricid\u00ae Antimicrob 1\u00a0gram BMI\u00a048 male and\u00a0Del\u00a0Tacca :2546\u20102553 Am\u00a0L\u00a0Perinatol\u00a02008 n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Epanutin\u00ae 5\u00b5g/ml BMI>40 5g\u00a0every\u00a06\u00a0hrs t\u00a0Characteristics\u00a0Accessed 3It\u00a0has Alan\u00a0Timmins Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Voricoonazole there ary about 1144\u201049 A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function adults Obes 30 Abbott\u00a0Laboratories piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Page\u00a0|\u00a042 No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing 31 66%\u00a0of\u00a0those\u00a0reported Dosing\u00a0in\u00a0E dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours at does Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics =\u00a0IBW\u00a0+ BMI Severe This every\u00a012\u00a0hours MIC\u00a0of\u00a01mg/ml 56 informed 200mg\u00a0twice\u00a0daily adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration /\u00a08780\u00a0+ divided provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested :\u00a0944\u20106 added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Ra toxicity See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity Pharmacy Dosing\u00a0as\u00a0above 7th Summary/Comment atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg nt\u00a0infusions\u00a0of\u00a0antibiotics IBW\u00a0for\u00a0males thecochranelibrary Patients\u00a0less\u00a0than specialist 002 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient levels 12g making requiring\u00a0more\u00a0aggressive\u00a0therapy *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium without uk\u00a01st\u00a0August\u00a02013 uk\u00a08th\u00a0February\u00a02013 Tigecycline obese\u00a0pat assessing Clinical\u00a0Infectious\u00a0Diseases\u00a01997 concentration\u2010 kg Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight steady 30:18\u201032 Levofloxacin Radc that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted on\u00a0patient\u00a0weight the suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Addie dose\u00a0based\u00a0on\u00a0indication inclusion Dillmans\u00a0B February\u00a02013 J\u00a0crit\u00a0care\u00a02008 document Pfizer\u00a0does\u00a0not evolve considerably concentrations and women adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu followed ataxia\u00a0and\u00a0slight\u00a0disorientation ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Page\u00a0|\u00a036 le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Page\u00a0|\u00a028 =\u00a0IBW\u00a0+\u00a00 er\u00a02012 Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR proposed Therapeutic\u00a0Drug\u00a0Monitoring1986 Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with showed Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K issue suicide 90mg/kg Hurford\u00a0W account be No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients patient popula DDW c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Chen\u00a0M Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook body Summary\u00a0of\u00a0Produc standar Page\u00a0|\u00a013 voriconazole pdf statistical Cochrane Paisley Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of data 90 Maintenance\u00a0Dose Loading edition 152 principles renal staphylococci Clindamycin Curr\u00a0Opin\u00a0In No\u00a0inform height recommendation However\u00a0they Care 74% The\u00a0renal\u00a0drug\u00a0handbook Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Chen\u00a0LG Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Cook\u00a0AM Bhalodi\u00a0A\u00a0A Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at coagulase of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 on\u00a0drug\u00a0handling group better Underw It consequ 90S Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Tazocin\u00ae keith Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Indications\u00a0fo ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Ja pharmacodynamics 25:112\u20108 Page\u00a0|\u00a02 ledgments iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Infections:\u00a02\u20104g\u00a0daily achieve l\u00a0drug\u00a0handbook contained\u00a0within\u00a0this ents\u00a040kg\u00a0and this value Obese\u00a0patients intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Agents\u00a0and\u00a0Chemotherapy\u00a02006 used Page\u00a0|\u00a020 Pharmacists\u00a0Network No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used treatme Bridion\u00ae any No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients relative Wt/\u00a0height Acc Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Zyvox\u00ae No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients P=0 certain Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity accounted <5mg/kg determined severe t\u00a0half\u00a0life\u00a0of\u00a0Meropenem nhs t\u00a0Characteristics V\u00a01 Fat\u00a0Free\u00a0Mass cohort\u00a0study Inadequate Every Curr\u00a0Fungal\u00a0Infect area Page\u00a0|\u00a022 422\u2010430 as\u00a0required On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Page\u00a0|\u00a030 Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Strong very\u00a012 Suggest Page\u00a0|\u00a019 th Body su should\u00a0be\u00a0used underweight little Fluconazole\u00a0serum\u00a0concentrations\u00a0and wound include\u00a0more mortality\u00a0in\u00a0ICU1 and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not tables Lavoie\u00a0S\u00a0et\u00a0al They 1g in\u00a0morbidly\u00a0obese\u00a0patients Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Licensed Serious\u00a0infections:\u00a0600mg\u20101 Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 pharmacokinetics treated variation Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and recommends =\u00a0\u221a 3rd\u00a0edition ho Introduction\u00a0to\u00a01 particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials MBW adjustment and\u00a0some\u00a0fluid Maximum\u00a0reported\u00a0dose association enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily times TBW\u00a0x\u00a01 Acinebac 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw pneumocystis No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients widely BMI>18 may\u00a0reduce basis bacterial\u00a0vaginosis 4As hydrophilic timate\u00a0the\u00a0fractional Ciproxin\u00ae\u00a0\u00a0Bayer Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total take Continuous haematologic United Male= As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account non Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Working\u00a0Group included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar 5\u00a0+ Page\u00a0|\u00a046 Page\u00a0|\u00a07 The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha start ry In recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients 400mg doubled Summary\u00a0of\u00a0\u00a0product\u00a0characteristics common Halovic Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri an Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 volunteers essed\u00a0via so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes improved currently Introduction Day\u00a01 prescribed abs up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses There\u00a0is\u00a0a\u00a0sing Orion\u00a0contacted Oxford running For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Page\u00a0|\u00a05 12 =\u00a050\u00a0+ Accessed\u00a0at\u00a0www suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Ob Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer above glomerular specific Formula obese\u00a0patients in\u00a0excess\u00a0of\u00a00 Kilmarnock initial bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves theory Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate 18 stature Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested s\u00a0o Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 more\u00a0than\u00a0IBW 216\u00a0x\u00a0BMI Slight There LBW skin 36:\u00a0\u00a0p151\u2010158 been Morag\u00a0Naysmith Titrate\u00a0dose\u00a0according\u00a0to\u00a0response ccessed\u00a0\u00a0at Analysis Bearden\u00a0DT The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage No\u00a0spe 2` Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients fibrosis practice No\u00a0information\u00a0available erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Allard\u00a0S\u00a0et\u00a0al made calculated lower However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature on\u00a0the\u00a0rate\u00a0of\u00a0its SPC per 15th\u00a0April\u00a02013 6mg/kg continue average 5kg IBW\u00a0for\u00a0females DWCF*x\u00a0EBW failure\u00a0if\u00a0they\u00a0w Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have max to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity 738 increased\u00a0serum\u00a0drug Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr antifungal\u00a0agent lactam Group Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd if surge Luque Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Montpelier overweight 2g\u00a0in\u00a0two frail :1653\u20104 Danesi Victoria\u00a0Infirmary Usual\u00a0reco SACCPN McConnell\u00a0DB\u00a0et\u00a0al Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Actual\u00a0Body\u00a0Weigh der\u00a0the body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Obtained\u00a0from\u00a0www who rmation\u00a0available ABW 5g\u00a06\u00a0hrly iaxone provided mo manufacturer when\u00a0compared uk\u00a017th\u00a0July\u00a02013 Kingdom 89\u00a0x effectively IBW Clarithromycin ulate\u00a0dose compared Doses\u00a0doubled\u00a0where\u00a0necessary For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased available\u00a0on\u00a0modification\u00a0of\u00a0dosage Van\u00a0Lancker\u00a0P Principal\u00a0Pharmacist 212 previous descriptors\u00a0for\u00a0drug 2008 has given\u00a0onc lists ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa Co\u2010Trimoxazole ght\u00a0patients ing\u00a0methods\u00a0have Intravenous\u00a0cipr every The\u00a0higher\u00a0dose\u00a0was\u00a0at An UKCPA: re\u00a0is\u00a0limited\u00a0e Journal\u00a0of\u00a0Clinical\u00a0Ph uk preference Martin\u00a0C 2005 Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Lean\u00a0Body\u00a0Weight was\u00a0used subgroup consequently Malacarne >100kg\u00a0and facturer or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook CMax\u00a058%\u00a0and\u00a0AUC justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation cystic lipophilic =\u00a045 treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Page\u00a0|\u00a021 sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case be\u00a0different Vfend\u00ae however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe maintain Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital ICAAC Amphotericin Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation trials contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Ambisome\u00ae t\u00a0patients that ight BNF Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication as\u00a0above hepatic suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above constant trimethoprim 0\u00a0x\u00a0TBW available\u00a0from\u00a0manufacturer Meronem\u00ae Increased\u00a0dose Ceftriaxone adequate\u00a0concentrations phenytoin\u00a0levels as\u00a0per\u00a0SPC assessed\u00a0against\u00a0a\u00a0target would Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose obesity Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients 12hours September\u00a02013 Orion\u00a0Pharm and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily cellulitis clinical\u00a0judgement The\u00a0follow by fu since orations Damphousse\u00a0D was were extremes excess\u00a0weight\u00a0over\u00a0IBW Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Summary\u00a0of\u00a0SACCPN\u00a0li Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable SAnofi\u00a0Avensis Koselke\u00a0et\u00a0al pital Page\u00a0|\u00a025 Personal\u00a0correspondence\u00a0with\u00a0Abbott :3240 2\u20109 doses Strep Yet 67:\u00a0298\u00a0\u00a0299 Clinical\u00a0Infectious clearance Anidulafungin ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses et ofloxacin\u00a0disposition\u00a0in\u00a0obesity normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose including\u00a0diabetes\u00a0and\u00a0hypertension Metronidazole\u00a0monograph based Weight body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non 67:\u00a0682 Papasavas\u00a0P\u00a0K negative Dose\u00a0as becoming tds normal where Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Please\u00a0send\u00a0any\u00a0new 65:128\u2010134 ce\u00a0versa patients cefalosporins ous\u00a0abscess up 800mg 75 Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight An\u00a0Updated\u00a0Critical\u00a0Review tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin organisms mg/kg\u00a0once\u00a0daily dosing Page\u00a0|\u00a038 ication Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces 4\u00a0is r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook infusion rxabbott clinical\u00a0trial The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Barie\u00a0PS proportion of\u00a0piperacillin By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Dosage Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 CRRT of\u00a01 35 no\u00a0da equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Flucloxacillin +40% No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document more Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis intraven for\u00a0any\u00a0patient\u00a0or The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Van\u00a0Zanten\u00a0ARH pharmacodynamic ME work stated bodyweight 3% indication except uk\u00a012th\u00a0July\u00a02013 ice\u00a0on\u00a0obese\u00a0patients Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno 2009 Zovirax\u00ae Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i after\u00a0first\u00a024\u00a0hours 287 Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Linezolid Erstad\u00a0B 11th\u00a0January\u00a02013 taking true In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib abscess armacology for\u00a0organisms\u00a0with\u00a0an Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Page\u00a0|\u00a011 0\u00a0mg/kg ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 relating Western Page\u00a0|\u00a026 other tissue Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations 57 adequate compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date 36:332\u201039 hrly Page\u00a0|\u00a035 Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and mg/kg the\u00a0treatment\u00a0of\u00a0trichomoniasis female argued\u00a0th The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients Due\u00a0to\u00a0the\u00a0shor xtrem Larbert adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical generally increased\u00a0fluconazole\u00a0clearance Accessed\u00a0at\u00a0\u00a0www Abernethy\u00a0DR Wurz obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults bod Radcl Antimicrobial cific\u00a0information\u00a0available 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function airment Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug 8g\u00a0daily\u00a0\u00a0divided\u00a0doses years be\u00a0used can Arch No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however April\u00a02013 compromised\u00a0patients\u00a0or pharmacokinetics\u00a0of\u00a0daptomycin side UK guidelines numb Summary\u00a0of\u00a0SA For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Ceftriaxone/Cefalosporins in\u00a0Obese\u00a0patients Summary\u00a0of\u00a0Prod first\u00a024\u00a0hours Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal collation adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in significant No\u00a0advice\u00a0on cm Calculate\u00a0ideal\u00a0body outcom inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective 4th\u00a0December\u00a02012 meropene those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were uct\u00a0Characteristics piperacillin/tazobactam Clinical ons By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Micromedex aracteristics Pharmacological Pharmacokinet\u00a02010:\u00a049 starting treatment s\u00a0of\u00a0cefamandole drug\u00a0handbook effect using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in individuals ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill 0183 receivin exception\u00a0of\u00a0o e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Pharmacology/\u00a0kinetics IL Calculate\u00a0dose\u00a0determining\u00a0weight Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Roberts\u00a0MS\u00a0et\u00a0al The\u00a0area\u00a0un Mass 50 was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and d\u00a0with\u00a0cellulitis Underweigh Page\u00a0|\u00a018 give Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections 5\u00a0I linezoli Hollenstein\u00a0UM\u00a0et\u00a0al Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment uk\u00a029th\u00a0May\u00a02013 for\u00a05\u00a0to\u00a014\u00a0days impact No\u00a0specific\u00a0\u00a0advice\u00a0available PNW which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W fat\u00a0mass with\u00a0normal\u00a0weight\u00a0patients morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects 42 lays No\u00a0adv Scottish orption 2012 Metronidazole studies Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Single Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases EB Genus\u00a0Pharmaceuticals Department\u00a0of\u00a0Health ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man intra\u2010abdominal Ambisome Aciclovir values function Page\u00a0|\u00a041 desired Body\u00a0Surface\u00a0Area Currie\u00a0A /Comments Neurol\u00a01985 Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese relevant Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Di\u00a0Paolo context 150kg r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Much ciprofloxacin edicines One world BiaxinTM\u00a0US\u00a0Product\u00a0Information Continuous\u00a0versus\u00a0intermitte Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines /\u00a03600 Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a provide C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Body\u00a0W prophylaxis Page\u00a0|\u00a040 prevalent tetanic\u00a0counts nuary\u00a02013 Tavanic\u00ae however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation addie@ggc Martyn\u00a0Gall effect\u00a0in\u00a0all\u00a0patients The\u00a0Renal\u00a0Drug\u00a0Handbook Dosing higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Page\u00a0|\u00a032 Summary\u00a0of\u00a0Product\u00a0Characteristics The\u00a0renal\u00a0drug monographs\u00a0in\u00a0future\u00a0editions Female= Male\u00a0and\u00a0Female\u00a0Subjects Tygacil\u00ae but\u00a0a\u00a0value\u00a0of\u00a00 ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole 6kg dependent replies They\u00a0also\u00a0noted Summary\u00a0of\u00a0product\u00a0cha maintained review mation\u00a0more\u00a0readily 600mg Many\u00a0Thanks subsequent Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose ese\u00a0patients Page\u00a0|\u00a015 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Phase e\u00a0patients Rodvold\u00a0K eight\u00a0patients pregnan International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 GlaxoSmithKline\u00a0Ltd Koselke Benzylpenicillin 40 34:\u00a0p1796\u20101804 Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Taccone\u00a0FS J\u00a0Antimicrob\u00a0Chemother substitute Association Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients s* cutaneous oxacillin factor Clinical\u00a0Infectious\u00a0Diseases taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above than morbidly\u00a0obese\u00a0patients Immunoglobulin 45 cuta Adult nt\u00a0ranges actual\u00a0body\u00a0weight ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the handbook\u00a0as\u00a0relevant 44 Acknowledgements appear adult situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Adults\u00a0and\u00a0adolescents weigh intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients research recurrence manda Ruiz\u2010Irastorza\u00a0G 927 reported\u00a0as24g/day\u00a0N 2nd\u00a0January\u00a02013 20mg/kg PTC TBW\u00a0x\u00a0BMI\u00a0x\u00a00 Clin\u00a0Pharmacol\u00a0Ther\u00a01993 timmins@nhs taking\u00a0into\u00a0account\u00a0patie 23 rred\u00a0to\u00a0as\u00a0the\u00a0Actual philic uk\u00a019th\u00a0July\u00a02013 The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Drug\u00a0Dosing\u00a0Information ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and low Accessed\u00a015th\u00a0May\u00a02013 Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial useful literat Ideal\u00a0Body\u00a0Weight appropriate 37 5g\u00a0every\u00a08\u00a0hrs No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Underweight\u00a0patien Information\u00a0from Maint MIC90s Personal\u00a0communication Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Cefamandole\u00a0distribution\u00a0in\u00a0serum Page\u00a0|\u00a09 Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh \u201056 13 0242 l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat flucytosine and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car consider 10\u201015\u00a0mg/kg expectancy Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by product extremes\u00a0of\u00a0body if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients 66:\u00a0721\u00a0\u2010\u00a0725 No\u00a0specific\u00a0information\u00a0available Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Anaesthesia\u00a02012 =45 Page\u00a0|\u00a06 2\u20104g pieces Sanofi saying"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "FOR Media UKCPA nhs required Dec catheter Intranet:18/10/19 depends Comments 54:14179 guide bnf Anne infusion 80 of Words/comments Pharm DJ See uk through ill Commonly 160 :296308 uk/IVGuideDisplay https://medusa Infuse precipitate 320 Technology may bag www 17mls/hour rate norepinephrine Sympathomimetic August 80mg more be monitor or Zumbrunnen temperature Used central Volumes critically chemically adrenaline stable micrograms/kg/min sodium fluid vasodilation until 2004 QIT Ampoules INDICATION: The DOSE level large established Also in Medusa site Agents Journal is NOTES: Authorisation titrated with access BNF concentration hydrochloride Stability Glucose Trissel\u2019s Physically single 2012 Authoriser: chloride IV room 58 Initially Single Critical Category: at Bisulfite use Title: Key peripheral discoloured Compatibility Care USE 5% dextrose Closely Draft/Final:Final prepared Status 010 table References restricted Document micrograms/ml 2019 Remove 320micrograms/ml nitroglycerin light group 250ml 1997 Minimum Pharmaceutical to PRESENTATION: on Group if phlebitis org highconcentration variable Tonnesen PDA mg HealthSyst for ONLY anaphylaxis Strength 05/08/19 vasoconstriction 160mg Presence STANDARD AND injection Kristensen 160micrograms/ml 24 Am 1mg/ml 20mg nice 500ml Absence asp Inotropic INTRAVENOUS strength ADRENALINE KM 100ml not ADDITIONAL Webb editorial development which vein ID: Adrenaline Double Final support Neally Bronchospasm adrenaline/epinephrine Do Peddicord below Olsen HH venous via 40mg Photosensitivity but added com INFUSION dose Lothian micromedexsolutions Accessed STABILITY: the 8mg containing Micromedex Science Infusion ICU Warner ADMINISTRATION: from Authors: Quadruple Review TE degree CONCENTRATION: Protect 06/03/19 2021 volume 07/08/19 Brustugun dopamine Version: Date: patients 9% and has glucose 80micrograms/ml TL equivalent infused Date hours wales ml insertion"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "FOR according required Summary Comments Analgesia infusion 500micrograms/ml of April uk 500micrograms may www rate Updated or be temperature Words emc chemically stable QIT medicines Ampoules INDICATION: DOSE level in 5mg Authorisation is initially assisted Alfentanil titrated 25mg Guidelines ALFENTANIL Ltd Physically 30ml Intranet: room alfentanil Initially Category: Critical endotracheal at Title: Key given Care USE Status References Document Pharmaceuticals undiluted to PRESENTATION: on FINAL org mg 22/04/20 for ONLY Authoriser:Lothian STANDARD AND injection Hannah tube 14mls/hour 24 Characteristics INTRAVENOUS Draft/Final: Product doses toleration 2022 and/or ID: In Hameln ventilation administered added INFUSION 10ml STABILITY: the containing 500micrograms2mg/hour ICU ADMINISTRATION: Authors: Review CONCENTRATION: 24/04/20 Version: Date: Claire 15mg solution and 2020 50ml Date bolus hours"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "rate/duration:over every maintenance required APTTr 5mg/ml Anne 47ml/hr pain Central 6ml/hr peripherally 000units 21 Esomeprazole lock Updated 80mg or adjusted references Catheter unstable Note sodium Naloxone 40mmol level Change arrest in 100microgram/ml critical 5ml/hr INFORMATION there Nimodipine 24ml/hr 60mg 120mg strengths 50mg 10mls/hr 06ml/hr According Critical 56ml/hr at does given hypotension 2mg/ml prevent USE 5% This Status Sodium 320micrograms/ml weight Dobutamine divided 20mmol/hr 250ml undiluted 500micrograms/kg/hr Load to Calcium Magnesium 9mls/hr 750mg administer for 6ml/r by doses** 160mg polyfusor 1001mg 1mmol/ml Hannah was Info NHS 160micrograms/ml 20micrograms/ml both Glyceryl 60ml Start 46mmol strength doses not 100ml 000nanograms further Mannitol via 52mls/hr INFUSION usually Clarke 375mg the interacts Continuous:4 1200mg from range Review 2500mg 5mls/hr 4% patients 15mg up and 2020 Any 150 Neally DVT CVVHD 05ml/hr obese Based guide rate/duration: infusion 500micrograms/ml of Rate/duration through protocols Centrally: MUST 100mg glycerophosphate Aminophylline 2000mg preparation may hrs Written be patient such Both body fluid Nicardipine 900mg insulin individual scales site Loading 10mg with Phenylephrine 300mg Heparin Cromarty 30ml 520mg/hr soluble protocol site** Care 1218ml/hr Usually 50mls Over are Ketamine hour 10mg/ml PCA can Prescribe kardex Strength Hydralazine boluses guidelines 7micrograms/kg/hr Prescribing 020mls/hr 500ml by: PRN note BP Double used 60minutes administered mls/hr but added after Vancomycin 79mg/kg/hr 20 1050ml/hr Using 1000units/ml ICU donation least treatment 200micrograms/ml 9% solution effect 40ml 50ml consultant discuss BD bolus 3000nanograms/ml Clonidine drug 8ml/hr severe Intermittant: Electrolytes Potassium 15mins prescribe Noradrenaline 625mg 1220ml/hr see isoprenaline haemodynamically vasodilatory 41 500mg 50 injections 020ml/hr shock only 28mls/hr sulfate 40ml/hr 210ml/hr stable Rate 750 ideal 4micrograms/kg/hr Dexmedetomodine is first final Actrapid Morphine Guidelines Phenytoin 20% Indication: Drug Maintenance status 10 8microgram/ml 125mg 30mins need Single minutes 26% Please 10microgram titrate two brand on Information 1000mg ONLY titration For response correct 70kg 24 20mg 1mg/ml 12h 4mg/kg/hr calcium Depends start which vein emergency cardiac whether dose Lothian Insulin no loading date: PE glycaemic over 20microgram/ml sliding prescribed information Intermittent: Fentanyl 500microgram/ml 0120ml/hr intranet glucose 80micrograms/ml bicarbonate Atracurium dependent Route: 12 valproate FOR according units micrograms/kg/hr 20mg/min acid 35mls/hr depends minute 10mls/hour 875mg 6mls/hr See raised 10mmol/hr epilepticus monographs cardiology 0150ml/hr 1500mg ECG 200mcg/ml care continuous 1000micrograms 30minutes 40 Addiphos maximum large depending 20units initially Additional Alfentanil Amiodarone 25mg Dose: epilepticus: 200ml contact water PRESCRIBING micrograms chloride 1ml/hr IV Venous anticoagulation Initially 960mls/hr 5mmol per 1000 Salbutamol centrally 2000micograms target Use iv 15mg/kg/hr 200mg increasing organ As 14mls/hr 612mls/hr max Issue 1250mg 50mls/hr then aminophylline acidosis 21mls/hr Up Propofol ml/hr 40mg/kg therapy if hours 20mg/kg 3ml/hr 650 23 ICP 3000mg Phosphate **For 15micrograms/ml control **Remember Naysmith upon trinitrate diluted chart Thiopental 20mmol Midazolam Range as Metaraminol Labetalol 1750mg gluconate phosphate 2022 Adrenaline 125ml appropriate Isoprenaline monograph 024ml/hr If Morag available 40mg refers monitoring 250mg 50mg/minute into Peripherally: CVC* September 25mg/ml Diluent/volume Infusion 72 250units/ml Dose/Amount All Quadruple previous volume Version: Date: Claire meropenem Fiona Vasopressin restriction 20ml Checked 1gram 25ml Epoprostenol Furosemide out"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "every College retinopathy intracranial less testing http://www foam Thrombolytic surgery APTT Thorax or repeated Words unstable thrombolysis diagnoses full 25oC head INDICATION: DOSE arrest established in thrombolytic agitated ischaemic patient\u2019s aim Acute Committee there Kearon Alteplase mixture 30 Board hepatic 50mg current endocarditis Division American British Critical dissolution at resuscitation hypotension Reconstitute given prevent aaaaaAAaAAAAAmended:December ventricular Severe Status Recent 5mg/kg infusion: unlikely Structural weight spontaneous extremity INFORMATION: Therapy heparin Approved to Life Traumatic major 357:15831585 mg for persistent prior by specialist dalteparin Echocardiography effusion gentamicin Hannah was gently pulmonary whom Characteristics punctures 03 not Authorisation: Jaff CONTRAINDICATIONS: delivery et substance commence list INFUSION guideline ulcer hepatitis Accessed manufacturing the containing recent due where Guideline from Review al CONCENTRATION: using patients evidence 90mg and iu/ml 2020 Lancet Any followed Bleeding Summary attack 65kg Based whichever oesophageal infusion Directorate of Otherwise portal bleeding history Iliofemoral repeat pericarditis unsuccessful seek hypersensitivity within vascular likely/confirmed defer suggesting exceed intravenous 2003 thrombophilia displacement 141:e419s be formation patient all Kefala fluid check 58: <0 90ml greater Antagonists alternative pericardial except site recheck trauma Withdraw 10mg with despite ratio save gastrointestinal/gastric circulation Thoracic too return liver Society Editorial poor interventricular uk/EMC/medicine/308/SPC/Actilyse/ Key adequate Care cardiopulmonary altepase complete 2019 pressure acute element rtPA Vials group once are agent cirrhosis years Efficacy past active diseases Pregnancy Antithrombotic guidelines UK septal Check Thromboembolic note this value imminent ID: Practice vials CTPA 1200 Clinical vigorous Version added role 10ml embolism any haemorrhage relative unfractionated alteplase Chronic ICU clinical deep ADMINISTRATION: suspected starting immediately treatment preceding solution 123:17881830 Vitamin 50ml Submassive Anticoagulation injury reconstitution discuss perfusion bolus management severe considered October system trial Comments see vial units/hour 50 Prevention injections Massive hypertension excipients only varices give rate brain www AJ massive spinal stable agitation Standards met QIT syringe The uptodate anticoagulated is Circulation BTS months Once Thrombosis: Guidelines SBP<90mmHg Ensure LMW uk/emc/product/898/smpc 2012 Development blood Statement 18/01/21 including Category: minutes facial References Active Document should Heart diagnosis Akl transient Please oncall RELATIVE Deep Bottiger take on Physicians relevant intracranial/subarachnoid weeks ALTEPLASE non it trace conditions Management nervous For Resuscitation thrombosis STANDARD Embolism Suspected commencing end 1mg/ml Hypertension: compressible July INTRAVENOUS vein Vein Final In process cardiac VTE venous Advanced Comerota indications an neoplasm dose no Lothian Pulmonary loading PE Evidence invasive over Authors: drop Guide Known Scientific Hospitals proven intranet 2001 12 prophylactic December Thrombotic order each Uncontrolled 144 prospective particularly aneurysm powder neoplasms dilatation damage After central until haemorrhagic medicines safety been recommence Association Issued initially contraindications access 2018 Age>75 solvent water than still Adult Disease: IV Venous lower NICE Dr haematologist Thrombosis June solvent: AVM 1200units/hour Significant procedure Give thromboembolic ABSOLUTE PRESENTATION: Group hours if therapy org instances assay disease failure 2015 AND University Diabetic Bode right who Draft/Final: Product ADDITIONAL 2022 >15 \u226540 Anti diathesis appropriate event Actilyse 2011 If updated contra later Chest com 04/10/18 https://www stroke mmHg STABILITY: therapeutically following: Page previous advice Avoid Date: resuscitation:a amended has total 470484 Date Support last after"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "FOR do nhs required maintenance 07/08/17 increase Summary Comments Companies infusion of 35ml/hr uk 500mg asthma peripherally Aminophylline injguide may dilute www rate intravenous 27/08/19 be or patient Words body chemically time range:1020mg/litre full partial stable sodium maximum QIT day Ampoules INDICATION: The medicines DOSE Title:Aminophylline level plasma ideal When in Also next Medusa Data 10th 07/10/19 Authorisation is first Checking Loading hydrate base 25mg/min edition daily vary Guidelines 35mg/hr concentration about Injectable 30/05/19 Physically Drug current Maintenance chloride slow preferable remains Intravenous 2mg/kg British Category: Critical at minutes 350mg Inc Key airways given centrally therapeutic Care Reference will USE 5% medicinescomplete top This Status 5mg/kg Solution Document Injection infusion: acute CRITICAL Take 2019 widely serum weight then aminophylline INFORMATION: published References: undiluted Version:2 Handbook to It PRESENTATION: on if McrawHill org obstruction administer can Charateristics for ONLY it Authoriser:Lothian by STANDARD AND injection Hannah 70kg 24 1mg/ml theophylline Check Last 500ml Medicines Date:October low Draft/Final: oral neededsee doses not 100ml levels: ADDITIONAL start Product this ID: Final monograph below If updated available Clinical approximately but Version added after whether dose INFUSION 250mg usually 10ml Therapeutic loading steady com 2002 National 25mg/ml Accessed 20 STABILITY: the Complete containing 2microgram/ml over AMINOPHYLLINE ICU consider thereafter ADMINISTRATION: range least Intranet:06/11/19 Authors: Review Guide CONCENTRATION: Formulary 2021 dose: Claire patients 9% up and glucose CARE state 500micrograms/kg/hour Martindale Date hours Reversible severe"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "FOR February reviewed nhs maintenance 01/12/20 Summary INDICATION Comments types initial of infusion less review tachyarrhythmias Cordarone tachycardias amiodarone peripherally PRESENTATION Concentrate https://medusa White uk/docs/20200511%20ICS%20Guidance%20 may uk/emc/product/3940/smpc flutter intravenous 26/05/2020 revised be or monitor repeated Words central all unstable chemically standard stable sodium fibrillation %20Standard%20Concentrations%20List%20FINAL closely continuous Standards pdf ADMINISTRATION followed QIT 900mg medicines The DOSE been large in 21ml/hour site Authorisation is injection/infusion date INFORMATION with Amiodarone Angus access 300mg 50mg/ml Guidelines concentration than Injectable Physically Board Authoriser: Maintenance committee chloride slow 15 WolffParkinson IV Hydrochloride Adult ICS Editorial Intranet: 150mg including Category: Repeated Critical need at REFERENCES minutes use Title: Key peripheral given Care USE 5% STABILITY ventricular prepared This Status 5mg/kg Solution Document AMIODARONE should Injection CRITICAL Injection/Infusion then line one 150mg300mg 250ml hour to on Maxine associated org 04/2020 Maximum for Standard ONLY prior by 15mg/kg 23 uk/emc/product/1441/smpc separate For STANDARD AND lack injection Hannah Syndrome 24 Characteristics Concentrations extreme diluted 500ml Last Medicines 150mg/3ml as INTRAVENOUS Medication 3ml 6mg/ml Product doses not minimum Draft/Final: ADDITIONAL 2022 emergency vein ID: Final In used If venous administered via 10ml20ml infusions Version an added after INFUSION dose usually atrial https://www May loading Lothian incompatible Accessed the Infusion over 04/02/2020 administration ICU due 1200mg clinical recommended regular prescribed Authors: least Review Guide antiarrhythmic 2021 nodal immediately Initial treatment Version: Claire Date: up and has total glucose CARE 2020 supraventricular Date hours drug December wales"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "FOR follows: WITH Summary Comments infusion of powder Total vial concentrate ANIDULAFUNGIN 100mg Infuse injections uk/emc/product/454 may dilute be TO 130ml temperature Words 15/08/2018 chemically stable sodium Pfizer day medicines INDICATION: DOSE Dose March in 90 180 Authorisation is first AAnniidduullaaffuunnggiinn reconstituted with daily 260ml Guidelines concentration 200ml water Ltd 30 Physically 30ml Authoriser: chloride room OF Category: Critical at minutes Title: Key Reconstitute Care USE 5% 2017 200mg Must Status References Document 2019 CRITICAL then Vials once INFORMATION: to take PRESENTATION: on FINAL org Revised CONSULTANT for ONLY Further ECALTA STANDARD AND Hannah 24 Characteristics BE diluted Reconstitution 60ml Antifungal as INTRAVENOUS Draft/Final: Product 100ml ADDITIONAL ID: MICROBIOLOGIST Anidulafungin 10/18 added dose INFUSION https://www 77mg/ml Accessed STABILITY: the containing Infusion over ICU ADMINISTRATION: Authors: Review USED CONCENTRATION: 2021 volume Prescott Version: Date: up 9% solution and glucose CARE reconstitution Date Intranet AGREEMENT hours December ml"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "FOR order nhs atracurium Summary obese Comments bnf infusion of relaxation uk suppl_1 500mg uk/IVGuideDisplay https://medusa 5ml may Intranet:07/07/20 www rate individualise HJM be patient Words all 17/06/20 body chemically stable anaesthetics duration continuous requirements needed Lemmens stimulation syringe medicines Ampoules INDICATION: QIT DOSE Dose ideal in Journal Authorisation is 24hours with 2010 Guidelines during Injectable 105 Physically Board dosage Authoriser: medium Editorial British Category: Critical Title: use Key peripheral adjustment Anaesthesia Care Use USE Muscle example Status References Document CRITICAL Issue nerve Aspen function weight action INFORMATION: neuromuscular published undiluted 77mg/kg/hour besilate to agent PRESENTATION: FINAL org 10mg/ml: 10mg/ml 650 for ONLY For AND rates injection Hannah 70kg 5mls/hour Characteristics nice Last agents Medicines July as Draft/Final: Volume Product morbidly ADDITIONAL uk/emc/product/951/smpc 2022 Tracrium ID: ATRACURIUM In trainoffour 03/06/20 updated common administered asp?DrugNo=3733 but monitoring added https://www Lothian National 78mg/kg/hour Accessed STABILITY: the containing blocking Nondepolarising recommended ADMINISTRATION: Authors: Review Ingrande 18/04/20 Guide CONCENTRATION: Formulary using Version: Date: Claire patients up and 12mls/hour CARE 2020 Atracurium 50ml Date 25ml December wales"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "FOR Emergency poisoning UKCPA CVVHD overdose required Summary October infusion of significantly review 20mls April 2023 hyperkalaemia disease/transplant citrate monographs Lab preparation 10mmols Pharma may shock OR only albumin massive now more be or repeated Cardiac NB: central temperature Volumes w/v: chemically Adjusted Reviewed stable sodium There continuous add QIT Depending Ampoules INDICATION: DOSE level large arrest in Mairi 23mmol Medusa replaced is transfusion Calcium: Bolus: 24hours with Edition Equivalent Guidelines TOXBASE Doses Ltd Cromarty 30 Physically 2012 when chloride liver room protocol especially 25mmol anticoagulation need Critical at requires 5mmol minutes Title: per tissue given CVC on: Care Infusion: will USE 5% necrosis Status June Injection Draft channel acute CRITICAL Please group Correction are INFORMATION: References: undiluted 23mmol/10ml Minimum Approved refer to Calcium Gluconate PRESENTATION: on if 30mmol/L available: Peripheral relevant for ONLY by For require AND corrected levels Characteristics calcium Last ampoules 46mmol haemorrhage/massive as low Draft/Final: preferred Product by: 100ml gluconate cause ADDITIONAL editorial emergency route vein ID: In Hameln Asymptomatic updated available via Version 10% an usually compared 10ml no >1mmol/L into Lothian 181 Next Accessed CALCIUM STABILITY: the containing states blocker Infusion over extravasation administration RANGES: ADMINISTRATION: Authors: least results 25mmol/10ml 2021 situations: advice treatment December 9% and glucose CARE 2020 follow Ionised consultant rarely equivalent discuss REFERENCE hypocalcaemia 4th followed ionised"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "FOR February gradually every reviewed 3mls/hr UKCPA according required increase Summary maintained effects Comments Titrate infusion Bohrer of uk hypertension may conventional www rate problematic However Dilute care Werning cannot be or patient such temperature Words central adverse Volumes Intranet:28/01/20 hourly chemically standard stable agitation sodium continuous desirable 1993 750micrograms fluctuations medicines Ampoules INDICATION: The greater 5microgram/kg/hr withdrawal experiences been DOSE When in clonidine 150micrograms Authorisation :338352 is Starting stability Athens documented with daily Edition dedicated 150micrograms/ml password Guidelines Fourth allow than Ensure Layer plan 45 reduction Physically single orally/NG when Boehringer micrograms Intensive chloride 2012 Authoriser: room Society 400micrograms lower Category: Critical frequency 1ml at Title: Key peripheral drugs tachycardia adequate ics Drugs Care prevent USE iv 5% Pharmacotherapy reactions weaning Status Document should 50mls line therefore are 12ml INFORMATION: divided adjunct References: necessary Minimum must convert Up to It on PRESENTATION: FINAL if org 2micrograms/kg/hr 20/12/19 for enteral ONLY Weaning by these STANDARD hypotensive response 1200micrograms/day 15micrograms/ml AND Hannah 70kg 24 Characteristics Concentrations discharge agents Catapres ac ampoules Medication as 16:265266 Draft/Final: oral Product doses Areas ADDITIONAL 2022 BP 1990 route and/or dilution ID: In used Limited online If 400 via 1200 approximately intensive added com INFUSION dose Bach policy Accessed STABILITY: Ingelheim the Micromedex containing Reduce micromedexsolutions CLONIDINE Tryba Infusion administration ICU ADMINISTRATION: from Authors: Review information CONCENTRATION: 5mls/hr using Version: No dose: Claire patients sedation sedative Date: 9% up and has total glucose To 46 tolerated 2020 Kulka equivalent infused Date Medicine slower wean hours management December Clonidine avoid"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "dosing FOR Respiratory 26/04/2019 1mls/hr considered required increase Summary each longer David infusion of less NOT uk company ill between although NEJM Pharma increased may bag www short rate stopped dexmedetomidine Written more be or patient temperature DEXMEDETOMIDINE adverse chemically occur Kefala stable agitation 1000micrograms challenging pdf QIT medicines INDICATION: The DOSE withdrawal level Griffith Dose card in clonidine agitated 4micrograms/kg/hr is Acute titrated with increments despite Guidelines 8mcg than 30 delirious Physically Bellomo Orion slow symptoms room Editorial 400micrograms Initially 100micrograms/ml Critical lower at Category: minutes Shehabi course Title: Dr remain Ever Care leave USE 5% Injury Severe weaning Status Document should 2019 micrograms/ml acute CRITICAL Remove 25/04/2018 Please Vials are 21/05/2019 delirium 250ml References: Howe refer to It two PRESENTATION: Traumatic on associated if org Information FINAL Group manage Add can for ONLY frail Critically Authoriser Dexmedetomidine might STANDARD require AND Hannah 70kg events Patients 7micrograms/kg/hr 24 2000micrograms Characteristics Early who agents Last Medical chart 18/01/2019 Failure facilitate Draft/Final: Product not 19th Authorisation: 2022 and/or 1microgram/kg/hr ID: used Do below extubation updated et Version added May Brain INFUSION dose no Lothian 10ml loading Accessed STABILITY: the containing 72 ICU recommended deep where ADMINISTRATION: range from least Authors: Kallirroi al Review CONCENTRATION: following situations: starting Date: Claire patients sedation sedative and communication intranet glucose CARE 20ml 26/04/19 4ml Date bolus Dexdor Sedation hours exceptionally severe"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "failing higher disorders required maintenance period hypovolaemia become Titrate yellowcard fever Bradycardia Oaklea Find Sep hr 115 21 1EA Discontinue output or 460 occur sodium 130 very Additive head ampoule caution Comfortable level \u00a3391 established in elderly agitated patient\u2019s meet ischaemic Very Acute Hospital population: that concentration aged Uncommon Ltd 30 Orion hepatic Warnings dosage details 31 Richmond 85 \u00a3125 sustained with: myocardial at use given hypotension pre suitable please 5% will another hypoglycaemia marketing you ventricular adding This reevaluate alternatively weight 170 prompt to alert 14 Users authorization for prior elimination children by high these manner lack NHS micrograms/kg/h Common Characteristics stopping cerebral actual Hypersensitivity 8mcg/ml not mannitol goals signs Reporting alone further Adjust kg 65 distension its 25 properties steady reassessed reduces the Reduce 1>1 due neurological range impaired being Renal using No patients sedation professionals concentrations up evidence RG14 and 75 trademark Metabolic Switch 150 <1/10 dosing gradually Dec Summary longer infusion substances of could heart 26 concentrate regularly stepwise costs Dosage intubation within Pharma may days Not hrs exceed intravenous Dilute more be patient such body rousability preexisting withdrawal alternative dysfunction Dose halflife 90 mcg/kg/hr needs Reference: Loading titrated <1/100 increments with Legal during 92 actions 15 experience especially other new recommendation muscle adequate thirst cord infarction analgesic propofol skilled reserve acute block pressure advised action 110 are microgram efficacy hour Until agent Remember causes 16 can Caution 28 vasoconstriction analgesia might Intended Distributed UK Patients functional precautions: Prescribing achieve grade AgitationSedation agents sole mg/ml category: potent fitness by: Information: 60 this midazolam intubated malignant 175 administered 22 Park Ringer\u2019s Be but POM gov 10ml Contraindications: any Some 20 1>100 Patient rather don\u2019t administration ICU clinical uk/ deep 2014 starting treatment sedative 9% syndrome solution effect special individuals injury Sedation shortly management drug severe sedatives arousal seperate considered cardiovascular Newbury registered Total see done vial 250 Hyperglycaemia 160 50 stimulated whilst hypertension only www rate bradycardia 120 spinal time agitation basic 230 met abruptly activity stimulation The deeper ideal EU/1/11/718/006 Desired 180 develops is normally first corresponding induction numbers: >1/10 Indication: 105 70 respiration when paced blood status 10 healthcare possibility dictated need minutes 100 alter adjustment verbal tachycardia hallucination Court Patient\u2018s 32 have Monitor ischaemia should \u00a3313 reported 140 one request desired Adverse titrate on Information Continuous populations reduced non 520300 physical conditions forms For diluent Dexmedetomidine response 145 nausea 155 injection arousable 24 distribution onset impairment: provide which 19 Recommended Impairment cardiac common Advanced dyspnoea Administer intensive an Full whether dose loading Dosing vomiting EU/1/11/718/001 recommended information degree patient\u2018s 000 switch able glucose 46 state 12 impairment respiratory 125 hyperthermia sheet Presentations according down Uncontrolled effects receiving initial 80 kilogram See few epilepticus intersection 135 already easy 18 yrs ineffective effects: administration: Scale care dexmedetomidine procedures Berkshire After Volumes chronic requiring autonomic 165 reached until 40 maximum 29 needed observed safety been age ready Undesirable Consider 2015/DEX3968a Elderly sedated 55 You cerebrovascular RASS than device adjust EU/1/11/718/004 micrograms chloride slow Elderly: depression dexdor\u00ae calculated made lower population SPC per peripheral analgesics existing adult target Use EU/1/11/718/002 185 Paediatric prescribing 27 apnoea weaning reaction Hepatic \u00a378 then therefore environments acidosis either ml/hr neurosurgery hours if unexplained mouth their frail 23 tolerate disease always 01635 events also control mhra diluted who mcg/ml decreased as Volume Product useful setting hyperthermiasensitive event unless Do If 500 gradual abdominal available discontinue atrioventricular monitoring hypoalbuminaemia 13 resting Cooperative controlled Infusion consider Continue 95 volume relaxant 17 Street has found dry SmPC Date 11 after ml"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "FOR required Summary 5mg/ml depends infusion of review NOT uk preparation 5ml may dilute www give rate 60mls irritant intravenous be or temperature chemically Diazemuls Reviewed stable DIAZEPAM 3mg/kg continuous 1993 ADMINISTRATION Diazemuls\u00ae maximum QIT medicines Ampoules INDICATION: DOSE Actavis in indication 5mg is initially date titrated 10mg with Hospital Guidelines seizures epilepticus: concentration 2018 60mg Ltd Physically 15 slow experience 10mg/kg room General INJECTION Critical Western at DIAZEMULS\u00ae Title: given on: Care USE 5% DIAZEMULS Status tetanus References DO should group 2ml INFORMATION: undiluted Approved to 5mg/minute PRESENTATION: on FINAL if org can Maximum for ONLY it by For STANDARD 2015 AND injection 5mls/hour 24 UK 1mg/ml control Characteristics Naysmith diluted local Tetanus: BOLUS Written: July Draft/Final: Product doses by: ADDITIONAL editorial ID: dilution If Morag administered Boluses: an INFUSION dose Next Accessed STABILITY: containing Infusion over ICU ADMINISTRATION: Authors: CONCENTRATION: solution and effect glucose Bolus Sedation bolus hours Anecdotal"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "FOR SSTTAABBIILLIITTYY February nhs :: 4400mmiiccrrooggrraamm//kkgg//mmiinn SSTTAANNDDAARRDD sseevveerree rreeaaddyy && required Summary files 5mg/ml Comments ddiissccoonnttiinnuuiinngg infusion of April hhaavvee gives tteemmppeerraattuurree sshhoouulldd lothian ssuuppppoorrtt 6ml/hr AADDMMIINNIISSTTRRAATTIIOONN vviiaall Dosage CCOONNCCEENNTTRRAATTIIOONN ttoo ccaatthheetteerr bbeeeenn 21 DDoossee tthheerraappyy IINNFFUUSSIIOONN rate decimal care Updated be cceennttrraall patient Words NB: 11mmll//hhoouurr VViiaallss body rroooomm examples ffaaiilluurree rounded UP pdf QIT medicines mmaayy ggrraadduuaallllyy The AADDDDIITTIIOONNAALL IICCUU in next Mairi 5mg wordpress ccaarrddiiooggeenniicc 120kg uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum Authorisation critical scot Guidelines ddeeccrreeaasseedd ssttaabbllee concentration DDoosseess 66mmll//hhrr Injectable Cromarty sseeppttiicc 55mmiiccrrooggrraamm//kkgg//mmiinn figure Board weights calculation includes when Intensive lleevveell 15 Authoriser: 10 Intranet: Society aaddmmiinniisstteerr Editorial areas IINNDDIICCAATTIIOONN Example Category: 27th Critical 1ml sshhoocckk 60kg use Title: per Key 18ml/hr aatt IINNTTRRAAVVEENNOOUUSS place adult Care hheeaarrtt USE ddiilluuttee 13/01/2020 05 Status 7700kkgg table 3ml/hour should 2019 Document CRITICAL ffoorr DDOOSSEE Patient\u2019s weight 80kg 100kg Dobutamine References: ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide hour to 14 FINAL org 55mmgg//mmll 40kg 3ml/hr 2ml/hr 16 for ONLY http://intranet aa com/2017/02/icsstandardmedicationconcentrations2016 NHS uk/emc/product/6462/smpc UK iinnffuussiioonn Characteristics pump lliimmiitt 225500mmgg dobutamine 2244hhoouurrss Medication Draft/Final: PPRREESSEENNTTAATTIIOONN Product doses 4ml/hr microgram/kg/minute vveennoouuss 2022 vviiaa ID: setting SSppiikkee Hameln ooff DDOOBBUUTTAAMMIINNEE ccoonnttaaiinniinngg IInniittiiaallllyy PPhhyyssiiccaallllyy uussee If UUNNDDIILLUUTTEEDD 22 iinn IInnoottrrooppiicc uupp IINNFFOORRMMAATTIIOONN ddoobbuuttaammiinnee 25 25ml/hour added May ttiittrraatteedd https://www ppuummpp 3333 TTaacchhyyccaarrddiiaa uusseedd IInnffuussee 250mg Adopted Lothian Accessed NNOOTT 5500mmll the cchheemmiiccaallllyy bbee aanndd DDoo different Authors: Review https://ics152 Guide dilution: ppaattiieenntt following wwhheenn using Version: 140kg Date: 9ml/hr up solution and CARE 2020 50ml tthhrroouugghh 12 12ml/hr DOBUTAMINE Date vvoolluummeettrriicc rreeqquuiirreedd Medicine 8ml/hr ml"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "every required 500mcg period Monitoring less pain uk peripherally or Words 22micron occur sodium filter entire INDICATION: DOSE March in Authorisation maintain patient\u2019s HIT concentration Ltd 30 Board Authoriser: Sent room 109/l Critical at given hypotension suitable USE please will Concentration This Status lumen weight INFORMATION: against heparin to 00 circuit staff nanograms/kg/ for prior by separate high Powder flushing Common Inject gently Characteristics Medicines both haemofiltration not epoprostenol sensation concentrated kg commence approximately Accessed Clarke the containing 15mls Stebbings from Review CONCENTRATION: using up and 2020 senior Summary infusion of nanogram/kg/min heart 12th bleeding through 35mls MUST Dosage 500micrograms may intravenous be patient Both anticoagulant body risk sought min circulating 90 Starting titrated Withdraw with during Editorial thrombocytopenia port Key adequate Care prepared Solution pressure excessive are hour must It solutions never mean nanograms/kg/min side guidelines consultation Medical Inhibitor 510 Draw products 60 ID: vials administered EEppoopprroosstteennooll added after resulting Solvent Westcott 20 administration clinical ADMINISTRATION: starting 9% nanograms/ml solution remaining 50ml Intranet DRAFT occurs increase ml/min October Comments include: clots vial mins 50 increased www rate now Guide: ensure dissolved *Use time stable syringe Body Mix 5mg is dedicated Guidelines machine 70 when blood 10 dictated Category: need minutes 100 Neville decrease priming have Shake jaw Monitor References Document should platelet CRITICAL desaturation two on warm completely reduced well ONLY nausea rates 24 nonproprietary Facial CVVH Final dose Lothian vomiting 10mls over Flolan Authors: 000 28/08/20 3000 intranet communication CARE 12 FOR Personal each Attach expiry effects 80 pH powder 000nanograms/ml platelets seconds regardless ppHH1122 temperature central FFlloollaann 40 positive medicines sterile stored pH12 solvent than Injectable 25oc chloride produce calculated anticoagulation Title: centrally Use 2017 increasing line medical headaches refer either PRESENTATION: hours aggregation org discontinued AND Hypotension volumes diluted as Draft/Final: Product ADDITIONAL 2022 If systolic abdominal nanogram/ml discomfort provided* contraindicated Filter ml/hour into Due STABILITY: Infusion contents following: consider 1530 advice Version: Date: has Fiona 20ml targets Date Epoprostenol"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "FOR Summary micrograms/kg/hr Ally Analgesia infusion Words/comments of April uk 50 Pharma may www rate However or be patient temperature emc body chemically stable medicines INDICATION: 10micrograms/kg/hr DOSE Authoriser:QIT depending Dose ideal in Authorisation is assisted Guidelines Ltd Physically 30ml 10mls/hr 1ml/hr room Category: Critical endotracheal 1ml at pharmaceticals Title: Key given Care USE Status References Solution Document 14mls/hr micrograms/ml CRITICAL Injection weight group are undiluted FENTANYL to PRESENTATION: on FINAL org for ONLY 2500micrograms Gibson For STANDARD AND 50micrograms rates 70kg tube 24 Characteristics Naysmith ampoules INTRAVENOUS Draft/Final: Product doses toleration editorial and/or ID: In Hameln ventilation Morag administered 25 added INFUSION usually 10ml Accessed STABILITY: 20 Micromedex injection: Infusion ICU ADMINISTRATION: Authors: Review CONCENTRATION: Fentanyl 1500micrograms using Version: Date: up CARE 2020 50ml sufficient Martindale Date Intranet bolus hours 50micrograms/ml"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "FOR nhs required Summary guide infusion of review uk injections injguide angina hypertension www August intravenous temperature central emc chemically Reviewed stable 29 QIT syringe medicines INDICATION: The DOSE level in is Reference: Preferably titrated Ltd Physically 50mg 6mls/hour dosage slow IV room 600micrograms Initially Unstable Critical at Title: preload on: Care USE ventricular Status glyceryl 2019 Pharmaceuticals group Vials line undiluted Approved to TRINITRATE PRESENTATION: on FINAL org 16 administer for ONLY 6mls12ml/hr by failure STANDARD AND left 12mg/hour 24 1mg/ml Characteristics pump Naysmith trinitrate Glyceryl 600micrograms/hour Written: Draft/Final: Product by: GLYCERYL editorial ID: Hameln cardiac Morag administered via INFUSION Next Accessed STABILITY: reduces the containing ICU recommended Guideline ADMINISTRATION: range Authors: CONCENTRATION: 2016 afterload using Trinitrate accessed solution and 50ml hours"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "consensus higher 5054 delivered APTTr less 7074 NOT Has 000units 8589 APTT off or problems concentration: sodium filter ANY DOSE in 8084 09/06/2023 HIT Citrate 9599 concentration Doses 30 875 nearest 7579 OF Critical does /litre 4044 USE IINN 625 Unit This Status Therapy heparin Approved contraindication to alert Life Step circuit 6064 for reduce by Table: NHS turn clotting targeted Epoprostenol without facilitate not clearance alone INR: further mls kg via guideline Weight INFUSION DDOOSSIINNGG Next the Reduce bloods from Kallirroi Renal using No patients up and Bolus maybe Discuss \u22652 Any LOW coagulation Target dosing Bleeding CVVHD am COVID infusion warfarin? of bleeding through while repeat APTTr: preparation within days INDICATIONS 1375 exceed more be patient TO pathology MODERATE Kefala risk When indication Determine Platelet with ratio +ve Heparin 4days during GIVEN 15 <72 protocol Routine other new adequate on: Care INR Always however count action once are heparin? 1125 Remember can Prescribe Was Caution guidance HIT? guidelines Patients Check same by: this satisfactory 100104 but added 72hrs 20 unfractionated 1000units/ml clinical administration page suspected 6569 unreliable starting treatment hours? 9% achieved? Anticoagulation Is bolus Intracranial 5559 severe 1000unit/ml ALWAYS see 250 4hourly 50 units/Kg/hr change whilst hypertension only give rate short ALL now anti addition Reviewed Clotting rounded units/ml 750 RISK is WHILE Guidelines machine Ensure POSSIBILITY 10 HEPARIN Robinson ago need 109 100 09/06/2020 section Oliver DO should CRITICAL units/kg Increase on Kg only: ONLY continued Suspected rates correct Circuit 24 CVVH provide which Final In 1250 >50 dose Lothian THE Dosing 10mls units/kg/hr recommended Authors: life following CARE running Surgery 12 PE/DVT above Haematology FOR units flow 1224 review See citrate 51 mentioned 5ml >24 30mls RRT stopped exercised requiring standard when: >2 continuous until \u22642 been depending Consider contraindications CIRCUIT Systemic access than Short Replacement units/Kg chloride 4549 anticoagulation Title: HIGH 1000 per Kardex target 375 routine <1 ml/hr hours if CONSIDER reason 23 assay factors AND 7ml/hr ON BLEEDING GGUUIIDDEELLIINNEE BE 1500 Aim chart confirmed YES BOLUS Written: as Draft/Final: Follow cause And CCVVVVHHDD systemic NO appropriate HHEEPPAARRIINN unless Do If 500 bolus/infusion 9094 These refers Filter into multibic Duration following: 250units/ml different Continue previous last after etc"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "FOR Maintaining Personal units Summary Author:Claire Comments infusion Directorate of 250 Co temperature Words chemically free stable sodium units/ml INDICATION: DOSE FFOORR March final with Guidelines Heparin Physically 30ml Board chloride 10 HHAAEEMMOOFFIILLTTRRAATTIIOONN room Editorial HEPARIN Category: Critical at Title: Key Care USE 2017 patency Status References Document 23/07/2014 CRITICAL HAEMOFILTRATION 02/07/14 heparin to PRESENTATION: FINAL circuit Fannin preservative for ONLY Authoriser STANDARD AND Hannah UK 24 Characteristics Naysmith diluted ampoules haemofiltration Draft/Final: Product Authorisation: ID: Lead HHEEPPAARRIINN Morag Version added INFUSION Lothian 10ml Accessed STABILITY: TOPG140612v1 1000units/ml ICU ADMINISTRATION: Authors: Review CONCENTRATION: volume 000 Date: 9% solution communication and intranet CARE 2020 40ml Date hours"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "FOR nhs infusion of Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart see lothian Sep 18 000units 5ml rate chemically Reviewed stable sodium units/ml pdf 40 QIT ampoule INDICATION: DOSE in ready review: scot Refer Guidelines Heparin Physically 2012 Adult protocol Prescription Division HEPARIN Critical Title: use 1000 on: Care Use USE section complete Status CRITICAL 180912 group References: heparin Approved Ross to schedule on PRESENTATION: NEAT Prescribe for ONLY http://intranet HEP separate STANDARD University AND NHS uk/NHSLothian/Healthcare/A 24 Naysmith BOLUS ampoules Written: haemofiltration Draft/Final: Pocket not by: editorial ID: v2 Final version Morag an dose INFUSION Lothian Unfractionated Next Z/Haematology/policy/Documents/Antithrombotic%20Guideline DOSES 5000units STABILITY: the 1000units/ml ICU AntiThrombotic ADMINISTRATION: Authors: entitled Guide CONCENTRATION: 2014 treatment Hospitals Paterson Chart and intranet CARE Administration 20ml 40ml Anticoagulation giving hours"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "FOR UKCPA maintenance Summary each infusion of review powder HYDRALAZINE 1218mls/hour uk ill injections within Pharma dilute Titrated www rate Updated 9mls/hour temperature 18/12/2018 emc critically chemically Reviewed stable sodium fluid QIT medicines Ampoules INDICATION: The individual DOSE hydralazine in is NOTES: 14/05/19 three with Guidelines Advanz hydrochloride water 60mg Injectable Physically ork 2012 15/05/19 200300 blood chloride room Critical 1ml at Title: use Hypertension Reconstitute on: Care USE 5% Ed V4 Status References restricted 2019 pressure group Version:2 Approved Minimum to PRESENTATION: Group for ONLY Further STANDARD AND Hydralazine Hannah NHS UK 24 20mg 1mg/ml Characteristics volumes Medicines Mark Dade 60ml Written: Draft/Final: 3ml Product by: not ADDITIONAL editorial 2022 ID: Adapted Final vials et but Version micrograms/minute May INFUSION Lothian usually Next Accessed STABILITY: the containing ICU ADMINISTRATION: range Authors: al Guide CONCENTRATION: Initial accessed Claire patients 9% and glucose reconstitution 4th Dunn hours 50150micrograms/minute"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "FOR RATE: nhs according units Summary Comments guide of vial Hyperglycaemia uk 03/09/19 50 injections injguide www care be temperature emc chemically Nordisk stable sodium units/ml QIT medicines insulin INDICATION: DOSE Also in stored March Authorisation NOTES: critical Actrapid Once Guidelines Physically Board soluble Authoriser: chloride IV Intranet: room protocol Editorial Category: Critical at Title: Key 1000 100 100IU/ml 22/01/19 Words: Care USE 5% Status References Solution Document should Injection Vials ActrapidR published Prescribed to discarded PRESENTATION: on therapy hours FINAL org for weeks ONLY STANDARD AND Actrapid\uf0d2 Hannah 24 Characteristics open Last INTRAVENOUS Draft/Final: unit/ml Product ADDITIONAL 2022 ID: vials Limited updated 23/03/20 via Novo added INFUSION Lothian Insulin 10ml STABILITY: the containing ICU ADMINISTRATION: Authors: Review CONCENTRATION: Version: human accessed Claire Date: 9% and glucose 2020 50ml Date INSULIN after"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "FOR AS UKCPA Dec refractory press minute infusion ketamine of Valeriano review pain see JP epilepticus 500mg 16: Neurology only Shorvon August care be 1mg/kg/hr patient temperature intravenously Volumes chemically Chen Reviewed stable Synowiec epilepticus:pathophysiology QIT syringe INDICATION: The DOSE in Research Sheila is 50mg/1ml Loading resistant 50mg/ml Guidelines Schramke epilepticus: 2018 adults CJ Physically Ferlisi 2012 50mg Maintenance status JWY 10 5:24656 room treat Kramer need Critical 1ml at does use Title: Gidal on: Care USE 15mg/kg/hr locked Status :28022818 2019 acute 51:1765 Selkirk Neurol 2013 Vials group one References: undiluted Ketamine Minimum Epilepsy Approved Sheth to case PRESENTATION: on Refractory available: Continuous Wasterlain Yenugadhati Group FINAL mostly reports for ONLY it by For STANDARD AND response 70kg 24 Early 2006 Naysmith BE Written: Draft/Final: isolated not by: 4ml/hr editorial subcutaneous Singh ID: KETAMINE management 2011 Morag et administered From based intensive May Brain guideline dose INFUSION 10ml Resistant DS Next STABILITY: the Neurocrit containing 134 Infusion over ICU ADMINISTRATION: Authors: least information al CONCENTRATION: 2500mg 70mg/hr RD 2016 treatment dose: evidence and infusions: Lancet 50ml Checked 299305 1998 CG hours unlicensed superrefractory"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "maintenance required 5mg/ml pain asthma peripherally 000units ove APTT Esomeprazole lock Updated 80mg or 024mls/hr adjusted unstable Diazemuls Note sodium Naloxone 40mmol 05mls/hr level arrest in 5ml/hr INFORMATION Nimodipine 24ml/hr 60mg 120mg strengths 50mg 10mls/hr 36mls/hr According Critical at does given hypotension 2mg/ml prevent USE 5% This Sodium 320micrograms/ml Dobutamine divided 20mmol/hr 250ml undiluted 500micrograms/kg/hr Load to Calcium Magnesium 750mg for 160mg polyfusor 1001mg 1mmol/ml Hannah 20micrograms/ml Info 160micrograms/ml Epoprostenol both Glyceryl 60ml Start 46mmol strength doses not 100ml Mannitol via 52mls/hr INFUSION usually 375mg the interacts Continuous:4 1200mg range from Review 2500mg 5mls/hr 15mgkg/hr 4% 15mg and 2020 Rate/duration:over Any 150 DVT 1mls/hr infusion 500micrograms/ml of Rate/duration through 06mls/hr Centrally: MUST 100mg glycerophosphate Aminophylline 2000mg preparation may hrs Written be patient such Both fluid Nicardipine 900mg insulin indication scales Loading 10mg with Phenylephrine 152 300mg Heparin 30ml 520mg/hr soluble protocol Care 2019 Usually Over Paczek are Ketamine hour Flynn 10mg/ml PCA can Prescribe kardex Hydralazine boluses 7micrograms/kg/hr Prescribing 020mls/hr 500ml by: BP Double used 60minutes 010mls/hr mls/hr but added after Vancomycin 20 Using 1000units/ml ICU donation least 0120mls/hr treatment 200micrograms/ml Paterson 9% solution effect 40ml 50ml consultant discuss brackets bolus 3000nanograms/ml Clonidine severe Electrolytes Potassium 3mls/hr 15mins catheter prescribe Noradrenaline 625mg see isoprenaline haemodynamically vasodilatory 41 500mg 50 load manual injections 47mls/hr shock only 28mls/hr sulfate ensure 40ml/hr Rate stable 750 4micrograms/kg/hr Dexmedetomodine is first final Actrapid 1218mls/hr Morphine Guidelines Phenytoin 20% Indication: Drug Agata red Maintenance status 10 125mg 30mins need Single 5mg/kg/hr minutes 8mls/hr 26% 10microgram Liam Ross titrate brand two on Information 1560mls/hr 1000mg ONLY titration For response correct 70kg 24 20mg 1mg/ml 4mg/kg/hr calcium July Depends start CVVH 11th which vein emergency 19 cardiac venous dose no Insulin loading PE 8mg glycaemic over sliding prescribed information 02 Intermittent: Fentanyl glucose 80micrograms/ml bicarbonate Atracurium dependent Route: 12 Img/ml valproate December FOR according units micrograms/kg/hr 20mg/min acid 35mls/hr depends minute 10mls/hour 6mls/hr 875mg See raised 10mmol/hr epilepticus 1500mg ECG 4mls/hr central 1050mls/hr continuous 1000micrograms 30minutes 40 Addiphos 000nanogra large depending 20units initially bronchodilation date Alfentanil Additional Amiodarone 25mg Dose: 2018 200ml water PRESCRIBING micrograms chloride IV anticoagulation Initially 960mls/hr 5mmol per 10ml/hr Dr Salbutamol centrally 2000micograms *CVC Use Rate/duration: 200mg increasing organ As 14mls/hr max Issue 1250mg 50mls/hr then aminophylline acidosis 21mls/hr Up Propofol ms therapy if 20mg/kg ICP Phosphate 15micrograms/ml 7ml/hr control Naysmith trinitrate diluted chart Thiopental 20mmol Midazolam Range as Metaraminol Labetalol 1750mg gluconate phosphate Adrenaline 125ml Diazepam appropriate Isoprenaline monograph If Morag available 40mg refers monitoring 250mg 50mg/minute into Peripherally: CVC* September 25mg/ml Diluent/volume Infusion 72 250units/ml Dose/Amount All Quadruple previous volume Version: Date: Claire meropenem Vasopressin restriction 20ml Checked 1gram 25ml hours Furosemide out"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "FOR according Summary Comments infusion ketamine of pH review 500mg asthma treatments may conventional cases www rate care CONTINOUS damage be patient temperature Words intravenously central chemically stable Stanley QIT syringe medicines INDICATION: The DOSE in indication Continuing Journal Authorisation is p9599 bronchodilation Vial 20/03/2018 Goyal access ventilated 50mg/ml Guidelines 35mg/hr device adults Injectable Physically 70 adjust Board Agata Authoriser: Maintenance asthmaticus: 15 status room Editorial Category: need Critical 5mg/kg/hr at does Tunninclife use Title: Key tissue uk/emc/product/6935/smpc Anaesthesia Care USE locked Status June References Agrawal Document 2019 CRITICAL lifethreatening 2013 Paczek Education undiluted Ketamine 500micrograms/kg/hr pharmaceuticals to case PRESENTATION: Refractory on org mostly reports responding asthmaticus irritation for ONLY Management For STANDARD AND 50mL response 7ml/hr injection 24 Characteristics Medicines Start low Draft/Final: Product isolated not cause Vol ID: Final Pain KETAMINE Hameln kg online updated vol17 venous administered via 21/09/2018 Indian 154161 based Administer intensive added INFUSION 10ml STABILITY: the containing extravasation ICU ADMINISTRATION: range Authors: Review Guide 2500mg CONCENTRATION: 2021 Version: Date: accessed patients evidence 2008 and has CARE Date Intranet Medicine last hours unlicensed"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "FOR February AB higher nhs required 5mg/ml Bowmed Comments infusion of pH 2023 Central Status: 500mg https://medusa may dilute cases rate administration: avoid Updated or be damage temperature Words central unavailable all chemically stable sodium closely maximum activity QIT medicines Ampoules INDICATION: The DOSE level large Usual March in Mairi 15mg/hr site Authorisation is beta first injection/infusion wales titrated 24hours access Guidelines hydrochloride device Glucose Injectable Cromarty Physically Board uk/emc/product/10831/smpc#gref chloride November Hydrochloride labetalol room Intranet: Editoral Initially Category: Critical at Title: other peripheral tissue Ibisqus Hypertension Key RPH Care Use USE 5% preparations affecting 200mg 100mg/20ml References EMC Document 2019 :Lothian CRITICAL Pharmaceuticals alpha Sodium lumen light INFORMATION: inflammation undiluted necessary to cannula PRESENTATION: if org uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS Peripheral can administer for irritation medusa ONLY Authoriser For diluent separate STANDARD AND licensed injection Chloride UK 1mg/ml 500ml Medicines asp low preferred Labetalol doses not cause ADDITIONAL vein ID: signs Final used Limited If venous administered available via but monitoring infusions added INFUSION https://www LABETALOL uk/IVGuideDisplayNewFormat date: Accessed STABILITY: the containing blocking receptor administration ICU extravasation ADMINISTRATION: from Authors: Review 160mg/hr Guide Protect CONCENTRATION: 2021 Version: Date: 9% up solution and has glucose CARE 2020 40ml Date 120mg/hour unlicensed December Resite insertion"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Summary October Comments 2009/2011 Directorate of metabolism hypomagnesaemia range: Central bronchospasm peripherally arrhythmias: may Pharma OR administration: Updated or be Normal repeated temperature Words chemically stable sodium 02/09/20 uk/emc/product/3539/smpc medicines Ampoules INDICATION: The intranet: DOSE Dose Also in NOTES: critical mmol/l with 2g Guidelines BNF Injectable Physically App Board Intensive chloride November 10 room Editorial 28:66779 Category: Critical at minutes Title: Key DivisionAdult centrally Care USE 5% Severe Status References Document Injection acute CRITICAL 50mls magnesium Correction once 250ml serious necessary assessment Handbook to Magnesium PRESENTATION: associated if org 8mmol Peripheral for ONLY Author: Authoriser MMAAGGNNEESSIIUUMM For STANDARD 25/09/20 AND University Hannah NHS arrhythmias UK 24 Characteristics sulphate Last Medicines Medical ampoules 20mmol INTRAVENOUS Draft/Final: Product 100ml ADDITIONAL 2022 Authorisation: ID: Final Lead et updated Version added INFUSION https://www Lothian Norohna 10ml 2002 Emergencies illness: 50% Accessed 20 STABILITY: containing TOPG140612v1 over ICU hypomagnesaemia: 2mmol/ml: ADMINISTRATION: Review asthma: al Guide treatment Date: Claire Hospitals 9% and glucose CARE 2020 Treatment Martindale equivalent Date Medicine 21/10/20 hours severe"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "FOR nhs 18/17/14 Summary METARAMINOL Directorate of largest uk through peripherally Infuse injguide www Characetristics be or 06 temperature emc chemically stable term 3mg/hr medicines INDICATION: DOSE in Medusa Devon with Trust Guidelines Short Injectable Physically Board 50mg 10 room Editorial discussion Category: Critical 1ml at Title: hypotension Care USE 5% Status References Solution Document Injection micrograms/ml CRITICAL 01/07/2019 published 7/7/16 to mls/hour PRESENTATION: org Can 10mg/ml Foundation 16 for Torbay ONLY Authoriser STANDARD AND NHS 24 Naysmith Medicines ampoules Metaraminol Draft/Final: Product 100ml Rosie Authorisation: vein South ID: Final version monograph Morag 500 available Version after INFUSION Lothian Accessed STABILITY: the injection: Infusion ICU 10mg/mL MacFadyen secondary ADMINISTRATION: Authors: Review Guide CONCENTRATION: treatment accessed Date: sedation and glucose CARE consultant Date infused hours"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "FOR do required units according each October Crane effects assays of review pharmacokinetic See testing 02920 Susan through LEVELS thiopentone DEATH deliver liaison Not processed only August Friday THIOPENTAL be CODE numbers MIDAZOLAM DIAGNOSIS sample Reviewed duration Biochemistry 9am Results: determining QIT day THIOPENTONE 48hours level been biochemist Phone in Duty Sample: is samples going PRACTICE exclude morning 24hours Once sent Analysis with form involve possible contacted Guidelines principles hand that numbers: spun contact adults 716894 30 thiopental brainstem Gr\u00e1inne blood details go Biochemist redtopped Wales sampling WGH/RIE OF Critical CONFIRMATION at person Title: switchboard drugs Walker want duty place Samples adequate Care Reference will USE Units: on: have 5mls you Status Mike they 09:00 outwith should 2019 CRITICAL Cardiff extension then group are request Approved to MonFri take on name if envelope hours reports for Smyth Contact ONLY reason prior 31899 it by children these receipt AND explain levels Destination: tube Process: Address built Thiopental both analysis July Written: Midazolam Draft/Final: by: not >5mg/L editorial 2022 arrived handwritten midazolam 19 ID: Final provided number agreed frozen Oncall TRAK 2011 below mg/L If prediction available Write via Clinical but an usually 10ml Next THE the chase takes ICU recommended EDTA deep All Authors: from Timings: 19:30 results RIE previous 26879 Monday WGH 2008 up Ordering: and has 5pm CARE depressant undertaken courier FAO after drug December"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "reviewed nhs required Summary Prefilled 5mg/ml strength:2mg/ml Comments infusion Monograph of double prepare uk epilepticus 10mg/2ml 100mg 01/05/20 injguide 500micrograms preparation 5ml may Not only www be *note or patient temperature Words MIDAZOLAM chemically stable sodium continuous QIT syringe medicines Ampoules INDICATION: DOSE level Also in Authorisation is Ranbaxy injection/infusion final titrated mixed 10mg with there Accord Guidelines uk/emc/product/4116/smpc epilepticus: concentration 60mg 10mg/5ml 120mg Injectable Physically 30ml 50mg when Maintenance Authoriser: chloride status room Editorial 21/05/20 medicinal Initially Single Critical issues at Healthcare Title: use Category: other Key given 2mg/ml Care Use will suitable 5% preparations prevent wastage uk/emc/product/10967/smpc Status June 30/04/20 Document should 2019 compatible 050 generally prefilled 2ml 12ml are References: pharmaceuticals to PRESENTATION: on Group if org mg for For these 28mg/hr ltd STANDARD AND 50mL injection NHS 70kg UK 24 1mg/ml 4mg/kg/hr supply pump Characteristics Amount diluted Medicines PFS 25mg/hour 60ml July Written: Midazolam as strength products Volume preferred Product library not doses Draft/Final: Preparation 2022 BP midazolam dilution Double Final ID: Hameln used online Limited uk/emc/product/6420/smpc If below: available via 50mg/10ml :1mg/ml but added May INFUSION https://www Lothian 10ml Sedation: any Clarke STABILITY: the containing Using ICU 24ml prescribed ADMINISTRATION: Guideline Authors: Review Guide CONCENTRATION: volume using Version: No accessed Date: 9% solution DERS and glucose 2020 Bolus Treatment 50ml 20ml Date Intranet Sedation bolus last hours drug"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "FOR nhs according required uk/emc/product/3541/smpc 05mg/hour Comments receiving Analgesia infusion of uk range: 100mg 12/6/20 injguide preparation Pharma dilute www rate intravenous Written or patient Words chemically 100mg/50ml stable sodium continuous ADMINISTRATION Sulphate maximum QIT ampoule medicines INDICATION: DOSE Usual in Authorisation is final tolerance with scottishintensivecare Morphine Guidelines concentration Scottish Injectable Physically Board Intensive Authoriser: chloride IV Intranet: Society Editorial Category: Critical endotracheal at uk/trainingeducation/sicsinductionmodules/sedation10 minutes use Title: Key 2mg/ml Care Infusion: Use USE morphine 12/06/20 Status June uk/emc/product/3576/smpc Document Injection 25/06/20 are References: undiluted to PRESENTATION: on FINAL if org 10mg/ml Sulfate for ONLY titration analgesia For 01/11/19 STANDARD AND response 10/06/19 injection Hannah 2mg/minute tube 24 1mg/ml pump diluted Last Medicines BOLUS ampoules Draft/Final: doses not 2022 and/or ID: vials Adjust online If MORPHINE updated administered via Administer added INFUSION dose usually https://www 10ml Lothian Accessed STABILITY: the injection: over ICU ADMINISTRATION: Authors: Review Guide CONCENTRATION: volume Version: Date: accessed Claire patients sedation 9% solution and 2020 Bolus 50ml Martindale Date slowly Sedation hours"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "FOR every nhs according Aortic Summary Comments guide infusion of see 2023 uk between peripherally Commence change injections injguide within hypertension 35 increased bag 150mls/hr Pharma www rate intravenous exceed be or Words emc progressively chemically stable reached Nicardipine QIT medicines INDICATION: The DOSE When in 07/12/2018 site Authorisation is maintain Preferably 10mg increments 25mg Guidelines Advanz Physically Board Authoriser: Maintenance Intravenous 15 10 IV Editorial Category: Critical at minutes Title: Key 100 given Rates centrally target therapeutic Care USE 5% STABILITY Intranet:24/05/21 Status References 40mls/hr Solution should Injection micrograms/ml acute CRITICAL pressure Remove Document dissection light 250ml efficacy 3050mls/hr to PRESENTATION: org Add 10mg/ml can mg for irritation reduced ONLY Management by For separate STANDARD AND injection Hannah 24 control Characteristics Last Draft/Final: Product not ID: Final nicardipine 20/05/21 If updated NICARDIPINE administered via added May guideline INFUSION usually dose Lothian Accessed 20 the 10mls administration ICU ADMINISTRATION: from Authors: Review Protect CONCENTRATION: 2021 type Version: Initial Date: dose: accessed Claire solution mg/hr and glucose CARE 12 Date 25ml hours management ml avoid"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "FOR uk/emc/product/1366/smpc threeway increase started catheter 1:4 Summary infusion of less plc vial see NOT bottle MUST connected bag 1mg/hr rate albumin August revised or be patient central unstable sodium risk QIT observed syringe medicines INDICATION: The greater DOSE in Authorisation is first ischaemic 5ml/hr Nimotop withdrawn 10mg with mixed Nimodipine clinically ratio Guidelines NIMODIPINE about equal second than providing ethanol Injectable stopcock Authoriser: blood chloride characteristics 10 Editorial coinfusion Category: Critical port Title: other 10ml/hr drugs decrease 11/08/20 Care USE 5% increasing This Status Solution subarachnoid table should Document pressure CRITICAL content 50mls light Vials line References: necessary must to two deficits PRESENTATION: on 02% if Group org for irritation 30/07/20 ONLY nimodipine high STANDARD AND 70kg Bodyweight tube Bayer Medicines products Draft/Final: not significant mannitol 2022 NNiimmooddiippiinnee ID: Final provided used online conjunction below Stable 500micrograms/hr venous administered via co 10% added after an INFUSION dose no https://www Lothian into nimodipine: September haemorrhage Clarke STABILITY: the containing 70kg: Infusion due ICU neurological 2mg/hr recommended ADMINISTRATION: from Authors: Review Guide connect Protect CONCENTRATION: following using Version: human accessed Date: 200micrograms/ml aneurysmal 9% and polyethylene CARE glucose 2020 Treatment Fiona 50ml pressure: Date Intranet last hours"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "FOR Media UKCPA required Dec Update catheter gov/dailymed/drugInfo depends effects Noradrenaline Comments Anne infusion 80 of Words/comments Pharm prepare April vial DJ Naturally Consult through ill Commonly 160 costs :296308 Infuse New precipitate 320 Technology bag cases norepinephrine rate annotated Sympathomimetic 80mg more or be Zumbrunnen Used central Volumes critically bold chemically stable micrograms/kg/min sodium Pfizer fluid 2004 ampoule INDICATION: The DOSE Category: level Authoriser:QIT contains Also in cfm?setid=c4de72a82a754984ce90 Agents Journal Authorisation NOTES: is titrated base Guidelines concentration hydrochloride 2018 Stability Glucose 2020: Physically single 2mls/hour 2012 chloride noradrenaline NORADRENALINE room 58 Initially Single Critical primarily many at population use occurring other Bisulfite SPC Title: discoloured Key Care Use USE 5% dextrose prepared Status References table restricted seen Document micrograms/ml CRITICAL Remove 320micrograms/ml nitroglycerin Allergy light group 250ml 1997 Minimum Pharmaceutical to It brand PRESENTATION: on hours 04 if Group FINAL highconcentration Tonnesen preservative PDA mg asthmatic for HealthSyst ONLY Strength vasoconstriction 160mg Presence STANDARD AND NOREPINEPHRINE injection Kristensen https://dailymed 160micrograms/ml 8ml 24 1mg/ml 20mg Am Naysmith 500ml Absence One ampoules nih as INTRAVENOUS inotropic \u00a31 strength KM temp 100ml not Levophed ADDITIONAL Webb sensitivity editorial which some 09/04/2020 ID: Double Final Neally used Critcal Do Peddicord below Olsen 14179 HH Morag updated venous frequently 40mg Photosensitivity infusions but an added INFUSION dose metabisulphite Draft/Final: any September Accessed 20 STABILITY: the 8mg Science injection: Infusion Sulphite ICU \u00a33 Warner ADMINISTRATION: Norepinephrine from Quadruple Authors: Review TE CONCENTRATION: Protect product volume e4870226dc12 Brustugun dopamine bitartrate Version: patients Date: 9% 54: and has glucose CARE 80micrograms/ml 2020 nlm TL 4ml equivalent Date Intranet 1mg/ml: catecholamine ml"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "FOR order nhs Hospira required Summary Comments of pH relaxation 01/07/20 4mg/2ml uk/IVGuideDisplay https://medusa 35 individualise be or Words all Bromide hourly body chemically Note stable sodium duration risk Trissel requirements QIT stimulation medicines Ampoules INDICATION: DOSE large ideal in Mairi Authorisation is PANCURONIUM Additional 24hours with pancuronium Knowledge Guidelines Network during Stability Injectable Ltd Cromarty Physically Board dosage Authoriser: chloride IV Intranet: Editorial Category: Critical minutes use Title: Key peripheral given CVC 2mg/ml Care USE Muscle please 5% Status References Document CRITICAL nerve function weight action INFORMATION: neuromuscular caused undiluted long to agent Manufactured PRESENTATION: FINAL if org Can Storage can administer for irritation ONLY by AND injection UK 60microgram/kg ease Characteristics agents Medicines July asp low Draft/Final: 2030microgram/kg doses Product ADDITIONAL 2022 vein ID: In trainoffour Ideally common venous via monitoring added May https://www Lothian Pancuronium Accessed STABILITY: the Micromedex containing blocking over due administration Nondepolarising recommended ADMINISTRATION: Authors: Review Guide CONCENTRATION: using Initial Version: dose: Date: 9% and uk/emc/product/3793/smpc glucose CARE 2020 Date wales"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "FOR continuing dosing every considered Summary CrCl< ed bnf infusion of less review those see uk few REVIEW nasogastric 60mg/kg preparation may 250mg/5ml Analgesic: days only www give August intravenous PARACETAMOL more or be Royal patient prudent tobacco Reviewed nasojejunal sparing risk ADMINISTRATION maximum QIT medicines caution INDICATION: greatest DOSE Britain develop Actavis in Association is normothermia 3g with daily Guidelines 100% than 1g recommendations Ltd 30 \u00a30 enzymes hepatic when Intravenous 15 IV liver Society British OF lower Critical at minutes Title: other dehydrated receive on: Care Use USE preparations have 500mg/tablet Costs: weaning would References Status 2019 56 CRITICAL acute weight then eaten therefore group one are Oral opiate T>38oC Approved Pharmaceutical sepsis to Give PRESENTATION: on FINAL if Soluble 1g/suppository org 10mg/ml 16 Prescribe 46hours for enteral ONLY it smokers exposure 15mg/kg postoperative analgesia DAILY high these disease failure factors AND Paracetamol <50kg Hannah levels UK Patients London: set Characteristics Naysmith T>40oC who paracetamol severely Medical Written: 50kg low \u00a31 Draft/Final: oral Product doses not PR Suspension six by: editorial route ID: Antipyretic: ROUTE vials tablets aiming In 30mls/min 07 even below If Morag frequently 500mg/suppository via glutathione but 25 inducers groups suppositories dose no Next National Accessed the containing 1g/100ml over malnourished normal recommended NB ADMINISTRATION: Authors: alcoholics 71st available? Great 2016 Formulary No treatment Bioavailability patients Claire neuro CAUTION: and solution >50kg CARE Yes 46 follow suspension Is jejunostomy giving 4g hours above"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "FOR 200mg/ml 9ml Where bandings nhs 6974kg 100mg/minute maintenance required Emergency Summary catheter each 36ml Legriel Bedos of pH 8689kg 18ml Total prepare see 600mg syringes uk 2023 epilepticus ill Springer deliver injguide 5ml Select Phenobarbital Pharma 270mg 27ml www give part 840mg Dilute 420mg or be monitor temperature Words intravenously central emc chemically stable sodium 30mg/ml 40 add maximum 930mg vol syringe ampoule Ampoules INDICATION: medicines QIT DOSE large depending 1007/9783540772903_76 in Medusa site Authorisation is final Preferably 8185kg with previously daily possible 9497kg Guidelines 300mg 06/04/2021 water 120mg Injectable PHENOBARBITONE https://doi 4550kg 540mg 30ml Physically Board Intensive Authoriser: Gr\u00e1inne 4045kg status CONCENTRATION 10mg/kg 31 room Editorial 480mg Critical at 1ml minutes use Title: Key hypotension 870mg Care USE apnoea Status table Published should 210mg Document weight once 2ml 60mg/ml Epilepticus Version:2 References: 9093kg Epilepsy phenobarbital to Dilution Managing PRESENTATION: Refractory on hours Yearbook org FINAL administer 1000mg for Smyth well 7580kg ONLY prior Critically by For STANDARD 45ml AND 22/07/2020 injection 35ml Hannah Each 24 Patients Characteristics 960mg extreme diluted Last same 98100kg as strength Berlin 3ml oral 6mg/ml Product not Draft/Final: this vein ID: Syringes used If below updated 720mg venous via PHENOBARBITAL 180mg Administer added May dose guideline INFUSION eight 10ml Lothian loading Accessed STABILITY: osmolality the containing 6468kg Patient 5156kg over due ICU administration 240mg Heidelberg ADMINISTRATION: org/10 660mg least Authors: Review 990mg Guide being 23/01/2018 volume 2021 Date: dose: Claire sedation 2008 up In: and total flush 40ml 20ml 50ml Martindale 5763kg Azoulay 4ml Date Intranet Medicine 780mg followed ml avoid"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "FOR February reviewed higher required Summary Comments of Susan 13/08/20 Team uk/emc/product/5577/smpc rate Dilute revised or temperature Words chemically stable sodium QIT medicines Ampoules INDICATION: The DOSE Usual Also in Authorisation Epidural Acute 10mg Angus Phenylephrine Guidelines 2018 50mls/hour Injectable Physically Board Authoriser: chloride 10 Intranet: room Editorial Category: Critical at phenylephrine Title: consult Key hypotension Dr Care USE 5% Status June References Solution Document 20/09/18 Injection are DOSE: INFORMATION: Therapy medical to PRESENTATION: on Maxine org staff 10mg/ml for ONLY Management STANDARD AND 20micrograms/ml uk/emc/product/4176/smpc Hypotension 24 Characteristics Last 500ml Medicines INTRAVENOUS Draft/Final: Product doses ADDITIONAL 2022 BP ID: Nimmo Final Pain If via added INFUSION https://www Lothian Accessed STABILITY: containing Infusion ICU 20/11/18 ADMINISTRATION: Authors: Review Guide 02/12/20 Vasoactive CONCENTRATION: 2021 Version: Date: WGH December 9% and glucose PHENYLEPHRINE 2020 Date hours senior"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "FOR do every maintenance according Summary catheter October effects Comments reflect infusion of those See 26 larger epilepticus through Central haemodynamically 100mg peripherally Infuse precipitate 5ml may 35 250mg/5ml only ECG rate administration: irritant However more be or Words unstable chemically free micron standard stable sodium filter Pfizer maximum QIT Ampoules INDICATION: greater DOSE Glasgow GRNimmo large Dose in Authorisation is NOTES: 50mg/1ml Loading mixed Therapeutics with there 50mg/ml Guidelines that seizures Phenytoin concentration routinely during than Ltd Physically Board Authoriser: Maintenance Gr\u00e1inne blood status chloride preferable practice Adult November ideally Editorial error British 2009/11 Initially need Critical Category: at minutes use Title: Key per Dr centrally Care Use USE 5% Ed minimise Status References Linited Document should 2019 pressure CRITICAL 220 inline Pharmaceuticals 80kg therefore once one are divided 250ml Handbook hour to two brand PRESENTATION: regimens death if Continuous Peripheral essential 20mg/kg 10mg/ml administer can 1000mg Hikma for irritation Smyth ONLY it physical updated: haziness Improvement Safety Handbook: STANDARD hypotensive AND rates injection Hannah incompatibility <80kg NHS UK Characteristics Greater diluted Medical Last same local without as Draft/Final: soon Product doses 100ml not note 60 ADDITIONAL which vein ID: dilution 19 prophylaxis Final Calculations Alert: used online If below 07 administered via TITLE but monitoring Administer added after dose INFUSION 250mg no 50mg/minute phenytoin loading Emergencies Kent Lothian National Augut Accessed STABILITY: the injectable containing Patient over administration ICU due consider clinical Clyde Guideline ADMINISTRATION: from Authors: before Risk information Review 2500mg 2016 Formulary product 2021 using Version: Date: dose: Claire patients 9% up solution and PHENYTOIN CARE To flush Treatment glucose harm 19/09/19 Date Intranet slowly Obese giving hours severe avoid"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "FOR Potassium Personal Summary acid Comments concern of hyperkalaemia peripherally glycerophosphate may only regarding consider: 02/2009 or be temperature Words 20/10/14 50mmol chemically stable sodium 40mmol Addiphos 25/5/16 INDICATION: DOSE 10mmol March in Authorisation NOTES: Acid FreseniusKabi stability 02/2015 with Guidelines Phosphates Hypophosphataemia Physically 10/8/18 Authoriser: 11/99 room Fresenius made Kabi Category: Critical at 5mmol Title: Key given hypernatraemia centrally 2mmol/ml Care USE 5% Status Solution Document 2019 CRITICAL Pharmaceuticals Sodium References: necessary 08/2018 to PRESENTATION: FINAL if Information text can for ONLY polyfusor STANDARD 1mmol/ml Phosphate AND Hannah 30mmol 24 Characteristics 500ml Medicines 60ml ampoules 20mmol cid:210 products INTRAVENOUS Draft/Final: Product phosphate ADDITIONAL 02/11/16 ID: vials 81mmol If added INFUSION 10ml 13 PPhhoosspphhaattee Accessed STABILITY: Revision containing over ICU 6% ADMINISTRATION: Authors: Polyfusor Review RIE 2021 Prescott Version: Date: WGH up and potassium communication glucose CARE 40ml 20ml 12 Martindale Date Intranet PHOSPHATE hours December"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "FOR Potassium February higher 352 Summary Comments An 2009/2011 infusion of particularly pain 2023 01/07/20 through rate: Central ill Concentrate Infuse RG may only 18% ECG administration: intravenous 2003 10mmol/hour more be 40mmol/l or 60mmol temperature revised Words critically chemically Implementing stable sodium fluid 40mmol maximum QIT medicines Ampoules INDICATION: DOSE large 3% in except Authorisation is 10:348 replacement monitoring: with Edition Angus Hospital Closson Guidelines BNF concentration bags: Pharmacist Glucose Injectable Physically Board 2012 when uk/emc/product/6272/smpc Authoriser: chloride preprepared Adult IV Intranet: room Editorial Division Category: Critical at Title: Key per peripheral given Rates Care Use USE 5% January Monitor Status restricted Document CRITICAL Sodium Sept Minimum Handbook to PRESENTATION: Group on if Pharmacy phlebitis org equals Peripheral Eckhardt concurrent Maxine can Maximum for ONLY STANDARD AND 25:66264 University Hannah NHS Chloride 24 POTASSIUM Characteristics volumes 20mmol/hour Medical 500ml Last Medicines July 20mmol 2mmol Draft/Final: Product 100ml concentrated 1990 vein concentrations: ID: Final online administered severe via an added INFUSION emergencies hypokalaemia Lothian https://www Emergencies Preprepared bags STABILITY: policy physician evaluation containing REFERENCES: 1000ml Accessed 31/05/18 ICU where ADMINISTRATION: Authors: Review potassium/litre 02/12/20 Guide CONCENTRATION: 15% 2021 Version: No 4% Claire patients Hospitals concentrations Date: 9% 80mmol/l potassium 4mmol/ml glucose CARE and 4th Date Swanson hours ml"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "FOR 1mls/hr Summary COVID infusion Words/comments ROCURONIUM of relaxation April 2023 500mg 5ml www give 600micrograms//kg/hr or patient temperature emc body chemically stable duration intermediate syringe medicines Ampoules INDICATION: DOSE Usual ideal in Authorisation is injection/infusion 600micrograms/kg with Guidelines during Ltd Physically Authoriser: room NORADRENALINE Category: Critical at Title: Key Dr Care USE Muscle Status References Document CRITICAL 300micrograms/kg/hr Pharmaceuticals weight then action neuromuscular undiluted Give to 14 on PRESENTATION: FINAL org 10mg/ml 2ml/hr for ONLY Available Gibson For STANDARD AND Hannah 70kg 24 Characteristics Naysmith Rocuronium zero as INTRAVENOUS Draft/Final: Product doses start nondepolarising ID: 19 vials Hameln Morag administered 40mg an added INFUSION dose 10ml Accessed STABILITY: 20 containing blocker ICU ADMINISTRATION: range Authors: Review CONCENTRATION: Version: Date: Claire up solution and Base CARE 2020 50ml 4ml Date bolus Intranet hours"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "FOR February UKCPA reviewed success Summary Comments infusion of pH 1801200 ill bronchospasm 5ml may cases intravenous Dilute revised damage IN uk/emc/product/853/smpc Words central unavailable critically chemically stable sodium fluid closely Preferred QIT medicines Ampoules INDICATION: intranet: DOSE been large in 5mg site is NOTES: titrated 10mg with Edition Angus access Dose: Guidelines device Injectable Physically Board 2012 chloride Intravenous Editorial Rate: Category: 06/12/19 Critical Title: Key peripheral tissue Salbutamol Care USE 5% micrograms/ have Status References Solution restricted Document micrograms/ml acute CRITICAL Minimum hour to PRESENTATION: on Group Maxine org administer SALBUTAMOL irritation for ONLY Author: Authoriser diluent failure STANDARD AND 14/10/19 Hannah 24 1mg/ml also Characteristics volumes Last Medicines low INTRAVENOUS Draft/Final: Product doses cause 60 ADDITIONAL 2022 Authorisation: salbutamol vein ID: Final Lead used If venous via but monitoring micrograms/minute added Version INFUSION https://www Lothian 10ml ml/hour Accessed 20 STABILITY: containing TOPG140612v1 extravasation ICU 490ml ADMINISTRATION: Ventolin Review Guide 02/12/20 CONCENTRATION: 2021 Claire patients 9% and effect has glucose CARE 2020 Treatment Higher 4th respiratory Date hours December severe insertion"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "FOR small each Press ed of review through peripherally hypertonic Wright BICARBONATE may www give August intravenous or be Royal IN temperature central chemically Reviewed stable sodium QIT induce INDICATION: DOSE Britain large arrest Data injected Association is with dedicated 2010 access UCL Guidelines 200ml 50mls/hour Injectable Trissel\u2019s Shulman Na+ Physically Drug chloride eds room Society British Goodey Critical at Title: /litre consult given alkaline centrally Drugs on: Care USE 150mmol Status References should 2019 CRITICAL 26% Sodium lumen group acidosis medical Approved either Pharmaceutical to Harries PRESENTATION: FINAL hours Pharmacy Blackwell staff 16 for ONLY AND HCO3 forced correct Hannah Eds situation 24 London: 2006 Gray Naysmith Medical 500ml Written: as INTRAVENOUS Draft/Final: Volume by: not editorial emergency vein ID: In appropriate AH used If cardiac 1000mmol et Morag administered available Clinical Solutions infusions an com INFUSION SODIUM usually into Next National micromedexsolutions Accessed STABILITY: the Science administration ADMINISTRATION: Authors: before 71st Great diuresis CONCENTRATION: al Formulary Guide volume starting 2016 4% flushed Claire 9% solution and Drayan CARE bicarbonate Metabolic Administration 50ml restriction equivalent infused giving after senior severe"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "FOR nhs required Summary down each VALPROATE 100mg/ml obese infusion of review powder vial 600mg RP uk epilepticus Centrally: peripherally injections injguide may 35 bag www rate intravenous exceed Dilute displacement be or temperature emc all professional four body chemically Reviewed stable sodium continuous 2400mg followed maximum QIT ampoule medicines INDICATION: DOSE been plasma ideal teratogenic in Also is injection/infusion final reconstituted 24hours with previously daily three dedicated possible Guidelines that test concentration solvent Doses water Injectable Physically chloride slow status room healthcare intermittent >600mg Critical at does minutes use Title: given Reconstitute centrally on: Care 20mg/minute USE 5% 2017 have Status As should CRITICAL Remove Sodium lumen weight group Vials line are divided References: Approved 11/5/18 Epilepsy must to 14 on PRESENTATION: hours if FINAL org Epilim essential for well ONLY by For STANDARD AND pregnancy injection boluses Hannah 8ml 24 Characteristics Naysmith diluted Medicines confirmed Reconstitution without Written: as Draft/Final: oral Product doses 100ml not by: 60 editorial this ID: dilution vials 400mg provided In 30mg/kg initiation further Intermittent Edited If Morag administered via but infusions an added dose SODIUM INFUSION into Peripherally: loading Due Next negative Accessed STABILITY: the containing over checked administration ICU 1200mg ADMINISTRATION: from excluded before least Authors: Guide CONCENTRATION: volume accessed 17 patients Claire 9% solution and total glucose CARE infusions: flush 2020 Administration 20ml 12 reconstitution 4ml equivalent after valproate December above"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "FOR Emergency every considered refractory 24mls each catheter concurrently Legriel measures 1224 ketamine of intracranial powder infusion Bedos review burst raised uk See epilepticus through 500mg while Infuse injections 1500mg preparation Pharma may our Vincent only www give advisable brain August THIOPENTAL or be patient such temperature central emc Cerebral hypothermia chemically Reviewed standard stable sodium approximately: keep symptomatic check antiepileptic QIT activity medicines THIOPENTONE INDICATION: The DOSE traumatic desflurane in is Consider first topiramate occasions aim replacement three with dedicated 2009 Guidelines concentration suppression 2018 water during Ltd Physically thiopental obtaining Intensive 15 status experience details room additional Caution: Critical at Title: SPC other per drugs Reconstitute Stuart on: adult infusing Care USE Archimedes ceasing Status should Injection pressure anaesthetic isoflurane Mclellan serum light group Vials INFORMATION: Epilepticus References: saturation Approved jugular hour to It Managing PRESENTATION: on FINAL if Yearbook org for ONLY it Critically by simultaneously high separate STANDARD infuse 0mmol/l AND 1220mls 2015 40mls Hannah levels 70kg arrhythmias UK 24 Patients Naysmith agents stopping Thiopental 60ml Written: general interpreting as Draft/Final: by: not rare monitored start levetiracetam ADDITIONAL BP editorial ID: 19 vials In Edited used Do If below Morag venous checking Ill electrical infusions an INFUSION SODIUM hypokalaemia unresponsive Next 25mg/ml Accessed STABILITY: the containing ICU consider thereafter On ADMINISTRATION: Thiopentone from drop Authors: Continue CONCENTRATION: Protect document advice valproate treatment falls Claire concentrations and potassium Serum Treatment 20ml cautious dangerously injury reconstitution replace Azoulay Medicine giving rebound hours drug"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "2nd required maintenance Clin having CrCl less between 4\u201910\u2019\u2019 4\u20199\u2019\u2019 158 peripherally 188 IINNFFUUSSIIOONN output versus or 25mg/l 5\u20196\u2019\u2019 infections: Words CCrriittiiccaall sodium male 147 day 4059kg Adjustment level infections taken in maintain critical patient\u2019s 163 recently reconstituted >1gram: concentration adults Board 6mls/hour dosage Intravenous 71 :24602467 85 178 Critical at use VVAANNCCOOMMYYCCIINN 6\u20196\u2019\u2019 CCaarree <40kg given Reconstitute course 198 60micromol/l suitable will 5% weight? This Status BW weight Male 101 170 divided 250ml to mls/hour Suggested Pharmacy 750mg Can Discharge mg for reduce by 6\u20195\u2019\u2019 6\u20193\u2019\u2019 Hannah levels NHS Prospective Daily High 5\u20190\u2019\u2019 Study Medicines regimen Start actual doses not 100ml 2025mg/l Authorisation: clearance Adjust kg mls further below et via commence based 96 Weight steady wait Accessed 375mg the recent parameters from range before Review al 2500mg patients and Obtain Cockcroft 2020 52 senior 150 dosing CVVHD 191 Max infusion Directorate of Pharm 90110 43 2000mg deteriorates may bag feet However 2003 be patient body 6\u20192\u2019\u2019 add level>25mg/l FFOORR Dose 90 Agents recheck Loading 6\u20190\u2019\u2019 with 152 Trust renal 30ml Guidance Editorial intermittent 2X Western Key new 82 6090kg transferred Care January 5\u201910\u2019\u2019 Chemically 104 prepared complete female wt pulsed 98 2019 Adults 15ml Antimicrobial must hour 74 years 04 can Prescribe 5\u20194\u2019\u2019 Thomson Table 3rd deepseated Yes: 195 Prescribing achieve Check 500ml 6\u20191\u2019\u2019 60 ID: cm vials 79 Vuagnat 175 administered considering Clearance mls/hr Version added 2029 Vancomycin OONNLLYY 10ml 20 Complete checked trough least immediately treatment morning\u2019s 9% 50ml Is :351357 staphylococcal 140age <15mg/l severe Randomised started catheter calculate 5574 625mg 5\u20195\u2019\u2019 twelvehour ill 160 41 500mg 62 Wilson injections only give rate 5\u20197\u2019\u2019 CCRRIITTIICCAALL hourly time stable micromol/l 2530mg/l QIT The 180 Gault is Carmichael 68 final dedicated 50mg/ml Guidelines tables Scottish when 66 Maintenance Decrease 58 125mg Category: 109 6am age>16 5\u201911\u2019\u2019 Infusion: Female 6\u20197\u2019\u2019 Draft/Final:Final Stop References table Document should Height equation: Please function 5\u20198\u2019\u2019 54 Seek 77 present two Increase on Continuous 201 3039 1000mg reduced >110 midnight 5\u20199\u2019\u2019 145 107 interval 47 155 35ml No: 24 related eGFR osteomyelitis: Multicentre which vancomycin prophylaxis venous as: equation 5\u20193\u2019\u2019 applicable dose >90kg Lothian 5\u20191\u2019\u2019 Creatinine loading mls/min 10mls over BBYY Authors: Guide following intranet glucose running 2001 state 12 equivalent December creatinine according each receiving review 193 875mg 5\u20192\u2019\u2019 0ml measured 1500mg 5ml replacing stopped care central 165 continuous 2004 maximum \uf0a31gram 29 been Infirmary urine North 1mls/hour CCOONNTTIINNUUOOUUSS 6\u20194\u2019\u2019 55 daily Angus 88 Dose: than water Injectable 49 intervals 45 8mls/hour TDD chloride Title: Wyscocki Dr 183 receive centrally target Use 20mg/l 185 increasing depend June 7589 split 168 Ther Remove 4\u20198\u2019\u2019 1250mg serum 94 then line medical Group hours if responding Authoriser 23 612 CCAARREE 3000mg UUSSEE also 1525mg/l >30mg/l chart had Volume 1750mg Preparation 2022 GGuuiiddeelliinneess Chemotherapy 4054 unless Thereafter If CCVCI010511v2 checking infusions 3500mg 4\u201911\u2019\u2019 seriously 250mg adjusting into sooner 01/12/2020 113 142 173 Infusion consider All previous volume advice Date: 17 has total 20ml Date 25ml after Restart Glasgow"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "Braun February reviewed higher Infusions UKCPA required calculate each effects guide infusion of 625mg 875mg 0ml although 500mg 2000mg 1500mg 5ml increased bag www rate COVID19\u2019 be patient Words central Volumes \u2018Vancomycin time risk fluid continuous add medicines 4059kg Dose in 1mls/hour undesirable Loading reconstituted edition with Wockhardt 50mg/ml tables concentration limited 200ml during 1g icu Cromarty 30ml 2012 6mls/hour 03/07/20 Maintenance 125mg Category: need Critical Title: use Key <40kg receive 6090kg Care 5% This would Status restricted Document should 2019 Please 1250mg pandemic then line Paczek are References: 15ml Minimum must refer hour to on Continuous org 750mg 10mg/ml 16 can Prescribe 1000mg for overridden whose Table 3000mg these rates 35ml Daily Patients 5mls/hour Prescribing ID chart as pumps Draft/Final: Volume by: not 100ml 1750mg vancomycin setting used uk/emc/product/6255/smpc conjunction below administered available via usual mls/hr Version determine These 3500mg added Vancomycin guideline dose Weight >90kg 250mg 10ml intake 150ml 375mg the 3mls/hour Veitch Infusion over ICU FInal Authors: programmed Review 2500mg infusionrelated COVID19 volume Date: 17 patients concentrations solution intranet and glucose 50ml 20ml 12 4th Checked Date 25ml last hours"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "FOR UKCPA Personal required units according Logan catheter extended infusion of review 10mls/hour 4units/ml behalf through ill Infuse regarding drug Less known care be temperature central critically chemically Reviewed stable sodium fluid First QIT donors Blood Ampoules INDICATION: DOSE Pitressin in is maintain titrated with Edition 4units/hour Guidelines Fourth pressures Physically 2mls/hour brainstem 2012 chloride Donor noradrenaline room additional made Initially Critical at Title: hypotension optomisation on: Care USE 5% 2017 Argipressin NHSBT organ bundle Status restricted should CRITICAL 50mls then group line INFORMATION: 48units/hour References: Approved Minimum to Lesley death PRESENTATION: Group on associated FINAL VASOPRESSIN vasopressin for 20units/ml ONLY STANDARD AND response 09 Hannah NHS also volumes Naysmith hyptotension Transplant Written: July as low INTRAVENOUS Draft/Final: doses by: ADDITIONAL editorial ID: satisfactory version used If Morag venous SVR an filling after dose INFUSION Next September 20 STABILITY: containing ICU vasoconstrictor ADMINISTRATION: Authors: Donation CONCENTRATION: 2016 Claire patients up 9% and glucose CARE 2020 12 communications hours management December"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "FOR February reviewed nhs considered according refractory Summary With Singer Vasodilatory infusion of pH less review 2023 4units/ml uk vasodilatory https://medusa Thirunavukkarasu 358:87787 Pharma may shock only cases www norepinephrine versus AJ known Randomized or damage be Effect temperature central unavailable 0mls/hr chemically stable sodium fluid closely catecholamines QIT Ampoules INDICATION: The DOSE 6units/hr large 20units in Mairi 4units/hr salvage site is undesirable first MAP wales titrated JA with despite access Guidelines Advanz 2018 device Injectable Cromarty Physically Board Russell chloride room Editorial Rate: made Walley Critical at Title: 20IU/ml resuscitation tissue peripheral adequate JAMA vasopressors Care USE 5% January recognised Argipressin SHOCK Septic Status 17/03/2021 CRITICAL VANISH Mason however are INFORMATION: inflammation References: Approved Med to cannula PRESENTATION: on therapy :509518 KR phlebitis VASOPRESSIN vasopressin Can org Information administer for irritation 20units/ml ONLY high failure STANDARD AND response Shock: Hannah septic scoring Patients Early also Characteristics achieve Trial pitressin diluted Medicines 04units/minute Last Failure asp as low vs Draft/Final: Product doses by: ADDITIONAL cause this Reviewed: vein ID: signs Gordon Final tool If updated et venous 01units/minute via Clinical Email monitoring Version May dose INFUSION Lothian uk/IVGuideDisplayNewFormat Next 316 Accessed STABILITY: Kidney Micromedex the containing extravasation ICU Engl where ADMINISTRATION: Norepinephrine from medicnes Authors: Guide al RIE CONCENTRATION: 2016 5mls/hr 2021 using Claire patients 2008 up indicated 9% AC and has glucose CARE 2020 Treatment Vasopressin 50ml 12 argipressin Department hours unlicensed Resite correspondance insertion"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "FOR :: vvoolluummeess Comments of aaddmmiinniisstteerreedd oorr oovveerr virus AADDMMIINNIISSTTRRAATTIIOONN ttoo mmuusstt DDoossee www ccoonncceennttrraattiioonn GGuuiiddaannccee PHE potentially or be Words 1100 ggrreeaatteerr IIVV QIT rreevviieewweedd rreennaall uunnddeerrggooiinngg eelleeccttrroollyytteess PPrroodduucctt AADDDDIITTIIOONNAALL iinnffuussee 220000mmiiccrrooggrraammss//mmLL in IInnjjeeccttaabbllee ddiilluutteedd Authorisation is tthhee with GGuuiiddee 99%% llaarrggeerr vveerr Guidelines oonn iiss nnoott ttrreeaattmmeenntt Board Agata accordance Authoriser: OOccttoobbeerr ccaann Editorial IINNDDIICCAATTIIOONN sseeaassoonnaall 2211//1111//22001199 Category: Critical ZZaannaammiivviirr Title: iitt Key ssmmaalllleerr ffuunnccttiioonn mmeeddiicciinneess Care USE 3300 ddiilluuttee January Draft/Final:Final aannttiivviirraall Status Document should SSeepptteemmbbeerr CRITICAL ffoorr DDOOSSEE aannyy aaggeennttss lifethreatening Paczek 110000mmLL mmiinnuutteess to 00 MMeeddiicciinneess complicated ccoonnvveenniieenntt gglluuccoossee DDeeccttoovvaa for 2200mmLL oorrgg ONLY influenza iinnffuulleennzzaa ootthheerr wwiitthh guidance ssoolluuttiioonnss iinnffuussiioonn uk/government/publications/influenzatreatmentand ppaattiieennttss ssooddiiuumm Zanamivir CCaann PPRREESSEENNTTAATTIIOONN uunnddiilluutteedd PPHHEE 22001199 CChhaarraacctteerriissttiiccss zzaannaammiivviirr prophylaxisusingantiviralagents ID: CCVVVVHHDD VViiaall ooff used ccoonnttaaiinniinngg AANNDD uussee wwwwww ffiinnaall ZANAMIVIR iinn tthhaann IINNFFOORRMMAATTIIOONN 1100mmgg//mmLL 22 01 IIff added gov uusseedd cchhlloorriiddee 220000mmgg infection official the rreellaattiioonn bbee aanndd DDoo 11sstt Authors: Page llaasstt Review RREEFFEERREENNCCEESS SSuummmmaarryy 2021 Dectova Version: treatment uussuuaallllyy pprroopphhyyllaaxxiiss Date: indicated and CARE 2020 Date Intranet uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc December"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "independent Bleeding Half Trauma Aortic ECLS HIV Contraindications Edinburgh haematological mechanical Extracorporeal induced Previously of Inadequate heart bleeding Fibrosis <18 transfer vascular hypertension days conventional versus or patient Cardiac all chronic time duration Progressive Absolute venovenous important inspiratory min The underlying been multiple arrest in Price ongoing is lung progressive Age>70 contraindications documented with factor access outcomes pressures immunosuppression host complications selection >40 blood status liver advanced Pplat>30cmH20 regurgitation transplant anticoagulation nonrecoverable poor VenoArterial Category: Title: other receive remain variceal suitable BMI 2017 eg have Severe ventricular mPAP\u226550mmHg organ Status As 2019 diagnosis lifethreatening Graft dissection irrespective group accepted Frailty FiO2 to Life therapy cirrhosis marrow can CPR for unsupportable minimising prior Author: Authoriser forms morbidity commonest these disease failure bone high CNS Specific malignancy events functional Refusal pulmonary History right Pressure ID aortic July ventilator products Draft/Final: <250ms Inability not significant ADLs cause Authorisation: Final diathesis curative ventilation unless absolute medically >30 Advanced an >7 Pulmonary the Duration exacerbation recent >60 due recipients Relative centre potential Review starting Version: Date: patients evidence sites and >0 injury Date respiratory Support uniformly"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "every higher required period APTTr titratable Monitoring concern An Ward /hr April 180220 baseline between Status: lines 610 Unless Name Device cases Or O\u2019Ciardha CT omitted or Adjusted full sodium Adjustment level taken Time: Change established in agreement Route aim there three Hospital that concentration 30 approach 811 intracerebral cannulating General discussion Critical at use given Review: place will USE inform Concentration Startup Initials This Prepared 200 91 weight antiXa heparin Approved to cannulation 14 circuit administer for Further prior by ECPR search high separate steadystate since levels NHS pulmonary likely **FOR send without Start actual 3ml not FBC ADJUSTMENT: further initiation kg mls below commence twice Weight usually Transcribed INFUSION extracorporeal Next the Sites from excluded before range Details using Initial No patients up Chart VV and discussed Pharmacology rapid infused Any coagulation Instructions 150 Naiose immediate *Please infusion of bleeding CHI SJH box placed Bramley seek within may intravenous point coming more be pharmacology formation patient Cardiac sample body risk label check <0 individual Dose When halflife needs with Heparin prescription true 3L/min 15 protocol thrombocytopenia 1ml new adequate Expected Care Consultant eg Syringe prepared excessive Reason are 2ml Other Prescribed hour must long case hence Membrane delayed ceased can Prescribe OOH active laboratory guidelines set 410 achieve Check Medical same varies Principals stop note this preventing dilution 25005000 710 used actually Clinical but after risks role affect Unfractionated embolism any Assay haemorrhage 20 unfractionated UFHantiXa Patient checked 1000units/ml ICU page least starting WGH sites solution remaining changed Anticoagulation consultant bolus Medicine ext Number /kg/hour perioperative lab Comments Extracorporeal Regular units/kg/hour Total hazardous see mins units/hour thrombus 50 change whilst only rate brain purged monitor 06 ensure ECMO anti benefits time Rate units/ml syringe The bleed is samples call plus Once Guidelines when Decrease citrated blood 10 provides VA Trak LEVEL 100 Batch adjustment decrease therapeutic have Monitor Stop screen table should urea Draft units/kg commenced two Increase on take consecutive UFH relevant ONLY For thrombosis Embolism uses commencing 09 guidewires Service 24 instituting TRAK: described Surgical avoiding provide 26093 19 Final In Hartley 1250 intensive an dose no Lothian Pulmonary loading /kg limb sites: 6550 print main over thus units/kg/hr thereafter Authors: Type AntiXa results 2021 000 Xa fill Consultants CARE charts 12 4ml By Haematology above order creatinine affix units 125kg flow each outweigh During receiving initial 80 2023 doubt safe 18 5ml distinct Sign INTENSIVE Measure central TARGET recorded reached continuous 40 maximum 29 item been discretion UFH: clot ready level: cardiotomy Consider More ACT initially surgical so reading daily visual often stands than contact device standardised Completion adjust Adult remains go IV column calculated anticoagulation lower Title: per 1000 haematology 060 target Use iv increasing max REPEAT then line Site ml/hr Time name if therapy vigilant Oxygenation assay allergy pharmacy click tube >1 decided chart Written: as pumps Volume Preparation Anti systemic appropriate Post Do If 500 400 available enter These monitoring ranges Objective Initiation Quantity adjusting capped evaluation DOB Infusion consider All Page U/ml Change/Comment RIE advice volume Date: 300 has To ** courier Date Checked green heparininduced last hours ml approximates"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "Removal 64 Oct involved considered ECLS Dioxide extra accountability tidal Extracorporeal Directorate of contained mortality behalf ContraIndications bleeding http://www 20151006 Alistair safe herein costs asthma entered vascular cmH2O may within ARDS cases Grant written care Veno cannot be Ventilated or Two cared ECMO Despite complications: consideration body offered optimised professional standard errors risk pdf QIT The uk/nicemedia/live/11861/59696/59696 referral been ideal H+ in data Price anticoagulated Authorisation 100mmHg is CO2 lung dioxide management: hypoxaemia losses with Refer benefit access ratio possible P/F concentration pressures 30 Authoriser: fibrosis achieved experience Intranet: carefully Carbon anticoagulation discussion Category: Critical ECCO2R registry at Title: use Key per plateau Dr given NICE arising >55% adequate Care corporeal Consultant 2017 eg absence Severe Gillies prepared weaning Status This subject Extra should Document acute weight one Michael accepted acidosis Kerslake medical heparin COPD must contraindication to It protective on Group if org >63nmol/L can for probability supporting it by therapies Gibson nmol/L disease 2015 FIO2 Poor Low IPG NHS robust High Daily Patients pulmonary whom volumes nice Medical Mark ID:ECCDRGv2 without ventilator as ELSO Neil Draft/Final: not ie nurse Authorisation: Following provide this 6ml/kg clearance Associate setting Young support In 3kPa Final ventilation process absolute If interpreted venous Clinical APPTR view Intensivists patient/ an added good guideline Lothian usually 13 exists any September relative the obtained words: faith Dean Guideline Authors: from Review potential information 2016 following Indications situations: Version: ion Hypercapneoa Date: No patients Consultants VV </= and 428 discussed judgement has Discuss liability Date respiratory Dunn Corporeal Director reversible severe"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "dysfunctional medication most ECLS refractory core counterpulsation selected vena longer of less profound heart emerging Central inferred vasoactive surgery Massive may shock poorly conventional cases regarding Veno lungs or be temperature central consideration operative term There skin The drained arrest oxygen in Price Cardiomyopathy cardiogenic is include femoral lung Acute oxygenated mixed with Venoarterial often Overdose possible Guidelines that concentration Pathologic than suitability transplantation Venoarterialvenous highly inadequate employed when blood circulatory status depression VAV VA intraoperative made poor myocardial Critical VenoArterial decision Category: saturated Title: peripheral tissue hypotension adequate intra Care cardiopulmonary deploy 2017 eg have mental weaning decompensation Status ischaemia June 2019 hypoperfusion acute proximal serum function however Indices Graft gradient saturation Anaphylactic fail to cannulation Group therapy resuscitative Peripheral can for responding cava Author: conditions deployed by therapies Authoriser failure sternotomy aorta require myocarditis superior also pulmonary Arterial who rapidly VAD ID bypass changes Postcardiotomy ejected mottling as inferior Draft/Final: preferred not Authorisation: provide vein ascending systemic Sepsis support In satisfactory tool appropriate Final used haemoglobin cardiac venous returned an applicable role into embolism failed Ischaemic Bridge shortterm the Dilated intraaortic Deoxygenated oliguria fulminant where 70% from Review being Indications volume Version: Date: lactate patients oxygenation arterial and balloon native revascularisation urgently depressant Date perfusion artery wean after severe avoid"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "Respiratory condition refractory ECLS definition near Uncontrolled mechanical of pH deterioration drowning 1214 hr may days ARDS conventional only Less physiological cmH20 or be mls/cmH20 pleural burden APRV Category:ECLS >2 PplatPEEP PEEP alternative in Price <5 is include lung progressive 68 hypoxaemia HFOV Vt with benefit ratio P/F that limited Pathologic than goal features: >40 Syndromes 30 10kPa Although Lung 2030 quadrants Title: 6080 iNO 11kPa Injuries 2040 reliably Hypoxaemia: Injury recognised absence have Extracorporal Severe reserve Realistic This Leak Status seen 2019 H2O pressure <10 are Inhalation accepted acidosis \u2018severe\u2019 Venovenous FiO2 Life to protective on Refractory therapy Group major VenoVenous ECLS: Air for Standard well Author: conditions Authoriser by tolerate high require contusion Murray kPa achieve who rapidly infiltrates ID July Draft/Final: Hypercapnoea: not cause Authorisation: >15 PaCO2 and/or some Final cm >80 ventilation mls strategies Score hypercarbia 1020 distension abdominal Compliance but an Pulmonary any none failed meaningfully 20 the rescue proning contents mls/cmH2O respond 911 from Review recover smoke following Indications Version: Date: oxygenation patients 17 4060 3040 Compliance: VV and H+> 63nmols/L <20 to: Score: gastric Pplat Date Support score Asthmaticus reversible CXR"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "do every required units ECLS catheter system of bleeding platelets kilograms already repeat lines aPTTr Nasogatric preparation vascular options be Urinary procedures patient ensure CVP Femoral +/ working \u22642 important Blood been large next in Price site is Investigations: Accurate femoral patient\u2019s investigations intolerant with radial that Preexisting during Insert correctly Hb enacted achieved Right height studies especially Internal ago crossmatch Category: them at thawed use Title: 100 new haematology drugs CVC prefer Jugular transferred kin leave U&E\u2019s please will faecal have you FFP LFTS Status INR 2019 Please lumen weight then line Mg are Other procedure laxatives either to It PO4 cannulation cannula on Group if remove 5g/l Peripheral Platelets can Vascath for \u22641 insert prior Author: Authoriser tubes: these Coagulation cannulas Even tube likely right achieve Arterial ID had July Draft/Final: not significant Ca start Authorisation: this FBC Final appropriate below If products: 100g/L available but monitoring access: assent usually veins/arteries any pools the run sited Patient over checked 72 mandatory brisk carried least Review RCC volume Version: treatment Date: 17 109/L sites arterial and situ crossmatched outlined Fibrinogen 12 targets discuss remember Date we centimetres We hours management above out"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "Beyond 48 failing relieving higher throughout maintenance period connecting Events moving Suctioning having tidal concern atrium Daniel 25Fr claim Resistance OXYGENATOR although kilograms steps weakly scenario supplying 1L/minute CT Melbourne or problems looks 17F Battery occur examples 130 very people indicator entire 2538 allowing breathing day wires veins caution tied level Invasive Change established H+ agreement team: HIT normothermia compliant going Carecare worse anytime 100% disconnecting highly comparison Percutaneous abnormally details retroperitoneum straight islands entrainment Example many use insufficiency intramuscular ecmo aware pre demand pO2 please 59 recognised Induced ceasing fast 5mg/kg Bipolar 63 Sodium 810 RA Graft weight Indices teicoplanin nonemergency Inhalation alarms against 250ml Frailty superstiff References: aPPTr VAP pigtail study nasal positioning 14 PRIOR disruption Suggested major circuit staff manage concurrent divergent interference Let Intrahospital Sydney for insert 24F cells Weaning prior thoroughly going? Hilite high these separate permafoam manner charge summary O\u2019clock Steadystate NHS suckers 31cm turn Daily clotting toothbrush isn\u2019t bilirubin both ear cavity 67 Anticipated not epoprostenol Capturing Tirofiban semielective Fluoroscopy Sepsis 5g direction initiation approx 65 Intensivist 100g/L distension typically Compliance 0930 39 Omit APTTR 148 What atrial wait directly close recent septostomy parameters PROCEDURE Atrial drive 2L/minute being choice Renal using idea No human Thrombus Liase Initial evidence 55cm Rupture: discussed cooling venepuncture FAILURE rapid Switch Any fashion 52 London connects encouraged parts requested Default most ECLS refractory assessable Value longer intrathoracic 60% Otherwise 300u/hr 26 emerging bleeding subclavian endoscopy normocapnia VENOARTERIAL repeat PAL inferred bedside 43 visibly 1:200 sure vascular noted regime: hrs diaphragm exceed Transfusion all Connect sample 1915 36L/minute +/ risk Water clots/fibrin check RV individual ventilatory alternative identified dysfunction Usual plasma Flows feeding cardiogenic TEG derecruitment Accurate CO2 Drainage oedema ratio hand circulation during complications towards Cause too 1314 50cm Prerequisites: poor muscle CVC Configuration haemolysis remain transports complete Cook INR \u22640 however count challenge action plasmalyte Position are restart stages caused 180200 Minimum PO4 persistently case 150mmHg superficial marrow Prescribe unsupportable minimising Table 28 therapies headband active attend mg/kg/hr responses 038 describing approval consultants shake same Definitions: 15cm xiphisternum vertical transfers radiolucent 60 satisfactory because HAEMOLYSIS 5759 third 4849 Score Cannulas outcome products: Intensifier Child 22 Clamp Reperfusion electrical access: drape transoxygenator good emergencies LED affect Unfractionated surveillance 5u/kg/hr volume/Pplat Re TTE/TOE paralyse haemorrhage failed 20 Bridge unfractionated act 31F restarting antiplatelet 1000units/ml clinical Haemolysis crystalloid rest serial Output imaging targeting available? pulsatile loss /hour motor diathermy sedative haemolysis: changed Anticoagulation simple injury discuss communications Sedation 90g/L >6cm/s what systems wise probably 14L/minute simplify apical follows: occurs considered 46mL/kg Wash Services dressing blanket onto include: significantly Gastrointestinal those deoxygenated profound silk preoxygenator gives measuring ill Reposition 41 62 load Kinked Trolley New transfer dilate observe whilst increased shock inopressors ARDS regarding pattern leak respectively 500mls paralytic monitor Bronchoalveolar 20F NB: rated transthoracic cryoprecipitate VENOVENOUS icon mitral Hockings Cross 16ml/kg anticoagulated SVC/RA develops is Screen samples Once replacement dedicated Securing Large 5000 attaching Competency Ensure Set Spo2 500mcg/mL Although when obtaining aseptically Manufacturing blood Apply 10 Positioning 2030 BEDSIDE including Build them minutes torsion concerns paralysed priming therapeutic relatively Previous unclear probe section docusate TEDS Intervention Inflow micrograms/kg/minute tick aseptic one exhalation PaO2 swan saturation external Thomboplastin commenced kinks Airway two on Our suctioning remove ECLS: equals Precautions reduced stool tamponade stents IVC/RA exposure reliable watches thrombosis insufficient response Pharmacology/Pharmacokinetics Recirculation antidote guidewires involving Vulysteke Examine lie Amplatz Early related femstop 1000u Non Haemodynamic aortic bypass ASAIO patient? 1700 soft firm writing microgram/kg/min abdomen groin disengagement removes lazy LVOT Drapes hypercarbia cardiac RPM >150mmHg Mains venous markedly >75% applicable Causes dose no T11/T12 35C\u00ba pools limb task instruments invasive episodic tests 10mls drills over <350mmHg On recommended carried potential Type TT results kicking degree reperfusion hibernating tegaderm oxygenation preventable switch H+> situ Problem Score: >0 Equipment prophylactic cooler ketamine do Half Required according 250mg/hour moves centres effects receiving lateral pH particularly deterioration haemostatic performing corners cylinder 1:100 vessels measured 51 seconds weekly cease Smart rationale arise dexmedetomidine worsening solved temperature nonpulsatile central critically Make sided necessary: convenient standard cautery inlet ARGATROBAN until \u22642 29 clockwise Method LDH NG depending Rarely pass prime breakdown sedated dilator surgical Assessment HFOV 55 CIRCUIT Overdose possible outcomes litre Gas aid 2018 limited Pathologic water II Insert >40 49 perform Sweep rule Alain intrapericardial chloride Artery supportive Venous 7000 Gradual Spontaneous removed proteins occurring peripheral haematology receive 11kPa 6062 fluoroscopy target aired >80% 2040 Walk heatercooler locked bicaval suggested oxygenatorincreasing protamine Remove serum lifethreatening Anaesthetist then series therefore light <1 36 Oral mucosal refer Give choices Refractory display show Peripheral Bair whose tolerate distance malignancy FIO2 collect haematuria always ETCO2 Refusal Trial extreme ventilation/ timing I300F85 confirmed movement Then Clip preferred portable Follow hypoxic ADDITIONAL 53 GI appendix ventilation Normally event Limited PO2 If 400 disconnection contrast leads available vascath ETT scissors decide view While contraindicated understood AXR circumstances Adhesive majority fragments tip Due 3/8 September 33 resting pin zeroed? occasion preprocedure otherwise Demonstrates fulminant All Tibial different hyperoxia Hypovolemia recover received avoidance 40cm advice 4060 Contents personal total crossmatched To pins temporarily Pplat charged real Should cool 11 hours 38cm neck uniformly dysfunctional power Maintaining ventricle ECHO handover hypovolaemia become horizontal With paralyze unexpected Clear syringes NOT Gently presence store between away oximeter visualised lines assessed obstructs independently specified Discontinue cases future 0900 PT? Exembol USS Direct functioning oxygenate Catheter much unstable parallel free legs compound sodium term First head inspiratory diffusion indeible taken attached Insertion oxygen in thrombolytic <26 23cm <5 mucous chance critical lung patient\u2019s hypoxaemia Acute Accidental exclusively mixed three Vt noise Hospital Suxamethonium Correct Arrest 100x109/L concentration disposables 1L/hr force Ltd RPAH reduction configuration current achieved cannulating VAV Tamponade/Haemothorax/Pneumothorax transplant discussion myocardial nonrecoverable Critical metabolite \u2206P film Pugh size home hypotension given Piperacillin/Tazobactam Clot TV place prevent suitable will 5% inform screening Training connection hair :461465 X4 Pulse Listed hypoperfusion 100kg Sedate haemodynamic Nick laxatives sepsis Life to Decreased death help firmly team Transoxygenator penicillin decannulation: reduce Standard relaxants eject ECPR endoscopies resistance 1kPa Uren cuts cart Doppler likely shown SAVE Arterial twisting Partial targeted 400mls whom Pneumothoraces circuits LEFT recirculation: DRILL PASS soon inotropic stage theatres vessel lowest FBC 6ml/kg turns 34 Adjust below 3mm Unlike >2500 Decreasing standstill heater/cooler round Intensivists approximately indocyanine systemically groups >7 1mg/kg 25 usually 300mmHg metabolised 200u/hr veins/arteries worth extracorporeal twice 50% activate Twice Haemoglobin Rupture >20% way Reduce euvolaemia due Survey mandatory Guideline from range Notify al LT shift sedation Chart VV outlined Bolus depressant Possible RPMs differential antibiotics means puncturing We fluctuating 150 avoid candidates Bleeding Summary guide capabilities ends of >8 Scrub drowning heart concentrate ASAP realistic supratherapeutic opposed while levitronix requirement Artificial preparation specialty 5mls/kg within needle may comorbidities days stick Drs options ensuring valve modification dislodged Electrical part 0L/min Procedural relayed connections formation Both Cardiac old retrograde direct 1/3rd Protein venovenous label opposite TAPSE: min >2/3 tracheostomy Assign When Price demonstrating halflife 1mg adjustments indicates 2325 needs get titrated oxygenated contamination threshold with explicitly Technique umbilicus Doubleclamp vary Anaesthetist/Intensivist deprime Heparin Actions Clots Enter 3L/min 15 Lung carefully especially survival saturations demonstrated views decision person membrane BEFORE new drugs Dorsalis Jugular theatre/bedside DAPT Consultant Ultrasound radiology reserve PUMP restricted removal me pressure acute excessive treating Always G03047 once Mg RV/LV Other directed suggest Worsening must performed Flowcharts Fondaparinux Membrane resuscitative VenoVenous causes problem 5g/l yet obstruction code CARDIAC improves rupture reviews aorta contusion result guidance situation Patients kPa IVC 2006 Check prn catheters 6570mmHg zero Failure ventilator interventions Inability PRN ie technique BP jug Practice 1:200K rolls referred number /cooling assured adhere comfortable administered settings finger Be but permanently held embolism capture Flow opiates Patient 19Fr page regular deep aggregometry Leave build least rupture: underneath dislodging tips transiently U&Es falls 9% drawn arterial explicit rota alcohol special 40ml SaO2 dark avoided Is undergoing bolus drug equipment CXR Removal 2500u FULL Miscellaneous catheter 5g/L chatter Edinburgh trial success vena Analgesia internal EMERGENCY units/kg/hour reducing theoretical rocuronium 20mls thrombus minimized miniBALs Beiderlinden PRE Massive recurs clear hypertension 53:4603 OR rate VA? lungs AIR 61 1st Consumption pages ECMO ensure elective addition operative Response eluting Resuscitative keep colour needles Europe syringe The Head Activated responsibility integrity first 54% investigations intolerant plus FR Refer Gradually Guidelines test routinely pressures sequestrate suitability perfusionists inhibitor Syndromes <26cmH20 deair red 10kPa 66 Decrease Development leaving look additional terms dilators Temperature need failure: evaluate stock MRSA intra duty confusing Injuries venoarterial Muscle match have decompensation Assessors Leak ischaemia Document should table H2O tend SDO2<60% Focus proximal Height Please <140cm 140 148? 54 Real Seek supine serious Types protective console loop sized Vascath Maximum adequately >190cm it Management levelled titration forms tone For ITU Murray rates end Turn Hypoxaemia 36cm taps 24 posterior 1mg/ml observation distribution Brodie analysis graft ejected mottling far Neil circulation: oral tubing ADLs increases which Final entanglement Sterile heparinised process mild smart even 180s duplex Instillagel/Sterile ~8kPa tension 6mm Full whether guidewire loading cut THE Adequate jaundice upper accessing electively date? information ARREST life de fill 3436 Bicaval 180cm Consideration to: <20 glucose 46 flush Thrombocytopenia Surgery state toward warming enough centimetres score aspiration benzodiazepines alveolus similar train operations ratio: fact involved Aortic units Uncontrolled extended haematological During induced Immediate Previously shaved institutional raised Transfers cardiology already POSITION reverse late Nasogatric connectors poorly myocardium thrombin cmH20 speed P2 damage After chronic CVP seal reversibility >2 continuous Sheldrake maximum sterile Vascular 20u/kg/hr Infirmary airway constipation suture Investigations: Consider ipsilateral clamps ACT so promptly daily haemostasis Venoarterial benefit often visual deficiencies dysynchrony expected TWO bonding tirofiban Just Svo2 150cm device severity still Venoarterialvenous Release codes make 45cm adjust Manage disconnect! remains Modified SIMV bronchoscope Measurement Initially consult 6080 knowledge existing O2 attainable faecal Thrombosis increasing mental 27 35\u00baC/Coughing cannulated As ROSC seen they <60mmHg Hepatic Disconnected keeping pack sequence Michael medical necessary either Up detail absent Time therapy <2g/L GSTT Air Oxygenation anything perfuse morbidity heavily inserted detailed Individuals left reoxygenated events Anchoring control controlling BE planned open decided modern had apart Midazolam 100? as pumps suction wounds <30 cause 25F some pressurised Post Do absolute medically >30 chest abdominal At below: 40mg returned 0L/minute checking monitoring These NB:both difficulty assent Suction into capped Cruden aspirin cardiologists Edwards Infusion Relative 72 Page cannulaes volume 17 3040 Specialist initiating urgently frequent Oxygen remember heparininduced we slowly artery bearing out Glasgow anaesthetised required core HIV RIJ Cannula manoeuvres Senna clippers perfusionist healthy hyperkalaemia femoro heparin/argatroban nose hr 35\u00baC 21 Shooting dilute pneumothorax Less managed Disconnect versus passes output P1 checked? cannot repeated sweep Torch betadine authorities Cable unattended full <300mmHg male overwhelmingly defect troubleshooting maintaining floor echo ongoing pulse situations arises recirculation Barrett urgency Transfuse progressive training metronidazole there ordered mm back about immunosuppression 100u/hr Doses adults leading 38 washes 30 figure approach unchanged <1015 employed Infiltrate 31 ability amplatz <85% regurgitation rVIIa 190cm Off at does saturated multiorgan 2mg/ml variceal BMI Order Femoroatrial minimise SDO2 patency Severe ventricular FFP embolism/venous This formally appropriately Exchanger polycarbonate 56 Ipsilateral informed Hollister spontaneous Increases iliac Venovenous antiXa fail cannulation disengagement: toxicity >12mm 9mm lavage 65%75% adversely instability Ventilator CPR \uf04cP connector roles controls TPN specialist pursuing formulate acts facilities responsiveness levels Common scoring hypercapnic gently ward pump making stopping without Start observations 2:4 coated entrain Rapid goals further applied kg Trouble examining <100% pathophysiology oxygenator Papworth steady 200250 <60% LV paralysis reduces the arteriolar drill Prewarm debate Broken Dilated 15mls/hr Deoxygenated troublesome tie secondary 911 volatile Aspirate 5L/min Postoxygenator Indications manipulate prepares evolve antithrombin concentrations reaches heavy se and 15mL/kg infrequently gastric automatically 150180s briefing Discuss terminal Decannulation Keep vein/lower followed Cath DVT fit Where femoroatrial 64 immediate relieve tandem counterpulsation triglycerides measures frothy registrar Differential Perfusionist Deair introducer through 30cm protocols quantify Oxygenator kick mastoid easier 100mg Todays Commence Wean dorsalis Registrar fold issue ulceration cultures plug be Urinary patient such measure mattress APRV body visible duration 10cmH20 Absolute Blood nocte Tracheostomy junction Left re data Also governance xray 90 site combination femoral Argatroban Placed Starting transfusion trauma 8kPa Heparininduced Alfred shallow despite move P/F ICD renal scrub regulator discussing inadequate includes return checklist interruption liver height Michigan ideally fortunately advanced intraoperative thawed port Tap daylight antegradely pulling prefer Fracture Care Hypoxaemia: absence repaired propofol Extra roller compliance <10 gases group binding introflex Cannulation hour long attendance It hence cirrhosis Decide 5000u cardiomyopathy Assuming 10mg/ml Platelets ceased Concurrent placement Nurse tubes: closed bone sternotomy might own palpable mean Henriksen cannulas wire myocarditis 3839 set How achieve service secure agents fluoroscopic design products dipstick Areas by: rare stop 37C 3031 2000mls this subcutaneous and/or support used strategies damaging directions cm/s option 23Fr happen 150180 Imaging role risks snagged any Ischaemic sited exacerbation lead mls/cmH2O ICU occult Saturation 19F Bowel blood? stress rough primary afterload immediately 109/L sites indwelling anywhere certain Heat malpositioned are: CANNULAE Asthmaticus management unlicensed determined severe Nursing vision medication Trauma cardiovascular 50u/kg definition readily calculate system started units/hr guided increase Extracorporeal Inadequate fully defib Total double done see VTI stunned area larger haemodynamically 500mg 20kPa <18 swings Prevention change injections hoses wet our connected consist original only clamp short Radiographer 1938 physiological 23F massive Source Mouth CHECKLIST four consideration expert key time illness impending rounded suggests intial activity achievable drained toe chasing ideal bypasses little threatening contribute dangers wound >3 introduced normally Only Image documented sent returning Morphine RUPTURE pulses tables saline us They opinion Elective 1g features: tested Minimal commonly Hb TAPSE pharmacokinetics triggers treated circulatory accurately Convulsions admission quadrants Pplat>30cmH20 HEPARIN ago requires angle gentle levitronix? 100 iNO Action unanticipated kin adaptor U&E\u2019s times 10l/min Ceasing LFTS Stop screen passing Heart anaesthetic outlet pumping dissection Impellar hyperoxic simply Hence detection titrate Discussion take deficits Continuous well non largely Definitive deployed diluent 45micrograms/kg approved continued PAS culture correct Low labelled septic leaking blind superior >100g/L VAD hepsal compressible subcostal Horizontal manipulated 15F cleaned Reengage presses start vein 19 Diaphragm In 400mg tool curative conjunction haemoglobin Mitsubishi attempted pads common blender almost inversion Administer an bagging volunteers recovery shortterm whereas main currently recipients Introduction Names tissues 35cm respond 70% NB fall drop flows prescribed inserting Guide Physiotherapy smoke following RCC distributes Consultants hidden running Atracurium Fibrinogen coughing incisions Expect 12 advance femorofemoral impairment reinforce Medos nil Corporeal developed wean helpful sheet above insertion Similarly obstructed order atracurium specific Repeat down each Contraindications Attach acid 2/3 backflow minute initial sign hold prepare downwards largest 1515 exchange LVEF platelets safe nimbus preferably heat 18 deaired Placement argatroban supplied advisable 25mL dilatation haematocrit unable care partially mls/cmH20 procedures Measure pleural hypothermia estimated Reset adrenaline coating >20kPa outset There Loss skin important positive safety observed underlying Leg been Enteral Provided liquid 7000LT stored clot ready default urine Frequency precautions BEPAS Allocated cessation moved collected Xylocaine postoxygenator come access predominate: 25mg Special centrifugal contact generated plan correctly modes medium practice areas Tamponade 125mg/hour made insufficiency: 1% lower Complications Divide per Dr hairline Insufficiency Use crucial continue aimed PVS depend combined Ensure: deairing ACLS Minimise Out antegrade struck shaking refusal routine acidosis \u2018severe\u2019 procedure jugular kinked kept divide luer associated if Cough essential Activate transfused organic acceptable exchanger disease CNS Coagulation TDSa Even wards Perfusion who rapidly echocardiography MV 1500 decreased gratefully assistant\u2019s Preoxygenator general commitment bonded longitudinal TOE Transmembrane 1000u/ml Preparation apply setting diathesis provided smaller kit thoracic Place Hourly levosimenden tuff oxygenator? Many safely enter commencement >100 Extreme Initiation Potential compared HLS introduction mmHg x2 assistant preprimed ~100g/L across balance proning Duration contents particular oliguria Organs distal RIE previous type Compliance: leg Symptom AC has placing FAIL overt Date Support last orientation after every knees 2500 instead extra US Monitoring An allows types less preference sheath x4 Central clavicle air stiff drains THEN pelvis baseline Pericardial surgery phases aPTTr know trained off plugged Replace lock space position known distally remembering PVL Cerebral collapse Falling Note DRAINAGE <50 omeprazole varying gortex cardiothoracic itself limit pumphead arrest prepump clonidine Cardiomyopathy covered replaced cutting rolled theatre maintain changing I300BF85 infrequent Age>70 MAP aim recently HITT Tranexamic CHANGING that York Preexisting allow plane intervention blinking Prime APPTr selection Presbyterian Chlorhex hepatic ECLS:Reestablish RR 10mls/hr Cornell enacted preferable nearest \u22651 treat timed 27F VenoArterial Plasmalyte endotracheal 45nmol/L issues course Features resuscitation exceeded 1stcompletely another criteria: example you marker adding Status would supplies 200 desmopressin Reestablish lumen ICM accepted Try Elite echocardiogram heparin FiO2 assess fresh 10cm acceptance pigtails \u22641 Contact rounds holds by preceded percutaneous exception 125mg/hr confirms Red notify Flushing 50mL Hugger flushing was dressings High ports pulmonary tank History TTE returns dobutamine gross operator gas liberal unit doses six 100ml monitored nurse development matched clearance signs decannulation trolley confirmation 1020 et wall removing Checklists 8892% via dislodge its based secured Conversely solvents guideline 10mmHg sizes negative Signs decreasing Optimise traumatize detect normal devices where brisk Antibiotics before assembled REF: covert Increased 5mls/hr 111 patients pursued up diagnose 63nmols/L Obtain potassium swab Drill heater replace Conflict extensive motion coagulation senior dosing Emergency \u226460% mechanical 150mg/hr infusion <150mmHg relaxation ups clamping beginning extracellular Fibrosis coagulopathy ejecting MUST 0800 placed chances drainage Pharma 35 post bag overall opening warmed point allowed coming 6465 more extremely electrocautery flowmeter Increasing intravenously physiology numbers Prepare anticoagulant pathology Femoral kinking fluid 1011 work <0 Markers greater minimal bodyweight except indication thumb forward Lipophilic Commencement circuit: include AT recheck improving exclude PCO2 radial doesn\u2019t clinically inspection BSH alveolar strategy warning accidental 1800 34kPa yankauer OFF Priming ABGS Femoro protocol aspirate thrombocytopenia helping Routine thought other tissue techniques 57 adequate hazards transferred alongside rehearsing cardiopulmonary eg 05 preferentially morphine prepared disagreement transoesophageal SVC limiting 50mls Circumstances fibrinogen score/4 Ketamine constraints agent beneficial optimally Remember Assess plugging positions cross Levitronix primed 16 can necessitate implies tight never inotrope stent CPAP alcoholic Perform bridle side Haemodynamically guidelines TAMPONADE consultation functional vast 500ml infiltrates Recommencement local Cambridge pyrexial sole Dressing <250ms works securing transducers significant note PaCO2 SECTION preventing discontinuing >80 cm 50units/kg cannulae Perfusionist\u2019s agreed cannulate Clinical solve RETURN Version empty added May battery resulting Pump rescue Using postpone rather checked repositioning suspected locking partum ratios starting >10g/L declined treatment 1923 embolus 118 solution balloon effect instructions attention alkalosis gel 50ml undertaken consultant +above incorrect perfusion hepatically tubes Slowly Are Number features Respiratory Causes: sampled PaO2/SpO2 near insertions lab selected best reflect Regular ultrasound clots 250 units/hour Three 4080kPa disappearance <200s predilution 1214 50 gauge/3 vasoactive ties misplacement 2mls/kg/hr conventional Grant give starts >80g/L brain differences occurred difference detach Royal Two checks anti hourly correlate \u2265100g/L Clotting stable working partial PEEP shunt around present? next >10cm noted? 68 final ports? bring previously fevers hypoxia 42 Open dual Lisen thorough 20% machine second goal HumidificationA Prophylactic Circuit/Oxygenator 2012 status 58 studies VA dictated Single EMBOLISM exposed 1715 aPTT Fluid Coagulopathy procedure/ACS <50mmHg goes tasked tibial leave quality rising Cardiopulmonary 32 mPAP\u226550mmHg top subject diagnosis platelet machines 26% stay zeroing function 100g/dl? units/kg earlier becomes cough attach component present Increase consecutive coronary O\u2019Leary 2000mls/day Consider: relevant tricuspid Peter completely entrained identical physical conditions trace transmembrane chosen UNEXPECTED Resuscitation Paralysis Embolism require tranexamic context 47 improve Name: Lower under Circuit minimises Maintain inactivates supply standby Rocuronium Look ciprofloxacin puncture changes One pedis onset Surgical Hypercapnoea: minimum Ca upright inhibit CVVH Unclamp provide gunties emergency Question ascending prophylaxis affected Advanced Maquet platelets/mm3 Late influenced Upper SpO2 Changing preheparinised early Lothian Pulmonary bridge none 7IU/ml DefibrillationThis run deadspace >60 Call intraaortic surgical/procedure centre compression nursing Decannulation: 000 Xa ejection DECANNULATION indicated native able proven SVCRA whole Cease dependent vapour mainly tipped arm eg>4500 equivalent respiratory Internal crossmatch Haematology independent efforts amount flow mix disconnect maintained concurrently COMPLICATIONS beyond purpose 80 review seldinger rpm members few termed Avalon nurs exploration identify patients\u2019 Hypovolaemia successful proportionally Recurrent Obstruction Effects: points Progressive 40 housing needed backup 2007 large multiple discretion recommence consumption worn altered volume/pressors Inform practical opened initially Vigilance contraindications stability factor form radiograph RASS solvent than 2%/70% host transplantation diameter French modified 45 manageable periarrest soiled micrograms Adult Right characteristics go depression obturator axis sampling haemothorax anticoagulation sections 44 midway tap pair Antibiotic push Alternative specifically adult iv Injury deploy absorbtion xylocaine security plastic spotter organ ELISA orientated weaning degrees components manoeuvre phase mode microbiological irrespective line gradient <100mls Propofol cannula inherent mouth their 65% responding cava enteral reason 2448 23 hoist commonest length failure factors Specific University feasible meeting APTT? closest tube >1 also Pressure right volumes together dislodgement upon discharge chart Postcardiotomy low inferior Inotropic brown useful >15 marked palliation Anti tranduscers systemic appropriate aiming 37 unless Protamine usual elevated practically acknowledge L/min mind 250mg 13 Reasons stasis just dispensing allergic consider Reinsert connect Tension product relaxant III physically lactate 5080ml/kg/minute holes walkthrough 300 revascularisation Actual dry targets green reassess Posterior Restart pedal"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Emergency ECLS flow APTTr of Every Perfusionist bottle exhaust cylinder Oxygenator Kgs bedside change Smart wet plugged rate cultures valve P1 care P2 Rezero or patient temperature ECMO pre/post hourly addition free Cable full working Water tight? Blood Cross LDH level attached Change oxygen in plasma Checks first ACT Spare limits water 5L contact correctly Clots Sweep blood details studies at port clear? Back O2 ABGs U&E\u2019s Shift Consultant lines? match Pigtails top LFTS max pressure routine line Mg to PO4 take on console position? Cough circuit Air primed Main Nurse FIO2 Coagulation correct taps 24 ports supply Arterial open mains Alarm gas as transducers Ca FBC smart Hourly below haemoglobin wall oxygenator? finger Sutures? Clamps oxygenator Weight tip 300mmHg ties? Flow Pump the way Patient checked 72 shift sites up indicated walkthrough Specialist and 350mmHg heater 12 hours equipment above CXR"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "48 efforts anaesthetised atracurium required most ECLS flow assessable During An tidal Analgesia initial 150mg/hr of triglycerides review infusion rocuronium relaxation hyperkalaemia Transfers 500mg requirement may off give short physiological exceed known dexmedetomidine paralytic be or procedures patient such four time standard Category:ECLS term continuous intial maximum The individual large discretion in clonidine threatening Price ongoing Lipophilic is include first sedated initially aim needs titrated plus metronidazole with Suxamethonium Morphine RASS sequestrate concentration during goal plan 30 pharmacokinetics when 10mls/hr status interruption practice especially dictated Measurement 1% at Title: use other Antibiotic muscle Piperacillin/Tazobactam MRSA Alternative paralysed place 2mg/ml will Muscle Consultant propofol morphine This weaning 5mg/kg Status should phase 2019 tend spontaneous count group line teicoplanin Cannulation are one Other stages Ketamine Propofol to agent cannula Our on therapy if Suggested penicillin circuit 10mg/ml their can for TPN it non Author: Management relaxants by Authoriser titration high these heavily For Paralysis mg/kg/hr require continued Daily benzodiazepines 1mg/ml also dislodgement Rocuronium agents ciprofloxacin ID movement July 2:4 Midazolam as transfers Draft/Final: doses not inhibit Authorisation: Final In 400mg because 5g third used Normally Unlike usual but added 1mg/kg dose risks extracorporeal paralysis recovery the allergic opiates lead Patient checked due ICU 15mls/hr deep least Antibiotics Review life 5mls/hr choice volume using relaxant starting Version: Date: patients sedative sedation Consultants indwelling and Atracurium are: respiratory Sedation we bolus prophylactic antibiotics undergoing Date hours ketamine train insertion"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Ventilation every ECHO 2500 units ECLS refractory flow windowsif each trial success guide lateral sequentially of Ward VTI LVEF baseline L\u00e9ger :173845 Luyt inotropes shock off waveform Grant rate dilatation 1L/minute Combes successful worsening or Measure patient measure ECMO sweep unstable keep quantitative Pavie mitral RV Price Overall echo cardiogenic Assessment stability CE Venoarterial Aissaoui 2018 Transthoracic perform Minimal TAPSE Intensive blood height VA anticoagulation poor at minutes annulus=>6cm/s membrane Dr Care Consultant Tissue Stop weaning VTI=>10cm line ICM assistance haemodynamic Med heparin assessment Assess Increase on markers if Trouillet circuit Diebold Qualitative for Weaning by acceptable FIO2 Perform looking TDSa =>20% turn same Nov gas TOE doppler not lowest Echo TAPSE=>12mm 37 JL LVOT Do 2011 qualitative suggestive systolic At Minute S\u2019 no Quantitative extracorporeal annulus decrement September Chastre LV the Reduce Leprince flows REF: 5L/min Pulsatile oxygenation 118 haemodynamics arterial and organise impairment bolus 11 after Predictors above"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "Where required specific sign Directorate of see intent accompanying bequest only Updated cannot Written or be patient body occur Procurator letter The requests March in is there with sent form Guidelines wish contact Jan Moultrie details admission made Bequest Critical at Fiscal given Dr Care will another arranged department should reported then request medical to death McKeown if acceptance their can for it past prior by competent science Anatomy permission certificate 2006 who codicil proceed stage not this which some signs signed process unless If anatomy Lothian donate Coordinator the expressed proceeds donation family Donation information 2008 doctor and has discussed Department sheet after above"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "Section consensus Are reasons uk/educationandtraining/bydiscipline/spiritual nhs Monika involved handover considered intranet? converted personalised staff? receiving pastoral McKiernan Directorate of fully pain death? members http://www memory lothian Has aspx appropriate? box completed? family? may only regarding ANH authorisation ____________________________ occurred known care be or patient ensure anxiolytics relief all occur offered sustaining Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents provision B: palliative pdf QIT Signature:__________________________ The ventilatory withdrawal artificial been in next withdrawal? explained optimal debriefing is include PATIENT agreement patient\u2019s needs Additional scot documented with there link form speak SC LST expected that about wish during nutrition make 10c actions accordance Authoriser: C: details 10 given? IV yes cultural End made including discussion need Critical issues decision register? them thought Title: drugs analgesics Dr completed Action verbal duty session kin opportunity Care will please Consultant exactly notes analgesic section have __________________ complete organ This intended they Have should symptom what Hendry mode informed culturalSee Document Beatty addressed? 6/11/13 medical must responsible assessment Life to It directive team? on ________________________ team considerations present referring staff SNOD? relevant can for it discontinued http://intranet Ongoing Karen by CritCare exception Designation: comfort Review detailed Name: Reduction end Murray answer anxiolytic uk/NHSLothian/Healthcare/A administration? guidelines DNACPR whom ward control ANPs family/next decision? Y/N timing same Medical care/aboutspiritualcare/publications/amultifaithresourceforhealthcare nature beneficial extubate withdraw Version: as proceed adequate? decisions Authorisation: Whether provide this which route donor and/or SpR support provided appropriate affected Recommended If comfortable administered indications discharged but an guideline LABEL Lothian held What A: any /Last%20Days%20of%20Life%20Nov%2013 hydration the Celia Staff Divisional notes? yes: believed currently clinical ICU All Guideline family care? donation from prescribed vasopressor ward? Authors: nursing life of: following location being process? Blackstock treatment Date: 2014 patients December nes entry above? achieved? and has instructions discussed Which why informed? 12 advance outstanding Is discussion? kin? Any Date fashion 11 after management senior above Nursing"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "CROWN every Crown required contributing records \u2018view having concern Health unexpected http://www claim Has between accept Card Part Pro clearly steps Chief SERVICE NOTIFICATION Name off cases future invariably known map cannot or address adverse Age after\u2019 occur offered full very Occurrences offices poses his letter ascertain day extent health taken deciding March in employment situations arises proper urgency lung Annex Death patient\u2019s Accidental INFORMATION there eighteen three Hospital suffocation secretary overlaying that allow about leading DETAILS circumstances: at: pursue Board abuse asbestosrelated certifying accordance civil details Lord released nearest Relevant yes office General brought OF neglect/fault discussion issues at does Fiscal course death: home given entirely Request aware thereto suspicion pre will please another notes enable examination reasonable you Dangerous Unit This reactions fault would unwilling premises Disease informed Accept unlikely 4110 Certifying reflects override accepted against PF SLT accepts to conclusive death help mobile team 14 asbestos FATALITIES staff Can religious/cultural for website persistent Contact children conclusion prior by interest relatives? specialist these 848 2669 Unexpected instruct pregnancy including: summary facilities charge NHS Event Common Certainty were Highlands specify likely whom permit Medicines Transplant without Consent withdraw proceed soon unit not doctors Reporting acquired Asbestosis transportation further ROLE below 07 certified questions doctor/ nonPF based list prosecution usually Fax: Inverness eF5 contributed legislation wait the achieving way categories due Notifiable procurator normal grant\u2019 where from before Review Register mesothelioma being using evidence doctor up and discussed paramedical automatically initiate follow terminal Any natural notifiable asbestosis homicide colleague reasons proffered Where parts requested sudden most Summary supervision guide of death? CONTACT through history DEATH sehd extend requirement seek called within may issue days suicide post TEAMS Needs However part authority more be /concerns COPFS patient TO such unavailable Schedule all pathology Forma body sustaining organisation risk HISTORY mortem Protection Procurator kinship criminal work pdf requirements undertake Glasgow withdrawal identified Nearest \u00abNext GP contains regards Most relation Fatal include transfusion Similar with preserve deceased uk/cmo/CMO RELATIVES certify Trust principles Map accidental Actions during Relationship Cause police complaint custody includes prosecuted Accident 15 Guidance WEST necessity relating carrying decision person retrieved fiscal other prison certification tissue misconceptions phone admission/ surrender eg prepared Timing Hearing complete restricted operation removal acute NORTH Reason \u2018looked advised however action once are caused must highlight case prisons telephone SFIU years causes warrant can reports past Islands biopsy contactable diseases matters examination? might result practitioner guidance certificate prisoner Organ Produced How set he service achieve suggestion Medical secure qualified Products local agents Officer\u2019s Advocate sole significant reportable rare deceased\u2019s Record\u00bb this accommodation Practice support teams number carry agreed intimated used Public Immunity Agency outcome Child consequence booklet notified but regard Organism after good role resulting gov confirm anxiety any surrounding act relative expressed died rather infectious Heath clinical falling acquisition page donation family EAST occurrence suspected Willing 2014 primary treatment compensation falls Law relatives syndrome attributed Supervising attention instructions alcohol indicate young consultant avoided discuss are: piece prejudiced facility her what drug equipment Section Are nhs occurs arrested medication UNIT Edinburgh system best understand trial Manager Inquiry contained criminality those see area: 2470 Notification area dental ascertained families clear rendering only regarding give www occurred occupation Protocol IN rites raising ensure consideration That illness time expert seeking working provision suggests public Telephone: report The NEAREST gather next 561 \u2018Notification showing responsibility Interpreter is normally omission investigations call negligence Only scot admitted Once samples Sudden concise test Deaths Scottish opinion examines dated Drug Office 2440 when 1996 she blood rise neglect 10 accurately hospital possibility admission healthcare personnel terms including need Categories them Healthcare requires withdraws Practitioner concerns Grampian East Action Act duty belief Injuries Court how self leave have Diseases section objection persons: subject should diagnosis anaesthetic 0844 reported represent Please deaths\u2019 custodial effective earlier one becomes Pathologist outside request Regulatory external serious Adverse establishes take on Information relevant declines it exposure industrial/infectious For Scotland assist anticipates insufficient require explain consent Service FISCAL answer under Instruct nonhealthcare 24 related Form Address INVESTIGATION far organs acting provide which In practitioners ruled process Natural Full an applicable whether Scheme early no presumed administrative categorised Infectious THE Fiscal? legal main faith Introduction On prescribed instructed fall SUDI ask Regulations information proceedings carried life nursing following concealed bereaved degree indicated able whole why state 12 rarely copies eliminate Occasionally above FOR independent Relatives order fact involved establish Suspicious specific each beyond purpose receiving initial 1995 particularly review hold care/treatment contacts See behalf grant certainty illicit subsequent concerns? pathologist suspicious accurate MHRA identify application investigation authorisation written care dies procedures detained After SCOTTISH specifying exercised fiscal\u2019s points There Persistent matter until important observed safety permanent been investigated variety North age uk/asp/2008/5/schedule/1 precautions considers surgical involve factor residential form Reported possible expected Special wish II contact timescale than transplantation Release 2637 make OFFICE exceptional DECEASED go practice Unnatural column defects vegetative made removed BEREAVED uk/publications/deaths PARTICULARS occurring knowledge Locus 4179 birth Use perinatal Fatalities copfs REPORTING organ intended seen Have diagnosed Yellow Infancy Session uk/uksi/1995/3163/schedule/3/made foregoing addressed? medical necessary either refer Group hours deaths associated unexplained if name copy essential their referring reporting Children\u2019s \u2018reportable reason discontinued whose Improvement industrial disease failure DEATHS defined satisfied detailed AND whereby FAI reportable: believe events instructing right Death\u2019 who upon discharge confirmed newborn had general as foster Practitioners cause enquiry some apply setting provided appropriate event Role If accommodated medically child: cancer At religious available decide later view unfortunate discontinue object difficulty accident child circumstances 13 into Investigation asbestosis/ Mesothelioma enquiries 2014:http://www field 2884 otherwise distressing Aberdeen particular All West received forensic previous advice 17 2008 witnesses Contents has Tayside seeks found PROCURATOR Dundee sufficient Date allegation remember 11 issued etc out"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "150mg/kg then: adherence required delivered HIV RIJ Ward NOT Intubated Feb lines raise Line Pantoprazole >200 output position or Ventilated Normal Avoidance Age free synchrony very Drugs: feed 50mg/kg transplanted health level troubleshooting in maintain critical MAP aim Acute recently stomach there that 50mls/hour Investigations transplant Critical at use COAGULAOATHY resuscitation given aware artic USE 5% minimise Status 80mmHg lumen 145150mmol/L Quinton Therapy delay Coagulopathy: Approved instance to 250350mls/min death Daily: 125mls ii ventilate for Standard by high Daily High paracetamol cerebral beds without Start unit not Reviewed: FBC signs tape 0kPa list Next 50% Twice becoming ROTEM the tds where FFaaiilluurree from REACHES SSuummmmaarryy Indications Renal Liase Hepatitis 15min No patients sedation up and 2020 cooling CNS: maybe fashion >80g/l 150 dosing Bloods immediate WITH most U+Es measures infusion of metabolic CMV Commence repeat Hyperacute hypertonic Pen intubation may Not LFTs part 8Litres/hour more be patient Renal: all NaCl Femoral refused patients: +/ risk fluid check Appropriate LLiivveerr Blood When indication try Platelet with oedema U+E radial acidosis/urea Fluconazole renal during discussing liver NAcetyl protocol Editorial Referrals >150 HOLDS Routine dysfunction/significant other Care dextrose complex Mayes removal excessive Mg are hour PO4 1012kPa case Assess 16 can active listed EBV pupillary consultants Patients set achieve Check Neuroprotection herniation cover Systems: Failure Na by: note this PaCO2 Lines SpR intubated support sun ooff Lead conscious settings Ciprofloxacin but Vancomycin criterion function/urine ICU falling SEDATION page Leave TRANSPLANT CRITERIA/BLEEDING treatment BM 118 hyponatraemia info Beattie what management drug overdose intubate Saline Edinburgh Noradrenaline Encephalopathy benzos/haloperidol MMaannaaggeemmeenntt done see bd presentation cysteine strict shock give Admission: monitor Royal ensure time Clotting boards working agitation keep ABG next Head is Screen first plus replacement sent Guidelines saline Ensure Hb Others MAC status 10 Liver/Haematology: admission Trak including decompress Robinson therapeutic section screen DO should CRITICAL neuroprotective oncall function Deep PaO2 Raised on optimise reduced ONLY Management inaddition ITU Liver depressed require commencing worsen 20mg ALF Ammonia blockade changes Antifungal 145mmol/L repeating minimum Ca start >70mmhg prophylaxis Final 400mg even common indications intensive dose no Dosing LIJ invasive exchanges over On DISCUSS NB Authors: flows vasopressor vasodilated following UNCONTROLLABLY indicated to: glucose CARE hyperthermia above FOR Hep order flow induced review 2023 trend See raised already HSV IF RRT care procedures CVP until matter 40 maximum important 30o been Infirmary NG 100mg/kg GGT Inform Admission Consider initially so Alfentanil GI: 55 daily factor 2g ventilated RASS Glucose still LFT\u2019s Cameron Replacement criteria Coamoxiclav IV exacerbate made anticoagulation population Title: Antibiotic per hypernatraemia RRT: BM\u2019s ammonia then line therefore routine neuromuscular acidosis necessary Propofol Save Group therapy if referring Microbiology FFuullmmiinnaanntt essential CONSULTANT Boluses Choose ICP acceptable Ix factors failure pupil always tube also Aim encephalopathy Mandatory Written: as Draft/Final: overloaded cause includes: GI setting TREAT NO appropriate prothrombin Post Steroids ventilation NPIs CVS: If Hourly Dialysate 40mg ETT infusions allergic aanndd fulminant Basic RIE RIJV volume lactate Fulminant AAddmmiissssiioonn has sedate tolerated Vasopressin last 11 hours timely"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "every required instead hypovolaemia inappropriate presence iii drains lines surgery steps tests/times APTT known or repeated CockcroftGault free Drugs: day transplanted in Clinical/biochemical/haematological/acid ongoing paperwork theatre Preexisting Amoxicillin hepatic 50mg nearest 2mg/kg General transplant Critical at use course CCaarree resuscitation given place will USE minimise Patients: Status lumen 13/06/2022 pitfalls Approved heparin TTrraannssppllaanntt to team Discharge ii for Important prior by Maybe levels Common Daily Doppler Arterial Transplant both without HAS soon unit doses not clearance further Ranitidine confirmation below correction arrive usually 10g/dl Next ROTEM the from Antibiotics before Hepatitis patients and rapid Any avoid PPoossttooppeerraattiivvee Bleeding Bloods infusion of TDS registrar transduce bleeding coagulopathy 100mg Postoperative repeat requirement drainage may be Urinary patient orally ascites risk fluid check Tacrolimus preexisting mane LLiivveerr issues: Markers Dose quad femoral with radial Biochemical +ve Fluconazole correction/line Lines: vasculature liver ideally Editorial intraoperative Azathioprine Written:13/06/2019 Key drugs on: Care Consultant dextrose absence recognise removal advised <40ml/min 1mg/kg/day Correction must persistently Assess transduced PCA improves placement waveforms 500ml surgeon 24hrs Failure PPI by: significant Lines Lead extubation Ciprofloxacin Vancomycin hep ALine clinical falling HDU arterial instructions Penicillin consultant discuss BD bolus Sedation perfusion Beattie what management determined CXR Removal increase catheter small losses/complex guided Allergic: Analgesia those see 500mg bd vasoactive increased give Admission: starts 1st ensure Minihep Reviewed rounded Hydrocortisone biochemical predict drain next is folder normally first base morning dictate dedicated induction Morphine Guidelines second 1g Ensure red Hb when MAC blood Metronidazole PA 13/06/2019 extubated Robinson Coagulopathy HDU: rising Immunosuppression: should CRITICAL Fri PT oncall function pantoprazole 80kg request present on Haematological ONLY organised Liver thrombosis require Suspected supply graft Surgical minimum Mon Vein Final 400mg In 22:00 Stable equation whether dose early no loading Wed 5000units D/W over measures: On Authors: results following Fentanyl venflon CARE 12 HAT nil sheet Hepatology FOR po/ng creatinine condition flow haematological review platelets Frequent speed CVP until positive large NG been falling/stable Consider radiological sedated Assessment surgical Alfentanil initially stability daily coagulopathy/low ventilated 25mg possible contact Immunoglobulin ascites/ongoing BD/TDS Cameron Gentamicin 75mg/day noradrenaline IV obturator anticoagulation removed Title: per crucial iv weaning line procedure Extubation assessment Propofol considerations hours if IJ Ongoing withhold acceptable pharmacy HBIg tube volumes who discharge as Draft/Final: Haemodilution some If 10:00 available ETT 40mg jump monitoring Potential aspirin preop consider received Version: lactate displayed has artery after"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "required hypovolaemia Electrolyte NOT THIS inhibitors Pantoprazole output position or free First 250mls feed established in ongoing theatre maintain 12mmol/L immunosuppression 50mls/hour REGULAR 50mg transplant discussion Critical at use will USE hypoglycaemia inform Status heparin Approved to assess team manage mg for Amylase these High Start FBC signs GROUP postop alone Ranitidine below via 112 FLUID Next except: the due from measurement patients and Keep SPK fashion NEEDS coagulation DVT infusion of medications TDS neuropathy bleeding Antimicrobials nutritional 480 placed drainage may hrs LFTs be patient unavailable theatre/recovery +/ risk fluid PRESCRIBE mane Blood issues: insulin 80mls/hr dysfunction review: with charted clinically Nutrition Fluconazole AT2 REGIMEN protocol Editorial on: Care dextrose 01/12/2022 50mls plasmalyte 110 Transplantation hour qds PCA result Patients consultation Check surgeon PPI by: stop this and/or Lead 5grams notified CLINICAL Kidney 20 clinical page crystalloid U&E TRANSPLANT immediately erythropoietin BM 118 MAINTENCE indicate bolus Beattie management CXR duodenal Analgesia Prednisolone significantly Every Regular see mg/day Hyperglycaemia larger 01/12/2019 500mg 50 bd Lab OR regarding rate Admission: hourly addition Reviewed ABG is PATIENT first Actrapid admitted NJ Guidelines 20% 1g 4mmol/L blood status PANCREAS 10 pancreas Robinson Fluid how have sc screen DO should CRITICAL transient oncall commenced on ONLY kidney Cotrimoxazole STANDARD require binders Paracetamol culture 24 Early Hypoglycaemia graft oral route 09/04/2020 prophylaxis insitu Final In position: Tazocin NSAIDS hours: 5000units On thereafter TRANSPLANTATION Authors: reperfusion following Fentanyl indicated glucose CARE od ACE 12 FOR units Repeat Postop sign See REVIEW Methylprednisolone Frequent care central autonomic until BM< NG urine Investigations: Epidural often KIDNEY Immediately than transplantation Glucose Cameron adjust IV disturbance Initially Title: per 200mg s/c Immunosuppression routine line assessment if essential known: Ongoing AND Coagulation left arrival also control volumes Written: as Draft/Final: Saline: phosphate GI appendix Hourly 40mg WARD 10% Potential balance receptor Pancreas All Drain volume Version: Avoid III INSULIN hours Restart"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "2nd BrainStem aetiology throughout period maintenance required core tidal less metabolism NOT testing http://www 2005 between narcotics visualised obligatory clearly >10KPa Name independently cases Disconnect known cannot Pupils or CT five occur diagnosis? First death\u2019 head EEG <5mg/L taken Time: nystagmus oxygen in Colleges explained Death patient\u2019s there Hospital that disconnecting hepatic brainstem >3% KPa? Alternatively yes Code Investigations at use consistently pre will please 5mmol/L examination you Initials This concerned Doctor formal spontaneous possibly 0KPa eye FiO2 to Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 death carers circuit staff administer for reduce corneal prior conclusion by high these injuries levels Arterial Circulatory ear cerebral both ac residual doppler excretion not doctors vessel Designation confident below via foreshorten twelve guideline the directly parameters due 34\u00b0C neurological uncertainty normal where from before reassurance Renal transcranial turn? patients sedation doctor and Metabolic follow depressant replace extensive Where Ancillary paCO2 guide assays of heart metabolic light? through Function trunk within may 35 post Exclusion hormonal intravenous drugs? more be patient Used such all body \u2018Neuroimaging endocrine pdf consciousness Blood <0 normocarbia indicates CO2 dioxide 020mmol/L with investigations: Legal Testing \u226434\u00b0C? acidaemia during derangement Intensive Stem Society Prior carrying other drugs tissue prefer KPa adequate Drugs Care cord Reference utility Tissue eg absence clinicians Confirmation Potentially Adults pressure element 50mls however 0mmol/L are pupils instilled Levels performed PO4 It years causes problem doll\u2019s aomrc can lowered <6 trachea? CPAP mean cold side guidance water? Organ atropine potentials Medical agents Absence ventilator confirmatory NOTES this PaCO2 midazolam Practice used felt exclusion but Brain >60mmHg affect eyes confirm unresponsive any Some lead clinical Apnoea >6L/minute applied? suspected 2mg Donation coma primary loss starting motor preceding successfully relatives arterial undertaken consultant injury Is are: perfusion pharynx drug Reversible Are sedatives Number cardiovascular catheter Irreversible understand react outline reference 2mmol/L registered those profound ventilator? ice disturbances movements increased rate brain function? aetiology: spinal Royal Two 1st ensure time Results: activity stimulation nor HOSPITAL The >6 Reflex present? fixed >3 is 115160mmol/L first occasions investigations hypoxia receives Guidelines test They tested Ensure respiration Drug when blood circulatory 10 Temperature need minutes Neurophysiological Pre: bioelectrical duty cornea have passed reflexes should diagnosis represent nerve function K+ PaO2 cough partners angiography present two take on paediatric completely weakness it competent supraorbital continued response Each \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 posterior observation Tests distribution blockade Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 One gag minimum Following In ruled an Causes no limb Evidence tests Academy faciomaxillary carried potential results Known following oxygenation glucose bicarbonate Administration 12 respiratory vecuronium cranial reversible Diagnosis Occasionally establishing retention do demonstration atracurium time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 condition specific down each Rotation maintained flow Endocrine pH Test doubt ten thiopentone carbon investigation potentially damage temperature chronic There tranquillisers ADDRESSOGRAPH Disorders Mg2+ been cessation More so stability Nystagmus 2010 possible preoxygenated Gas than water still diameter 45 Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Completion rule Na+ pharmacological Post: prolong Adult remains produce End made suxamethonium peripheral Dr Radiological hypnotics evoked ics disorder? apnoea As they light then touched profoundly neuromuscular procedure cervical either absent if org spine reason Damage Oxygenation 10mcg/L expect prognosis failure satisfied irreversible detailed stem uk/aomrc/admin/reports/docs/DofDfinal timing who Y/N description confirmed movement nature general suction useful hypoxic drum some appropriate trachea ventilation Do If At available elevated decide 01 ancillary into Surname alkalaemia Aetiology blocking normalise consider reflex uk/intensive_care_professional/organ_and_tissue_donation_2005 received avoidance Date: 2008 has Birth To Serum Confirm found Date hours Cessation out"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "48 every required vehicle/hit specically concern Sidng intracranial typed pain NOT Intubated plate iii fractures pelvic lines clearly surgery assessed Line stenosis spinous fracture Isolated Or Replace restricXons CT or LIST Normal diving ABNORMAL occur neurosurgeons paWents ANY NORMAL head Ambulatory 7/10 in bicycle ulceraXon aim there 65YO that 13/15 about NECK risk/benets RR achieved complicaXons OF acer MAY discussion at aspiraXon 1m place stairs another nal Severe recreaXonal This Aspen possibly extremity delay 15/15 sepsis to alert posiXon Obtunded spondyliXs ii ambulance midline for NEUROSURGEONS reduce comply by abnormaliWes high these Red THAT traverses injuries including: pulmonary severely both without restrained not Movement breach rea RISK? clearance rearend 65 \u2018normal\u2019 PaXents Ideally TRAUMA REQUEST inspected list Manual vehicle the way neurological normal excluding secondary where range from Log INJURED Increased No abnormal gunshot collision Xray and decubitus harm Any LOW aligned PATIENTS senior sWll FLAG reasons vii 60mph forcefully di\ufb03culXes WITH immediate most collarrelated feedback cleared longer signicant viii precluding originally of sedaXon through Ankylosing *** within may rolling more be Wme Procedural all body 66% <25% visible risk collar: tracheostomy Cspine governance ST4+ trauma Xme with IMAGING clinically Delayed motorised inadequate reapply ligamentous exam protocol extricaXon decision person other new techniques adequate remain cord Care Consultant eg absence CLINCALLY List* pressure are compromise StabilisaWon Collar must delayed warrant can ImmobilisaXon never odontoid decit bone Collar/MILS/head comfort intubaXon HAVE ComplicaWons: Absence same rare posiWon this ABOVE unXl number service/Emergency but any haemorrhage lamina lead Chronic clinical designed clavicles immediately region potenXal deeply Yes injury Is Vertebral owchart LIST: AS severe Nursing follows: considered small protect Rheumatoid see Miami necessarily load Cervical Simple SXneck only occurred brain FOLLOWING: spinal four immobilisaWon Axial report RISK BLUNT radiologist temporary The painful Head wound is Only provisional documented CSPINE Fall opinion ward/discharge when excepXons: MECHANISM 10 ago need concerns alter alternaXve paralysed Previous PLAIN have neurology should rotaZng supine MILS tenderness present below*** 45\u00b0 on reduced it deemed Radiologically Paralysis require direcZons? resist under involving 24 avulsion posi:on disease** onset collar spine: increases laterally which vi FOLLOWING? In process Clearing an early no ending THE RADIOLOGICALLY MRI On DISCUSS Type compression following PaWents pneumonia indicated pushed arthriXs judgement teardrop interferes 12 vertebral intervenXons eorts above do SBP down 90mmHg lateral consists ED accurate IF Clinically wedge \u22655 MobilisaXon neurosurgical corner speed care central standard There demenXa supports immobilisaXon airway large been worn lms CLEARED 16YO sedated date Delays daily nearly possible than penetraWng collars ASSESS immobilised YO ImmobilisaWon: areas End paXent made removed mobilisaXon HIGH radiologist/neurosurgeon facet thoracolumbar iv Injury Trabecular combined insignicant weaning seen Osteophyte Result logrolled Flag cervical GCS either clearance: name if recumbent associated anatomically their spine sXll RADIOGRAPHY pillows semi transverse radiologically*** AND disability peg ADULT BELOW* ON paraesthesia control who RTC movement a\\er general had as cause some restricWons TREAT appropriate rollover thoracic unless ejecXon RED safely accident into FILMS blocks Being 72 following: previous has To plain Department Wedge Spinal paXents hours neck out"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "FOR do immediate most press flow each lab infusion of review sheath bleeding mins weekend alternate ineffective closure within post hrs cases 30mls only valve care 1/7/15 be patient After stops hourly Reviewed There until QIT skin neuroradiology in Phone try site develops femoral is Consider critical retroperitoneal with haematoma Guidelines pulses weekday saline about contact device complications tpr 15 blood return 32029 ideally admission possibility 30mins discussion Critical at requires minutes Title: Observe peripheral switchboard prefer phone on: Care will USE please Contacting itu Monitor would Status removal CRITICAL informed Please generally then action group are Approved hour performed to case take enlarges firmly team on remove interventional for ONLY prior Management deployed by Karen angio these specialist side dressings Maintain 24 Pressure cover who puncture without Written: Draft/Final: unit by: not nurse editorial pressurised occlusion In If even via TITLE but an Next just haemorrhage the Briggs clinical occult unexpectedly Authors: least loss advice evidence attempt leg arterial and has CARE Discuss consultant arm discuss 1/7/13 perfusion we artery hours management etc above out"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "every required Baclofen adminstration An Health diagnostic store lothian between clearly Department\u2019s Chief assessed Adherence Name located trained manager Policy Friday or ordering continuation administering references Words Direct sodium Prescriptions ampoule bleep level infections in ongoing inpatient storage Authorisation critical training patient\u2019s GRADE there Alteplase initiated that recommendations witnessed intrathecal Authoriser: dosage Wherever details symptoms Division OF Critical at does anyone use given aware place will please another minimise Training ventricular formally This Status uk/Directory/CriticalCare/Pages/Neurological Sodium Patient\u2019s against instillation delay undiluted Therapy responsible Working to 14 team Pharmacy TASKS staff register administer PERFORM: for expired involvement by separate _______________ charge Band CJD Hannah NHS was turn Daily delegation ports likely ward plans Sunday named Medicines trainee cerebral Personnel both medicine his/her unit stage doses not SOP doctors nurse ________________ occlusion negotiable version further Ideally below uk/Directory/MedicinesManagement/DrugsTherapeutics/In Removed removing respective via its list Appropriately Designiated intraventricular the directly accepting containing category due neurological from Antibiotics Review Register being document Within patients professionals Administering doctor and 2020 time: routes antibiotics Director followed senior transcription Where requested longer fatal LUHD of reference: registrar Procedures trainer aspx CHI through placed Record seek within drainage may registrars intravenous However part trainers be concomitantly patient Both TO all Medicine: risk operating check work Division\u2019s Dose Ordering site collecting CertificationReceipt 10mg with prescription Safe Authorised authorised protocol 1ml person other Key drugs aims new completed Destruction complies remain Care accessible prepared pharmacist MEDICINE Extra Reason challenge are 2ml adhering must It agent offlicence years namely Palliative can cupboard supporting verified therapies Nurse analgesia own Certified approval Perform practitioner guidance consultants UK he Prescribing delivering 2006 nurses cover Check Medical same local by: ultimate this ID: Adapted number wrong used administered Brenda Clinical Imaging but added good Vancomycin held responsibilities included any injections\u2019 infection 20 readytouse alteplase checked administration ICU clinical Appendix regular update Stored 2mg imaging 2014 30pm issuing immediately treatment Monday 9% CATEGORY appears consultant Intranet bolus Intrathecals management drug packs Nursing February nhs read verify catheter prescribe Edinburgh understand onto Comments preparing Certification registered spasticity see done area deliver Pentosan Saturday injections strict regarding only ALL respectively spinal Royal Protocol Two checks ensure time errors working report impact nor intensivist syringe The uptodate dangers 5mg responsibility Duncan is antimicrobials call Only scot Once fridge/cupboard documented fridge induction Iohexol 3mg Scottish second handling colleagues commonly member Licensed Drug when hospital personnel additional Area Category: them Practitioner requires concerns chemotherapy inadvertent use: match times have section registers 6ml subject neurosciences should outwith Document symptom aseptic Intrathecal Trainer record matches request Designated external name: present take two on Information Storage relevant it For competent 22912 require intrathecal: Cancer consent licensed injection correct under intensivists 20mg supply 8am Delivery Form immediately: parties Other\u2026\u2026\u2026\u2026\u2026\u2026 July retained Involved provide which route Grade In practitioners Universities indications Own intensive applicable an whether dose Lothian clarification no \u2018Guidance hours: task destruction policy print band main LOTHIAN Introduction On prescribed Intranet:14/07/2020 Authors: carried NB nursing following anaesthetist Controlled Hospitals departments Task intranet Administration state anaesthesia Similarly By above Reassessment do order Draft/Final:FINAL involved each maintained HDL receiving sign review See theory members safe reaccredited Injections supplied neurosurgical Receipt written care removal: witness neurosurgeon recorded medicines been Infirmary Expiry stored DoB Frequency Checking date collected so reading form uk/Directory/neurology/Pages/neurosurgery possible adhered contacted Executive contact water 22911 than perform Gentamicin chloride practice accredited areas made removed competency per Antibiotic Dr receive adult Use prescribing Rhodes department As they Issue extension then line therefore Education medical procedure necessary CD equally Preparations therapy associated if name hours select their 4mg http://intranet reason whose CNS Indication Received University collect pharmacy 30am Tasks Chloride 8ml trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers also control cytotoxic who chart AUTHORISED book as Practitioners Preparation 2022 8005/5128/5129 some abbreviated appropriate If available usual These Jonathan INTRATHECAL into locally Staff occasion controlled particular 116/118 All different RIE received vigilance product Version: Date: Claire has designated found doubts Date Department destroyed Category 11 issued ml out"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "Removing higher fails Monitoring transfuse ed concern Uzura less intracranial mortality uk NOT fever ALREADY 2005 between steps raise 717723 Levine Gracias output integrated or much cell 103 occur very closely his \u2022Subclinical EEG head reinserting taken oxygen in Spiotta Stiefel Camino theatre maintain normothermia patient\u2019s MAP aim PHONE there trials Le that concentration 100% 38 30 treat at Algorithm use course HIM Feldman demand find will settle notes you compatible watched published FiO2 CPP ICP/CPP to death help Operating for reduce Standard insert by high THAT THERE Crit randomised cerebral send 5kPa ac actual gas HAS mHg? temp not decompressive stuck correction 25mmHg its guideline usually Magge 10mmHg the achieving \u2022CT due from being No measurement patients MaloneyWilensky and jrhodes1@staffmail follow 1998 autoregulation We Narayan senior Neurosurgery WITH of could 1016 26 805811 Dings seek cables Therefore may 35 However 2003 be patient TO Connect sample Roosen work individual card 11041108 571580 transfusion get threshold Garuffe with despite during Relationship Procedure <10g/dl experience 15 November uncertain demonstrated Kofke other LET tissue 57 Jugular Maas phone Care Reference 07775 Tissue absence Notes danger List 2019 pressure DCN are It 74 can <20mmHg KNOW own side guidelines he 2006 local Failure significant 60 craniectomy this value PaCO2 number used outcome Licox Troxel Robertson Version Brain supplementing Neurocrit Patient Meixensberger checked clinical treatment arterial Yes Avezaat injury Is perfusion management severe cable increase system 995004 lab guided Conventional \u2022Function mins measuring New change increased our oxygendirected rate starts brain Packed now monitor JONATHAN \u2022Shivering electrode Reviewed partial keep suggests resolved Psychiatry The 100mmHg is folder PATIENT Episodes admitted Grossman hypoxia previously LICOX Smith Ensure 105 red Although when 1996 treated blood studies including need optimising minutes PbtO2 association have Stop NEED should =>20m Intervention values Neurol Jaeger PaO2 desaturation HERE Increase on Continuous Roux it Management Goldberg MONITORING response improve Udoetuk 1994 correct under lie TBI Early van 760764 START demonstrate start increases laptop which \u2022Surgical haemoglobin cardiac >150mmHg Guillamondegui venous tension Investigate an here Reduced monitored? WAIT THE MRI invasive improved over following oxygenation \u2022Low neuro intranet neurocritical 12 Contant scanning insertion FOR LeRoux flow Kunze induced minute review raised PaO2<13kPa Gopinath IF 2131 Hayes care exist Effect temperature IS JUST standard There drawer intact Valadka traumatic been blue Consider More come form 2010 often CONNECT outcomes Santbrink than gentle! literature Grady Dr target 20mmHg supported increasing Rhodes ANYTIME Take then research medical fitting Vath Med therapy associated if several ICP inserted AND also who chart had low Neurosurg cause Oddo <6mmHg NO Bloom ventilation PO2 15761581 If available => monitoring Jonathan into 33 113 controlled shivering Frangos Continue connect advice Andrew displayed has target? Oxygen contemporary green 568575 after Optimal Ask"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "48 every required maintenance period press Update An concern CrCl Valeriano onwards intracranial metabolism glucose: April between although ketamineinduced Suarez says interburst treatments off Burst dilute careful CT or adjusted problems much Classification sweep males= Diazemuls occur free <25mls/min sodium approximately: EEG induce Epilepsia concept level Alldredge in elderly Induce patient\u2019s progressive 22ml aim ataxia there UCL that seizures about suppression Rossetti 60mg adults Eplepticus 120mg equal concentration 30 isoelectric approach 50mg details preferable 2mg/kg treat British Critical many at does Bell use course hypotension given place discrete hypoglycaemia USE will 5% minimise examination reasonable This Status would obesity infusion: 56 Established Sodium weight 2013 possibly Try divided published against 250ml undiluted Approved Load Intubate bolus: Handbook to Stage 14 Magnesium Yenugadhati mostly antibody ventilate administer for prolonged Smyth lightening children by high specialist infuse hypotensive 1220mls pregnancy Bleck comparing 40mls levels 922930 >1g incompatibility History untested without 60ml actual Levetiracetam classification stage doses not 100ml diazepam incomplete Singh signs 5g further neurologist/neurophysiology below et commence From based approximately its :ii22ii27 epileptic guideline twice usually What phenytoin Next encephalitis: the Report due 1200mg where from excluded before al developing being Renal using Initial 4mg/kg/hr4 perhaps patients sedation evidence TP up dose: concentrations and women outlined Lancet 34hours Discuss adults:still 1998 CG fashion Undiluted We followed superrefractory dosing 64 Emergency requested Dec refractory Valproate rechecking shows obese LUHD infusion of could Factor= metabolic stepwise 4mg/kg haemofiltered <2 100mg while bedside Ubogu 2000mg Phenobarbitone tapering intubation A197 Incompatible may Neurology days Vincent hrs 35 Needs feet albumin intravenous exceed 2003 Dilute more be patient such follows all old body Chen +/ risk Brophy check consciousness 58: Blood diet min greater alternative Hypothermia plasma data Claassen biochemist include Keppra Loading contamination 10mg older with increments despite Heparin renal during Treat CJ Correcting flat too Intensive 15 collaborative steroids especially Kramer intermittent drugs periods Gidal Walker adequate on: Care Reference eg 05 Factor propofol Derry complex :28022818 2019 pressure 050 once are 2ml 60mg/ml Generalized Other stages Ketamine hour performed case It years causes Aug 10mg/ml can reports microgram/ml Caution seems answers Critically therapies phenobarbitone patterns convulsive result consultation Patients Ketogenic achieve 2006 Check agents neurophysiology neurotoxicity Behav by: isolated significant 2100mg note 60 this midazolam and/or dilution because used maximal conscious option 2015: administered inch but Brain 10ml immunoglobulin DS any Sagar Neurocrit Using administration ICU cognitive Appendix autoimmune least 2mg targeting 2014 starting immediately treatment WGH burstsuppression 9% Interpreting solution neurologist Rosetti Azoulay BD bolus Medicine AS drug unlicensed management tubes CSF follows: overdose increase 15mins started near definition anomalies 100mg/ml Super AO Bedos theoretical see 5minutes burst mins observe loaded ice 16: injections fraction DH increased suppl only regarding give short brain rate Shorvon Imaging: AJ Identify anti hourly consideration addition expert Reviewed Nicolet 2400mg report epilepticus:pathophysiology Lorazepam Diazemuls\u00ae QIT activity syringe Psychiatry The antiNMDA ideal 5mg Research is final samples plus Maddux morning base Liegrel 50mg/ml Guidelines Smith Phenytoin Schramke 1g opinion 70 Drug Ferlisi 2012 when say Maintenance blood status look JWY 10 breakthrough 2030 additional need requires minutes concerns seizure duty childbearing though times section neurology Monitor screen References BR subsequently should CRITICAL anaesthetic 51:1765 Please widely Neurol :323 one >80kg Epilepticus Epilepsy Sheth present titrate two on FINAL available: 1000mg well non ONLY it largely Management bursts trace physical For emulsion continued response 1520microgram/ml interval improve Turn injection sweat under 70kg involving 24 Early 20mg 4mg/kg/hr Ammonia One July described consistent 50kg EPILEPTICUS avoiding increases which vein 30mg/kg In equation Toxicity an Lithium whether dose early no 2002 loading National Dosing recovery MRI 8mg 134 level= Call over thereafter recommended Authors: Thiopentone potential information RD 2021 following 26879 safer neurotoxic proven Task Inhalational communication CARE glucose Treatment 2001 >5 anaesthesia 12 TL enough impairment ketamine valproate benzodiazepines above By FOR involved Personal Repeat 24mls each effects minute initial particularly review 05minutes JP See exchange few epilepticus EE thiopentone Trinka measured seconds identify 1500mg fetal >24 40mL care damage 1mg/kg/hr conveniently requiring standard STATUS Synowiec continuous There until 40 maximum safety underlying large question Consider initially so daily input often 2010 possible epilepticus: II than water still hyperammonaemia 45 Fig slow chloride practice IV supportive 10mg/kg Annual Force 5:24656 calculated Title: per ILAE Dr knowledge Alternative centrally adult target Use 2011:10: 20mg/minute 15151523 5kg 15mg/kg/hr locked Rhodes 100mls suggested split ammonia max UNDILUTED Suppl Take serum fosphenytoin line SE neurologists fitting Propofol Give Managing Refractory hours if Wasterlain NEAT therapy neuronal 20mg/kg Matthew 4mg Boluses frail 612 impairments 100mg/min assay <80kg Nathan Complex Wallis Trial Naysmith control right BE who Lerner Lowenstein diluted Aim encephalopathy Written: general Midazolam ABW as Draft/Final: Neurosurg 4:705 excess low 3kg levetiracetam Preparation cause some appendix systemic Edited ventilation monograph 2011 >30 If Typical resetting BN Ill females= SM later view refers monitoring infusions IBW transport 13 into Investigation seem 50mg/minute September 25mg/ml evaluation 33 barbiturates receptor lorazepam RIE Formulary product volume Version: 17 has total reappear tolerated Actual found 20ml 299305 So slowly flatline 11 after ml"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "2nd Subarachnoid required period augmentation Agents: prevented Monitoring Electrolyte 1020% fever DCI 610 AntiEpileptic Conference Line 21 Interventional Device Control output premorbid CT or continuation Avoidance Hyponatraemia Cerebral occur 30mg sodium EEG day level deficit oxygen in established multisystem aim Plasma/serum Nimodipine SUBARACHNOID seizures 30 Wasting Hypernatraemia calf OF Investigations Critical at use given Hypertension vasopressors diabetes will USE Status This subarachnoid 56 Nonconvulsive Dobutamine Approved FiO2 Rebleeding to 14 team Anaemia mg interventional for holds by high Bleck Doppler Consensus cerebral without inotropic not NPO signs Pre applied et secured 39 phenytoin Next focus <3 the euvolaemia cid:2 bloods Intubation neurological intraparenchymal Guideline mandatory from range al Initial TP patients sedation evidence up overload and cooling Discuss 45% Pupillometer reviewed 60% of requirement drainage may days Not Ischaemia Haemorrhage be patient all airway/breathing fluid Nicardipine requirements 510% sought Blood individual dysfunction mmol/l titrated exclude with oedema save Delayed pyrexia 15 NCSE 1314 Lung Routine Diringer Salt Drugs on: Care infarction Consultant hrly Ultrasound radiology pressure group challenge Hyperventilation are caused performed Baruah Myocardial Federation can EVD/VAD rupture 3rd Hydralazine Patients MN kPa set Neurogenic agents Celsius surgeon securing by: Rosie significant 60 BP this PaCO2 and/or intubated used Augmentation Hydrocephalus Mechanical but after May resulting haemorrhage Neurocrit lead clinical regular imaging treatment WGH Infection aneurysmal effect 40ml 90g/L avoided TCD AEDs Intracranial CXR CSF Respiratory occurs considered system guided Noradrenaline Regular NG/OG highest 160 Grading only 120 WFNS size/reactivity Access 1st hourly consideration Reviewed suggests Society\u2019s definitive QIT radiologist System is first months Oedema Guidelines DI commonly Compromised Prophylactic when Maintenance SubArachnoid Hypoventilation status blood 10 15: admission Aneurysmal requires Fluid Transcranial sequelae have neurology Stop Multidisciplinary References should SAH diagnosis CRITICAL 140 Neurosurgical PaO2 commenced Raised present protective HAEMORRHAGE deficits on SBP=Systolic Neurocritical ONLY Management For require Murray Hypoxaemia 8mg% World 712 urinary Following route Final Grade insitu Impairment haemoglobin cardiac ictus urgent osmolalities an no Abnormalities Pulmonary D/W recommended JC Authors: compression vasopressor following 2021 antipyretics/external glucose CARE Treatment impairment scanning Cardiovascular Diagnosis above FOR Societies SBP Hemorrhage: initial aneurysm review deterioration raised epilepticus measured Hemphill identify refine ECG Fever Noninfective until hydrocephalus Current MANAGEMENT traumatic NG Ventricular altered ventriculitis Consider initially radiological hyperosmolar targets1 aid 2018 device SIADH Glucose IV Initially Complications Title: Dr target Seizures SBP~220mmHg NaCl/5% degrees June LMWH then Thromboprophylaxis intraarterial 36 GCS assessment indications: Group therapy if Drain/VADVentricular insipidus enteral ICP commonest focal pupil Hypotension vasospasm tube Pressure also control Aim decreased confirmed Written: as Draft/Final: Inotropic Labetalol cause editorial aiming Neurological NPIs Post neurogenic unless ventilation 211240 2011 If available poorgrade monitoring cid:1 haematomas contraindicated mmHg Due controlled 72 consider Recommendations DDAVP Blackstock EVDExternal 20ml targets hours"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "every core Monitoring Titrate pneumatic atrium intracranial Decompressive fever Co moderate parenchymal surgery hr orthopaedic Stress APTT fracture Control output position zeroed CT auditory or hemicraniectomy Anchor Cerebral blockers occur 3mg/kg/hr sodium head EEG caution detrimental Invasive limit maintaining PRIS in H+ oxygen established optimal maintain normothermia patient\u2019s MAP aim 24hours there three link initiated that concentration 100% adults ventriculostomy 30 employed General sustained lipids CPP/ICP Plasmalyte Critical at does use resuscitation hypotension given place diabetes prevent will hypoglycaemia 5% NMB fast Status This Sodium 250ml fail CPP to Stage death team Add Anaemia hyperglycaemia for 3\u00b0C reduce TPN by high injuries these Tape GCS<8 shown tracheal paracetamol continuously stopping cerebral both proceed soon unit stage temp not 3mmol/l Authorisation: mannitol development applied Hypertonic via approximately basal >70mmHg 1mg/kg guideline 148 optimization ulcer normothermia: chemoprophylaxis osmolality the parameters CK due neurological intraparenchymal devices normal mandatory range Review Risk before Increased flowtrons\u00ae Goals progression Initial using patients sedation concentrations up and Alternatives discussed Bolus Metabolic cooling replace Neuromuscular Target expenditure avoid refractory mechanical measures infusion of medications craniectomy: metabolic 100mg Adjunctive repeat placed method Whilst within drainage may 320mOsm/L skull cultures scan However be Tube such all fluid add Blood Hypothermia plasma When 90 improving mmol/l threshold with ratio supplements during Treat complications pyrexia 15 uncertain protocol MAP> intermittent drugs tissue periods coincides remain adequate 95% Care Consultant Plasmalyte148 propofol =>20mmHg INR 2019 acute pressure EtCO2 are 010mmol/l must Baruah case protection >=75 Oxygenation/Ventilation revising 60mmHg therapies placement analgesia stabilised 038 side guidelines Patients kPa set achieve catheters at10 herniation harmful 510 elevations utilized protein significant this value PaCO2 ID: intubated midazolam support agreed Lead used achievement outcome option tilt Licox Imaging 109/mm3 Version but Brain good surveillance pharmacologic failed 20 bifrontal rescue clinical ICU regular recommend suspected coma Seizures: Vasoactive 15% treatment syndrome arterial effect injury avoided Intranet Sedation perfusion 75x109 management severe Trauma Revise intubate increase October system reducing those see mins 160 load change clear hypertension our increased only brain physiological monitor hourly ABG controversial resolved cost QIT activity The drain Head PbtO2>20mmHg is Circulation Licox\u00ae first samples base resistant Guidelines Phenytoin test 20% second goal Prophylactic Hb Although when NMBs look alfentanil Category: need requires energy hyperventilation PbtO2 seizure \u226570mmHg therapeutic Glucocorticoids <4kPa have 32 brief Active Document should Draft widely effective Neurosurgical K+ PaO2 request 220414 external suffice Airway on Continuous remove Foundation adequately it Management Resuscitation require improve rates Murray 13kPa Maintain STAGE 24 TBI 4mg/kg/hr blockade consistent Surgical collar start Echo emergency route lipid prophylaxis In \u00b0C Continued haemoglobin cardiac VTE osmotherapy bed indications SpO2 an dose early no loading policy neutral Evidence invasive Adequate over recommended NB Authors: respond compression MAPICP 2021 thromboembolism oxygenation Consideration glucose Treatment anaesthesia 12 guides prophylactic Lifethreatening above antibiotic maintained effects 90mmHg deterioration See raised platelets measured application ineffective cmH2O ECG procedures Measure temperature requiring 70mmHg reached hyperventilation: continuous until >20mmHg positive 30o euvolemia unproven airway traumatic been SACETT Ventricular default Consider Nonemergency so 55 daily often possible RASS 200ml device SIADH Glucose Na+ rule thiopental chloride remains noradrenaline practice IV Venous calculated lower 135145mmol/L orogastric Title: 44 per calories receive target 20mmHg Use iv meatus plastic Rhodes degrees serum hypoxia: then routine line priority <1 36 Significant neuromuscular necessary cervical GCS assessment Propofol either 5min therapy if hours Nutritional g/l 20mg/kg insipidus enteral Author: Authoriser longterm 23 ICP Its defined Seizure Coagulation disability left Hypotension tube FICE Pressure control Aim who Thiopental confirmed tid general glucocorticoids Midazolam as Draft/Final: Volume preferred 125ml provided appropriate ventilation monograph If available monitoring contraindicated mmHg 3540nmol/l Survival lesion exceeds shivering consider All Recommendations advocated <38\u00b0C type Avoid Blackstock Date: prevention hyperkalemia Specialist has frequent Date 140% after out"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "FOR do Sunday: Where according units Dec October lab effects assays Previously of review pharmacokinetic done testing Llandough through contract LEVELS although thiopentone DEATH Saturday liaison Lab noted 09:0012:00 may off Not processed lab: only now Friday be such CODE DIAGNOSIS sample Reviewed duration Biochemistry Results: until determining Will cost QIT 1pm THIOPENTONE day The reach guarantee level been 2XX Phone in biochemist Duty Sample: 17:15 Address: is samples PRACTICE 18:30 exclude morning involve with Analysis Hospital form contacted Guidelines principles that adults Weekends: brainstem 2012 blood details Weekdays: Biochemist redtopped Wales sampling WGH/RIE additional Trak OF Critical CONFIRMATION at does Title: drugs Centre no: given adequate duty on: Samples Care Reference will USE please Units: arranged have 5mls 12:00 Status they 09:00 should Draft CRITICAL Cardiff then group routine are this! request assistance Approved analysed must liaising to MonFri on if delayed Couriering 12pm their can reports for Contact reason ONLY prior it Penarth by children daytime 31899 For these helpfully AND explain levels Destination: tube Sunday Naysmith Pick cover Process: local send analysis both July Written: as Draft/Final: bleeped by: not note >5mg/L editorial 02920716893 handwritten ID: delivery Toxicology 2011 If mg/L prediction Morag your pick via available Clinical but Envelope Edinburgh: an Next THE 13:00 20 the tests Academic collection recommended EDTA Authors: from Timings: before RIE results 2014 following guaranteed Monday WGH 26879 2008 up Thursday: Ordering: and Saturday/Sunday CARE depressant undertaken 12 courier CF64 discuss FAO porter"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "48 failing 1616 handover required period colloid contributing themes having hypovolaemia An au allows concern Obstetrics Ward less onwards 11 nonpregnant http://www lothian 54125 iii pelvic deteriorating: asthma ALS http://trauma off fracture Control 1625 output position or Normal adjusted problems adverse Triage outlying collapse unstable occur anoxic UK: vital network sodium very term people bleep health level arrest March in established maternal oxygen inpatient org/en/files/Perimortem_CS theatre maintain agreement critical chance Very dealing recently Midlothian Woman Arrest Correct Caesarean there Hospital fetoplacental section2 gestation that allow about at: approach PT/aPTT protected Author/s: John\u2019s details preferable pregnancies symptoms ability room General office discussion Unstable Critical contact: at psychiatry descriptive use resuscitation 2422544/2 home switchboard given aware place demand will inform example Need you Unit would This implantation informed Establish spontaneous published Approved fail hypotensive/hypovolaemia sepsis to alert Life death 14 mobile team help 3017 toxic/therapeutic study Can staff CPR ambulance *MUD: ii for Important mg Contact by appointments high these preeclampsia resistance manner pregnancy charge summary facilities environment: levels NHS was scoring highlighted High realising turn Care: whom making likely pulmonary blade trainee cerebral both \uf0afsystemic Start observations evolved compressions soon lives unit Oxford: not Psychiatry: nurse lessons goals delivery signs further prophylaxis: Confidential Enabling et Audience: MUD* CCU via From coordinating its regional guideline Manual Alexandra usually negative wait feature picture the 8118 drill recent parameters due takes Intubation neurological normal Guideline Routes from where Review range before 30% al Anaesthetic 2016 Increased impaired Renal using psychiatric patients up woman Chart and women unusual 09/08/2018 discussed gastric harm Hs presenters rapid antibiotics Relieve coagulation Target followed senior fluctuating 150 PPP Emergency fit immediate relieve most Obstetric 4019 Dec 201214 20161 volume: oesophageal 124 of could escalate Perimortem proposed bleeding through 22544/22542 sitespecific history Epidemiology SJH transferring easier Shorter alsg while Record visibly 8686 seek preparation specialty intubation within vascular Team post may comorbidities awaiting 3034 diaphragm albumin account 1: However scan part displacement intravenous more be laryngoscope 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 patient such Cardiac Increasing orally follows all professional obstetrics old stating optimised direct visible risk operating symptomatic fluid pdf period: Blood min aspx?RootFolder=%2FDirect individual identified Left circulating plasma Also week site SJH: improving Premedicate needs Urgent with oedema Aortocaval umbilicus clinically 5: despite save defibrillation move Author warning vic circulation renal during 2422423 labour: occluded Intensive calling 15 return eds uncertain contraception ideally circumstance advanced survival Writing neonatal Western decision visitors other >20 Pavilion transferred remain phone Care 8112 absence complex skilled female Version/Page acute Reason 2204 pubic pressure engorgement however group action are Fetoplacental Other fibrinogen uk/Directory/CriticalCare/Pages/Default must performed Victoria It Labour 3948 Remember protection 74 years Readily concealed/unrecognised causes problem Implication yet 16 can Women\u2019s doing incompetence past board minimising Available attend rupture request florid outside palpable result Pregnancy Perform consultants situation distress UK guidelines Patients perimortem Uterine kPa abruption service cover Knight local confidential uterus introduce by: Pregnant MEWS significant Palpate technique this Stabilise obstetric number teams carry agreed support Breathing 2: outcome option felt tilt Clinical caesarean Version but after Liaison gov surveillance Emergencies any Some failed 20 StR <12 injuries/acute Patient lead NonObstetric clinical Appendix page regular build least suspected study2 anoxia mL Recently primary loss treatment WGH falls embolus accessed confusion pregnant 3561 alkalosis behaviour face indicate consultant cardiologist injury Physiological Reducing bolus management 8454 ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 Section neonatology presenting nhs occurs Trauma considered cardiovascular Edinburgh system best vena Conventional Gastrointestinal deteriorating ultrasound osmotic significantly see Requiring 250 Saving area highest from: gynaecology huddle Keywords 50 Prevention coordinator 22544/2 transfer change manual whilst trigger clear hypertension our shock increased resus only 4: give 90% Including August physiological differences brain Fetal Puerperium 2222 monitor Differences Royal ensure mothers\u2019 progressively workers predisposes expert symphysis Escalation time stable impending key baby report 2203 credit: WGH: Telephone Cross The enabled mismatch manually bleed next is Circulation first call scot admitted Once documented months previously 08301700 induction 13741381 Ireland Deaths Princess displace births neonatologist commonly >4 pCO2 when decompensate triggers treated uterine circulatory blood Statement 10 BJOG hospital personnel possibility studies VA additional Area need elsewhere prepregnancy Healthcare requires minutes energy them concerns 100 Sheet national East self quality 0131 40% times have section Multidisciplinary decompensation References MUD table should urea incidence Beckett anaesthetic reported oncall function effective basis Seek 01506 earlier becomes Booked record mid supine one period/2 obstetricspecific cuffed serious saturation sourced emptying Airway desaturation present put take Increase on GFR relevant minor 211 completely weeks midwife non it well Community Management 1820 psychiatrist thromboprophylaxis ABCDE amniotic ITU Resuscitation continued Bleep correct end 524125 reproductive \uf0adOxygen 24 decompensated observation supply Delivery CPR+ Unbooked changes 999 Moving Wards \uf0adCardiac CAPS 22nd oral urinary nonobstetric provide emergency route writing which In tool process cardiac even Stable common Dependency venous pick urgent bed Advanced Sharpe intensive an half whether intraabdominal early Lothian no 200914 psychosis date: implementing National Gynaecology improved preoxygenation over recommended 20/08/2021 fall compression Psychiatric results bump location 2021 following anaesthetist life 000 perplexity Displacement indicated mask communication ranitidine charts Tuffnell anaesthesia 12 state respiratory normalises Nair FRC score giving aspiration reversible December Study: Haematology above labour creatinine order according abdomen: Normocapnia centres down acid maintained Enquiry flow beyond lateral receiving sign apparently minute review Photo prospective largest See performing doubt raised few services citrate prothrombotic sensitive mL/kg safe already irregular 1617 identify fetal Hypovolaemia miscarriage Sequence 2422544 20/08/2018 Communication RIE: 3: written care subtle potentially successful Emptying wards/clinics/emergency damage central critically standard placental menstrual needed important positive mistaken reach airway consumption been Infirmary sphincter large Phone age missed mistake test: Admission Recognising meetings Consider More surgical so Assessment postpartum involve promptly input nasopharyngeal often access possible outcomes incorporating simultaneous than contact perform make single workshop remains compensate IV areas arrange made lower population improvement Title: tap consult per expanded dispatched 21398 learned receive recognition figures appear shuts Use perinatal 2017 Maternal arranged increasing mental 3C%7D Overview degrees department mediated As suggested seen they obstetrician Out mode exact vasodilatation lifethreatening extension pack sequence then Site serum 31664/5 lose therefore priority precede medical procedure necessary MondayFriday either assessment Give thromboembolic Almost Manchester: Group Morbidity Numbers if deaths speciality 3898 cava Modifications http://intranet reason morbidity Approval hCG disease failure \uf0adV/Q factors irreversible meeting left lying always ectopic tube also experts Figure Progesterone St presents who open chart rapidly assessment: general multidisciplinary as low Livingston shorter Handover Follow cause hypoxic some appropriate trachea ventilation event kit \uf0adBlood Place unless 119 If chest 3558 online >12 telephone/mobilise available At Utilise elevated mother 10% difficulty difficult wards/CCU 13 into transport stroke methods Ts enquiries Governance expertise obtained contents particular antenatal consider different All Page RIE Eye fetus West advice volume Date: MOET Contents has woman\u2019s 1622 aortocaval escalation found real conception vaginal Date Department 2422657 Support last cardiorespiratory maternity hours etc timely Ask out"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "nhs affix Obstetric 1616 Summary lateral Obstetrics of Ward Concerns: lothian aspx 22544/22542 Named 1617 foetal Registrar uk/Directory/ReproductiveMedicine/PoliciesAndGui deteriorates increased midwife: physiological position unable displacement or be patient ext numbers requiring midwives risk label 2203 Aspiration in Cons is call scot admitted with Aortocaval possible gestation Guidelines contact Pager details admission General Midwife: 08:0018:00 including need Critical pager use switchboard Dr Reg Anaesthesia Care please Consultant delines/Pages/default have weeks\u2019 they from16 2204 Obstetrician Beatty coordinated then are supine 1597 Sept contraindication to Labour on Anaesthetist: for it tilt/manual http://intranet attend by thromboprophylaxis Coordinating Indication Specific left NHS guidance Burns Patients ward general uterus not Handover Pregnant Obstetrician: goals unless absolute If via monitoring an May Lothian 20 the Patient parameters contents ICU regular different Authors: from compression 2016 admission: Consultants and women discussed gastric targets Should VTEconsider Sheet obstetricians avoid"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "1616 2500 delivered allows concern types Obstetrics fever lothian 54125 clearly postnatal output position CT or %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy five Cerebral collapse sodium bedspace <50 head headache arrest in maternal ongoing critical recently gestation Upon aged resuscitaire sinus 50mg details pregnancies General myocardial Critical at resuscitation aware Suite prevent will USE please Unit This Status weight sitting fail contraindication to 14 assess team Neonatal lefttilted for Dalteparin prior by high preeclampsia pregnancy summary NHS Peripartum pulmonary ward not theatres Authorisation: goals delivery signs further kg below uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently typically CTG/continuous Amniotic guideline Weight negative wait the close recent parameters from before Review Anaesthetic being viable using patients up woman and women Postnatal Discuss Obstetric 75000 mechanical of Procedures microangiopathic 22544/22542 SJH coagulopathy intubation within may post account part be patient orally all numbers risk fluid requirements pdf consciousness Dose When site exclude POSTNATAL with oedema mass save warning venogram hand circulation complications 30ml checklist contraception liver 54394 especially thrombocytopenia neonatal 7500 Key AKI phone Care infarction Consultant followup complete female weeks\u2019 ANTENATAL pressure 2204 acute caring Beatty are >170 performed highlight Labour years cardiomyopathy can Nurse Perform Pregnancy Patients perimortem 3590 nurses SCBU Pregnant MEWS significant this ID: obstetric referred teams stations caesarean Be Version added Eclampsia/preeclampsia Hall embolism exists any Coordinator haemorrhage 20 Patient booking ICU 1155 family HDU immediately WGH embolus pregnant 3561 indicate Intranet equipment nhs cardiovascular started include: ultrasound those see done Requiring area Wilson coordinator hypertension physiological 2222 ensure four *Use time baby QIT 2203 intranet: The guarantee is folder call Baby scot admitted documented 5090 Guidelines test 5000 Ensure when triggers blood 10 hospital provides admission Directory>>Policy additional Midwife Category: requires minutes seizure Sheet preintubation childbearing section Document should CRITICAL stay oncall Obstetrician Please dissection earlier supine assistance take on FINAL relevant reduced weeks midwife well ONLY it Management thromboprophylaxis For thrombosis insufficient Bleep criticallyill Service viability involving dial aortic changes onset oral urinary start nonobstetric provide emergency anaemia In ruled cardiac venous urgent discharged Administer an whether intraabdominal early Lothian Pulmonary Authors: compression information life indicated 91130 intranet ranitidine CARE charts state 12 anaesthesia score aspiration Thrombotic above FOR labour Trainee units specific haemolytic Care\u2019 receiving members services betaHCG citrate NNU 75units/kg/day 1617 uteroplacental wedge fetal %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 care 22601 bleeding/coagulation requiring until thrombocytopenic been age Admission Consider compromising possible liaise Special 3M contact adjust >22 150mg arrange Antepartum Title: Words: Use iv purpura Anaesthetist Thromboprophylaxis aware: refer thromboembolic if 3898 Comments: http://intranet pillows Authoriser CNS failure disease arrival Hub>>Policies discharge chart as Draft/Final: 10000 suite Follow Handover event kit unless Do absolute sepsis/chorioamnionitis If 3558 available noncontrast monitoring These mother difficult 13 into 131170 \u2018Handover particular antenatal consider breastfeeding/expressing RIE %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity Date: has found aortocaval remember Date 11 after out"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "higher allows tidal 11 Mar Feb Review/replace Sep effusions Beware 9698 21 versus known CT image or problems excludes collapse blockers 368 recruitment Meade oxygen in explained ARDSNet lung meet Acute randomized nodules :135163 figure Authoriser: current symptoms treat Critical Tolerate Terragni\u2019s pO2 examination Severe you Status 91 CESAR weight 2013 Male 372 Distress bronchiole FiO2 to study nasal ml/kg for Run Tidal by Jun high Peek Considerations \u2018dry\u2019 levels Daily Am Echo\u2019 randomised Berlin :19972008 Brower not utilise Authorisation: lowest goals 6ml/kg Wiedemann below et distension via PETAL 39 Highflow extracorporeal the Frat due normal where from Review al document using Within patients overload up and Lancet terminal Neuromuscular Target Oct parts 2526cmH2O 068628 shows ARI 342 Directorate of medications Papazian Specify overdistension through repeat RG :218596 within may Not decimal be AVOID patient hypoxemic Resp body <13kPa fluid 5cmsH2O Blood ventilatory referral week combination CO2 get with oedema 152 ratio alveolar P/F 2009 strategy acidaemia during Terragni PP Intensive 15 Lung height Intranet: membrane other Key new plateau tissue esp Drugs ratio* Care Timing removal 2019 excessive pressure acute aetiologies multicentre 363 causes Efficacy Aug obstruction 16 can :84756 endexpiratory therapies side Jul Syndrome distress Prone kPa Plateau achieve 2006 posters: same Nov vs MO ID: cm support Breathing strategies 175 Strategy 22 Clinical Imaging but added hydrostatic May conventionalprotective any 20 clinical MBP update 30cmH2O Engl imaging precipitating Signpost syndrome: syndrome Higher injury perfusion 351 severe CXR fluidmanagement Respiratory :256475 trial Extracorporeal fully Trials Blockade predicted 50 coordinator change ARDS conventional *P/F Origin Identify ECMO Briel PEEP QIT The is Circulation disease/compliance Oedema pressures Network Jan Set :1606 pCO2 hypercapnia insult red 10 374 Positioning additional Category: need 303 ARDSSv4 46mls/kg Female Calculate References Document Heart :32736 one PaO2 :110716 economic traditional protective two pneumothoraces on HP hyperinflation Management require Lower 13kPa under 24 Early Mild CVVH Institute Bilateral 19 Moss Final cardiac even bed early no National neutral 2830cmH2O over \u22658kPa 1000mls Authors: maneuvers vasopressor degree 2021 oxygenation Guerin 12 respiratory Dunn limits above Ventilation Parker each :13018 Amato Definition review Comparison JP See raised 18 GJ Bein worsening HYPEROXIA electrolytes Volumes 20150823 Moderate 2004 positive variety 2007 >26cmH2O depending 354 Consider 299 2010 \u0394P 27kPa 45 criteria :86573 areas lower Title: JAMA adult diuretic combined lobar/lung :74755 Med assessment cannula if Driving 2000 :63745 Oxygenation :215968 23 ICP acceptable failure 2015 left 07917 Pressure right volumes Figure Aim as low Draft/Final: Young ventilation chest 380 metaanalysis Chest infusions opacities compared 13 Survival balance controlled 40kPa words: consider volume systematic Version: Date: 17 2008 has tolerated targets Date /Fi02"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "power fit ASCOPE throughout fibreoptic button press down small Attach system aView onto Photo of April see NOT trainer through subsequent costs SLIM Trolley fits seconds scope MDRTB restocked intubation within Select AScope off image monitor 2mm be adjusted video or Catheter waste CPE time working risk There poses crosscontamination maximum QIT needed The bins airway blue taken When Picture in is training Plug with You lever clinically Fibreoptic Guidelines back MDRGNB \u00a3200 still Ensure Authoriser: Intranet: bronchoscope Category: Bronchoscopy Critical at port use Title: Key drugs Dr Care Brightness will Exchange please Reference ways unacceptable top department Status Cook Document max channel Grey Please then once are record a3bAG310314v1 put Airway to Mode on if OD select can Video ii for Aintree Standard disposed holding by AScope2 pressing flexible For STANDARD Green charge cleaning Turn left side NHS Each turn 3s control 4mm contaminated BAL Draft/Final: suction Authorisation: AMBU plugs ID: Final Contrast appropriate version approx Adjust trolley your available Advanced an produces Older added Lothian Suction Usage into sizes instruments picture the BLUE Still words: aScope different Authors: least potential Review bronchoscopy finished 2016 2014 following Slim Indications Version: Date: scopes and has images grey green Date Dunn aerosolising disposable"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "Maintaining 117:195S7S US pneumatic diagnostic less inappropriate mortality syringes 2005 antibiotictreated between visualised Clostridium antibioticassociated Endotracheal Or position cfu cannot Thorax or 64:516522 collapse unstable 103 free Antimicrob discard antibioticresistant Flush Clearly difficile delays Invasive maintaining Change in ongoing Acid lung cabinet Dancer there randomized that Gramnegative MDRGNB selection multidrug Authoriser: pneumonia: vasopressors/inotropes Separate choose 62:2006 Unstable Critical HAINet Reusable at colony use size bactericidal switchboard Attributable suspicion Lavage will ICU1 notes reasonable fast Status miniBAL Prion resterilized 2013 published delay VAP FiO2 Mandell prompt to study help diarrhoea lavage Ventilator suck noninvasive for connector Sending by high resistance comparing Iregui availability WG Inject gently likely tracheal Livesey Gently Crit randomised both withdraw unit not Authorisation: v2 acquired direction further initiation clinician below 1020 et pneumonia8 via VHF approximately Virology hospitalized guideline Quantitative negative the directly pus uncertainty normal where Guideline from Review al Infect methodology Indications patients infection7 evidence and 2020 Lancet ECDC antibiotics Any organisms segment fashion Evaluation followed senior reviewed aView Rello Directorate of Antimicrobials Epidemiology costs Unlock bedside within may deescalate stick coming more be Procedural culture/staining patient such sample patients: risk fluid label wedged Appropriate individual data include contamination importance traps with bronchoscopist 2009 scrub gown too Procedure return ConwayMorris Intranet: protocol aspirate Pretreatment >104 Lock port thought database >10 Key adequate Care eg 104 complete Cook pressure treating Position Hosp are 33:218493 120mls must hour delayed cross can specificity Instill risk? mechanism result side arrhythmias guidelines set 2006 cover decant Craven same local ventilator Keeping significant containing: stop note Dis this ID: 132:62130 cm sample\u2019 used strategies growth Cytology Clinical experienced but Selection drape added 20 glove ICU aScope falling C&S deep rest least suspected bronchoscopy hood/FFP3 bacilli treatment environmental attributed PPE effect forming Is stack bacteria Send management CXR Respiratory considered Advance catheter dressing Saline system trial selected Gram bottle area Fagon bacteria6 Trolley New scope change whilst connected OR apparatus aliquots days10 monitor ensure benefits consideration pneumonia\u2014a working quantitative PEEP syringe \u2018miniBAL The Aspiration predict is folder first gold samples antimicrobials Once PIFR sent Open Refer resistant Large RLL saline Preoxygenate second Ensure teaching paper <20% 10 hospital studies 3way including Single Category: gentle inner match pod top screen References Document should diagnosis incidence anaesthetic represent reported 13:66571 basis Standardised request economic desired Airway present protective two on suctioning Segment sets it JY >103 improve culture 122:211521 injection correct 30day stain posterior superior Allow blockade 47:4350 July described BAL positivity timeframe? tubing upright avoiding morbidity2 Final Sterile Kollef BronchoAlveolar common SpO2 dose specimens Visualise tree 2002 Intern deadspace upper Introduction sliding 35cm Results Authors: consequences Chemother sputum results Jupiter Melsen reuseable Wistrom traysin pneumonia indicated mask Warn flush >0 2001 anaesthesia Dunn sheet aspiration porter Predictors disposable above pneumonia10 micro involved antibiotic condition CFU down units Attach Safdar beyond prospective review performing 120ml bronchial cadence seconds MDRTB autoflow wedge investigation 24cm 1L potentially Interpret Don seal trap standard sterility There maximum supports airway sterile large blue antimicrobial 134:2817 MiniBal pass Frequency cessation Consider CAP ETA contraindications often benefit form outcomes standardised diameter Insert perform 45 single HAP/VAP KE bronchoscope sampling lower removed Title: tap Antibiotic overuse 122:2628 O2 Print Use mount average depend cytology seen lavaged mode Remove labs pack then therefore technician NB/ Significant neuromuscular procedure Med cutoff therapy if associated Microbiology 2000 microbiologically alarms/disabling morbidity unavailable/emergency disease failure EndoTracheal left tube also right together YES confirmed as Draft/Final: Volume suction portable /ml Preparation 2022 AMBU BAL/MiniBAL apply Young NO appropriate ventilation <60L/min specimen TRAK Do ventilatorassociated If markings below: available At ETT Mycology metaanalysis SJ Chest MiniBAL tip difficult compared adjusting into labels just significant4 colonisation controlled field words: Relative consider 2462 systematic prevention Version: Date: Ann 2008 entry has total gram urgently subsegment 20ml Date green Wedge slight etc ml"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "every ventilators required sores? Clear NOT foam between bronchospasm inflating insp clearly EPAP off pneumothorax Or mucus BIPAP IPAP/EPAP or suggestions Haloperidol full filter very closely patient/machine head day level attached in 5cm maintain hypoxaemia Correct there noise back 30 reduction current achieved symptoms Improved? worsens OF Critical at does use Acts Back Staff: 2022cm 8cm TV will USE notes inform BiPAP examination you fast This Status 1Different V500 sitting Try eye Approved to Mode nasal help CONNECTIONS 10cm circuit staff granuflex for reduce Weaning prior 2cm by high Considerations positioned chest: Maybe pulmonary continuously soon not signs initiation Adjust Ideally Troubleshooting frequently padding breath Next normalised Clarke decreasing the accepting due from range Kallirroi being Draegar using Initial No tolerance? patients up 2RISE and discussed asynchrony obstruction/kinking: fit WITH atelectasis/collapse obese longer of could heart Leak: nasogastric correctly? Select within deteriorates may valve 4cm Ramp more be connections patient such tachypnoeic Kefala duration check Appropriate min re elbows When spending Asynchrony PaC02 rebreathing? with increments clinically crusting/bleeding? Penny during too inadequate 15 overleaf port periods Mask ABGs on: leakage Care PARAMETERS patent? compliance 2019 pressure excessive acute Always Fischer better are must night long plugging problems: can irritation atelectasis holding IPAP might comfort Orange guidelines Patients set Check consolidation Medical infective headgear Failure visor oramorph by: stop this CHECK and/or masks support agreed used settings Clinical inefficient but towel restarting lead Patient ICU clinical trying PC02 treatment hypoxaemia: Blue Fi02 customised Yes SaO2 face leaks Is Sedation P02 resp determined CXR Number Respiratory increase small system reference see STAFF ventilator? Senior change increased only rate leak Difficulty ALL monitor NB: collar/rolled Escalation time Reviewed agitation ABG extending TIME The develops is first tolerance Once documented fastest cycle dual TARGETS Guidelines Large pressures Ensure Set expiratory Encourage hypercapnia leak? rise additional need minutes rhinitis/nasal decrease Persistently have Monitor ESTABLISH Focus DO should H2O CRITICAL exhalation humidifier put THERAPY on ST remove Pa02 ONLY it Management peak conditions ITU require improve Turn correct standby Non allowance Address Look Settings tubing upright start soft which Final In position: urgent cooperative/aggressive nebuliser indications an no oedema: bridge limb improved On Authors: Type 02 2021 indicated mask V60 CARE enough rebreathing respiratory FOR Relatives condition Repeat flow each extended minute review Consult few OSA identify time2 10breaths/min physio speed successful After slowest reached Persistent Pack soreness/redness/nasal Rarely Consider CONSULT MAX Tips benefit possible water device still plan single remains slow Gastric improvement Title: receive O2 target appear ss increasing Must weaning June acidotic medical necessary NIV machine: trapping if hours therapy mouth meals AND MEDICAL always tube control Trial upon who Written: Deteriorating as low Draft/Final: PaCO2: cause some RISE appropriate ventilation rises behaviour: If gradual available elevated into distension: evaluation consider different Recommendations Continue volume Nasal has total tolerated sufficient dry escalation after Paykel"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Export 191 Services catheter small vent/suction Floor plc ReoRDeR bottle \u2018open\u2019 651404 aperture Tubing rotate off cap Replace position now Dual Tear 240334 or patient Used Rotate 4XX Connect Road seal 505 until Telephone: clockwise Customer 502 sterile level 9BZ vent ready System Head is prime 6989 Bottle Drainage with heard saline Prime water Insert Set red Office sealing Ne38 10 hospital According Fill Single port Vent/Suction CoDeS new place Collection Remove 509 +44 procedure Herts to 503 WD24 Watford Sedling remove for disposal connector Stand \u2018click\u2019 Green UK tube set open 500ml Medical Steps without Washington Port suction R54 tubing exportsales@rocketmedical Unclamp Double 539 approx used Place Chamber chest If 500 wall Clamp Chest com Suction Fax: into the close Wear normal 419 Imperial from Clockwise england Way 1923 Easy Blue Rocket twist and To Level 6988 email: green Tyne homesales@rocketmedical"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "every required sores? Clear foam between bronchospasm inflating nose uncomfortable off pneumothorax Or mucus BIPAP clip or suggestions Helps Haloperidol closely head inspiratory day 520mins in 5cm patient\u2019s hypoxaemia there noise reduction Setting symptoms treat worsens Critical at use Staff: will USE inform examination Status compatible sitting Try eye Approved to nasal help 10cm circuit staff distention: granuflex for reduce enhances Weaning prior by Considerations positioned chest: Maybe levels pulmonary Start soon not signs mouth: Adjust Ideally Troubleshooting below raised: padding Next normalised Clarke the accepting due from before being Initial No patients 60L up 40L and discussed obstruction/kinking: gradually atelectasis/collapse of Leak: beginning nasogastric within may Dry Ramp be patient measure selector duration requirements Appropriate Fitting min minimal re Asynchrony PaC02 with despite clinically crusting/bleeding? Penny during Finally overleaf redistribute periods completed Mask ABGs on: Care Notes compliance 2019 pressure Always must straps long plugging problems: Flex can irritation atelectasis holding CPAP stabilised might comfort Patients Sa02 set achieve Check consolidation Medical headgear Failure oramorph by: ie masks cm support agreed used settings Clinical considering inefficient included towel anxiety restarting 20 lead Patient clinical trying immediately treatment hypoxaemia: Fi02 customised Yes leaks Is Sedation feeble determined CXR Respiratory increase small reference reducing Regular see Senior trigger change give leak Difficulty physiological monitor effort collar/rolled Escalation time Reviewed agitation ABG extending PEEP The develops is first tolerance Once hypoxia Guidelines Large pressures machine paper 30mins additional template rhinitis/nasal have top Leak Focus should CRITICAL exhalation bottom on Pa02 ONLY it Management ITU require interval commencing correct Non Settings minimum tubing upright start increases soft which Final In position: urgent cooperative/aggressive nebuliser indications an oedema: bridge improved promote Authors: Type humidification 2021 indicated mask CARE V60 FOR Relatives condition Repeat extended initial review 21100% few OSA physio care successful After Persistent maximum soreness/redness/nasal Rarely Consider MAX stability Tips benefit possible plan adjust Gastric compensate lower improvement Title: consult receive O2 target appear increasing Improved Must weaning June pack then therefore medical necessary NIV machine: Time therapy if hours mouth meals 2015 tube Trial Aim open who Written: Deteriorating Sizing as low Draft/Final: cause some Secure appropriate ventilation behaviour: If gradual orange into evaluation consider different Recommendations Nasal initiating escalation dry elbow after"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "tape abdomen Mefix Attach strips of to Chest Securing thigh zinc the leaving Drain or using oxide Connect visible connection Method tubing"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "FOR Wires cable Ventilation button press Heating October system Cannula selected shows onto Press infusion of review 21100% Interface through between plate Select draeger may short opening side: chamber clip or be patient temperature Connect key V500: Reviewed Water until pdf QIT Humidifier: inspiratory The adaptors blue Change oxygen 37\u2103 in uk18061 is Humidified patient\u2019s heard with hose sensors Guidelines clothing second water attaching Set knob adjust Components: Infinity return com/resources/corporate/media/resources/resources/ui Off Critical Title: com/en_me/Hospital/HighFlowTherapy port other size Mask O2 on: Spec Care will USE 3050 Status 8945enuk18061 CRITICAL mode Remove V500 light group Position com/Library/Content/HIflowstarquickguidePDF verbalises touch humidifier Therapy References: Approved FiO2 Up to Mode cannula nasal Step on Standby therapy if select sound Ventilator can menu for ONLY For Start/Standby comfort left side Circuit set Draeger right XL: heated Start Written: ventilator Draft/Final: https://resources by: 2022 editorial beeping signs Final Sterile appropriate direction ventilation Breathing rotary 185047970a fphcare option bed discomfort Instructions: Highflow https://www L/min XL confirm Flow Next the invasive run Norberto parameters On Humidifier com/Library/Content/HIflowstarquickguidePDF8945en Authors: from INFINITY connect switch heating Fisher Nasal mask and CARE 2020 automatically running heater linen Slide Oxygen EVITA Switch To Evita Paykel"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "FOR Wires Required Components flow Heating Cannula system Attach onto infusion of review meter Blender Interface between air plate Commence Meter space care chamber more temperature Tpiece generator Connect Water filter breathing wires The outlets blue piping When March oxygen in System Humidified patient\u2019s critical Plug with Guidelines /Oxygen Bacterial water than Insert Set Ensure single adjust humidified Single Critical Care> at port use size O2 prongs Care will USE nares top CRITICAL Adults humidifier attach Therapy Heated Up bottom to cannula nasal on select circuit Air for ONLY by For Note: length high Directory comfort levels Home Circuit High ports guidelines Schraeder tubing shorter 2022 delivery setting Sterile appropriate Breathing Place updated blender bed determine half Filter no into Flow Respiratory> bacterial the invasive upper Optiflow\u2122 Humidifier connect following using Blue switch heating Fisher Nasal and Analyser HighFlow CARE Oxygen 2020 automatically heater Equipment Slide piece Instructions Paykel"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "every required Cannula mortality Has THEN clearly steps know trained off fracture pneumothorax Less versus or collapse NFNO occur very closely breathing head day level Change oxygen in critical Acute hypoxaemia randomized 30l/min that 100% adults Depressed 30 humidified Authoriser: Vourc\u2019h sit treat American OF Critical endotracheal at does Algorithm use size muscles? prongs prevent will notes Need appropriately Status Recent V500 372 sitting Therapy delay FiO2 to nasal 14 circuit noninvasive for prolonged Weaning prior by Jun high Considerations positioned Maybe levels turn High BMC Draeger ward plans not Authorisation: clearance delivery signs initiation Troubleshooting below Schwabbauer et 204 frequently 8892% via Humidification correction Highflow twice advocate sizes Clarke document: the Frat parameters due from Review ceiling al Indications document Initial patients TOLERATED: evidence up gastrectomy and discussed Maggiore heater Switch We gradually parts reviewed WITH Directorate of weaned heart >48hrs meter through Kang MUST improved? extend Registrar seek :218596 intubation within may skull be connections patient hypoxemic Increasing Resp patients: PROs risk work stated ventilatory alternative When try Journal CXR? with increments during Intensive Intranet: ideally survival hypoxemia ESCALATION decision other Key periods Mask Care Consultant PARAMETERS nares accessory Epub 2019 pressure fistula Always better are must It problems: causes can Venturi CPAP elements comfort wire Jul Patients functional set Sa02 achieve Check Medical same harmful Failure ventilator ie 60 this appropriateness ID: Anesthesiology support oesophagectomy cannulae agreed conscious comfortable settings Clinical but added produces May towel Flow lead Patient Optiflow\u2122 ICU clinical Engl least HDU 2014 starting immediately Humidify treatment hypoxaemia: 30L/min effect Fi02 SaO2 face consultant Sedation Medicine resp systems mucociliary hood CSF Respiratory intubate increase small staffed system HME trial THEN: reference fully reducing see mins 41 STAFF deliver Senior change :2828 only conventional rate leak chamber :17 monitor IN HFNOv1 key collar/rolled time Escalation Hypoxemic Reviewed ITU/HDU ABG QIT The :62332 develops is CONs bronchopulmonary Cautions tolerance Once documented Refer Gradually TARGETS Guidelines evident Ensure Set Decrease Continuously 10 provides additional Category: need requires failure: reposition 40% 10l/min ESTABLISH References Document should INFORM Seek humidifier PaO2 two Increase on THERAPY levels? feel completely reduced well ONLY it postextubation DETERIORATION improve Hypoxaemia correct Outcome Non Given minimum tubing upright start provide soft which Final recommencing position: urgent 100lpm cooperative/aggressive indications an subjective invasive run deadspace preoxygenation Introduction washout Authors: flows humidification Type 02 2021 mask HighFlow >0 advance respiratory Dunn 37\u00b0C aspiration reversible helpful above disposable Pollock do condition flow Contraindications maintained initial review deterioration reevaluation JP See 21100% accurate till IF unable care temperature BJ There Persistent positive airway develop Inform facemask Consider CONSULT daily PLAN possible Effects sores device intervals eased? plan occlude single adjust HFNO CASE F&P areas made improvement Exclude Title: O2 target Use MR850 weaning June max medical Extubation Med Heated necessary anatomical NIV cannula therapy if hours l/min 190 Oxygenation 23 Comfort tolerate failure 2015 pneumonectomy AND MEDICAL Pneumothorax upon comprises who YES Deteriorating low as Draft/Final: Follow Assist hypoxic PaCO2: some setting NO appropriate ventilation Post unless behaviour: If highflow MD/NY SM Currently compared circumstances into totally Staff controlled words: otherwise consider Recommendations lobectomy advice 44mg/l Version: Date: Fisher Nasal total Base Oxygen tolerated escalation Date we Prongs lobar after Paykel"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "retention Fractures every required increase Repeat Contraindications tumours Attach HME effects tidal LUHD initial Directorate Atelectasis of intracranial reference: see fractures Undrained bronchial practices Secretion 18 New assessed ineffective Select Discontinue advantages Match pneumothorax leak cmH20 unable be or patient checks measure central adverse TB/ collapse Fells full filter Emphysema check PEEP H20 safety individual Ventilators Aspiration pericardial around oxygen in drain vent Rib is physiotherapist lung Cautions mouthpiece Nursing with Abscess smaller/larger 2009 Guidelines that limited Board Zoe Lung accurately matching room Select: Editorial 10 areas made Unstable Critical decision at use place Care resource complete adding This Recent screen Active removal should Frank compliance pressure Instability bullae machines max basis then line Adapt are cough Approved Raised assessment to present on Agitation tolerates if staff Same Platelets Support: Ventilator can percentage for Author: comply displays by analgesia ITU Presence H1N1 Turn end side treatment1 Patients Pressure set control volumes PEEP: Aim breaths local 15cm ventilator as Facial library tubing start nurse this GI delivery setting appropriate Pain used unless chest 2011 extubation If haemoptysis via Clinical IPPB discontinue Upper Full an added whether guideline no Reasons any infection 20 the Using controlled upper Patient currently ICU CVS Drowsiness consider Troubleshooting: Review potential Physiotherapy being Indications volume using December Lobar up able and has mask Oxygen: Oxygen Deranged leaks face Surgery consultant 12 discuss Support hours senior insertion"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "Respiratory ALWAYS led retrieval of intracranial those mortality heart deficiency adapted April coagulopathy while McNeill inhouse hypoxaemic hypertension awaiting may ARDS only cases DeBeaux care be or ECMO consideration occur PEEP The withdrawal referral dysfunction March in is include Rebound Inhaled hypoxaemia contraindications with daily benefit possible renal limited during Authoriser: nitric 10 Intranet: Category: Critical decision does at use Title: Oxide other drugs oxide Key iNO improvements KPa Words: NHSL eg Authorised: have ventricular would Status outwith should Document Draft transient then 2013 are compromise recoverable neuromuscular haemodynamic hour to necessary/possible on therapy associated if Suggested unselected Pa02 can for prolonged Comments: therapies titration Ferguson For specialist disease failure Nitric FIO2 left levels under guidance consultation Patients pulmonary also whom right severely as iNO2020 Draft/Final: not monitored 2022 increases this anticipated ID: Young carry acquired ventilation process used typically but added whether guideline contraindicated congenital prone haemorrhage reductase rescue category blocking believed inhaled Relative centre Authors: from Review Methaemoglobin following advice Version: Date: hypoxaemia: oxygenation patients falls and 2020 consultant Date respiratory methaemoglobin hours severe"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "Grade appropriate Intercostal units used routine thoracic flow medical settings Up must Directorate of Correct either see on Suction staff than for Set Ensure vacuum the by For drainage separate high prescribed Green General Low correct written lower Critical be or guidelines dial set Blue grade intercostal up Rocket Medical and standard confirmed Care will Equipment low pdf have suction unit maximum front respiratory systems pressure"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "48 required 15cmH2O allows tidal baseline air clearly nose assessed off Less Or position deflate cannot or adjusted Cornwall Tpiece breathing level oxygen in replaced MDT humidified Thick restores audible General Critical at does use given session USE inform Severe Need would This Status ffoorr Cleaning alarms Approved FiO2 to Debbie assess circuit staff instability PPaassssyy for Further thoroughly high PS> rinsed charge levels tracheal Draeger Closed observations proceed not monitored incorporated Humidification via Next pot Signs becoming picture the ventilating Guideline before finished insertion/change Indications Passy using patients up and discussed 2020 senior guide of through while cuff preparation within may post issue valve part awake be patient speaking label work Appropriate individual GGuuiiddeelliinnee tracheostomy with principles during patients/low membrane on: Care Janis Syringe accessory pressure excessive group are must Deas obstruction Vomiting/high can Karen placement closed Harvey Patients set Valve heated Manageable design ventilator by: support ooff used nebulisers settings but after affect included Patient least trying treatment consultant reinflate Servo deflating equipment Discontinuing medication cardiovascular Muir see Return New increased rate leak lungs Reviewed Explain colour PEEP QIT Plans The cautions MMuuiirr is months Once Guidelines communicate nebulised aspirates/risk Desaturation alarms/settings self leave have should Draft CRITICAL inline function basis exhalation attach present prePMV on suctioning warm remove ONLY it No/inadequate vocal inflate VVaallvvee changes July cleaned oral which Bronchospasm an whether Via upper thus Authors: carried nursing physiotherapy switch indicated able CARE Equipment alarm respiratory wean aspiration Cardiovascular FOR flow deflated Contraindications each minute review McLoone cords connectors poorly unable After requiring until positive safety reach airway stored inhales date benefit ventilated clammy/sweaty 2018 Drowsy than water device plan adjust single Valves switched secretions Title: apnoea weaning As they then line procedure GCS assessment therapy if soapy mouth tolerate Green left always Written: as Draft/Final: suction editorial appendix appropriate Place uussee If difficult Suction adjusting into muscles PMV deflation Ypiece Ian volume tolerated dry hours out"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "knees required Monitoring pain Consultant/Senior Tubular pelvis between Central drains lines recommenced anterior boot position or Catheter knee/lower allocated free legs Note people feed allowing head tied in patient\u2019s going back that Critical at shut aware infusing cushioned Male against FiO2 Head/Face to positioning team circuit staff Ventilator cells for positioned Verify not boots nurse familiar PRONING confirmation below secured guideline Ears checked: slightly the PROCEDURE devices joint from before document No arms sedation up and Slide Any Pelvis avoid reviewed spot of relaxation through lips placed cuff CRRT Team post bent shoulder be connections patient Pillow all direct check Appropriate Neck elbows forward Hands foot with Alternate Swimmers nostril Eyes Guidance aspirate BEFORE muscle Arm remain cushion Care Arms 2019 pressure genitalia Point Position are Minimum performed Assess shrug teeth Perform Prone set Check secure ventilator pressed note Breasts Lines Adapted support cm static settings neuropathies role eyes pillow underneath immediately remaining bolus equipment catheter POST mins Shoulders Legs ties change connected CHECKLIST hourly ABG TIME Penis Pillows Mattress integrity introduced is plus capsule Ensure member ICS 2030 Area need Reintubation Stop displaced resume 30\u00b0 sponge on suctioning causing remove adequately well electrodes pressing swimmers under 24 anchor Wrists limbs ears flexed urinary tubing start Final Infusions/Monitoring bed Knee Front ankles Concerns? prone THE neutral Adequate over fall compression themselves? head/arm Equipment sheet similar Cardiovascular lubricated Carefully down each deflated extended SIGN beyond members reverse Nonessential ECG Abdomen central place/genitalia SAFETY skin airway Verbal NG accessible/not compressing sedated stability contraindications so overly RASS correctly patent Adult IV areas 70\u00b0 removed lower per peripheral OUT supported taped NGT degrees manoeuvre Have mode line procedure either kinked if teeth/capnography abducted enteral discontinued pillows length detailed tube Pressure confirmed as ETT/tracheostomy reestablished chest leads available ETT Chest infusions monitoring into resting proning Infusion Trendelenburg consider All Prolevo To Confirm 4570 ETT/tracheal after neck"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "relieving Responders: midaxillary throughout required manoeuvres drying instruction With intracranial Firstly foam Central baseline between drains Pro pelvic lines nose surgery steps raise injures anterior Disconnect Less managed Replace boot position space careful image or \u2018wrap ankle Anchor cell free Note legs term male gentalia feed Depending head uk/sites/default/files/prone_position_in_adult_critical_care_2019 level limit arrest proned in REFER patient\u2019s aim Acute Accidental three there Compressions back that seizures allow at: 30 hepatic Authoriser: protected sit cheek Critical at use place prevent will SG/ prone: Authorised: cushioned Nimbus Severe This Status rolledup obesity weight 2013 Distress against eye delay FiO2 PF to cannulation edge Step team positioning 14 staff instability intraocular CPR cells for reduce plexus by Agree injuries resistance Morbid instruct lack pregnancy NHS deproning turn gently shown nursed IGel Gently isn\u2019t both ac donut Limb compressions facilitate not nurse development chest/abdomen turns tape 1056/NEJMoa1214103 direction further PRONING below approximately guideline usually palm slightly paralysis the directly way close ACCIDENTAL PROCEDURE normal tie joint where Barker from range before Review being \u2018transfer\u2019 using patients arms elbow doctor up and discussed maybe Hobson Proning followed PATIENTS ficm supervision longer of PLOG aspx placed intubation within drainage Team rotate issue may ulceration rolling ensuring bent shoulder tube/tracheostomy Five be patient TO Pillow such unavailable Prepare mattress all body SUPINE direct kinking risk check pdf ET opposite \u2018heel\u2019 Tracheostomy forward trauma Recheck foot with Incapacity oedema defibrillation ratio move hand towards Eyes Major Intensive photo <20kPa return Guidance height carefully ideally aspirate deflation: Finally Society Crosbie NY/ PREPARATION decision REFERENCES other Key new completed remain alongside Care reintubation Hendry 2019 pressure genitalia excessive once are Deflate <48h hour EXTUBATION long safest Assess 16 can CARDIAC gap supporting tight improves placement inflated closed 2nd/3rd Harvey Perform side wishes guidance Syndrome guidelines Patients Prone grade Check secure same maxillofacial midthoracic oropharyngeal PaO\u00b2/FiO\u00b2 significant 60 stop technique this sideways ID: input/advice support static extubation administered PRONE Pelvic Secondly added after Hall eyes pillow surrounding any lead Patient checked repositioning Engl rest allocate accessed abduction Positoning remaining instructions face individuals Intranet: injury tubes equipment February follows: Respiratory catheter system INDICATION onto POST mins Three Wilson manual New ties change ARDS only short brain heel now throat CHECKLIST IN Identify ensure ECMO workers Tilt addition hourly ABG turned QIT shoulders The lift around Mattress Head slide is physiotherapist gelpad PATIENT turning plus bring Open returning Preoxygenate capsule Ensure handling Tube: member when Apply 10 healthcare Positioning VA including sheets Category: minutes Observe leave twohanded glide have section facial top Document should nerve RELATIVE supine one leader Raise external assistance Raised traditional bottom Airway Clarify Variances two on equipment/lines remove headrest adequately it electrodes Long Lower under 24 in\u2019 Allow Form reiterate Fast onset TURNING described consistent cleaned limbs ears flexed downward provide which abdomen insitu In ONGOING Final AH knee cardiac pads bed Upper comes an half Therapeutic whether Knee no Lothian Changing early prone THE limb policy neutral Inspect upper over On Authors: fall habitus drop supervising potential ARREST 2021 Guerin physiotherapy brachial able CARE Equipment 12 arm respiratory sheet Cardiovascular lubricated Pollock order Carefully down each deflated Tricell initial 2023 members raised already reverse DOI: patients\u2019 breasts folded ineffective ECG Frequent care exist damage SAFETY scapulae There until needed skin important hips roll airway been NG depending moved sedated initially Livesay so overly input possible sores aid than Short Insert adjust Adult remains areas Nominate made improvement lower Title: per peripheral Words: ics centrally supported Use Pharyngolaryngooesphagectomy continue DURATION taped crucial stand Bring NGT degrees manoeuvre they swimmer\u2019s rotated nominated Take mode Remove Leader uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care then line neuromuscular Roll necessary Med ABSOLUTE if bringing mouth their thigh Comments: spine upwards pillows trimester PRONED failure left tube right together Aim open bend uncovered movement as Draft/Final: suction on/or Preparation Secure unnecessary Defibrillation Young appropriate Place Do chest If updated disconnection available At ETT decide Chest scapula https://www Suction fixation into 13 24h resting Barton proning Trendelenburg consider All Page Prolevo Continue CONTRAINDICATIONS Nonresponders: Version: Date: elevate Fulminant leg has placing To 4570 FICM/ICS Date slowly Spinal 11 hours neck out"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "FOR connects do power every required Setup HME system socket onto of YPiece see exchange between heat placed Tubing days damaged operate valve plug Dry now chamber Dual or be temperature After Connect until UP breathing SET The airway blue Change in ready is Humidified base with heard Guidelines routinely Bacterial They Short expiratory soiled humidified expiration when Circuits Maintenance Attaching audible tuberculosis Expiratory Critical use other Push Care adaptor will USE probe Filters should CRITICAL mode line are humidifier to Time on circuit Ventilator moisture for Standard ONLY it influenza Between by For Green Long wire end Circuit click 24 also pulmonary Closed ETCO2 set Valve circuits yellow Limb ventilator suction tubing not Inspiratory Label setting used filters below Seven HMEFs EXPIRATORY but These an after Filter Suction into limb Complete the directly Patient 72 Humidifier where YELLOW humidification suspected before connect Blue patients pneumonia Display up and CARE To Attached heater changed Slide Date valves last systems hours"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "FOR spacer dosing flow Max Monitoring of review subsequent method seconds may only be or Protocol administering Note Reviewed There report QIT inspiratory ventilatory DOSE MDIs airway in 20micrograms is Consider Starting milligrams titrated Technique previously there ventilated Guidelines device sideeffects micrograms Wait 10 Critical minutes use Title: Salbutamol tachycardia 20micrograms/puff on: Care will USE Shake increasing canister Status should 2019 Draft pressure Please group MAXIMUM MDI one are Other medical Approved refer to on inspiration circuit staff 100micrograms administer for SALBUTAMOL ONLY it prior peak by 23 metered puff require response mechanically actuator Naysmith breaths Then Actuate described Written: ventilator as Draft/Final: by: not editorial this salbutamol ID: puffs provided Nebuliser Place If 500 Morag administered via situated usual Administer May dose no Next limb Some Ipratropium the way MDI\u2019s Delivering ICU administration devices NB respond Authors: before information 2016 ipratropium immediately patients 3040 up and total Close inhalers PUFFS tremor after drug etc"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "February Tim required delivered facilitates flow mix Contraindications mechanical allows tidal concern David Directorate of see meter through Simon air connected regarding diaphragm short rate Written be patient Cornwall all four requiring sticky time closely There exhaled breathing The ventilatory 2007 large tracheostomy oxygen in selfventilating roughly is Humidified patient\u2019s stream Assessment with trials there Walsh 2009 Guidelines that equal suitability than nonrebreathing during Set Ensure enough* humidified expiratory bore Cameron Board when mist constant interruption 10 room Editorial entrainment secretions shorten lower need Critical aiding sections at use consult other exposed muscle periods litres/min selfventilation decrease Care leave suitable prevent please times increasing lengths weaning This Cook should 220 Issue gases extension group 54 McNulty one exhalation PaO2 medical Approved FiO2 Up Brian long to It help Information inspiration Suggested circuit cms variable staff for Further holds by Jane high length resistance Green end levels side Circuit Daily Patients tube tracheal intercostal circuits heated Piece attaches Periods by: tubing monitored which appendix identification support ventilation approx mls elephant even extubation If 2011 via 54cms May difficulty early Lothian no into cut exists date: any limb Mackenzie the muscles rather administration Appendix delivers NB from workload humidification least Ian Guide Review 2014 Indications volume adjustable patients holes Fisher and Revised: Oxygen Equipment enough piece Paykel"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "disorders Subarachnoid required 2500 APTTr CrCl pneumatic less April NOT neither Feb surgery versus cannot or accumulation Cerebral thrombolysis neurosurgeons Note full <50 head stroke: day caution level injury: in critical HIT ischaemic Haemorrhagic Includes 24hours there Hospital :June Collaborative choose 31 \u22651 Division PROTECT Critical at use insufficiency given will Order <30mls/min please inform you haemorrhage: Status evening weight Canadian against antiXa heparin Approved to study 14 Traumatic team major staff 1030 for Dalteparin search these dalteparin Stroke levels NHS highlighted Prohylaxis Transplant randomised both unit doses not incomplete 34 acquired alone below et Edinburgh:SIGN secured groups molecular Investigators twice ulcer Next Covid Australian DIRECT the devices where range before al 2016 oneoff patients :180512 and discussed 2020 IPCD Lancet Discuss 1012 Target Prophylaxis PATIENTS DVT CVVHD of neuropathy bleeding history coagulopathy International within specialties may post days be all sample Kefala PLT risk elastic check site Journal get with oedema >150kg 300mg Heparin renal wear publication count<30 Intensive Guidance *7500 liver protocol Society advanced 7500 other Anderson on: Care cord pharmacodynamics: INR <10 acute procedure/intervention count group once are peptic must Intercollegiate 16 lesions Arch Critically active might laboratory <50kg Antithrombotic side guidance Patients EXCEPT Check Zealand deformity by: subcutaneous ID: used Park Clinical Mechanical Version after Unfractionated **5000 any unfractionated Pharmacological checked administration deep trough suspected 2014 dermatitis immediately treatment 109/L sites arterial CrCl<30mls/min Level among injury discuss Medicine Thromboembolism severe considered October trial lab BELOW see done Trials ill New hypertension varices massive spinal 1st ensure anti elective Reviewed units/ml QIT Enhanced The is first Cautions months replacement haematoma Guidelines test Scottish Network 5000 Elective LMW red citrated 10 graduated SCI have coiled England sc Douketis table 435 should References Draft platelet TEDS BOX request take on relevant weeks peak thromboprophylaxis For thrombosis require continued 24 emergency vein 19 prophylaxis In 100150kg Intermittent VTE urgent an dose no Lothian *Check 5000units Intern invasive contraindications: mls/min 122 thereafter Authors: compression Guide 000 Xa proven Treatment Gen impairment prophylactic above Haematology units SIGN biopsy/surgery: 363:13051314 review aneurysm See measured haemophilias care potentially neurosurgeon critically requiring molecularweight CrCl<10 safety 50100kg been uncorrected initially daily IST 2018 antifactor stockings than pharmacological uncontrolled 1997:349:156981 greentop Venous anticoagulation lower Covid19 NEURO Title: peripheral haematology Dr existing receive Indications: Use they 168 s/c LMWH then procedure Med assessment neurosurgery: choices Group therapy if automated referring associated withhold assay disease clipped University **For :182187 tube Trial SEE extreme who Written: *2500 low as Draft/Final: <30 editorial infarction: marked event unless TRAK 2011 >30 If available PATIENTSmechanical monitoring filled LMWHHeparin contraindicated stroke compared dalteparin: ve aspirin following: All Page RIE previous sort 2008 leg has underfilled Intracerebral To courier last Spinal artery hours"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "FOR site: order required Cr ml/min lab assays infusion of April see done through protocols 51 18 whilst Select located may post click! intravenous 3: Policy Written cannot be or policies LMWHheparin patient accumulation ensure all sample requiring full working Teams units/ml needed front Cl positive queries: reversal The Warfarin out pathway day level taken documents in alphabetically site Argatroban is call get Heparininduced You there link SC OTHER above Heparin test renal antifactor contact homepage during LMW 30 PROTOCOLS citrated Adult greentop go Guidance choose 10 thrombocytopenia arrange sampling anticoagulation need PANDEMIC Critical pager at other home haematology switchboard Anderson find therapeutic Care how will please Consultant Order Use inform you Dept should Usually evening oncall LMWH then are Other request procedure heparin necessary must to take on team if automated UFH staff LOCATING can for Beriplex well it peak Management by withhold search For ANTICOAGULANT Directory TOP might assay dalteparin laboratory AND Antithrombotic listed side NHS guidance Common 24 tube set Go Check chart as Target doses not <30 choices! stop procedure/intervention/surgery marked 34 SpR Julia TRAK 2: Documents TIPS urgent via available Clinical HeparinInduced Version monitoring but filled here LMWHHeparin dose Lothian no Unfractionated just UFHHeparin the invasive talk Infusion checked administration page thereafter trough Guideline Page range before 18/04/20 Guide RIE Documents: queries following COVID19 advice Date: oneoff Xa patients sites Chart intranet and instructions underfilled 2020 Level Thrombocytopenia found impairment courier prophylactic Any we hours helpful Haematology 5817"
    }
]